{ "title": "UK BUSINESS AI UNIVERSE: Start-ups: Health", "built": "2026-10-31 17:13 UTC", "last_checked": "2026-10-29", "checked_range": [ "2026-10-29", "2026-10-29" ], "as_of": "2026-10-29", "buckets": [ { "key": "co", "label": "Companies", "color": "#d1495b", "count": 146 }, { "key": "inv", "label": "Investors and funds", "color": "#2e86de", "count": 0 }, { "key": "deal", "label": "Deals", "color": "#10ac84", "count": 0 }, { "key": "prog", "label": "Schemes, programmes and AI lines", "color": "#f39c12", "count": 0 }, { "key": "site", "label": "Data centres and compute sites", "color": "#8e44ad", "count": 0 }, { "key": "org", "label": "Networks, bodies, events and media", "color": "#34495e", "count": 0 }, { "key": "part", "label": "Partnerships and contracts", "color": "#e67e22", "count": 0 }, { "key": "prod", "label": "Chips, models and products", "color": "#e84393", "count": 0 }, { "key": "person", "label": "People", "color": "#9bbf00", "count": 0 } ], "divisions": [ { "key": "health", "label": "Health", "count": 146, "depts": [ { "dept": "Health", "count": 39 }, { "dept": "drug discovery", "count": 21 }, { "dept": "health", "count": 19 }, { "dept": "medical imaging", "count": 6 }, { "dept": "surgery", "count": 3 }, { "dept": "mental health", "count": 3 }, { "dept": "home care", "count": 2 }, { "dept": "dermatology", "count": 2 }, { "dept": "cardiology", "count": 2 }, { "dept": "medical devices", "count": 2 }, { "dept": "health data", "count": 2 }, { "dept": "digital pathology", "count": 2 }, { "dept": "health administration", "count": 2 }, { "dept": "diagnostics", "count": 2 }, { "dept": "ophthalmology", "count": 2 }, { "dept": "social care", "count": 2 }, { "dept": "radiology", "count": 1 }, { "dept": "rare disease", "count": 1 }, { "dept": "oncology", "count": 1 }, { "dept": "pathology", "count": 1 }, { "dept": "diabetes", "count": 1 }, { "dept": "respiratory disease", "count": 1 }, { "dept": "liver disease", "count": 1 }, { "dept": "digital primary care", "count": 1 }, { "dept": "respiratory diagnostics", "count": 1 }, { "dept": "physiotherapy", "count": 1 }, { "dept": "health workforce", "count": 1 }, { "dept": "medical device regulation", "count": 1 }, { "dept": "respiratory care", "count": 1 }, { "dept": "AI deployment and monitoring in hospitals", "count": 1 }, { "dept": "clinical decision support", "count": 1 }, { "dept": "ambient voice", "count": 1 }, { "dept": "hospital operations", "count": 1 }, { "dept": "population health", "count": 1 }, { "dept": "consumer health", "count": 1 }, { "dept": "gene therapy", "count": 1 }, { "dept": "ultrasound", "count": 1 }, { "dept": "drug safety", "count": 1 }, { "dept": "musculoskeletal health", "count": 1 }, { "dept": "long-term conditions", "count": 1 }, { "dept": "brain injury", "count": 1 }, { "dept": "fertility", "count": 1 }, { "dept": "dentistry", "count": 1 }, { "dept": "primary care", "count": 1 }, { "dept": "clinical trials", "count": 1 }, { "dept": "eye health", "count": 1 }, { "dept": "remote patient monitoring", "count": 1 }, { "dept": "workplace wellbeing", "count": 1 }, { "dept": "digital health", "count": 1 }, { "dept": "healthcare training", "count": 1 }, { "dept": "bioinformatics", "count": 1 } ] } ], "colleges": [], "nodes": [ { "id": "BIZ-SAFE-017", "name": "Aival", "bucket": "co", "status": "active", "status_date": null, "status_detail": "Its two products are listed in the GOV.UK AI assurance techniques portfolio (opened 29 October 2026); no dated company evidence, registration or website could be opened in this session.", "one_line": "Provides software for hospitals to test, compare and monitor AI products, such as radiology AI, on their own data.", "description": "Aival has two GOV.UK assurance case studies: Aival Evaluate, which validates third-party AI products for performance, fairness, robustness and explainability on a customer's internal data, and Aival Monitor, which tracks how a deployed AI product performs over time. A Companies House search for \"Aival\" returned no matching company, so its legal name is unknown. Location and founders were not confirmed in this session. [Round 4, 30 Oct 2026] START-UPS: Software that lets clinical users independently validate commercial radiology AI products at their own sites; UKRI Accelerating trustworthy AI phase 2. [Round 4, 30 Oct 2026] assurance case studies: Two DSIT portfolio case studies (Aival Monitor; Aival Evaluate, both with Aival Analysis Lab)", "uk_status": "uk", "company": { "ch_number": null, "registered_office": null, "incorporated": null, "legal_form": null, "owner_or_acquirer": null, "headcount": null, "ch_number_clean": null, "companies_house_url": null, "ch_note": null }, "place": { "text": null, "postcode": null, "lat": null, "lng": null, "region": null }, "people": [], "money": [], "site": null, "product": null, "dsit_domains": [ "AI security and assurance" ], "sectors": [ "health AI evaluation" ], "confidence": "single_source", "checked": "2026-10-29", "as_of": "2026-10-29", "applied": null, "held": [], "same_as": null, "package1_id": "biz-aival", "type": "Companies", "category": "health AI evaluation", "function": "Provides software for hospitals to test, compare and monitor AI products, such as radiology AI, on their own data.", "affiliation": "Assurance", "sources": [ "https://www.gov.uk/ai-assurance-techniques", "https://find-and-update.company-information.service.gov.uk/search/companies?q=Aival+Limited", "https://www.ukri.org/news/19-million-to-accelerate-trustworthy-and-responsible-ai/" ], "source_quotes": [ { "url": "https://www.gov.uk/ai-assurance-techniques", "quotes": [ "Aival Evaluate, Aival Analysis Lab: Validating third-party AI by assessing performance, fairness, robustness and explainability on internal data" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/search/companies?q=Aival+Limited", "quotes": [ "AIVALUATE LIMITED\" \"16419152\" \"Incorporated on 30 April 2025", "AIVALUELAB LIMITED\" \"17156786\" (no \"AIVAL LIMITED\" listed)" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://www.ukri.org/news/19-million-to-accelerate-trustworthy-and-responsible-ai/", "quotes": [ "Accelerating trustworthy AI in radiology: scalable software for clinical users to independently validate commercial products at local sites" ], "accessed": "2026-10-30", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [ "AI security and assurance" ], "one_source": true, "confidence_raw": "single_source", "depts": [ { "dept": "health", "div": "health" } ], "div_label": "Health", "location": null, "status_group": "active", "ext_links": [], "label_links": [ { "kind": "funded_by", "name": "UKRI Technology Missions Fund (Accelerating trustworthy AI)" } ], "degree": 0, "related_ids": [], "cross_listed_from": "Assurance" }, { "id": "BIZ-SU-HLT-063", "name": "Cera", "bucket": "co", "status": "active", "status_date": "2026-10-31", "status_detail": "UKTN reported on 4 August 2022 that Cera raised US$320m (£263.6m) in equity and debt; Companies House shows Cera Care Limited active on 29 October 2026. Companies House shows CERA CARE LIMITED as Active (checked 31 Oct 2026).", "one_line": "London home-care company whose digital platform organises care at home and which says its AI predicts when patients' health will worsen.", "description": "Cera Care Limited, incorporated in November 2015 (first named Golden Era Club Ltd, renamed July 2018), provides home care, nursing and prescription deliveries through a digital platform. UKTN reported in August 2022 that Cera \"claims its AI tech can predict patient health deterioration before it occurs\", and that it had raised US$320m (£263.6m) in equity and debt from investors including Schroders Capital, Jane Street Capital, KairosHQ and Vanderbilt University. Dr Ben Maruthappu is founder and chief executive. Its head-office company is registered in Camden, London. No later funding page was opened.", "uk_status": "uk", "company": { "ch_number": "09874278", "registered_office": "Labs Hawley Lock Offices 029, 032, 033 & 34, 1 Water Lane, Camden, London, England, NW1 8NZ", "incorporated": "2015-11-16", "legal_form": "ltd", "owner_or_acquirer": null, "headcount": null, "ch_number_clean": "09874278", "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/09874278", "ch_note": null }, "place": { "text": "London (NW1 8NZ)", "postcode": "NW1 8NZ", "lat": 51.541973, "lng": -0.142187, "region": "England: London", "admin_district": "Camden", "geocoded": "postcodes.io" }, "people": [ { "name": "Dr Ben Maruthappu", "role": "Founder and CEO", "from": null, "source": "https://www.uktech.news/medtech/cera-health-tech-funding-20220804" } ], "money": [ { "kind": "funding_round", "amount": 320000000, "currency": "USD", "date": "2022-08-04", "detail": "equity and debt; Schroders Capital, Jane Street Capital, KairosHQ, Vanderbilt University", "raw": "funding_round: 320000000 USD 2022-08-04 — equity and debt; Schroders Capital, Jane Street Capital, KairosHQ, Vanderbilt University", "amount_gbp": 264222608, "fx_rate": 1.2111, "fx_source": "Bank of England daily spot rate (series XUDLUSS, XUDLERS), US$1.2111 per £ on 2022-08-04", "fx_date": "2022-08-04", "fx_note": "", "txt": "US$320m", "gbp_txt": "£264.2m" } ], "site": null, "product": null, "dsit_domains": [ "AI implementation", "Knowledge generation" ], "sectors": [ "home care", "social care", "nursing" ], "confidence": "single_source", "checked": "2026-10-29", "as_of": "2026-10-29", "applied": null, "held": [], "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "London home-care company whose digital platform organises care at home and which says its AI predicts when patients' health will worsen.", "affiliation": "Start-ups", "sources": [ "https://www.uktech.news/medtech/cera-health-tech-funding-20220804", "https://find-and-update.company-information.service.gov.uk/company/09874278" ], "source_quotes": [ { "url": "https://www.uktech.news/medtech/cera-health-tech-funding-20220804", "quotes": [ "raised $320m (£263.6m) in an equity and debt funding round", "Cera claims its AI tech can predict patient health deterioration before it occurs", "Cera founder and CEO Dr Ben Maruthappu MBE\" (dated 4 August 2022)" ], "accessed": "2026-10-29", "trade": true, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/09874278", "quotes": [ "CERA CARE LIMITED\" \"Active\" \"16 November 2015\" \"GOLDEN ERA CLUB LTD" ], "accessed": "2026-10-29", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [ "AI implementation", "Knowledge generation" ], "one_source": true, "confidence_raw": "single_source", "depts": [ { "dept": "home care", "div": "health" } ], "div_label": "Health", "location": "London (NW1 8NZ)", "status_group": "active", "ext_links": [ { "kind": "funded_by", "id": "BIZ-INV-061", "name": "Schroders Capital", "page": "investors", "href": "../../investors/#org=BIZ-INV-061", "page_label": "Investors" } ], "label_links": [ { "kind": "funded_by", "name": "Jane Street Capital" }, { "kind": "funded_by", "name": "KairosHQ" }, { "kind": "funded_by", "name": "Vanderbilt University" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-064", "name": "Perspectum", "bucket": "co", "status": "active", "status_date": "2026-10-31", "status_detail": "Closed US$36m (£30.4m) in the first part of a Series C led by Oppenheimer Holdings, reported 6 January 2023; Companies House shows Perspectum Ltd active on 29 October 2026. Companies House shows PERSPECTUM LTD as Active (checked 31 Oct 2026).", "one_line": "Oxford company whose software connects to MRI scanners and uses AI to help doctors diagnose disease from body scans.", "description": "Perspectum Ltd was incorporated in Oxford in September 2012 as Perspectum Diagnostics Ltd and took its current name in February 2020. UKTN describes it as providing \"body imagery software that connects to MRI machines\" which \"uses artificial intelligence (AI) to aid with diagnosis\". In June 2021 it was among winners of the second round of the NHS AI in Health and Care Award for First PLUS, which uses AI to measure the placenta in the first trimester. In January 2023 it closed US$36m (£30.4m) in the first part of a Series C led by Oppenheimer Holdings, with HealthQuest Capital, the Blue Venture Fund and British Patient Capital. Rajarshi Banerjee is chief executive. [Round 4, 30 Oct 2026] investor: Oxford Science Enterprises portfolio company", "uk_status": "uk", "company": { "ch_number": "08219473", "registered_office": "Gemini One John Smith Drive, Oxford Business Park South, Oxford, Oxfordshire, United Kingdom, OX4 2LL", "incorporated": "2012-09-18", "legal_form": "ltd", "owner_or_acquirer": null, "headcount": null, "ch_number_clean": "08219473", "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/08219473", "ch_note": null }, "place": { "text": "Oxford (OX4 2LL)", "postcode": "OX4 2LL", "lat": 51.729011, "lng": -1.206878, "region": "England: South East", "admin_district": "Oxford", "geocoded": "postcodes.io" }, "people": [ { "name": "Rajarshi Banerjee", "role": "CEO", "from": null, "source": "https://www.uktech.news/medtech/perspectum-funding-20230106" } ], "money": [ { "kind": "funding_round", "amount": 36000000, "currency": "USD", "date": "2023-01-06", "detail": "first round of Series C led by Oppenheimer Holdings; HealthQuest Capital, Blue Venture Fund, British Patient Capital", "raw": "funding_round: 36000000 USD 2023-01-06 — first round of Series C led by Oppenheimer Holdings; HealthQuest Capital, Blue Venture Fund, British Patient Capital", "amount_gbp": 29882958, "fx_rate": 1.2047, "fx_source": "Bank of England daily spot rate (series XUDLUSS, XUDLERS), US$1.2047 per £ on 2023-01-06", "fx_date": "2023-01-06", "fx_note": "", "txt": "US$36m", "gbp_txt": "£29.9m" } ], "site": null, "product": null, "dsit_domains": [ "Perceptual systems" ], "sectors": [ "medical imaging", "MRI", "diagnostics" ], "confidence": "verified", "checked": "2026-10-29", "as_of": "2026-10-29", "applied": null, "held": [], "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "Oxford company whose software connects to MRI scanners and uses AI to help doctors diagnose disease from body scans.", "affiliation": "Start-ups", "sources": [ "https://www.uktech.news/medtech/perspectum-funding-20230106", "https://www.gov.uk/government/news/36-million-boost-for-ai-technologies-to-revolutionise-nhs-care", "https://find-and-update.company-information.service.gov.uk/company/08219473", "https://www.oxfordscienceenterprises.com/portfolio/" ], "source_quotes": [ { "url": "https://www.uktech.news/medtech/perspectum-funding-20230106", "quotes": [ "closed $36m (£30.4m) in its first round of Series C funding", "Oxford headquartered Perspectum", "uses artificial intelligence (AI) to aid with diagnosis\" (dated 6 January 2023)" ], "accessed": "2026-10-29", "trade": true, "amendment": false }, { "url": "https://www.gov.uk/government/news/36-million-boost-for-ai-technologies-to-revolutionise-nhs-care", "quotes": [ "The First PLUS project uses AI (artificial intelligence) to analyse the size of the placenta during the first trimester\" (dated 16 June 2021)" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/08219473", "quotes": [ "PERSPECTUM LTD\" \"Active\" \"18 September 2012\" \"PERSPECTUM DIAGNOSTICS LTD" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://www.oxfordscienceenterprises.com/portfolio/", "quotes": [ "Imaging to detect diseases of vital organs earlier and manage them better" ], "accessed": "2026-10-30", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [ "Perceptual systems" ], "one_source": false, "confidence_raw": "verified", "depts": [ { "dept": "medical imaging", "div": "health" } ], "div_label": "Health", "location": "Oxford (OX4 2LL)", "status_group": "active", "ext_links": [ { "kind": "funded_by", "id": "BIZ-INV-003", "name": "British Patient Capital", "page": "investors", "href": "../../investors/#org=BIZ-INV-003", "page_label": "Investors" } ], "label_links": [ { "kind": "funded_by", "name": "Oppenheimer Holdings" }, { "kind": "funded_by", "name": "HealthQuest Capital" }, { "kind": "funded_by", "name": "Blue Venture Fund" }, { "kind": "supplies_government", "name": "Government: NHS AI in Health and Care Award (round 2, 2021)" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-065", "name": "Peptone", "bucket": "co", "status": "active", "status_date": "2026-10-31", "status_detail": "Raised a US$2.5m (about £1.84m) seed round led by Hoxton Ventures, reported 8 January 2021; Companies House shows Peptone Ltd active on 29 October 2026. No later page was opened. Companies House shows PEPTONE LTD as Active (checked 31 Oct 2026).", "one_line": "Protein-engineering software company that uses AI and physics-based computing to help design medicines.", "description": "Peptone Ltd was incorporated in April 2018. UKTN reported in January 2021 that it builds a \"Protein Engineering Operating System (PeOS)\" and \"uses Artificial Intelligence (AI) and quantum computing\" to make drug discovery faster. Its US$2.5m seed round was led by Hoxton Ventures, with Novartis's investment arm, Founders Factory and angel investors. Dr Kamil Tamiola is founder and chief executive. The article said it was building a supercomputing stack in Switzerland. Its registered office is in Mansfield, Nottinghamshire; the operating head office was not confirmed. [Labs Round 8, 31 Oct 2026] offices: Bellinzona (Switzerland); Mansfield (UK); San Francisco (USA) [Labs Round 8, 31 Oct 2026] Listed on Labs (Protein design): models the physics of disordered proteins with AI; PepTron-o structure model with NVIDIA (2025-06-12)", "uk_status": "uk", "company": { "ch_number": "11296080", "registered_office": "Cromwell House, 68, West Gate, Mansfield, Nottinghamshire, England, NG18 1RR", "incorporated": "6 April 2018", "legal_form": "ltd", "owner_or_acquirer": null, "headcount": null, "ch_number_clean": "11296080", "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/11296080", "ch_note": null, "ch_name": "PEPTONE LTD", "legal_name": "PEPTONE LTD", "status_registry": "Active", "sic_codes": [ "72110 R&D on biotechnology" ] }, "place": { "text": "null (registered office NG18 1RR)", "postcode": "NG18 1RR", "lat": 53.146328, "lng": -1.198982, "region": null, "admin_district": "Mansfield", "geocoded": "postcodes.io" }, "people": [ { "name": "Dr Kamil Tamiola", "role": "Founder and CEO", "from": null, "source": "https://www.uktech.news/news/uk-biotech-peptone-funding-for-faster-drug-discovery-20210108" } ], "money": [ { "kind": "funding_round", "amount": 2500000, "currency": "USD", "date": "2021-01-08", "detail": "seed led by Hoxton Ventures; Novartis investment arm, Founders Factory, angels", "raw": "funding_round: 2500000 USD 2021-01-08 — seed led by Hoxton Ventures; Novartis investment arm, Founders Factory, angels", "amount_gbp": 1839588, "fx_rate": 1.359, "fx_source": "Bank of England daily spot rate (series XUDLUSS, XUDLERS), US$1.359 per £ on 2021-01-08", "fx_date": "2021-01-08", "fx_note": "", "txt": "US$2.5m", "gbp_txt": "£1.8m" } ], "site": null, "product": null, "dsit_domains": [ "Knowledge generation", "AI development and training" ], "sectors": [ "drug discovery", "protein engineering" ], "confidence": "verified", "checked": "2026-10-29", "as_of": "2026-10-29", "applied": null, "held": [], "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "Protein-engineering software company that uses AI and physics-based computing to help design medicines.", "affiliation": "Start-ups", "sources": [ "https://www.uktech.news/news/uk-biotech-peptone-funding-for-faster-drug-discovery-20210108", "https://find-and-update.company-information.service.gov.uk/company/11296080", "https://find-and-update.company-information.service.gov.uk/company/11296080/officers", "https://peptone.io/" ], "source_quotes": [ { "url": "https://www.uktech.news/news/uk-biotech-peptone-funding-for-faster-drug-discovery-20210108", "quotes": [ "$2.5M (nearly £1.84M)", "uses Artificial Intelligence (AI) and quantum computing", "CEO and founder of Peptone\" (dated 8 January 2021)" ], "accessed": "2026-10-29", "trade": true, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/11296080", "quotes": [ "PEPTONE LTD\" \"Active\" \"6 April 2018\" \"Cromwell House, 68, West Gate, Mansfield" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/11296080/officers", "quotes": [ "TAMIOLA, Kamil, Dr\" Director appointed \"6 April 2018\" (active)", "KANJI, Hussein\" Director \"18 November 2020" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://peptone.io/", "quotes": [ "Peptone is building a Product Engine to generate small-molecule drug candidates against intrinsically disordered proteins." ], "accessed": "2026-10-30", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [ "Knowledge generation", "AI development and training" ], "one_source": false, "confidence_raw": "verified", "depts": [ { "dept": "drug discovery", "div": "health" } ], "div_label": "Health", "location": "null (registered office NG18 1RR)", "status_group": "active", "ext_links": [ { "kind": "funded_by", "id": "BIZ-INV-203", "name": "Hoxton Ventures", "page": "investors", "href": "../../investors/#org=BIZ-INV-203", "page_label": "Investors" }, { "kind": "funded_by", "id": "BIZ-TAL-190", "name": "Founders Factory", "page": "talent", "href": "../../talent/#org=BIZ-TAL-190", "page_label": "Talent" }, { "kind": "linked from: funds", "id": "BIZ-INV-203", "name": "Hoxton Ventures", "page": "investors", "href": "../../investors/#org=BIZ-INV-203", "page_label": "Investors" }, { "kind": "linked from: made_by", "id": "BIZ-LAB-12023", "name": "PepTron-o (Peptone)", "page": "labs", "href": "../../labs/#org=BIZ-LAB-12023", "page_label": "Labs" } ], "label_links": [ { "kind": "funded_by", "name": "Novartis (investment arm)" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-066", "name": "Skin Analytics", "bucket": "co", "status": "active", "status_date": "2026-10-31", "status_detail": "Named on 16 June 2021 among Phase 4 winners of the second round of the NHS AI in Health and Care Award for DERM; Companies House shows Skin Analytics Ltd active on 29 October 2026. Companies House shows SKIN ANALYTICS LTD as Active (checked 31 Oct 2026).", "one_line": "Makes DERM, AI software that analyses images of skin lesions to tell cancerous, pre-cancerous and harmless ones apart for the NHS.", "description": "Skin Analytics Ltd was incorporated in January 2012. Its product DERM analyses images of skin lesions. On 16 June 2021 the Department of Health and Social Care named it among Phase 4 winners of the NHS AI in Health and Care Award, for expanding trials of DERM in \"distinguishing between cancerous, pre-cancerous and benign lesions\". Its registered office is in Cambridge (an accountant's address); its operating office was not confirmed. No funding or people page was opened in this session. [Round 4, 30 Oct 2026] funding: Case study states a £15M Series B round [Round 4, 30 Oct 2026] recognition: British Data Awards AI Company of the Year 2025 [Round 4, 30 Oct 2026] regulatory: DERM approved by NICE for triage on urgent suspected skin cancer pathway", "uk_status": "uk", "company": { "ch_number": "07919560", "registered_office": "Pem, Salisbury House, 2-3 Salisbury Villas, Cambridge, England, CB1 2LA", "incorporated": "2012-01-23", "legal_form": "ltd", "owner_or_acquirer": null, "headcount": null, "ch_number_clean": "07919560", "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/07919560", "ch_note": null }, "place": { "text": "null (registered office CB1 2LA)", "postcode": "CB1 2LA", "lat": 52.194995, "lng": 0.134061, "region": null, "admin_district": "Cambridge", "geocoded": "postcodes.io" }, "people": [], "money": [], "site": null, "product": { "maker": "Skin Analytics", "launched": null, "what_it_does": "DERM, AI analysis of skin lesion images for skin cancer triage" }, "dsit_domains": [ "Perceptual systems" ], "sectors": [ "dermatology", "skin cancer", "diagnostics" ], "confidence": "verified", "checked": "2026-10-29", "as_of": "2026-10-29", "applied": null, "held": [], "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "Makes DERM, AI software that analyses images of skin lesions to tell cancerous, pre-cancerous and harmless ones apart for the NHS.", "affiliation": "Start-ups", "sources": [ "https://www.gov.uk/government/news/36-million-boost-for-ai-technologies-to-revolutionise-nhs-care", "https://find-and-update.company-information.service.gov.uk/company/07919560", "https://sbrihealthcare.co.uk/nhs-cancer-programme/case-studies/skin-analytics" ], "source_quotes": [ { "url": "https://www.gov.uk/government/news/36-million-boost-for-ai-technologies-to-revolutionise-nhs-care", "quotes": [ "Expanding trials of the use of AI (artificial intelligence) in the analysis of images of skin lesions", "distinguishing between cancerous, pre-cancerous and benign lesions\" (dated 16 June 2021)" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/07919560", "quotes": [ "SKIN ANALYTICS LTD\" \"Active\" \"23 January 2012" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://sbrihealthcare.co.uk/nhs-cancer-programme/case-studies/skin-analytics", "quotes": [ "Raised £15M series B investment round" ], "accessed": "2026-10-30", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [ "Perceptual systems" ], "one_source": false, "confidence_raw": "verified", "depts": [ { "dept": "dermatology", "div": "health" } ], "div_label": "Health", "location": "null (registered office CB1 2LA)", "status_group": "active", "ext_links": [], "label_links": [ { "kind": "supplies_government", "name": "Government: NHS AI in Health and Care Award (round 2, Phase 4, 2021)" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-067", "name": "Behold.ai", "bucket": "co", "status": "wound_down", "status_date": "2025-01-21", "status_detail": "A court order to wind up Behold.AI Technologies Limited was filed on 21 January 2025 and a liquidator appointed on 26 March 2025; the company was still in liquidation on 29 October 2026, with a progress report filed 26 May 2026.", "one_line": "Made AI that read chest X-rays to speed up diagnosis of suspected lung cancer; the company is now in compulsory liquidation.", "description": "Behold.AI Technologies Limited was incorporated in August 2017. On 16 June 2021 it was named among Phase 4 winners of the NHS AI in Health and Care Award for real-world testing of an AI algorithm on chest X-rays \"to fast-track the diagnosis of suspected lung cancer\". Companies House records a court winding-up order (filed 21 January 2025), appointment of a liquidator (filed 26 March 2025), a move of registered office to Brighton in April 2025 and a progress report in a winding up by the court (26 May 2026). The liquidator's name was not read, as the insolvency page would not open.", "uk_status": "uk", "company": { "ch_number": "10903206", "registered_office": "68 Ship Street, Brighton, East Sussex, BN1 1AE", "incorporated": "2017-08-07", "legal_form": "ltd", "owner_or_acquirer": null, "headcount": null, "ch_number_clean": "10903206", "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/10903206", "ch_note": null }, "place": { "text": null, "postcode": null, "lat": null, "lng": null, "region": null }, "people": [], "money": [], "site": null, "product": null, "dsit_domains": [ "Perceptual systems" ], "sectors": [ "radiology", "chest X-ray", "lung cancer" ], "confidence": "verified", "checked": "2026-10-29", "as_of": "2026-10-29", "applied": null, "held": [], "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "Made AI that read chest X-rays to speed up diagnosis of suspected lung cancer; the company is now in compulsory liquidation.", "affiliation": "Start-ups", "sources": [ "https://www.gov.uk/government/news/36-million-boost-for-ai-technologies-to-revolutionise-nhs-care", "https://find-and-update.company-information.service.gov.uk/company/10903206", "https://find-and-update.company-information.service.gov.uk/company/10903206/filing-history" ], "source_quotes": [ { "url": "https://www.gov.uk/government/news/36-million-boost-for-ai-technologies-to-revolutionise-nhs-care", "quotes": [ "Real-world testing of an AI (artificial intelligence) algorithm to fast-track the diagnosis of suspected lung cancer\" (dated 16 June 2021)" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/10903206", "quotes": [ "BEHOLD.AI TECHNOLOGIES LIMITED\" \"Liquidation\" \"7 August 2017" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/10903206/filing-history", "quotes": [ "Order of court\" to wind up (21 Jan 2025)", "Appointment of a liquidator\" (26 Mar 2025)", "Progress report in a winding up by the court\" (26 May 2026)" ], "accessed": "2026-10-29", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [ "Perceptual systems" ], "one_source": false, "confidence_raw": "verified", "depts": [ { "dept": "radiology", "div": "health" } ], "div_label": "Health", "location": null, "status_group": "wound_down", "ext_links": [], "label_links": [ { "kind": "supplies_government", "name": "Government: NHS AI in Health and Care Award (round 2, Phase 4, 2021)" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-068", "name": "Mendelian", "bucket": "co", "status": "active", "status_date": "2026-10-31", "status_detail": "Awarded £1,430,848 in the third round of the AI in Health and Care Awards, announced 3 March 2023; the only Companies House match, Mendelian Ltd, is active. Companies House shows MENDELIAN LTD as Active (checked 31 Oct 2026).", "one_line": "Digital health start-up whose software searches electronic health records for signs of rare diseases to help doctors reach a diagnosis.", "description": "On 3 March 2023 the government named Mendelian Limited among nine winners of nearly £16m in the third round of the AI in Health and Care Awards, with £1,430,848. GOV.UK describes it as a digital health start-up \"capturing disease features from electronic health records\" and matching patients against published diagnostic criteria for hundreds of rare diseases. The only Companies House match is Mendelian Ltd, incorporated April 2015, registered in New Malden, Surrey; the link between the two rests on the name only. No funding or people page was opened. [Round 4, 30 Oct 2026] programme: MendelScan NHS AI Award phase 3 winner", "uk_status": "uk", "company": { "ch_number": "09570139", "registered_office": "86 Burlington Road, New Malden, Surrey, England, KT3 4NT", "incorporated": "2015-04-30", "legal_form": "ltd", "owner_or_acquirer": null, "headcount": null, "ch_number_clean": "09570139", "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/09570139", "ch_note": null }, "place": { "text": null, "postcode": null, "lat": null, "lng": null, "region": null }, "people": [], "money": [ { "kind": "grant", "amount": 1430848, "currency": "GBP", "date": "2023-03-03", "detail": "AI in Health and Care Award, round 3", "raw": "grant: 1430848 GBP 2023-03-03 — AI in Health and Care Award, round 3", "amount_gbp": 1430848, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£1.4m", "gbp_txt": "" } ], "site": null, "product": null, "dsit_domains": [ "Knowledge generation", "Natural language applications" ], "sectors": [ "rare disease", "diagnosis", "health records" ], "confidence": "verified", "checked": "2026-10-29", "as_of": "2026-10-29", "applied": null, "held": [], "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "Digital health start-up whose software searches electronic health records for signs of rare diseases to help doctors reach a diagnosis.", "affiliation": "Start-ups", "sources": [ "https://www.gov.uk/government/news/thousands-of-patients-to-benefit-from-quicker-diagnosis-more-accurate-tests-from-ground-breaking-ai-research", "https://find-and-update.company-information.service.gov.uk/company/09570139", "https://find-and-update.company-information.service.gov.uk/company/09570139", "https://transform.england.nhs.uk/ai-lab/ai-lab-programmes/ai-health-and-care-award/ai-health-and-care-award-winners" ], "source_quotes": [ { "url": "https://www.gov.uk/government/news/thousands-of-patients-to-benefit-from-quicker-diagnosis-more-accurate-tests-from-ground-breaking-ai-research", "quotes": [ "Mendelian Limited (£1,430,848)", "capturing disease features from electronic health records\" (dated 3 March 2023)" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/09570139", "quotes": [ "MENDELIAN LTD\" \"Active\" \"30 April 2015" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/09570139", "quotes": [ "MENDELIAN LTD", "Active", "30 April 2015", "62020 - Information technology consultancy activities" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://transform.england.nhs.uk/ai-lab/ai-lab-programmes/ai-health-and-care-award/ai-health-and-care-award-winners", "quotes": [ "MendelScan uses AI to diagnose rare diseases" ], "accessed": "2026-10-30", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [ "Knowledge generation", "Natural language applications" ], "one_source": false, "confidence_raw": "verified", "depts": [ { "dept": "rare disease", "div": "health" } ], "div_label": "Health", "location": null, "status_group": "active", "ext_links": [], "label_links": [ { "kind": "supplies_government", "name": "Government: NHS AI in Health and Care Award (round 3, 2023)" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-069", "name": "Oxford Cancer Biomarkers", "bucket": "co", "status": "active", "status_date": "2026-10-31", "status_detail": "Awarded £1,475,357 in the third round of the AI in Health and Care Awards, announced 3 March 2023; no later page opened. Companies House shows OXFORD CANCER BIOMARKERS LIMITED as Active (checked 31 Oct 2026).", "one_line": "Uses AI to find biomarkers that help doctors personalise care for people with bowel (colorectal) cancer.", "description": "On 3 March 2023 the government named Oxford Cancer Biomarkers Limited among winners of the third round of the AI in Health and Care Awards, with £1,475,357. GOV.UK says it uses AI \"to identify biomarkers\" that may signal predisposition to disease, to help clinicians personalise care for patients with colorectal cancer. Companies House and university spin-out status were not checked (fetch limit reached). [Round 4, 30 Oct 2026] programme: OncoProg NHS AI Award phase 3 winner", "uk_status": "uk", "company": { "ch_number": "SC379069", "registered_office": null, "incorporated": null, "legal_form": "ltd", "owner_or_acquirer": null, "headcount": null, "ch_number_clean": "SC379069", "from_round2": true, "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/SC379069", "ch_note": null }, "place": { "text": null, "postcode": "PA13 4AE", "lat": 55.894043, "lng": -4.626818, "region": null, "admin_district": "Inverclyde", "geocoded": "postcodes.io" }, "people": [], "money": [ { "kind": "grant", "amount": 1475357, "currency": "GBP", "date": "2023-03-03", "detail": "AI in Health and Care Award, round 3", "raw": "grant: 1475357 GBP 2023-03-03 — AI in Health and Care Award, round 3", "amount_gbp": 1475357, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£1.5m", "gbp_txt": "" } ], "site": null, "product": null, "dsit_domains": [ "Knowledge generation" ], "sectors": [ "oncology", "colorectal cancer", "biomarkers" ], "confidence": "verified", "checked": "2026-10-29", "as_of": "2026-10-29", "applied": [ { "from": "Companies House check, 29 Oct 2026", "field": "company.ch_number", "text": "company.ch_number → SC379069 (a Scottish-registered company)" } ], "held": [], "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "Uses AI to find biomarkers that help doctors personalise care for people with bowel (colorectal) cancer.", "affiliation": "Start-ups", "sources": [ "https://www.gov.uk/government/news/thousands-of-patients-to-benefit-from-quicker-diagnosis-more-accurate-tests-from-ground-breaking-ai-research", "https://find-and-update.company-information.service.gov.uk/company/SC379069", "https://transform.england.nhs.uk/ai-lab/ai-lab-programmes/ai-health-and-care-award/ai-health-and-care-award-winners" ], "source_quotes": [ { "url": "https://www.gov.uk/government/news/thousands-of-patients-to-benefit-from-quicker-diagnosis-more-accurate-tests-from-ground-breaking-ai-research", "quotes": [ "Oxford Cancer Biomarkers Limited (£1,475,357)", "uses AI \"to identify biomarkers\" (dated 3 March 2023)" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/SC379069", "quotes": [ "OXFORD CANCER BIOMARKERS LIMITED", "C/O Douglas Mcdonald Ca, 2 Octavia Buildings, Kilmacolm, PA13 4AE", "Active", "24 May 2010", "86900 - Other human health activities" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://transform.england.nhs.uk/ai-lab/ai-lab-programmes/ai-health-and-care-award/ai-health-and-care-award-winners", "quotes": [ "OncoProg uses AI to help identify people who will benefit from chemotherapy" ], "accessed": "2026-10-30", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [ "Knowledge generation" ], "one_source": false, "confidence_raw": "verified", "depts": [ { "dept": "oncology", "div": "health" } ], "div_label": "Health", "location": null, "status_group": "active", "ext_links": [], "label_links": [ { "kind": "supplies_government", "name": "Government: NHS AI in Health and Care Award (round 3, 2023)" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-070", "name": "Caristo Diagnostics", "bucket": "co", "status": "active", "status_date": "2026-10-31", "status_detail": "Named on 16 June 2021 among Phase 3 winners of the NHS AI in Health and Care Award for CaRi-HEART; no later page opened. Companies House shows CARISTO DIAGNOSTICS LIMITED as Active (checked 31 Oct 2026).", "one_line": "Makes CaRi-HEART, which uses AI on heart scans to detect inflammation linked to heart attack risk.", "description": "Caristo Diagnostics Ltd was named on 16 June 2021 among Phase 3 winners in the second round of the NHS AI in Health and Care Award for CaRi-HEART, which uses AI \"to detect the invisible signatures of inflammation in the heart\". Its Companies House record, head office and any university origin were not checked in this session (fetch limit reached). [Round 4, 30 Oct 2026] investor: Oxford Science Enterprises portfolio company", "uk_status": "uk", "company": { "ch_number": "11429590", "registered_office": null, "incorporated": null, "legal_form": "ltd", "owner_or_acquirer": null, "headcount": null, "ch_number_clean": "11429590", "from_round2": true, "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/11429590", "ch_note": null }, "place": { "text": "Oxford (OX2 0HP)", "postcode": "OX2 0HP", "lat": 51.753694, "lng": -1.288661, "region": "England: South East", "admin_district": "Oxford", "geocoded": "postcodes.io" }, "people": [], "money": [], "site": null, "product": { "maker": "Caristo Diagnostics", "launched": null, "what_it_does": "CaRi-HEART, AI analysis of heart scans for inflammation" }, "dsit_domains": [ "Perceptual systems" ], "sectors": [ "cardiology", "medical imaging" ], "confidence": "verified", "checked": "2026-10-29", "as_of": "2026-10-29", "applied": [ { "from": "Companies House check, 29 Oct 2026", "field": "place", "text": "place → Oxford (registered office, OX2 0HP) — region: England: South East (record had null)" } ], "held": [], "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "Makes CaRi-HEART, which uses AI on heart scans to detect inflammation linked to heart attack risk.", "affiliation": "Start-ups", "sources": [ "https://www.gov.uk/government/news/36-million-boost-for-ai-technologies-to-revolutionise-nhs-care", "https://find-and-update.company-information.service.gov.uk/company/11429590", "https://www.oxfordscienceenterprises.com/portfolio/" ], "source_quotes": [ { "url": "https://www.gov.uk/government/news/36-million-boost-for-ai-technologies-to-revolutionise-nhs-care", "quotes": [ "Using AI (artificial intelligence) to detect the invisible signatures of inflammation in the heart\" (Caristo Diagnostics Ltd, CaRi-HEART; dated 16 June 2021)" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/11429590", "quotes": [ "CARISTO DIAGNOSTICS LIMITED\" \"New Barclay House, 234 Botley Road, Oxford, United Kingdom, OX2 0HP\" \"Active\" \"22 June 2018\" \"CARISTO TECHNOLOGIES LIMITED" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://www.oxfordscienceenterprises.com/portfolio/", "quotes": [ "Revealing hidden heart risk before it's too late" ], "accessed": "2026-10-30", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [ "Perceptual systems" ], "one_source": false, "confidence_raw": "verified", "depts": [ { "dept": "cardiology", "div": "health" } ], "div_label": "Health", "location": "Oxford (OX2 0HP)", "status_group": "active", "ext_links": [], "label_links": [ { "kind": "supplies_government", "name": "Government: NHS AI in Health and Care Award (round 2, Phase 3, 2021)" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-071", "name": "Sonrai Analytics", "bucket": "co", "status": "active", "status_date": "2026-10-31", "status_detail": "Named on 16 June 2021 among Phase 2 winners of the NHS AI in Health and Care Award for ImageDx; no later page opened. Companies House shows SONRAI ANALYTICS LTD as Active (checked 31 Oct 2026).", "one_line": "Makes ImageDx, AI software for faster and more accurate testing of cancer biopsy tissue.", "description": "Sonrai Analytics Ltd was named on 16 June 2021 among Phase 2 winners of the second round of the NHS AI in Health and Care Award for ImageDx, described as \"A centralised, AI (artificial intelligence)-based solution for faster and more accurate testing on cancer biopsy tissue\". Its Companies House record and head office were not checked in this session.", "uk_status": "uk", "company": { "ch_number": "NI650803", "registered_office": null, "incorporated": null, "legal_form": "ltd", "owner_or_acquirer": null, "headcount": null, "ch_number_clean": "NI650803", "from_round2": true, "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/NI650803", "ch_note": null }, "place": { "text": "Belfast (BT3 9DT)", "postcode": "BT3 9DT", "lat": 54.613619, "lng": -5.898562, "region": "Northern Ireland", "admin_district": "Belfast", "geocoded": "postcodes.io" }, "people": [], "money": [], "site": null, "product": { "maker": "Sonrai Analytics", "launched": null, "what_it_does": "ImageDx, AI-based testing of cancer biopsy tissue" }, "dsit_domains": [ "Perceptual systems" ], "sectors": [ "pathology", "oncology" ], "confidence": "verified", "checked": "2026-10-29", "as_of": "2026-10-29", "applied": [ { "from": "Companies House check, 29 Oct 2026", "field": "place", "text": "place → Belfast (BT3 9DT) — region: Northern Ireland (was null)" } ], "held": [], "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "Makes ImageDx, AI software for faster and more accurate testing of cancer biopsy tissue.", "affiliation": "Start-ups", "sources": [ "https://www.gov.uk/government/news/36-million-boost-for-ai-technologies-to-revolutionise-nhs-care", "https://find-and-update.company-information.service.gov.uk/search/companies?q=sonrai", "https://alumni.qub.ac.uk/pmc-and-sonrai-analytics-to-deliver-nhs-ai-cancer-screenings-", "https://find-and-update.company-information.service.gov.uk/company/NI650803" ], "source_quotes": [ { "url": "https://www.gov.uk/government/news/36-million-boost-for-ai-technologies-to-revolutionise-nhs-care", "quotes": [ "A centralised, AI (artificial intelligence)-based solution for faster and more accurate testing on cancer biopsy tissue\" (dated 16 June 2021)" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/search/companies?q=sonrai", "quotes": [ "SONRAI ANALYTICS LTD", "NI650803", "Incorporated on 6 February 2018", "Concourse Building 2 Unit 2, Suite 1, Queens Road, Belfast, Northern Ireland, BT3 9DT" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://alumni.qub.ac.uk/pmc-and-sonrai-analytics-to-deliver-nhs-ai-cancer-screenings-", "quotes": [ "Queen's Precision Medicine Centre and University spin-out company Sonrai Analytics to deliver NHS AI cancer screenings\" (page last modified 18 June 2021)" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/NI650803", "quotes": [ "SONRAI ANALYTICS LTD | Company number NI650803 | Active" ], "accessed": "2026-10-31", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [ "Perceptual systems" ], "one_source": false, "confidence_raw": "verified", "depts": [ { "dept": "pathology", "div": "health" } ], "div_label": "Health", "location": "Belfast (BT3 9DT)", "status_group": "active", "ext_links": [ { "kind": "spun_out_of", "id": "UNI:queens/QUBAI-030", "name": "Universities: queens/QUBAI-030", "page": "universities", "href": "https://hazy-wreath-hez6.here.now/queens/", "page_label": "UK Universities AI Universe (new tab)" } ], "label_links": [ { "kind": "supplies_government", "name": "Government: NHS AI in Health and Care Award (round 2, Phase 2, 2021)" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-072", "name": "MyWay Digital Health", "bucket": "co", "status": "active", "status_date": "2021-06-16", "status_detail": "Named on 16 June 2021 among Phase 2 winners of the NHS AI in Health and Care Award for MyDiabetes IQ; no later page opened.", "one_line": "Scottish digital health company testing an AI tool that predicts diabetes complications and helps choose treatment.", "description": "MyWay Digital Health was founded in 2017 by Debbie Wake and Scott Cunningham, according to a UKTN list of Edinburgh AI companies (February 2021), which says it works on \"data-driven and cost-effective digital solutions\" for chronic disease. On 16 June 2021 it was named among Phase 2 winners of the NHS AI in Health and Care Award for MyDiabetes IQ, an AI tool \"for predicting diabetes complications and treatment\" choices. Whether it is a University of Dundee spin-out was not confirmed on a page opened; Companies House was not checked.", "uk_status": "uk", "company": { "ch_number": null, "registered_office": null, "incorporated": null, "legal_form": "ltd", "owner_or_acquirer": null, "headcount": null, "ch_number_clean": null, "companies_house_url": null, "ch_note": null }, "place": { "text": null, "postcode": null, "lat": null, "lng": null, "region": "Scotland" }, "people": [ { "name": "Debbie Wake", "role": "Co-founder", "from": "2017", "source": "https://www.uktech.news/news/edinburgh-ai-companies-ready-to-slay-in-2021-20210226" }, { "name": "Scott Cunningham", "role": "Co-founder", "from": "2017", "source": "https://www.uktech.news/news/edinburgh-ai-companies-ready-to-slay-in-2021-20210226" } ], "money": [], "site": null, "product": { "maker": "MyWay Digital Health", "launched": null, "what_it_does": "MyDiabetes IQ, AI prediction of diabetes complications and treatment choices" }, "dsit_domains": [ "Knowledge generation", "AI implementation" ], "sectors": [ "diabetes", "chronic disease" ], "confidence": "verified", "checked": "2026-10-29", "as_of": "2026-10-29", "applied": null, "held": [], "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "Scottish digital health company testing an AI tool that predicts diabetes complications and helps choose treatment.", "affiliation": "Start-ups", "sources": [ "https://www.gov.uk/government/news/36-million-boost-for-ai-technologies-to-revolutionise-nhs-care", "https://www.uktech.news/news/edinburgh-ai-companies-ready-to-slay-in-2021-20210226" ], "source_quotes": [ { "url": "https://www.gov.uk/government/news/36-million-boost-for-ai-technologies-to-revolutionise-nhs-care", "quotes": [ "MyWay Digital health is testing an AI (artificial intelligence) tool for predicting diabetes complications and treatment\" (dated 16 June 2021)" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://www.uktech.news/news/edinburgh-ai-companies-ready-to-slay-in-2021-20210226", "quotes": [ "intends to transform chronic disease outcomes all over the world with data-driven and cost-effective digital solutions\" (founders Debbie Wake, Scott Cunningham; founded 2017)" ], "accessed": "2026-10-29", "trade": true, "amendment": false } ], "website": [], "colleges": [], "topics": [ "Knowledge generation", "AI implementation" ], "one_source": false, "confidence_raw": "verified", "depts": [ { "dept": "diabetes", "div": "health" } ], "div_label": "Health", "location": null, "status_group": "active", "ext_links": [], "label_links": [ { "kind": "supplies_government", "name": "Government: NHS AI in Health and Care Award (round 2, Phase 2, 2021)" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-073", "name": "Storm ID", "bucket": "co", "status": "active", "status_date": "2026-10-31", "status_detail": "Named on 16 June 2021 among Phase 3 winners of the NHS AI in Health and Care Award for the Lenus COPD Management Service; no later page opened. Companies House shows STORM (ID) LTD. as Active (checked 31 Oct 2026).", "one_line": "Runs Lenus, a service using AI on patients' daily monitoring and wearable data to help people with COPD manage their lung condition.", "description": "Storm ID Ltd was named on 16 June 2021 among Phase 3 winners of the second round of the NHS AI in Health and Care Award for the Lenus COPD Management Service, which introduces prevention and self-management for people with COPD \"using AI (artificial intelligence)\" to analyse output from daily monitoring and wearable devices. Its Companies House record and head office were not checked in this session; whether health is its main business was not confirmed.", "uk_status": "uk", "company": { "ch_number": "SC216070", "registered_office": null, "incorporated": null, "legal_form": "ltd", "owner_or_acquirer": null, "headcount": null, "ch_number_clean": "SC216070", "from_round2": true, "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/SC216070", "ch_note": null }, "place": { "text": "Edinburgh (EH6 7BG)", "postcode": "EH6 7BG", "lat": 55.97483, "lng": -3.166772, "region": "Scotland", "admin_district": "City of Edinburgh", "geocoded": "postcodes.io" }, "people": [], "money": [], "site": null, "product": { "maker": "Storm ID", "launched": null, "what_it_does": "Lenus COPD Management Service, AI on remote monitoring data for COPD patients" }, "dsit_domains": [ "AI implementation" ], "sectors": [ "respiratory disease", "remote monitoring" ], "confidence": "single_source", "checked": "2026-10-29", "as_of": "2026-10-29", "applied": [ { "from": "Companies House check, 29 Oct 2026", "field": "place", "text": "place → Edinburgh (EH6 7BG) — region: Scotland (was null), subject to the check above" } ], "held": [], "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "Runs Lenus, a service using AI on patients' daily monitoring and wearable data to help people with COPD manage their lung condition.", "affiliation": "Start-ups", "sources": [ "https://www.gov.uk/government/news/36-million-boost-for-ai-technologies-to-revolutionise-nhs-care", "https://find-and-update.company-information.service.gov.uk/search/companies?q=Storm+ID+Limited", "https://find-and-update.company-information.service.gov.uk/company/SC216070" ], "source_quotes": [ { "url": "https://www.gov.uk/government/news/36-million-boost-for-ai-technologies-to-revolutionise-nhs-care", "quotes": [ "Introducing prevention and self-management to people with COPD lung disorder, using AI (artificial intelligence)", "analyse output from patients’ daily monitoring and wearable devices\" (dated 16 June 2021)" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/search/companies?q=Storm+ID+Limited", "quotes": [ "STORM (ID) LTD.\" \"SC216070\" \"Incorporated on 22 February 2001\" \"Leith Assembly Rooms, 43 Constitution Street, Edinburgh, EH6 7BG" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/SC216070", "quotes": [ "STORM (ID) LTD. | Company number SC216070 | Active" ], "accessed": "2026-10-31", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [ "AI implementation" ], "one_source": true, "confidence_raw": "single_source", "depts": [ { "dept": "respiratory disease", "div": "health" } ], "div_label": "Health", "location": "Edinburgh (EH6 7BG)", "status_group": "active", "ext_links": [], "label_links": [ { "kind": "supplies_government", "name": "Government: NHS AI in Health and Care Award (round 2, Phase 3, 2021)" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-074", "name": "CyberLiver", "bucket": "co", "status": "active", "status_date": "2026-10-31", "status_detail": "Named on 16 June 2021 among Phase 1 winners of the NHS AI in Health and Care Award for CirrhoCare; no later page opened. Companies House shows CYBERLIVER LIMITED as Active (checked 31 Oct 2026).", "one_line": "Developing CirrhoCare, which proposes using AI to examine outcomes for patients with liver cirrhosis.", "description": "Cyberliver Ltd was named on 16 June 2021 among Phase 1 winners of the second round of the NHS AI in Health and Care Award. GOV.UK says \"CyberLiver proposes using AI (artificial intelligence) to examine the outcomes for patients with cirrhosis\" through its CirrhoCare project. Companies House, head office and people were not checked in this session. [Round 4, 30 Oct 2026] person: Anu Balaji, Head of Product (NHS Innovation Accelerator fellow)", "uk_status": "uk", "company": { "ch_number": "08052630", "registered_office": null, "incorporated": null, "legal_form": "ltd", "owner_or_acquirer": null, "headcount": null, "ch_number_clean": "08052630", "from_round2": true, "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/08052630", "ch_note": null }, "place": { "text": null, "postcode": "HA7 1JS", "lat": 51.603468, "lng": -0.297254, "region": null, "admin_district": "Harrow", "geocoded": "postcodes.io" }, "people": [ { "name": "Anu Balaji", "role": "Head of Product; NIA Fellow", "from": null, "source": "https://nhsaccelerator.com/about-the-nia-programme/fellows/", "round4": true } ], "money": [], "site": null, "product": null, "dsit_domains": [ "AI implementation" ], "sectors": [ "liver disease", "remote monitoring" ], "confidence": "verified", "checked": "2026-10-29", "as_of": "2026-10-29", "applied": null, "held": [], "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "Developing CirrhoCare, which proposes using AI to examine outcomes for patients with liver cirrhosis.", "affiliation": "Start-ups", "sources": [ "https://www.gov.uk/government/news/36-million-boost-for-ai-technologies-to-revolutionise-nhs-care", "https://find-and-update.company-information.service.gov.uk/company/08052630", "https://nhsaccelerator.com/about-the-nia-programme/fellows/" ], "source_quotes": [ { "url": "https://www.gov.uk/government/news/36-million-boost-for-ai-technologies-to-revolutionise-nhs-care", "quotes": [ "CyberLiver proposes using AI (artificial intelligence) to examine the outcomes for patients with cirrhosis\" (dated 16 June 2021)" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/08052630", "quotes": [ "CYBERLIVER LIMITED\" \"Burnells Devonshire House, 582 Honeypot Lane, Stanmore, Middlesex", "HA7 1JS\" \"Active\" \"1 May 2012" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://nhsaccelerator.com/about-the-nia-programme/fellows/", "quotes": [ "Head of Product, CyberLiver" ], "accessed": "2026-10-30", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [ "AI implementation" ], "one_source": false, "confidence_raw": "verified", "depts": [ { "dept": "liver disease", "div": "health" } ], "div_label": "Health", "location": null, "status_group": "active", "ext_links": [], "label_links": [ { "kind": "supplies_government", "name": "Government: NHS AI in Health and Care Award (round 2, Phase 1, 2021)" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-075", "name": "BioLiberty", "bucket": "co", "status": "active", "status_date": "2026-10-31", "status_detail": "Listed by UKTN on 26 February 2021 among Edinburgh AI start-ups; no later page opened, so its status on 29 October 2026 is unconfirmed. Companies House shows BIOLIBERTY LTD as Active (checked 31 Oct 2026).", "one_line": "Edinburgh health start-up that designed an AI-powered robotic glove to strengthen the grip of people with weak hands.", "description": "BioLiberty was founded in 2020 by Shea Quinn, Rowan Armstrong and Ross O'Hanlon, according to a UKTN list of Edinburgh AI start-ups published in February 2021. UKTN says it \"bridges the gap between hand weakness and independent living\" and \"has designed an AI-powered robotic glove that strengthens the user's grip\". Companies House and current status were not checked.", "uk_status": "uk", "company": { "ch_number": "SC663888", "registered_office": null, "incorporated": null, "legal_form": null, "owner_or_acquirer": null, "headcount": null, "ch_number_clean": "SC663888", "from_round2": true, "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/SC663888", "ch_note": null }, "place": { "text": "Edinburgh (per UKTN list)", "postcode": "EH3 8EG", "lat": 55.947684, "lng": -3.210759, "region": "Scotland", "admin_district": "City of Edinburgh", "geocoded": "postcodes.io" }, "people": [ { "name": "Shea Quinn", "role": "Co-founder", "from": "2020", "source": "https://www.uktech.news/news/edinburgh-ai-companies-ready-to-slay-in-2021-20210226" }, { "name": "Rowan Armstrong", "role": "Co-founder", "from": "2020", "source": null }, { "name": "Ross O'Hanlon", "role": "Co-founder", "from": "2020", "source": null } ], "money": [], "site": null, "product": null, "dsit_domains": [ "Autonomous and agent systems", "AI implementation" ], "sectors": [ "medical devices", "assistive technology" ], "confidence": "verified", "checked": "2026-10-29", "as_of": "2026-10-29", "applied": null, "held": [], "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "Edinburgh health start-up that designed an AI-powered robotic glove to strengthen the grip of people with weak hands.", "affiliation": "Start-ups", "sources": [ "https://www.uktech.news/news/edinburgh-ai-companies-ready-to-slay-in-2021-20210226", "https://find-and-update.company-information.service.gov.uk/search/companies?q=bioliberty", "https://thenationalrobotarium.com/wp-content/uploads/The-National-Robotarium-Annual-Review-2024-Digital.pdf", "https://thenationalrobotarium.com/innovate-uk-funding-accelerates-robotic-stroke-rehabilitation-device-towards-launch/", "https://find-and-update.company-information.service.gov.uk/company/SC663888" ], "source_quotes": [ { "url": "https://www.uktech.news/news/edinburgh-ai-companies-ready-to-slay-in-2021-20210226", "quotes": [ "is a healthtech startup, which bridges the gap between hand weakness and independent living", "The company has designed an AI-powered robotic glove that strengthens the user's grip." ], "accessed": "2026-10-29", "trade": true, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/search/companies?q=bioliberty", "quotes": [ "BIOLIBERTY LTD", "SC663888", "Incorporated on 11 June 2020", "Third Floor, Canning Exchange, Canning Street, Edinburgh, Scotland, EH3 8EG" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://thenationalrobotarium.com/wp-content/uploads/The-National-Robotarium-Annual-Review-2024-Digital.pdf", "quotes": [ "a spinout from The University of Edinburgh\" (Bioliberty, resident company)" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://thenationalrobotarium.com/innovate-uk-funding-accelerates-robotic-stroke-rehabilitation-device-towards-launch/", "quotes": [ "Bioliberty is a tenant at the National Robotarium", "£435,000 project from the Biomedical Catalyst", "developing the machine learning and data collection elements of the product." ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/SC663888", "quotes": [ "BIOLIBERTY LTD | Company number SC663888 | Active" ], "accessed": "2026-10-31", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [ "Autonomous and agent systems", "AI implementation" ], "one_source": false, "confidence_raw": "verified", "depts": [ { "dept": "medical devices", "div": "health" } ], "div_label": "Health", "location": "Edinburgh (per UKTN list)", "status_group": "active", "ext_links": [ { "kind": "partner_of", "id": "UNI:heriotwatt/HWAI-055", "name": "Universities: heriotwatt/HWAI-055", "page": "universities", "href": "https://hazy-wreath-hez6.here.now/heriotwatt/", "page_label": "UK Universities AI Universe (new tab)" } ], "label_links": [ { "kind": "spun_out_of", "name": "University of Edinburgh (current academic post)" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-001", "name": "Babylon Health", "bucket": "co", "status": "wound_down", "status_date": "2023-08-30", "status_detail": "Babylon Group Holdings Limited and Babylon Partners Limited went into administration with Alvarez & Marsal in late August 2023, and the administrators sold UK businesses and assets to eMed Healthcare UK Limited; Babylon Partners Limited was renamed BPL Realisations Limited and was still in administration on Companies House on 29 October 2026.", "one_line": "Digital GP and AI symptom-checker company that collapsed into administration in August 2023; its UK business was sold to eMed.", "description": "Babylon was founded in 2013 to provide technology and clinical services through a digital-first platform, including an AI symptom checker and triage tools. In August 2023, after a planned merger with digital therapeutics firm MindMaze fell through and its US arm entered Chapter 7 proceedings, Alvarez & Marsal were appointed administrators over the parent company and its subsidiary Babylon Partners Limited. The administrators sold certain UK businesses and assets to eMed Healthcare UK Limited. Sources disagree on GP at Hand: UKTN reported the clinical services business, including GP at Hand, was sold to eMed, while Pharmaphorum reported GP at Hand was not included. Babylon had listed on the New York Stock Exchange in 2021 at a reported US$4.2bn valuation and agreed in June 2023 to delist and become private again. The former Babylon Partners Limited is now named BPL Realisations Limited and remains in administration.", "uk_status": "uk", "company": { "ch_number": "08493276", "registered_office": "Suite 3 Avery House, 69 North Street, Brighton, East Sussex, BN41 1DH (administrators' address)", "incorporated": "2013-04-17", "legal_form": "ltd", "owner_or_acquirer": "eMed Healthcare UK Limited (bought UK businesses and assets)", "headcount": null, "ch_number_clean": "08493276", "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/08493276", "ch_note": null }, "place": { "text": null, "postcode": null, "lat": null, "lng": null, "region": "England: London" }, "people": [], "money": [ { "kind": "valuation_reported", "amount": 4200000000, "currency": "USD", "date": "2021", "detail": "at New York Stock Exchange listing (as reported by UKTN; year only)", "raw": "valuation_reported: 4200000000 USD 2021 — at New York Stock Exchange listing (as reported by UKTN; year only)", "amount_gbp": 3077148509, "fx_rate": 1.3649, "fx_source": "Bank of England daily spot rate (series XUDLUSS, XUDLERS), US$1.3649 per £ on 2020-12-31", "fx_date": "2020-12-31", "fx_note": "year only given: rate for 1 January", "txt": "US$4.20bn", "gbp_txt": "£3.08bn" } ], "site": null, "product": null, "dsit_domains": [ "Natural language applications", "AI implementation" ], "sectors": [ "digital primary care", "symptom checking", "triage" ], "confidence": "verified", "checked": "2026-10-29", "as_of": "2026-10-29", "applied": null, "held": [], "same_as": null, "package1_id": "biz-babylon-health", "type": "Companies", "category": "health", "function": "Digital GP and AI symptom-checker company that collapsed into administration in August 2023; its UK business was sold to eMed.", "affiliation": "Start-ups", "sources": [ "https://htn.co.uk/2023/08/31/digital-first-care-company-babylon-puts-two-divisions-into-administration/", "https://pharmaphorum.com/news/two-babylon-health-divisions-have-been-sold-emed", "https://find-and-update.company-information.service.gov.uk/company/08493276", "https://www.uktech.news/medtech/babylon-health-administration-20230831", "https://www.uktech.news/medtech/babylon-delist-from-new-york-20230626" ], "source_quotes": [ { "url": "https://htn.co.uk/2023/08/31/digital-first-care-company-babylon-puts-two-divisions-into-administration/", "quotes": [ "acting as administrators over Babylon Group Holdings Limited and subsidiary Babylon Partners Limited", "has secured the future of the Babylon UK operations\" (dated 31 August 2023)" ], "accessed": "2026-10-29", "trade": true, "amendment": false }, { "url": "https://pharmaphorum.com/news/two-babylon-health-divisions-have-been-sold-emed", "quotes": [ "two of the company's divisions have been sold to US digital health business eMed", "will not be included in the sale of the UK businesses\" (dated 5 September 2023)" ], "accessed": "2026-10-29", "trade": true, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/08493276", "quotes": [ "BPL REALISATIONS LIMITED\" \"BABYLON PARTNERS LIMITED (17 Apr 2013 to 13 Sep 2023)\" \"In Administration" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://www.uktech.news/medtech/babylon-health-administration-20230831", "quotes": [ "It has sold its clinical services business, which includes GP at Hand, to US health tech company eMed Healthcare.\" \"It was valued at $4.2bn when it listed on the New York Stock Exchange" ], "accessed": "2026-10-29", "trade": true, "amendment": false }, { "url": "https://www.uktech.news/medtech/babylon-delist-from-new-york-20230626", "quotes": [ "Babylon has agreed to delist itself from the New York Stock Exchange to become a private company again.\" (dated 26 June 2023)" ], "accessed": "2026-10-29", "trade": true, "amendment": false } ], "website": [], "colleges": [], "topics": [ "Natural language applications", "AI implementation" ], "one_source": false, "confidence_raw": "verified", "depts": [ { "dept": "digital primary care", "div": "health" } ], "div_label": "Health", "location": null, "status_group": "wound_down", "ext_links": [], "label_links": [ { "kind": "acquired_by", "name": "eMed Healthcare UK Limited (UK businesses and assets, out of administration)" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-002", "name": "BenevolentAI", "bucket": "co", "status": "merged", "status_date": "2025-03-12", "status_detail": "On 12 March 2025 BenevolentAI merged into Osaka Holdings S.à r.l., which took the BenevolentAI name, and its shares were delisted from Euronext Amsterdam with effect from 13 March 2025; the UK operating company BenevolentAI Limited is active.", "one_line": "London company that uses AI to find drug targets and develop its own medicines; taken private and delisted from Amsterdam in March 2025.", "description": "BenevolentAI describes itself as working on AI-driven drug discovery. Its UK company was incorporated in September 2015 and is registered at Maple Street, London. Sifted reported in 2022 that it used its approach to identify a rheumatoid arthritis drug that could also treat Covid-19. After listing on Euronext Amsterdam, shareholders approved a merger into Osaka Holdings S.à r.l. on 12 March 2025; the merged company converted to an S.A. and took the BenevolentAI name, and the shares were delisted. Ken Mulvany is Executive Chairman.", "uk_status": "uk", "company": { "ch_number": "09781806", "registered_office": "4-8 Maple Street, London, United Kingdom, W1T 5HD", "incorporated": "2015-09-17", "legal_form": "ltd", "owner_or_acquirer": "Osaka Holdings S.à r.l. (renamed BenevolentAI S.A.)", "headcount": null, "ch_number_clean": "09781806", "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/09781806", "ch_note": null }, "place": { "text": "4-8 Maple Street, London (W1T 5HD)", "postcode": "W1T 5HD", "lat": 51.522903, "lng": -0.137341, "region": "England: London", "admin_district": "Camden", "geocoded": "postcodes.io" }, "people": [ { "name": "Ken Mulvany", "role": "Executive Chairman", "from": null, "source": "https://www.businesswire.com/news/home/20250312584164/en" } ], "money": [], "site": null, "product": null, "dsit_domains": [ "Knowledge generation", "AI implementation" ], "sectors": [ "drug discovery" ], "confidence": "verified", "checked": "2026-10-29", "as_of": "2026-10-29", "applied": null, "held": [], "same_as": null, "package1_id": "biz-benevolentai", "type": "Companies", "category": "health", "function": "London company that uses AI to find drug targets and develop its own medicines; taken private and delisted from Amsterdam in March 2025.", "affiliation": "Start-ups", "sources": [ "https://www.businesswire.com/news/home/20250312584164/en", "https://find-and-update.company-information.service.gov.uk/company/09781806", "https://sifted.eu/articles/ai-drug-discovery-startups" ], "source_quotes": [ { "url": "https://www.businesswire.com/news/home/20250312584164/en", "quotes": [ "Effective immediately, BenevolentAI has merged into Osaka Holdings S.à r.l.", "BenevolentAI shares will be delisted from Euronext Amsterdam effective 13 March 2025.", "Executive Chairman of BenevolentAI" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/09781806", "quotes": [ "BENEVOLENTAI LIMITED\" \"4-8 Maple Street, London, United Kingdom, W1T 5HD\" \"Active\" \"17 September 2015" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://sifted.eu/articles/ai-drug-discovery-startups", "quotes": [ "BenevolentAI used a similar approach two years ago to identify a rheumatoid arthritis drug that could also treat Covid-19.\" (c. November 2022)" ], "accessed": "2026-10-29", "trade": true, "amendment": false } ], "website": [], "colleges": [], "topics": [ "Knowledge generation", "AI implementation" ], "one_source": false, "confidence_raw": "verified", "depts": [ { "dept": "drug discovery", "div": "health" } ], "div_label": "Health", "location": "4-8 Maple Street, London (W1T 5HD)", "status_group": "merged", "ext_links": [ { "kind": "linked from: works_at", "id": "BIZ-TAL-169", "name": "Ken Mulvany", "page": "talent", "href": "../../talent/#org=BIZ-TAL-169", "page_label": "Talent" } ], "label_links": [ { "kind": "merged_into", "name": "Osaka Holdings S.à r.l." } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-003", "name": "Exscientia", "bucket": "co", "status": "acquired", "status_date": "2024-11-20", "status_detail": "Became a wholly owned subsidiary of Recursion in November 2024; its UK parent company re-registered from Exscientia plc to Exscientia Limited on 16 December 2024 and is active, registered at Pancras Square, London.", "one_line": "Oxford company that used AI to design small-molecule drugs; bought by US firm Recursion in November 2024.", "description": "Sifted reported in 2022 that Exscientia, founded in 2012, was the first AI drug discovery company, that its 2021 IPO raised $510m and that Sanofi had signed a deal worth up to $5.2bn with it. The first drug discovered with AI to enter clinical trials was found by Exscientia. In November 2024 Recursion announced on 20 November 2024 that the combination was complete, that Exscientia was a wholly owned subsidiary and that its Nasdaq ADSs would be delisted; Recursion lists the Oxford area and London among its primary offices. Companies House shows the holding company changed from a plc to a limited company on 16 December 2024. Former Exscientia executives Ben Taylor and Dave Hallett became Recursion's CFO (and President of Recursion UK) and Chief Scientific Officer.", "uk_status": "uk", "company": { "ch_number": "13483814", "registered_office": "4th Floor South, 3 Pancras Square, King's Cross, London, England, N1C 4AG", "incorporated": "2021-06-29", "legal_form": "ltd", "owner_or_acquirer": "Recursion Pharmaceuticals", "headcount": null, "ch_number_clean": "13483814", "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/13483814", "ch_note": null }, "place": { "text": "Oxford", "postcode": null, "lat": null, "lng": null, "region": "England: South East" }, "people": [ { "name": "Ben Taylor", "role": "President of Recursion UK and CFO of Recursion (former CFSO of Exscientia)", "from": "2024-11-20", "source": "https://ir.recursion.com/news-releases/news-release-details/recursion-and-exscientia-two-leaders-ai-drug-discovery-space" }, { "name": "Dave Hallett", "role": "CSO of Recursion (former Interim CEO of Exscientia)", "from": "2024-11-20", "source": null } ], "money": [ { "kind": "funding_round", "amount": 510000000, "currency": "USD", "date": "2021", "detail": "IPO (as reported by Sifted, year only)", "raw": "funding_round: 510000000 USD 2021 — IPO (as reported by Sifted, year only)", "amount_gbp": 373653748, "fx_rate": 1.3649, "fx_source": "Bank of England daily spot rate (series XUDLUSS, XUDLERS), US$1.3649 per £ on 2020-12-31", "fx_date": "2020-12-31", "fx_note": "year only given: rate for 1 January", "txt": "US$510m", "gbp_txt": "£373.7m" } ], "site": null, "product": null, "dsit_domains": [ "Knowledge generation", "AI implementation" ], "sectors": [ "drug discovery" ], "confidence": "verified", "checked": "2026-10-29", "as_of": "2026-10-29", "applied": null, "held": [], "same_as": null, "package1_id": "biz-exscientia", "type": "Companies", "category": "health", "function": "Oxford company that used AI to design small-molecule drugs; bought by US firm Recursion in November 2024.", "affiliation": "Start-ups", "sources": [ "https://find-and-update.company-information.service.gov.uk/company/13483814", "https://sifted.eu/articles/ai-drug-discovery-startups", "https://ir.recursion.com/news-releases/news-release-details/recursion-and-exscientia-two-leaders-ai-drug-discovery-space", "https://find-and-update.company-information.service.gov.uk/company/13483814/persons-with-significant-control" ], "source_quotes": [ { "url": "https://find-and-update.company-information.service.gov.uk/company/13483814", "quotes": [ "EXSCIENTIA LIMITED\" \"Active\" \"29 June 2021\" \"EXSCIENTIA PLC (22 Sep 2021 to 16 Dec 2024)" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://sifted.eu/articles/ai-drug-discovery-startups", "quotes": [ "UK-based Exscientia — founded in 2012 — was the first AI drug discovery company.\" \"Its $510m IPO last year was one of the biggest ever in the biotech industry." ], "accessed": "2026-10-29", "trade": true, "amendment": false }, { "url": "https://ir.recursion.com/news-releases/news-release-details/recursion-and-exscientia-two-leaders-ai-drug-discovery-space", "quotes": [ "November 20, 2024\" \"has been completed, with Exscientia becoming a wholly owned subsidiary of Recursion\" \"Exscientia ADSs (Nasdaq: EXAI) ceased trading and will be delisted from Nasdaq." ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/13483814/persons-with-significant-control", "quotes": [ "Recursion Pharmaceuticals, Inc. | Notified on 20 November 2024" ], "accessed": "2026-10-31", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [ "Knowledge generation", "AI implementation" ], "one_source": false, "confidence_raw": "verified", "depts": [ { "dept": "drug discovery", "div": "health" } ], "div_label": "Health", "location": "Oxford", "status_group": "acquired", "ext_links": [ { "kind": "linked from: alumni_of", "id": "BIZ-TAL-167", "name": "Ben Taylor", "page": "talent", "href": "../../talent/#org=BIZ-TAL-167", "page_label": "Talent" }, { "kind": "linked from: alumni_of", "id": "BIZ-TAL-168", "name": "Dave Hallett", "page": "talent", "href": "../../talent/#org=BIZ-TAL-168", "page_label": "Talent" } ], "label_links": [ { "kind": "acquired_by", "name": "Recursion Pharmaceuticals" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-004", "name": "Kheiron Medical Technologies (now DeepHealth UK)", "bucket": "co", "status": "renamed", "status_date": "2026-01-22", "status_detail": "Bought by DeepHealth, a RadNet subsidiary, in October 2024; the UK company changed its name from Kheiron Medical Technologies Ltd to DeepHealth UK Limited on 22 January 2026.", "one_line": "London maker of Mia, AI software that reads mammograms in breast screening; now the UK arm of US radiology firm DeepHealth.", "description": "Kheiron was incorporated in May 2016 (first as MaesterAI Limited). Its product, Mammography Intelligent Assessment (Mia), is an AI platform for breast screening that flags possible cancers on mammograms. In October 2024 DeepHealth, part of RadNet, announced it had acquired the London-based company; the price was not disclosed. Companies House shows the company renamed DeepHealth UK Limited on 22 January 2026, still active and registered in east London.", "uk_status": "uk", "company": { "ch_number": "10184103", "registered_office": "1 Blossom Yard, Fourth Floor, London, United Kingdom, E1 6RS", "incorporated": "2016-05-17", "legal_form": "ltd", "owner_or_acquirer": "DeepHealth (RadNet, Inc.)", "headcount": null, "ch_number_clean": "10184103", "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/10184103", "ch_note": null }, "place": { "text": "1 Blossom Yard, London (E1 6RS)", "postcode": "E1 6RS", "lat": 51.52146, "lng": -0.077982, "region": "England: London", "admin_district": "Tower Hamlets", "geocoded": "postcodes.io" }, "people": [ { "name": "Peter Kecskemethy", "role": "Co-founder", "from": null, "source": "https://htn.co.uk/2024/10/25/deephealth-acquires-ai-diagnostic-company-to-support-breast-cancer-care/" } ], "money": [], "site": null, "product": { "maker": "Kheiron Medical Technologies", "launched": null, "what_it_does": "Mia (Mammography Intelligent Assessment), AI for breast screening" }, "dsit_domains": [ "Perceptual systems", "AI implementation" ], "sectors": [ "medical imaging", "breast cancer screening" ], "confidence": "verified", "checked": "2026-10-29", "as_of": "2026-10-29", "applied": null, "held": [], "same_as": null, "package1_id": "biz-kheiron-medical-technologies", "type": "Companies", "category": "health", "function": "London maker of Mia, AI software that reads mammograms in breast screening; now the UK arm of US radiology firm DeepHealth.", "affiliation": "Start-ups", "sources": [ "https://htn.co.uk/2024/10/25/deephealth-acquires-ai-diagnostic-company-to-support-breast-cancer-care/", "https://find-and-update.company-information.service.gov.uk/company/10184103" ], "source_quotes": [ { "url": "https://htn.co.uk/2024/10/25/deephealth-acquires-ai-diagnostic-company-to-support-breast-cancer-care/", "quotes": [ "has acquired London-based cancer diagnostic company Kheiron Medical Technologies Limited", "co-founder Peter Kecskemethy\" (dated 25 October 2024)" ], "accessed": "2026-10-29", "trade": true, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/10184103", "quotes": [ "DEEPHEALTH UK LIMITED\" \"KHEIRON MEDICAL TECHNOLOGIES LTD: 08 Jun 2016 to 22 Jan 2026\" \"Active" ], "accessed": "2026-10-29", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [ "Perceptual systems", "AI implementation" ], "one_source": false, "confidence_raw": "verified", "depts": [ { "dept": "medical imaging", "div": "health" } ], "div_label": "Health", "location": "1 Blossom Yard, London (E1 6RS)", "status_group": "renamed", "ext_links": [ { "kind": "supplies_government", "id": "GOV-SCOT-061", "name": "Mia breast screening AI at NHS Grampian (GEMINI evaluation)", "page": "government", "href": "../../../government/scotland/#org=GOV-SCOT-061", "page_label": "UK Government AI Universe" } ], "label_links": [ { "kind": "acquired_by", "name": "DeepHealth (RadNet, Inc.)" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-005", "name": "Sensyne Health (now Arcturis Data)", "bucket": "co", "status": "renamed", "status_date": "2022-10-17", "status_detail": "Sensyne Health plc re-registered as a private limited company on 13 July 2022 and changed its name to Arcturis Data Limited on 17 October 2022; the company is active, registered at Oxford Technology Park, Kidlington, and filed a confirmation statement on 28 June 2026.", "one_line": "Oxford company that analysed anonymised NHS patient records with AI for drug research; renamed Arcturis Data in 2022.", "description": "Sensyne Health's main company was incorporated in June 2018 and was a public company (Sensyne Health plc) from August 2018 to July 2022, when it re-registered as a private limited company. An earlier pass recorded that it was listed on AIM and delisted in 2022; those pages were not reopened here. Companies House shows the name changed to Arcturis Data Limited on 17 October 2022, with sister companies Arcturis Data Holdings Limited and Arcturis Data (UK) Limited at the same Kidlington address. Recent filings show share allotments in March and August 2025 and group accounts to 31 December 2024. What Arcturis Data does today was not confirmed on an opened page.", "uk_status": "uk", "company": { "ch_number": "11425451", "registered_office": "Building One Oxford Technology Park, Technology Drive, Kidlington, United Kingdom, OX5 1GN", "incorporated": "2018-06-20", "legal_form": "ltd", "owner_or_acquirer": null, "headcount": null, "ch_number_clean": "11425451", "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/11425451", "ch_note": null }, "place": { "text": "Oxford Technology Park, Kidlington (OX5 1GN)", "postcode": "OX5 1GN", "lat": 51.828815, "lng": -1.311147, "region": "England: South East", "admin_district": "Cherwell", "geocoded": "postcodes.io" }, "people": [], "money": [], "site": null, "product": null, "dsit_domains": [ "Knowledge generation", "AI implementation" ], "sectors": [ "health data", "drug research" ], "confidence": "verified", "checked": "2026-10-29", "as_of": "2026-10-29", "applied": null, "held": [], "same_as": null, "package1_id": "biz-sensyne-health", "type": "Companies", "category": "health", "function": "Oxford company that analysed anonymised NHS patient records with AI for drug research; renamed Arcturis Data in 2022.", "affiliation": "Start-ups", "sources": [ "https://find-and-update.company-information.service.gov.uk/company/11425451", "https://find-and-update.company-information.service.gov.uk/company/11425451/filing-history" ], "source_quotes": [ { "url": "https://find-and-update.company-information.service.gov.uk/company/11425451", "quotes": [ "ARCTURIS DATA LIMITED\" \"Active\" \"SENSYNE HEALTH PLC | 13 Aug 2018 – 13 Jul 2022\" \"SENSYNE HEALTH LIMITED | 13 Jul 2022 – 17 Oct 2022" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/11425451/filing-history", "quotes": [ "28 Jun 2026: Confirmation statement", "Group of companies' accounts (AA), made up to 31 December 2024" ], "accessed": "2026-10-29", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [ "Knowledge generation", "AI implementation" ], "one_source": false, "confidence_raw": "verified", "depts": [ { "dept": "health data", "div": "health" } ], "div_label": "Health", "location": "Oxford Technology Park, Kidlington (OX5 1GN)", "status_group": "renamed", "ext_links": [], "label_links": [], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-006", "name": "Brainomix", "bucket": "co", "status": "active", "status_date": "2026-10-31", "status_detail": "On 24 February 2026 extended its Series C by £4.8m, led by Parkwalk Advisors and Hostplus with new US investor Modi Ventures, taking the round to £18.8m. Companies House shows BRAINOMIX LIMITED as Active (checked 31 Oct 2026).", "one_line": "Oxford spin-out whose software reads brain and lung scans to help doctors treat stroke and track lung fibrosis.", "description": "Brainomix is a University of Oxford spin-out. Its Brainomix 360 Stroke platform gives automated assessment of stroke scans to support treatment decisions, and its e-Lung platform uses CT biomarkers to predict and monitor pulmonary fibrosis. It raised £14m in a Series C in 2025 and added £4.8m in February 2026, bringing the round to £18.8m, to support US expansion. Michalis Papadakis is co-founder and chief executive. Its company was incorporated in November 2010 and is registered at Seacourt Tower, Oxford.", "uk_status": "uk", "company": { "ch_number": "07426406", "registered_office": "First Floor Seacourt Tower, West Way, Oxford, United Kingdom, OX2 0JJ", "incorporated": "2010-11-02", "legal_form": "ltd", "owner_or_acquirer": null, "headcount": null, "ch_number_clean": "07426406", "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/07426406", "ch_note": null }, "place": { "text": "Oxford (OX2 0JJ)", "postcode": "OX2 0JJ", "lat": 51.75367, "lng": -1.295167, "region": "England: South East", "admin_district": "Vale of White Horse", "geocoded": "postcodes.io" }, "people": [ { "name": "Michalis Papadakis", "role": "Co-founder and CEO", "from": null, "source": "https://www.uktech.news/medtech/brainomix-extends-series-c-with-new-5m-investment-20260224" } ], "money": [ { "kind": "funding_round", "amount": 4800000, "currency": "GBP", "date": "2026-02-24", "detail": "Series C extension led by Parkwalk Advisors and Hostplus (via IP Group Hostplus Innovation Fund), with Modi Ventures; round total £18.8m", "raw": "funding_round: 4800000 GBP 2026-02-24 — Series C extension led by Parkwalk Advisors and Hostplus (via IP Group Hostplus Innovation Fund), with Modi Ventures; round total £18.8m", "amount_gbp": 4800000, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£4.8m", "gbp_txt": "" }, { "kind": "funding_round", "amount": 14000000, "currency": "GBP", "date": "2025", "detail": "original Series C (year as reported)", "raw": "funding_round: 14000000 GBP 2025 — original Series C (year as reported)", "amount_gbp": 14000000, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£14m", "gbp_txt": "" } ], "site": null, "product": null, "dsit_domains": [ "Perceptual systems", "AI implementation" ], "sectors": [ "medical imaging", "stroke", "lung fibrosis" ], "confidence": "verified", "checked": "2026-10-29", "as_of": "2026-10-29", "applied": null, "held": [], "same_as": null, "package1_id": "biz-brainomix", "type": "Companies", "category": "health", "function": "Oxford spin-out whose software reads brain and lung scans to help doctors treat stroke and track lung fibrosis.", "affiliation": "Start-ups", "sources": [ "https://www.uktech.news/medtech/brainomix-extends-series-c-with-new-5m-investment-20260224", "https://htn.co.uk/2026/02/25/university-of-oxford-spinout-brainomix-takes-total-funding-to-18-8million-in-support-of-us-expansion/", "https://find-and-update.company-information.service.gov.uk/search/companies?q=brainomix", "https://find-and-update.company-information.service.gov.uk/company/07426406", "https://www.uktech.news/medtech/brainomix-extends-series-c-with-new-5m-investment-20260224" ], "source_quotes": [ { "url": "https://www.uktech.news/medtech/brainomix-extends-series-c-with-new-5m-investment-20260224", "quotes": [ "an Oxford-based developer of AI imaging tools for stroke and lung fibrosis", "led by existing investors Parkwalk Advisors and Hostplus via the IP Group Hostplus Innovation Fund", "has now reached £18.8m" ], "accessed": "2026-10-29", "trade": true, "amendment": false }, { "url": "https://htn.co.uk/2026/02/25/university-of-oxford-spinout-brainomix-takes-total-funding-to-18-8million-in-support-of-us-expansion/", "quotes": [ "has successfully raised £18.8 million in Series C funding", "Michalis Papadakis, Brainomix CEO and co-founder" ], "accessed": "2026-10-29", "trade": true, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/search/companies?q=brainomix", "quotes": [ "BRAINOMIX LIMITED\" \"07426406\" \"2 November 2010\" \"First Floor Seacourt Tower, West Way, Oxford, United Kingdom, OX2 0JJ" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/07426406", "quotes": [ "BRAINOMIX LIMITED", "Active", "2 November 2010", "62090 - Other information technology service activities" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://www.uktech.news/medtech/brainomix-extends-series-c-with-new-5m-investment-20260224", "quotes": [ "The University of Oxford spinout secured its £14m Series C round in March of last year.\" (24 Feb 2026)" ], "accessed": "2026-10-29", "trade": true, "amendment": false } ], "website": [], "colleges": [], "topics": [ "Perceptual systems", "AI implementation" ], "one_source": false, "confidence_raw": "verified", "depts": [ { "dept": "medical imaging", "div": "health" } ], "div_label": "Health", "location": "Oxford (OX2 0JJ)", "status_group": "active", "ext_links": [ { "kind": "spun_out_of", "id": "UNI:oxford", "name": "Universities: oxford", "page": "universities", "href": "https://hazy-wreath-hez6.here.now/oxford/", "page_label": "UK Universities AI Universe (new tab)" }, { "kind": "linked from: works_at", "id": "BIZ-TAL-165", "name": "Michalis Papadakis", "page": "talent", "href": "../../talent/#org=BIZ-TAL-165", "page_label": "Talent" }, { "kind": "linked from: founder_of", "id": "BIZ-TAL-165", "name": "Michalis Papadakis", "page": "talent", "href": "../../talent/#org=BIZ-TAL-165", "page_label": "Talent" }, { "kind": "supplies_government", "id": "GOV-DHSC-049", "name": "AI stroke imaging (Brainomix e-Stroke) across NHS stroke networks", "page": "government", "href": "../../../government/health/#org=GOV-DHSC-049", "page_label": "UK Government AI Universe" } ], "label_links": [ { "kind": "spun_out_of", "name": "University of Oxford" }, { "kind": "funded_by", "name": "Parkwalk Advisors" }, { "kind": "funded_by", "name": "IP Group Hostplus Innovation Fund" }, { "kind": "funded_by", "name": "Modi Ventures" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-007", "name": "Ultromics", "bucket": "co", "status": "active", "status_date": "2026-10-31", "status_detail": "Raised a US$55m (£41.4m) Series C led by L&G, Allegis Capital and Lightrock, announced 31 July 2025, for US expansion. Companies House shows ULTROMICS LIMITED as Active (checked 31 Oct 2026).", "one_line": "Oxford company whose software reads heart ultrasound scans to help doctors spot hard-to-find forms of heart failure.", "description": "Ultromics was founded in Oxford in 2017 and develops AI to help clinicians detect forms of heart failure that are hard to find on routine heart ultrasound. It raised a £24m Series B in 2021 and a US$55m Series C in July 2025, led by L&G, Allegis Capital and Lightrock with University of Chicago Medicine and UPMC Enterprises, to grow in the US. Ross Upton is founder and chief executive. Its company is registered at Oxford Business Park. [Round 4, 30 Oct 2026] investor: Oxford Science Enterprises portfolio company", "uk_status": "uk", "company": { "ch_number": "10684811", "registered_office": "4630 Kingsgate Cascade Way, Oxford Business Park South, Oxford, Oxfordshire, United Kingdom, OX4 2SU", "incorporated": "2017-03-22", "legal_form": "ltd", "owner_or_acquirer": null, "headcount": null, "ch_number_clean": "10684811", "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/10684811", "ch_note": null }, "place": { "text": "Oxford (OX4 2SU)", "postcode": "OX4 2SU", "lat": 51.731455, "lng": -1.208023, "region": "England: South East", "admin_district": "Oxford", "geocoded": "postcodes.io" }, "people": [ { "name": "Ross Upton", "role": "Founder and CEO", "from": null, "source": "https://www.uktech.news/medtech/ai-cardiology-group-ultromics-gears-up-for-us-growth-with-40m-round-20250731" } ], "money": [ { "kind": "funding_round", "amount": 55000000, "currency": "USD", "date": "2025-07-31", "detail": "Series C led by L&G, Allegis Capital and Lightrock", "raw": "funding_round: 55000000 USD 2025-07-31 — Series C led by L&G, Allegis Capital and Lightrock", "amount_gbp": 41565901, "fx_rate": 1.3232, "fx_source": "Bank of England daily spot rate (series XUDLUSS, XUDLERS), US$1.3232 per £ on 2025-07-31", "fx_date": "2025-07-31", "fx_note": "", "txt": "US$55m", "gbp_txt": "£41.6m" }, { "kind": "funding_round", "amount": 24000000, "currency": "GBP", "date": "2021", "detail": "Series B (year only, as reported)", "raw": "funding_round: 24000000 GBP 2021 — Series B (year only, as reported)", "amount_gbp": 24000000, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£24m", "gbp_txt": "" } ], "site": null, "product": null, "dsit_domains": [ "Perceptual systems", "AI implementation" ], "sectors": [ "cardiology", "medical imaging" ], "confidence": "verified", "checked": "2026-10-29", "as_of": "2026-10-29", "applied": null, "held": [], "same_as": null, "package1_id": "biz-ultromics", "type": "Companies", "category": "health", "function": "Oxford company whose software reads heart ultrasound scans to help doctors spot hard-to-find forms of heart failure.", "affiliation": "Start-ups", "sources": [ "https://www.uktech.news/medtech/ai-cardiology-group-ultromics-gears-up-for-us-growth-with-40m-round-20250731", "https://find-and-update.company-information.service.gov.uk/search/companies?q=ultromics", "https://find-and-update.company-information.service.gov.uk/company/10684811/officers", "https://www.oxfordscienceenterprises.com/portfolio/", "https://find-and-update.company-information.service.gov.uk/company/10684811" ], "source_quotes": [ { "url": "https://www.uktech.news/medtech/ai-cardiology-group-ultromics-gears-up-for-us-growth-with-40m-round-20250731", "quotes": [ "The Oxford-headquartered group specialises in AI cardiology diagnostics", "was led by L&G, Allegis Capital and Lightrock", "Founded in Oxford in 2017" ], "accessed": "2026-10-29", "trade": true, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/search/companies?q=ultromics", "quotes": [ "ULTROMICS LIMITED\" \"10684811\" \"22 March 2017\" \"Oxford Business Park South" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/10684811/officers", "quotes": [ "UPTON, Ross, Dr\" Director appointed \"18 May 2017\" (active)" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://www.oxfordscienceenterprises.com/portfolio/", "quotes": [ "Using AI to augment echocardiography – detecting heart disease earlier" ], "accessed": "2026-10-30", "trade": false, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/10684811", "quotes": [ "ULTROMICS LIMITED | Company number 10684811 | Active" ], "accessed": "2026-10-31", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [ "Perceptual systems", "AI implementation" ], "one_source": false, "confidence_raw": "verified", "depts": [ { "dept": "cardiology", "div": "health" } ], "div_label": "Health", "location": "Oxford (OX4 2SU)", "status_group": "active", "ext_links": [ { "kind": "linked from: partner_of", "id": "BIZ-EST-084", "name": "L&G co-led investment in Ultromics (AI cardiology)", "page": "established", "href": "../../established/#org=BIZ-EST-084", "page_label": "Established firms" }, { "kind": "linked from: funds", "id": "BIZ-INV-007", "name": "Oxford Science Enterprises", "page": "investors", "href": "../../investors/#org=BIZ-INV-007", "page_label": "Investors" }, { "kind": "linked from: works_at", "id": "BIZ-TAL-166", "name": "Ross Upton", "page": "talent", "href": "../../talent/#org=BIZ-TAL-166", "page_label": "Talent" }, { "kind": "linked from: founder_of", "id": "BIZ-TAL-166", "name": "Ross Upton", "page": "talent", "href": "../../talent/#org=BIZ-TAL-166", "page_label": "Talent" }, { "kind": "linked from: portfolio_of", "id": "BIZ-INV-2017", "name": "Allegis Capital", "page": "investors", "href": "../../investors/#org=BIZ-INV-2017", "page_label": "Investors" }, { "kind": "funded_by", "id": "BIZ-INV-2017", "name": "Allegis Capital", "page": "investors", "href": "../../investors/#org=BIZ-INV-2017", "page_label": "Investors" }, { "kind": "linked from: portfolio_of", "id": "BIZ-INV-2155", "name": "L&G", "page": "investors", "href": "../../investors/#org=BIZ-INV-2155", "page_label": "Investors" }, { "kind": "funded_by", "id": "BIZ-INV-2155", "name": "L&G", "page": "investors", "href": "../../investors/#org=BIZ-INV-2155", "page_label": "Investors" }, { "kind": "linked from: portfolio_of", "id": "BIZ-INV-2159", "name": "Lightrock", "page": "investors", "href": "../../investors/#org=BIZ-INV-2159", "page_label": "Investors" }, { "kind": "funded_by", "id": "BIZ-INV-2159", "name": "Lightrock", "page": "investors", "href": "../../investors/#org=BIZ-INV-2159", "page_label": "Investors" }, { "kind": "linked from: portfolio_of", "id": "BIZ-INV-2256", "name": "University of Chicago Medicine", "page": "investors", "href": "../../investors/#org=BIZ-INV-2256", "page_label": "Investors" }, { "kind": "funded_by", "id": "BIZ-INV-2256", "name": "University of Chicago Medicine", "page": "investors", "href": "../../investors/#org=BIZ-INV-2256", "page_label": "Investors" }, { "kind": "linked from: portfolio_of", "id": "BIZ-INV-2258", "name": "UPMC Enterprises", "page": "investors", "href": "../../investors/#org=BIZ-INV-2258", "page_label": "Investors" }, { "kind": "funded_by", "id": "BIZ-INV-2258", "name": "UPMC Enterprises", "page": "investors", "href": "../../investors/#org=BIZ-INV-2258", "page_label": "Investors" } ], "label_links": [ { "kind": "funded_by", "name": "L&G" }, { "kind": "funded_by", "name": "Allegis Capital" }, { "kind": "funded_by", "name": "Lightrock" }, { "kind": "funded_by", "name": "UPMC Enterprises" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-008", "name": "TidalSense", "bucket": "co", "status": "active", "status_date": "2026-07-24", "status_detail": "Raised US$19m (£14.2m), reported 24 July 2026, from investors including Cross-Border Impact Ventures, BGF, Airstream Capital and Foresight Group, to sell its COPD test in Europe and the US.", "one_line": "Cambridge company whose handheld device and AI software diagnose chronic lung disease from 75 seconds of normal breathing.", "description": "TidalSense makes N-Tidal Diagnose, a portable AI tool for chronic obstructive pulmonary disease (COPD). Patients breathe normally into it for 75 seconds and it analyses the carbon dioxide waveform. In July 2026 it raised £14.2m from Cross-Border Impact Ventures and returning backers BGF, Airstream Capital and Foresight Group. Ameera Patel is chief executive. The company was incorporated in 2013 and is registered in Cambridge.", "uk_status": "uk", "company": { "ch_number": "08500211", "registered_office": "The Vinery, 15a Vinery Road, Cambridge, England, CB1 3DN", "incorporated": "2013-04-23", "legal_form": "ltd", "owner_or_acquirer": null, "headcount": null, "ch_number_clean": "08500211", "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/08500211", "ch_note": null }, "place": { "text": "Cambridge (CB1 3DN)", "postcode": "CB1 3DN", "lat": 52.198006, "lng": 0.151487, "region": "England: East of England", "admin_district": "Cambridge", "geocoded": "postcodes.io" }, "people": [ { "name": "Ameera Patel", "role": "Chief Executive", "from": null, "source": "https://www.uktech.news/medtech/tidalsense-secures-14-2m-for-ai-breath-test-20260724" } ], "money": [ { "kind": "funding_round", "amount": 14200000, "currency": "GBP", "date": "2026-07-24", "detail": "investors Cross-Border Impact Ventures, BGF, Airstream Capital, Foresight Group (lead not stated)", "raw": "funding_round: 14200000 GBP 2026-07-24 — investors Cross-Border Impact Ventures, BGF, Airstream Capital, Foresight Group (lead not stated)", "amount_gbp": 14200000, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£14.2m", "gbp_txt": "" } ], "site": null, "product": { "maker": "TidalSense", "launched": null, "what_it_does": "N-Tidal Diagnose, a handheld AI breath test for COPD" }, "dsit_domains": [ "Perceptual systems", "AI implementation" ], "sectors": [ "respiratory diagnostics", "medical devices" ], "confidence": "verified", "checked": "2026-10-29", "as_of": "2026-10-29", "applied": [ { "from": "Companies House check, 29 Oct 2026", "field": "description", "text": "description → add previous name CAMBRIDGE RESPIRATORY INNOVATIONS LIMITED (23 Apr 2013 – 10 May 2023)" } ], "held": [], "same_as": null, "package1_id": "biz-tidalsense", "type": "Companies", "category": "health", "function": "Cambridge company whose handheld device and AI software diagnose chronic lung disease from 75 seconds of normal breathing.", "affiliation": "Start-ups", "sources": [ "https://www.uktech.news/medtech/tidalsense-secures-14-2m-for-ai-breath-test-20260724", "https://find-and-update.company-information.service.gov.uk/search/companies?q=tidalsense", "https://find-and-update.company-information.service.gov.uk/company/08500211" ], "source_quotes": [ { "url": "https://www.uktech.news/medtech/tidalsense-secures-14-2m-for-ai-breath-test-20260724", "quotes": [ "Cambridge-based health tech startup", "$19m (£14.2m)", "Cross-Border Impact Ventures", "BGF, Airstream Capital and Foresight Group (dated 24 July 2026)" ], "accessed": "2026-10-29", "trade": true, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/search/companies?q=tidalsense", "quotes": [ "TIDALSENSE LIMITED\" \"08500211\" \"23 April 2013\" \"The Vinery, 15a Vinery Road, Cambridge, England, CB1 3DN" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/08500211", "quotes": [ "TIDALSENSE LIMITED", "Active", "23 April 2013", "CAMBRIDGE RESPIRATORY INNOVATIONS LIMITED (23 Apr 2013 - 10 May 2023)" ], "accessed": "2026-10-29", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [ "Perceptual systems", "AI implementation" ], "one_source": false, "confidence_raw": "verified", "depts": [ { "dept": "respiratory diagnostics", "div": "health" } ], "div_label": "Health", "location": "Cambridge (CB1 3DN)", "status_group": "active", "ext_links": [ { "kind": "linked from: works_at", "id": "BIZ-TAL-174", "name": "Ameera Patel", "page": "talent", "href": "../../talent/#org=BIZ-TAL-174", "page_label": "Talent" }, { "kind": "linked from: portfolio_of", "id": "BIZ-INV-2013", "name": "Airstream Capital", "page": "investors", "href": "../../investors/#org=BIZ-INV-2013", "page_label": "Investors" }, { "kind": "funded_by", "id": "BIZ-INV-2013", "name": "Airstream Capital", "page": "investors", "href": "../../investors/#org=BIZ-INV-2013", "page_label": "Investors" }, { "kind": "linked from: portfolio_of", "id": "BIZ-INV-2037", "name": "BGF", "page": "investors", "href": "../../investors/#org=BIZ-INV-2037", "page_label": "Investors" }, { "kind": "funded_by", "id": "BIZ-INV-2037", "name": "BGF", "page": "investors", "href": "../../investors/#org=BIZ-INV-2037", "page_label": "Investors" }, { "kind": "linked from: portfolio_of", "id": "BIZ-INV-2074", "name": "Cross-Border Impact Ventures", "page": "investors", "href": "../../investors/#org=BIZ-INV-2074", "page_label": "Investors" }, { "kind": "funded_by", "id": "BIZ-INV-2074", "name": "Cross-Border Impact Ventures", "page": "investors", "href": "../../investors/#org=BIZ-INV-2074", "page_label": "Investors" }, { "kind": "linked from: portfolio_of", "id": "BIZ-INV-2100", "name": "Foresight Group", "page": "investors", "href": "../../investors/#org=BIZ-INV-2100", "page_label": "Investors" }, { "kind": "funded_by", "id": "BIZ-INV-2100", "name": "Foresight Group", "page": "investors", "href": "../../investors/#org=BIZ-INV-2100", "page_label": "Investors" } ], "label_links": [ { "kind": "funded_by", "name": "Cross-Border Impact Ventures" }, { "kind": "funded_by", "name": "BGF" }, { "kind": "funded_by", "name": "Foresight Group" }, { "kind": "funded_by", "name": "Airstream Capital" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-009", "name": "Qureight", "bucket": "co", "status": "active", "status_date": "2026-07-29", "status_detail": "Closed a US$20m (£15m) Series B led by Molten Ventures, reported 29 July 2026.", "one_line": "Cambridge company whose deep-learning platform analyses lung and heart scans for drug companies running clinical trials.", "description": "Qureight runs an AI clinical trial imaging platform, including a 3D deep learning system to curate, analyse and extract measurements from lung and heart scans for trial sponsors. It was founded by pulmonologist Muhunthan Thillai and radiologist Alessandro Ruggiero. It raised US$8.5m led by Hargreave Hale AIM VCT in April 2024, and in July 2026 a US$20m Series B led by Molten Ventures, with existing backers Hargreave Hale AIM VCT, XTX Ventures, Guinness Ventures, Meltwind and Ascension. The company was incorporated in January 2018 and is registered on Station Road, Cambridge.", "uk_status": "uk", "company": { "ch_number": "11132399", "registered_office": "50 - 60 Station Road, Cambridge, England, CB1 2JH", "incorporated": "2018-01-04", "legal_form": "ltd", "owner_or_acquirer": null, "headcount": null, "ch_number_clean": "11132399", "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/11132399", "ch_note": null }, "place": { "text": "Cambridge (CB1 2JH)", "postcode": "CB1 2JH", "lat": 52.194361, "lng": 0.135318, "region": "England: East of England", "admin_district": "Cambridge", "geocoded": "postcodes.io" }, "people": [ { "name": "Muhunthan Thillai", "role": "Founder and CEO", "from": null, "source": "https://www.uktech.news/medtech/qureight-funding-ai-medical-data-20240416" }, { "name": "Alessandro Ruggiero", "role": "Co-founder", "from": null, "source": null } ], "money": [ { "kind": "funding_round", "amount": 20000000, "currency": "USD", "date": "2026-07-29", "detail": "Series B led by Molten Ventures", "raw": "funding_round: 20000000 USD 2026-07-29 — Series B led by Molten Ventures", "amount_gbp": 15052307, "fx_rate": 1.3287, "fx_source": "Bank of England daily spot rate (series XUDLUSS, XUDLERS), US$1.3287 per £ on 2026-07-29", "fx_date": "2026-07-29", "fx_note": "", "txt": "US$20m", "gbp_txt": "£15.1m" }, { "kind": "funding_round", "amount": 8500000, "currency": "USD", "date": "2024-04-16", "detail": "led by Hargreave Hale AIM VCT", "raw": "funding_round: 8500000 USD 2024-04-16 — led by Hargreave Hale AIM VCT", "amount_gbp": 6831699, "fx_rate": 1.2442, "fx_source": "Bank of England daily spot rate (series XUDLUSS, XUDLERS), US$1.2442 per £ on 2024-04-16", "fx_date": "2024-04-16", "fx_note": "", "txt": "US$8.5m", "gbp_txt": "£6.8m" } ], "site": null, "product": null, "dsit_domains": [ "Perceptual systems", "Knowledge generation" ], "sectors": [ "medical imaging", "clinical trials" ], "confidence": "verified", "checked": "2026-10-29", "as_of": "2026-10-29", "applied": null, "held": [], "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "Cambridge company whose deep-learning platform analyses lung and heart scans for drug companies running clinical trials.", "affiliation": "Start-ups", "sources": [ "https://www.uktech.news/medtech/qureight-closes-15m-round-to-scale-ai-imaging-platform-20260729", "https://find-and-update.company-information.service.gov.uk/search/companies?q=qureight", "https://www.uktech.news/medtech/qureight-funding-ai-medical-data-20240416", "https://find-and-update.company-information.service.gov.uk/company/11132399" ], "source_quotes": [ { "url": "https://www.uktech.news/medtech/qureight-closes-15m-round-to-scale-ai-imaging-platform-20260729", "quotes": [ "AI-powered clinical trial imaging platform", "3D deep learning platform designed to curate, analyse, and extract precision endpoints", "The round was led by Molten Ventures" ], "accessed": "2026-10-29", "trade": true, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/search/companies?q=qureight", "quotes": [ "QUREIGHT LIMITED\" \"11132399\" \"4 January 2018\" \"50 - 60 Station Road, Cambridge, England, CB1 2JH" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://www.uktech.news/medtech/qureight-funding-ai-medical-data-20240416", "quotes": [ "has raised $8.5m (£6.8m)\" \"The investment was led by Hargreave Hale AIM VCT\" \"founder and CEO Dr Muhunthan Thillai" ], "accessed": "2026-10-29", "trade": true, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/11132399", "quotes": [ "QUREIGHT LIMITED", "50 - 60 Station Road, Cambridge, England, CB1 2JH", "Active", "4 January 2018" ], "accessed": "2026-10-29", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [ "Perceptual systems", "Knowledge generation" ], "one_source": false, "confidence_raw": "verified", "depts": [ { "dept": "medical imaging", "div": "health" } ], "div_label": "Health", "location": "Cambridge (CB1 2JH)", "status_group": "active", "ext_links": [ { "kind": "funded_by", "id": "BIZ-INV-044", "name": "XTX Ventures", "page": "investors", "href": "../../investors/#org=BIZ-INV-044", "page_label": "Investors" }, { "kind": "linked from: portfolio_of", "id": "BIZ-INV-2027", "name": "Ascension", "page": "investors", "href": "../../investors/#org=BIZ-INV-2027", "page_label": "Investors" }, { "kind": "funded_by", "id": "BIZ-INV-2027", "name": "Ascension", "page": "investors", "href": "../../investors/#org=BIZ-INV-2027", "page_label": "Investors" }, { "kind": "linked from: portfolio_of", "id": "BIZ-INV-2117", "name": "Guinness Ventures", "page": "investors", "href": "../../investors/#org=BIZ-INV-2117", "page_label": "Investors" }, { "kind": "funded_by", "id": "BIZ-INV-2117", "name": "Guinness Ventures", "page": "investors", "href": "../../investors/#org=BIZ-INV-2117", "page_label": "Investors" }, { "kind": "linked from: portfolio_of", "id": "BIZ-INV-2121", "name": "Hargreave Hale AIM VCT", "page": "investors", "href": "../../investors/#org=BIZ-INV-2121", "page_label": "Investors" }, { "kind": "funded_by", "id": "BIZ-INV-2121", "name": "Hargreave Hale AIM VCT", "page": "investors", "href": "../../investors/#org=BIZ-INV-2121", "page_label": "Investors" }, { "kind": "linked from: portfolio_of", "id": "BIZ-INV-2173", "name": "Meltwind", "page": "investors", "href": "../../investors/#org=BIZ-INV-2173", "page_label": "Investors" }, { "kind": "funded_by", "id": "BIZ-INV-2173", "name": "Meltwind", "page": "investors", "href": "../../investors/#org=BIZ-INV-2173", "page_label": "Investors" }, { "kind": "linked from: portfolio_of", "id": "BIZ-INV-2178", "name": "Molten Ventures", "page": "investors", "href": "../../investors/#org=BIZ-INV-2178", "page_label": "Investors" }, { "kind": "funded_by", "id": "BIZ-INV-2178", "name": "Molten Ventures", "page": "investors", "href": "../../investors/#org=BIZ-INV-2178", "page_label": "Investors" }, { "kind": "linked from: portfolio_of", "id": "BIZ-INV-044", "name": "XTX Ventures", "page": "investors", "href": "../../investors/#org=BIZ-INV-044", "page_label": "Investors" }, { "kind": "funded_by", "id": "BIZ-INV-044", "name": "XTX Ventures", "page": "investors", "href": "../../investors/#org=BIZ-INV-044", "page_label": "Investors" } ], "label_links": [ { "kind": "funded_by", "name": "Molten Ventures" }, { "kind": "funded_by", "name": "Hargreave Hale AIM VCT" }, { "kind": "funded_by", "name": "Ascension" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-010", "name": "Relation Therapeutics", "bucket": "co", "status": "active", "status_date": "2026-10-31", "status_detail": "In August 2025 took another 7,000 sq ft of lab space at Regent's Place, London, bringing its London footprint to 13,000 sq ft; it had raised over US$106m across several rounds by then. Companies House shows RELATION THERAPEUTICS LIMITED as Active (checked 31 Oct 2026).", "one_line": "London biotech that uses genomics and machine learning to find and develop new medicines.", "description": "Relation describes itself as an end-to-end biotech that combines genomics and machine learning to develop medicines. Its headquarters has been at Regent's Place on the Euston Road since 2022. In August 2025 it took an extra 7,000 sq ft of laboratory space there. UKTN reported it had raised over US$106m (£78m) across several rounds. Its 2024–2026 collaborations with GSK and Novartis, recorded in an earlier pass, were not re-opened in this session (see Gaps).", "uk_status": "uk", "company": { "ch_number": "12305953", "registered_office": null, "incorporated": null, "legal_form": null, "owner_or_acquirer": null, "headcount": null, "ch_number_clean": "12305953", "from_round2": true, "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/12305953", "ch_note": null }, "place": { "text": "Regent's Place, Euston Road, London", "postcode": "NW1 3BG", "lat": 51.524572, "lng": -0.141598, "region": "England: London", "admin_district": "Camden", "geocoded": "postcodes.io" }, "people": [ { "name": "Rosie Rodriguez", "role": "SVP of growth", "from": null, "source": "https://www.uktech.news/medtech/relation-doubles-london-footprint-20250813" } ], "money": [], "site": null, "product": null, "dsit_domains": [ "Knowledge generation", "AI development and training" ], "sectors": [ "drug discovery", "genomics" ], "confidence": "verified", "checked": "2026-10-29", "as_of": "2026-10-29", "applied": null, "held": [], "same_as": null, "package1_id": "biz-relation-therapeutics", "type": "Companies", "category": "health", "function": "London biotech that uses genomics and machine learning to find and develop new medicines.", "affiliation": "Start-ups", "sources": [ "https://www.uktech.news/medtech/relation-doubles-london-footprint-20250813", "https://find-and-update.company-information.service.gov.uk/company/12305953" ], "source_quotes": [ { "url": "https://www.uktech.news/medtech/relation-doubles-london-footprint-20250813", "quotes": [ "has not only been our headquarters since 2022", "taking and additional 7,000 sq ft. of lab space at the Euston Road site", "raised over $106m (£78m) across multiple rounds of funding" ], "accessed": "2026-10-29", "trade": true, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/12305953", "quotes": [ "RELATION THERAPEUTICS LIMITED\" \"Regents Place, 338 Euston Road, London, England, NW1 3BG\" \"Active\" \"8 November 2019" ], "accessed": "2026-10-29", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [ "Knowledge generation", "AI development and training" ], "one_source": false, "confidence_raw": "verified", "depts": [ { "dept": "drug discovery", "div": "health" } ], "div_label": "Health", "location": "Regent's Place, Euston Road, London", "status_group": "active", "ext_links": [ { "kind": "linked from: funds", "id": "BIZ-INV-206", "name": "firstminute capital", "page": "investors", "href": "../../investors/#org=BIZ-INV-206", "page_label": "Investors" } ], "label_links": [], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-011", "name": "Lucida Medical", "bucket": "co", "status": "active", "status_date": "2026-10-31", "status_detail": "Raised £8.7m in a round led by IW Capital, with XTX Ventures and Macmillan Cancer Support, reported 30 March 2026. Companies House shows LUCIDA MEDICAL LTD as Active (checked 31 Oct 2026).", "one_line": "Cambridge company whose AI helps doctors find prostate cancer on MRI scans; already used in the NHS.", "description": "Lucida Medical provides an AI diagnostic service that helps clinicians detect prostate cancer on MRI scans, and UKTN reports it is already used in the NHS. In March 2026 it raised £8.7m led by IW Capital, with XTX Ventures and Macmillan Cancer Support taking part. Antony Rix is co-founder and chief executive. The company was incorporated in November 2019 and is registered at King's Hedges Road, Cambridge.", "uk_status": "uk", "company": { "ch_number": "12320979", "registered_office": "Allia Future Business Centre, King's Hedges Road, Cambridge, England, CB4 2HY", "incorporated": "2019-11-19", "legal_form": "ltd", "owner_or_acquirer": null, "headcount": null, "ch_number_clean": "12320979", "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/12320979", "ch_note": null }, "place": { "text": "Cambridge (CB4 2HY)", "postcode": "CB4 2HY", "lat": 52.234821, "lng": 0.129527, "region": "England: East of England", "admin_district": "Cambridge", "geocoded": "postcodes.io" }, "people": [ { "name": "Antony Rix", "role": "Co-founder and CEO", "from": null, "source": "https://www.uktech.news/medtech/ai-diagnostic-startup-raises-9m-in-macmillan-backed-round-20260330" } ], "money": [ { "kind": "funding_round", "amount": 8700000, "currency": "GBP", "date": "2026-03-30", "detail": "led by IW Capital, with XTX Ventures and Macmillan Cancer Support", "raw": "funding_round: 8700000 GBP 2026-03-30 — led by IW Capital, with XTX Ventures and Macmillan Cancer Support", "amount_gbp": 8700000, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£8.7m", "gbp_txt": "" } ], "site": null, "product": null, "dsit_domains": [ "Perceptual systems", "AI implementation" ], "sectors": [ "medical imaging", "prostate cancer" ], "confidence": "single_source", "checked": "2026-10-29", "as_of": "2026-10-29", "applied": null, "held": [], "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "Cambridge company whose AI helps doctors find prostate cancer on MRI scans; already used in the NHS.", "affiliation": "Start-ups", "sources": [ "https://www.uktech.news/medtech/ai-diagnostic-startup-raises-9m-in-macmillan-backed-round-20260330", "https://find-and-update.company-information.service.gov.uk/search/companies?q=lucida+medical", "https://find-and-update.company-information.service.gov.uk/company/12320979" ], "source_quotes": [ { "url": "https://www.uktech.news/medtech/ai-diagnostic-startup-raises-9m-in-macmillan-backed-round-20260330", "quotes": [ "Lucida Medical, a startup using AI to support the cancer diagnostic process has raised £8.7m in a funding round.", "A Cambridge-based startup" ], "accessed": "2026-10-29", "trade": true, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/search/companies?q=lucida+medical", "quotes": [ "LUCIDA MEDICAL LTD\" \"12320979\" \"19 November 2019\" \"King's Hedges Road, Cambridge" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/12320979", "quotes": [ "LUCIDA MEDICAL LTD | Company number 12320979 | Active" ], "accessed": "2026-10-31", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [ "Perceptual systems", "AI implementation" ], "one_source": true, "confidence_raw": "single_source", "depts": [ { "dept": "medical imaging", "div": "health" } ], "div_label": "Health", "location": "Cambridge (CB4 2HY)", "status_group": "active", "ext_links": [ { "kind": "funded_by", "id": "BIZ-INV-044", "name": "XTX Ventures", "page": "investors", "href": "../../investors/#org=BIZ-INV-044", "page_label": "Investors" }, { "kind": "linked from: portfolio_of", "id": "BIZ-INV-2146", "name": "IW Capital", "page": "investors", "href": "../../investors/#org=BIZ-INV-2146", "page_label": "Investors" }, { "kind": "funded_by", "id": "BIZ-INV-2146", "name": "IW Capital", "page": "investors", "href": "../../investors/#org=BIZ-INV-2146", "page_label": "Investors" }, { "kind": "linked from: portfolio_of", "id": "BIZ-INV-2167", "name": "Macmillan Cancer Support", "page": "investors", "href": "../../investors/#org=BIZ-INV-2167", "page_label": "Investors" }, { "kind": "funded_by", "id": "BIZ-INV-2167", "name": "Macmillan Cancer Support", "page": "investors", "href": "../../investors/#org=BIZ-INV-2167", "page_label": "Investors" }, { "kind": "linked from: portfolio_of", "id": "BIZ-INV-044", "name": "XTX Ventures", "page": "investors", "href": "../../investors/#org=BIZ-INV-044", "page_label": "Investors" }, { "kind": "funded_by", "id": "BIZ-INV-044", "name": "XTX Ventures", "page": "investors", "href": "../../investors/#org=BIZ-INV-044", "page_label": "Investors" } ], "label_links": [ { "kind": "funded_by", "name": "IW Capital" }, { "kind": "funded_by", "name": "Macmillan Cancer Support" }, { "kind": "supplies", "name": "NHS" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-012", "name": "Spotlight Pathology", "bucket": "co", "status": "active", "status_date": "2026-10-31", "status_detail": "Secured £1.4m in seed funding co-led by the UK Innovation and Science Seed Fund and the Liverpool City Region Seed Fund, announced 16 March 2026, with first NHS deployments expected later in 2026. Companies House shows SPOTLIGHT PATHOLOGY LTD as Active (checked 31 Oct 2026).", "one_line": "University of Manchester spin-out whose AI analyses digital pathology slides to help diagnose blood cancers such as lymphoma.", "description": "Spotlight Pathology spun out of the University of Manchester in 2020 and builds AI software that analyses digital pathology images to help identify blood cancers earlier; its first product is a lymphoma diagnostic device. It is based at Sci-Tech Daresbury in Cheshire. It took £125,000 from LYVA Labs in July 2024, and in March 2026 raised £1.4m co-led by UKI2S and the Liverpool City Region Seed Fund, with Deepbridge, Lyva Labs, EHE Ventures and River Capital. Sam Perona is chief executive.", "uk_status": "uk", "company": { "ch_number": "12435884", "registered_office": "The Innovation Centre, Sci-Tech Daresbury Keckwick Lane, Daresbury, Warrington, Cheshire, England, WA4 4FS", "incorporated": "2020-01-31", "legal_form": "ltd", "owner_or_acquirer": null, "headcount": null, "ch_number_clean": "12435884", "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/12435884", "ch_note": null }, "place": { "text": "Sci-Tech Daresbury, Warrington (WA4 4FS)", "postcode": "WA4 4FS", "lat": 53.345237, "lng": -2.639191, "region": "England: North West", "admin_district": "Halton", "geocoded": "postcodes.io" }, "people": [ { "name": "Sam Perona", "role": "CEO", "from": null, "source": "https://htn.co.uk/2026/03/16/spotlight-pathology-secures-1-4-million-seed-investment-for-ai-blood-cancer-diagnostics/" } ], "money": [ { "kind": "funding_round", "amount": 1400000, "currency": "GBP", "date": "2026-03-16", "detail": "seed, co-led by UKI2S and Liverpool City Region Seed Fund", "raw": "funding_round: 1400000 GBP 2026-03-16 — seed, co-led by UKI2S and Liverpool City Region Seed Fund", "amount_gbp": 1400000, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£1.4m", "gbp_txt": "" }, { "kind": "funding_round", "amount": 125000, "currency": "GBP", "date": "2024-07-18", "detail": "investment from LYVA Labs", "raw": "funding_round: 125000 GBP 2024-07-18 — investment from LYVA Labs", "amount_gbp": 125000, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£125,000", "gbp_txt": "" } ], "site": null, "product": null, "dsit_domains": [ "Perceptual systems", "AI implementation" ], "sectors": [ "digital pathology", "blood cancer" ], "confidence": "verified", "checked": "2026-10-29", "as_of": "2026-10-29", "applied": null, "held": [], "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "University of Manchester spin-out whose AI analyses digital pathology slides to help diagnose blood cancers such as lymphoma.", "affiliation": "Start-ups", "sources": [ "https://htn.co.uk/2026/03/16/spotlight-pathology-secures-1-4-million-seed-investment-for-ai-blood-cancer-diagnostics/", "https://www.uktech.news/medtech/spotlight-pathology-secures-new-funding-for-ai-cancer-diagnostics-20260320", "https://www.uktech.news/medtech/spotlight-pathology-ai-blood-diagnosis-20240718", "https://find-and-update.company-information.service.gov.uk/search/companies?q=spotlight+pathology", "https://find-and-update.company-information.service.gov.uk/company/12435884" ], "source_quotes": [ { "url": "https://htn.co.uk/2026/03/16/spotlight-pathology-secures-1-4-million-seed-investment-for-ai-blood-cancer-diagnostics/", "quotes": [ "has secured £1.4 million in seed funding.\" \"The funding round was co-led by the UK Innovation and Science Seed Fund (UKI2S) and Liverpool City Region Seed Fund." ], "accessed": "2026-10-29", "trade": true, "amendment": false }, { "url": "https://www.uktech.news/medtech/spotlight-pathology-secures-new-funding-for-ai-cancer-diagnostics-20260320", "quotes": [ "Spotlight Pathology is developing AI-powered tools for diagnosing blood cancer.\" \"Spotlight Pathology, a spinout from the University of Manchester." ], "accessed": "2026-10-29", "trade": true, "amendment": false }, { "url": "https://www.uktech.news/medtech/spotlight-pathology-ai-blood-diagnosis-20240718", "quotes": [ "Daresbury-based life science startup Spotlight Pathology has raised £125,000 in the latest investment from LYVA Labs." ], "accessed": "2026-10-29", "trade": true, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/search/companies?q=spotlight+pathology", "quotes": [ "SPOTLIGHT PATHOLOGY LTD\" \"12435884\" \"31 January 2020" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/12435884", "quotes": [ "SPOTLIGHT PATHOLOGY LTD", "Sci-Tech Daresbury", "Active", "31 January 2020" ], "accessed": "2026-10-29", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [ "Perceptual systems", "AI implementation" ], "one_source": false, "confidence_raw": "verified", "depts": [ { "dept": "digital pathology", "div": "health" } ], "div_label": "Health", "location": "Sci-Tech Daresbury, Warrington (WA4 4FS)", "status_group": "active", "ext_links": [], "label_links": [ { "kind": "spun_out_of", "name": "University of Manchester" }, { "kind": "funded_by", "name": "UK Innovation and Science Seed Fund" }, { "kind": "funded_by", "name": "Liverpool City Region Seed Fund" }, { "kind": "funded_by", "name": "LYVA Labs" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-013", "name": "Antiverse", "bucket": "co", "status": "active", "status_date": "2026-10-31", "status_detail": "Raised a US$9.3m (£7m) Series A led by Soulmates Ventures, reported 3 March 2026. Companies House shows ANTIVERSE LTD as Active (checked 31 Oct 2026).", "one_line": "Cardiff company that uses AI to design antibody drugs against targets that are hard to reach with existing methods.", "description": "Antiverse develops therapeutic antibodies designed with an AI-led computational system, aimed at biological targets that conventional antibody discovery has struggled to drug. In March 2026 it raised a £7m Series A led by Soulmates Ventures, joined by Innovation Investment Capital, DOMiNO Ventures, the Development Bank of Wales, Kadmos Capital and the i&i Biotech Fund. Murat Tunaboylu is co-founder and chief executive. The company was incorporated in April 2017 and is registered at Maindy Road, Cardiff. [Labs Round 7, 30 Oct 2026] key_facts: Chief executive and co-founder Murat Tunaboylu; lead investor Soulmates Ventures; others Innovation Investment Capital, DOMiNO Ventures, DBW, Kadmos Capital, i&i Biotech Fund; collaboration with the Cystic Fibrosis Foundation [Labs Round 7, 30 Oct 2026] founders: Founded 2017 in Cardiff by Ben Holland, Murat Tunaboylu (chief executive) and Rowina Westermeier [Labs Round 7, 30 Oct 2026] Listed on Labs (Protein design): Cardiff company whose generative antibody design platform is its main work; $9.3m (£7m) Series A 2026-03-03 already on site (DEAL-INV-015) [Labs Round 8, 31 Oct 2026] what_it_does: Generative AI plus wet-lab antibody discovery for GPCRs and other hard targets; models retrained on its own results [Labs Round 8, 31 Oct 2026] research_focus: GPCR and transmembrane training data since 2017; \">240\" proprietary stable cell lines for GPCRs and ion channels; \"100B Ab-ag interactions probed\" [Labs Round 8, 31 Oct 2026] customers_or_partners: Cystic Fibrosis Foundation (research agreement, 2026-03-10); Nxera Pharma (GPCR antibodies, by 2024-12-28); GlobalBio, Inc. (extended 2023-10-16) [Labs Round 8, 31 Oct 2026] research_leads: Ben Holland — CTO and co-founder [Labs Round 8, 31 Oct 2026] customers_or_partners: Research agreement with the Cystic Fibrosis Foundation, announced alongside a $9.3M Series A (no date on page)", "uk_status": "uk", "company": { "ch_number": "10736975", "registered_office": "Sbarc, Spark 5th Floor, Maindy Rd, Cardiff, United Kingdom, CF24 4HQ", "incorporated": "2017-04-24", "legal_form": "ltd", "owner_or_acquirer": null, "headcount": null, "ch_number_clean": "10736975", "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/10736975", "ch_note": null }, "place": { "text": "Cardiff (CF24 4HQ)", "postcode": "CF24 4HQ", "lat": 51.493078, "lng": -3.184173, "region": "Wales", "admin_district": "Cardiff", "geocoded": "postcodes.io" }, "people": [ { "name": "Murat Tunaboylu", "role": "Co-founder and CEO", "from": null, "source": "https://www.uktech.news/ai/welsh-biotech-raises-7m-for-ai-designed-antibodies-20260303" }, { "name": "Murat Tunaboylu", "role": "co-founder and chief executive", "from": null, "source": "https://www.uktech.news/ai/welsh-biotech-raises-7m-for-ai-designed-antibodies-20260303", "round4": true }, { "name": "Ben Holland", "role": "CTO and co-founder", "from": null, "source": "https://www.antiverse.io/news", "round4": true }, { "name": "Murat Tunaboylu", "role": "co-founder and CEO", "from": null, "source": "https://www.antiverse.io/about", "round4": true }, { "name": "Thane Kreiner", "role": "Board Chair", "from": null, "source": "https://www.antiverse.io/about", "round4": true } ], "money": [ { "kind": "funding_round", "amount": 9300000, "currency": "USD", "date": "2026-03-03", "detail": "Series A led by Soulmates Ventures", "raw": "funding_round: 9300000 USD 2026-03-03 — Series A led by Soulmates Ventures", "amount_gbp": 6991430, "fx_rate": 1.3302, "fx_source": "Bank of England daily spot rate (series XUDLUSS, XUDLERS), US$1.3302 per £ on 2026-03-03", "fx_date": "2026-03-03", "fx_note": "", "txt": "US$9.3m", "gbp_txt": "£7m" } ], "site": null, "product": null, "dsit_domains": [ "Knowledge generation", "AI development and training" ], "sectors": [ "drug discovery", "antibodies" ], "confidence": "verified", "checked": "2026-10-29", "as_of": "2026-10-29", "applied": null, "held": [], "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "Cardiff company that uses AI to design antibody drugs against targets that are hard to reach with existing methods.", "affiliation": "Start-ups", "sources": [ "https://www.uktech.news/ai/welsh-biotech-raises-7m-for-ai-designed-antibodies-20260303", "https://find-and-update.company-information.service.gov.uk/search/companies?q=antiverse+ltd", "https://find-and-update.company-information.service.gov.uk/company/10736975", "https://www.uktech.news/featured/wales-antibody-drug-discovery-platform-antiverse-funding-20210318", "https://www.antiverse.io/platform", "https://www.antiverse.io/", "https://www.antiverse.io/news", "https://www.antiverse.io/about", "https://tech.eu/2026/03/03/antiverse-secures-93m-series-a-for-ai-antibody-platform/" ], "source_quotes": [ { "url": "https://www.uktech.news/ai/welsh-biotech-raises-7m-for-ai-designed-antibodies-20260303", "quotes": [ "Many biologically important targets have remained difficult to drug using conventional antibody discovery methods,", "$9.3m (£7m) Series A", "Soulmates Ventures" ], "accessed": "2026-10-29", "trade": true, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/search/companies?q=antiverse+ltd", "quotes": [ "ANTIVERSE LTD\" \"10736975\" \"24 April 2017\" \"Sbarc, Spark 5th Floor, Maindy Rd, Cardiff, United Kingdom, CF24 4HQ" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/10736975", "quotes": [ "ANTIVERSE LTD\" \"Sbarc, Spark 5th Floor, Maindy Rd, Cardiff, United Kingdom, CF24 4HQ\" \"Active\" \"Private limited Company\" \"24 April 2017" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://www.uktech.news/featured/wales-antibody-drug-discovery-platform-antiverse-funding-20210318", "quotes": [ "Founded in 2017 by Ben Holland, Murat Tunaboylu, and Rowina Westermeier" ], "accessed": "2026-10-30", "trade": true, "amendment": false }, { "url": "https://www.antiverse.io/platform", "quotes": [ "Results feed directly back into the generative model, so the next design cycle starts smarter than the last." ], "accessed": "2026-10-30", "trade": false, "amendment": false }, { "url": "https://www.antiverse.io/", "quotes": [ "Training data purpose built for GPCRs and transmembrane proteins, since 2017." ], "accessed": "2026-10-30", "trade": false, "amendment": false }, { "url": "https://www.antiverse.io/news", "quotes": [ "Antiverse and GlobalBio, Inc. extend collaboration to advance antibody cancer therapeutics" ], "accessed": "2026-10-30", "trade": false, "amendment": false }, { "url": "https://www.antiverse.io/about", "quotes": [ "Antiverse is headquartered in Cardiff, UK, and has offices in Boston, USA and Prague, Czechia." ], "accessed": "2026-10-30", "trade": false, "amendment": false }, { "url": "https://tech.eu/2026/03/03/antiverse-secures-93m-series-a-for-ai-antibody-platform/", "quotes": [ "(trade) — \"The financing brings Antiverse’s total capital raised to more than $20 million." ], "accessed": "2026-10-30", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [ "Knowledge generation", "AI development and training" ], "one_source": false, "confidence_raw": "verified", "depts": [ { "dept": "drug discovery", "div": "health" } ], "div_label": "Health", "location": "Cardiff (CF24 4HQ)", "status_group": "active", "ext_links": [ { "kind": "linked from: funds", "id": "BIZ-INV-052", "name": "Development Bank of Wales", "page": "investors", "href": "../../investors/#org=BIZ-INV-052", "page_label": "Investors" }, { "kind": "linked from: funds", "id": "BIZ-INV-053", "name": "Innovation Investment Capital (Cardiff Capital Region)", "page": "investors", "href": "../../investors/#org=BIZ-INV-053", "page_label": "Investors" }, { "kind": "funded_by", "id": "BIZ-INV-052", "name": "Development Bank of Wales", "page": "investors", "href": "../../investors/#org=BIZ-INV-052", "page_label": "Investors" }, { "kind": "linked from: made_by", "id": "BIZ-LAB-14057", "name": "Antiverse Platform", "page": "labs", "href": "../../labs/#org=BIZ-LAB-14057", "page_label": "Labs" }, { "kind": "linked from: made_by", "id": "BIZ-LAB-14058", "name": "AntiConf (antibody-antigen confidence score)", "page": "labs", "href": "../../labs/#org=BIZ-LAB-14058", "page_label": "Labs" } ], "label_links": [ { "kind": "funded_by", "name": "Soulmates Ventures" }, { "kind": "funded_by", "name": "Kadmos Capital" }, { "kind": "funded_by", "name": "i&i Biotech Fund" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-014", "name": "Frontier Health", "bucket": "co", "status": "active", "status_date": "2026-06-19", "status_detail": "Raised US$16m (£12.09m) in seed funding led by Atomico, with firstminute capital and XYZ, reported 19 June 2026.", "one_line": "Makes JUNO, an AI 'teammate' that takes on administrative work inside NHS organisations.", "description": "Frontier Health offers AI administrative tools to the NHS; its product JUNO is described as an AI teammate that adapts to the processes of the systems it is connected to. It was founded in 2024 by Rachel Finegold, formerly healthcare lead at Palantir Technologies, who is chief executive. In June 2026 it raised a US$16m seed round led by Atomico. Its city and Companies House record were not confirmed (several companies share the name).", "uk_status": "uk", "company": { "ch_number": null, "registered_office": null, "incorporated": null, "legal_form": null, "owner_or_acquirer": null, "headcount": null, "ch_number_clean": null, "companies_house_url": null, "ch_note": null }, "place": { "text": null, "postcode": null, "lat": null, "lng": null, "region": null }, "people": [ { "name": "Rachel Finegold", "role": "Founder and CEO", "from": "2024", "source": "https://www.uktech.news/medtech/ai-health-tech-from-ex-palantir-lead-raises-12m-20260619" } ], "money": [ { "kind": "funding_round", "amount": 16000000, "currency": "USD", "date": "2026-06-19", "detail": "seed led by Atomico, with firstminute capital and XYZ", "raw": "funding_round: 16000000 USD 2026-06-19 — seed led by Atomico, with firstminute capital and XYZ", "amount_gbp": 12092812, "fx_rate": 1.3231, "fx_source": "Bank of England daily spot rate (series XUDLUSS, XUDLERS), US$1.3231 per £ on 2026-06-19", "fx_date": "2026-06-19", "fx_note": "", "txt": "US$16m", "gbp_txt": "£12.1m" } ], "site": null, "product": null, "dsit_domains": [ "Autonomous and agent systems", "Natural language applications" ], "sectors": [ "health administration" ], "confidence": "single_source", "checked": "2026-10-29", "as_of": "2026-10-29", "applied": null, "held": [], "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "Makes JUNO, an AI 'teammate' that takes on administrative work inside NHS organisations.", "affiliation": "Start-ups", "sources": [ "https://www.uktech.news/medtech/ai-health-tech-from-ex-palantir-lead-raises-12m-20260619" ], "source_quotes": [ { "url": "https://www.uktech.news/medtech/ai-health-tech-from-ex-palantir-lead-raises-12m-20260619", "quotes": [ "AI health tech from ex-Palantir lead raises £12m; $16m (£12.09m) seed; led by Atomico; JUNO, an AI \"teammate\"; founded 2024" ], "accessed": "2026-10-29", "trade": true, "amendment": false } ], "website": [], "colleges": [], "topics": [ "Autonomous and agent systems", "Natural language applications" ], "one_source": true, "confidence_raw": "single_source", "depts": [ { "dept": "health administration", "div": "health" } ], "div_label": "Health", "location": null, "status_group": "active", "ext_links": [ { "kind": "funded_by", "id": "BIZ-INV-011", "name": "Atomico", "page": "investors", "href": "../../investors/#org=BIZ-INV-011", "page_label": "Investors" }, { "kind": "funded_by", "id": "BIZ-INV-206", "name": "firstminute capital", "page": "investors", "href": "../../investors/#org=BIZ-INV-206", "page_label": "Investors" }, { "kind": "linked from: works_at", "id": "BIZ-TAL-164", "name": "Rachel Finegold", "page": "talent", "href": "../../talent/#org=BIZ-TAL-164", "page_label": "Talent" }, { "kind": "linked from: founder_of", "id": "BIZ-TAL-164", "name": "Rachel Finegold", "page": "talent", "href": "../../talent/#org=BIZ-TAL-164", "page_label": "Talent" }, { "kind": "linked from: portfolio_of", "id": "BIZ-INV-2263", "name": "XYZ", "page": "investors", "href": "../../investors/#org=BIZ-INV-2263", "page_label": "Investors" }, { "kind": "funded_by", "id": "BIZ-INV-2263", "name": "XYZ", "page": "investors", "href": "../../investors/#org=BIZ-INV-2263", "page_label": "Investors" }, { "kind": "linked from: portfolio_of", "id": "BIZ-INV-011", "name": "Atomico", "page": "investors", "href": "../../investors/#org=BIZ-INV-011", "page_label": "Investors" }, { "kind": "funded_by", "id": "BIZ-INV-011", "name": "Atomico", "page": "investors", "href": "../../investors/#org=BIZ-INV-011", "page_label": "Investors" }, { "kind": "linked from: portfolio_of", "id": "BIZ-INV-206", "name": "firstminute capital", "page": "investors", "href": "../../investors/#org=BIZ-INV-206", "page_label": "Investors" }, { "kind": "funded_by", "id": "BIZ-INV-206", "name": "firstminute capital", "page": "investors", "href": "../../investors/#org=BIZ-INV-206", "page_label": "Investors" } ], "label_links": [ { "kind": "supplies", "name": "NHS" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-015", "name": "Flok Health", "bucket": "co", "status": "active", "status_date": "2026-06-03", "status_detail": "Raised a US$12.5m (£9.5m) Series A led by Albion VC, with Eka VC, Form Ventures and Mercia Ventures, reported 3 June 2026.", "one_line": "Cambridge company that runs an AI physiotherapy clinic, offering NHS patients back-pain appointments through an app.", "description": "Flok Health was co-founded in 2022 by Finn Stevenson (chief executive) and Ric da Silva (chief technology officer). It runs an AI-operated digital physiotherapy clinic for musculoskeletal conditions; patients can self-refer and start with an AI digital doctor appointment. By May 2024 it had raised £2m and held Care Quality Commission approval. In June 2026 it raised a £9.5m Series A led by Albion VC to scale its service to NHS patients. The company is registered near Cambridge. [Round 4, 30 Oct 2026] programme: DigitalHealth.London Accelerator cohort (cohort filter 422)", "uk_status": "uk", "company": { "ch_number": "13873781", "registered_office": "Lime Tree Barn, Foxes Bridge Farm, Royston Lane, Comberton, Cambridge, Cambridgeshire, England, CB23 7EE", "incorporated": "2022-01-26", "legal_form": "ltd", "owner_or_acquirer": null, "headcount": null, "ch_number_clean": "13873781", "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/13873781", "ch_note": null }, "place": { "text": "Cambridge (CB23 7EE)", "postcode": "CB23 7EE", "lat": 52.180275, "lng": 0.021194, "region": "England: East of England", "admin_district": "South Cambridgeshire", "geocoded": "postcodes.io" }, "people": [ { "name": "Finn Stevenson", "role": "Co-founder and CEO", "from": "2022", "source": "https://www.uktech.news/medtech/flok-health-raises-9-3m-to-scale-its-ai-clinician-20260603" }, { "name": "Ric da Silva", "role": "Co-founder and CTO", "from": "2022", "source": null } ], "money": [ { "kind": "funding_round", "amount": 12500000, "currency": "USD", "date": "2026-06-03", "detail": "Series A led by Albion VC (UKTN gives both £9.5m and £9.3m)", "raw": "funding_round: 12500000 USD 2026-06-03 — Series A led by Albion VC (UKTN gives both £9.5m and £9.3m)", "amount_gbp": 9302672, "fx_rate": 1.3437, "fx_source": "Bank of England daily spot rate (series XUDLUSS, XUDLERS), US$1.3437 per £ on 2026-06-03", "fx_date": "2026-06-03", "fx_note": "", "txt": "US$12.5m", "gbp_txt": "£9.3m" }, { "kind": "funding_round", "amount": 2000000, "currency": "GBP", "date": "2024-05-24", "detail": "total raised to date (as reported)", "raw": "funding_round: 2000000 GBP 2024-05-24 — total raised to date (as reported)", "amount_gbp": 2000000, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£2m", "gbp_txt": "" } ], "site": null, "product": null, "dsit_domains": [ "Autonomous and agent systems", "AI implementation" ], "sectors": [ "physiotherapy", "musculoskeletal care" ], "confidence": "verified", "checked": "2026-10-29", "as_of": "2026-10-29", "applied": null, "held": [], "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "Cambridge company that runs an AI physiotherapy clinic, offering NHS patients back-pain appointments through an app.", "affiliation": "Start-ups", "sources": [ "https://www.uktech.news/medtech/flok-health-raises-9-3m-to-scale-its-ai-clinician-20260603", "https://www.uktech.news/news/founder-interviews/flok-health-founder-finn-stevenson-20240524", "https://find-and-update.company-information.service.gov.uk/search/companies?q=flok+health", "https://find-and-update.company-information.service.gov.uk/company/13873781", "https://digitalhealth.london/innovation-directory?areainnovation=§or=&technology=&cohort=422" ], "source_quotes": [ { "url": "https://www.uktech.news/medtech/flok-health-raises-9-3m-to-scale-its-ai-clinician-20260603", "quotes": [ "delivers entire healthcare pathways autonomously without requiring human oversight", "$12.5m (£9.5m) Series A", "Albion VC" ], "accessed": "2026-10-29", "trade": true, "amendment": false }, { "url": "https://www.uktech.news/news/founder-interviews/flok-health-founder-finn-stevenson-20240524", "quotes": [ "AI-powered digital physiotherapy clinic for treating musculoskeletal (MSK) conditions", "co-founded Flok Health in 2022 with Ric da Silva", "has raised £2m in funding" ], "accessed": "2026-10-29", "trade": true, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/search/companies?q=flok+health", "quotes": [ "FLOK HEALTH LTD\" \"13873781\" \"26 January 2022" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/13873781", "quotes": [ "FLOK HEALTH LTD", "Active", "26 January 2022", "86900 - Other human health activities" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://digitalhealth.london/innovation-directory?areainnovation=§or=&technology=&cohort=422", "quotes": [ "Flok Health’s AI Back Pain Clinic is an AI physiotherapy clinic" ], "accessed": "2026-10-30", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [ "Autonomous and agent systems", "AI implementation" ], "one_source": false, "confidence_raw": "verified", "depts": [ { "dept": "physiotherapy", "div": "health" } ], "div_label": "Health", "location": "Cambridge (CB23 7EE)", "status_group": "active", "ext_links": [ { "kind": "linked from: works_at", "id": "BIZ-TAL-175", "name": "Finn Stevenson", "page": "talent", "href": "../../talent/#org=BIZ-TAL-175", "page_label": "Talent" }, { "kind": "linked from: founder_of", "id": "BIZ-TAL-175", "name": "Finn Stevenson", "page": "talent", "href": "../../talent/#org=BIZ-TAL-175", "page_label": "Talent" }, { "kind": "linked from: works_at", "id": "BIZ-TAL-176", "name": "Ric da Silva", "page": "talent", "href": "../../talent/#org=BIZ-TAL-176", "page_label": "Talent" }, { "kind": "linked from: founder_of", "id": "BIZ-TAL-176", "name": "Ric da Silva", "page": "talent", "href": "../../talent/#org=BIZ-TAL-176", "page_label": "Talent" } ], "label_links": [ { "kind": "funded_by", "name": "AlbionVC" }, { "kind": "funded_by", "name": "Eka VC" }, { "kind": "funded_by", "name": "Form Ventures" }, { "kind": "funded_by", "name": "Mercia Ventures" }, { "kind": "supplies", "name": "NHS" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-016", "name": "Ternary Therapeutics", "bucket": "co", "status": "active", "status_date": "2026-10-31", "status_detail": "Secured a £3.6m seed investment led by daphni, with Pace Ventures, the i&i Biotech Fund and the UK Innovation & Science Seed Fund, reported 16 March 2026. Companies House shows TERNARY THERAPEUTICS LTD as Active (checked 31 Oct 2026).", "one_line": "London start-up building an AI platform to design 'molecular glue' medicines.", "description": "Ternary Therapeutics was founded in 2024 and is building an AI platform to create molecular glues, a class of medicines, combining machine learning, physics-based molecular modelling and rapid laboratory testing. In March 2026 it raised a £3.6m seed round led by daphni. Chris Tame is a co-founder. The company is registered at Triton Street, London. [Labs Round 8, 31 Oct 2026] Listed on Labs (Drug discovery): London start-up (founded 2024) whose AI models design molecular glues, retrained on its own lab results", "uk_status": "uk", "company": { "ch_number": "16004737", "registered_office": "Office E, Level 2, 20 Triton Street, London, England, NW1 3BF", "incorporated": "2024-10-08", "legal_form": "ltd", "owner_or_acquirer": null, "headcount": null, "ch_number_clean": "16004737", "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/16004737", "ch_note": null }, "place": { "text": "London (NW1 3BF)", "postcode": "NW1 3BF", "lat": 51.524907, "lng": -0.142319, "region": "England: London", "admin_district": "Camden", "geocoded": "postcodes.io" }, "people": [ { "name": "Chris Tame", "role": "Co-founder", "from": "2024", "source": "https://www.uktech.news/medtech/biotech-building-molecular-glues-ai-platform-raises-3-6m-20260316" }, { "name": "Chris Tame", "role": "Co-founder and CEO", "from": "as of 2026-03-16", "source": "https://www.uktech.news/medtech/biotech-building-molecular-glues-ai-platform-raises-3-6m-20260316", "round4": true } ], "money": [ { "kind": "funding_round", "amount": 3600000, "currency": "GBP", "date": "2026-03-16", "detail": "seed led by daphni", "raw": "funding_round: 3600000 GBP 2026-03-16 — seed led by daphni", "amount_gbp": 3600000, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£3.6m", "gbp_txt": "" } ], "site": null, "product": null, "dsit_domains": [ "Knowledge generation", "AI development and training" ], "sectors": [ "drug discovery" ], "confidence": "verified", "checked": "2026-10-29", "as_of": "2026-10-29", "applied": null, "held": [], "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "London start-up building an AI platform to design 'molecular glue' medicines.", "affiliation": "Start-ups", "sources": [ "https://www.uktech.news/medtech/biotech-building-molecular-glues-ai-platform-raises-3-6m-20260316", "https://find-and-update.company-information.service.gov.uk/search/companies?q=ternary+therapeutics", "https://find-and-update.company-information.service.gov.uk/company/16004737/officers", "https://find-and-update.company-information.service.gov.uk/company/16004737" ], "source_quotes": [ { "url": "https://www.uktech.news/medtech/biotech-building-molecular-glues-ai-platform-raises-3-6m-20260316", "quotes": [ "London-based business\" \"an AI platform to create a class of medicines known as “molecular glues”,\" \"has secured a £3.6m seed investment\" \"was founded in 2024" ], "accessed": "2026-10-29", "trade": true, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/search/companies?q=ternary+therapeutics", "quotes": [ "TERNARY THERAPEUTICS LTD\" \"16004737\" \"8 October 2024" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/16004737/officers", "quotes": [ "TAME, Christopher John, Dr.\" Director appointed \"8 October 2024\" (Active)", "MEERSCHMAN, Pierre-Yves\" Director \"23 July 2026" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/16004737", "quotes": [ "TERNARY THERAPEUTICS LTD | Company number 16004737 | Active" ], "accessed": "2026-10-31", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [ "Knowledge generation", "AI development and training" ], "one_source": false, "confidence_raw": "verified", "depts": [ { "dept": "drug discovery", "div": "health" } ], "div_label": "Health", "location": "London (NW1 3BF)", "status_group": "active", "ext_links": [], "label_links": [ { "kind": "funded_by", "name": "daphni" }, { "kind": "funded_by", "name": "Pace Ventures" }, { "kind": "funded_by", "name": "i&i Biotech Fund" }, { "kind": "funded_by", "name": "UK Innovation & Science Seed Fund" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-017", "name": "Gladys", "bucket": "co", "status": "active", "status_date": "2026-10-31", "status_detail": "Raised a £1.5m seed round led by Cornerstone VC, reported 13 October 2025. Companies House shows GLADYS LTD as Active (checked 31 Oct 2026).", "one_line": "Bath company whose AI platform matches people who need home care with local carers and helpers.", "description": "Gladys is a Bath-based AI platform for the home care sector that matches people seeking care with local carers and helpers. It was founded in 2023; Georgina Robinson is co-founder and chief executive and Alex Sorisi is a co-founder. In October 2025 it raised £1.5m led by Cornerstone VC, with Exceptional Ventures, Embryo Ventures, Ufi Ventures, Houghton Street Ventures and Conduit EIS Impact Fund.", "uk_status": "uk", "company": { "ch_number": "15041725", "registered_office": null, "incorporated": null, "legal_form": null, "owner_or_acquirer": null, "headcount": null, "ch_number_clean": "15041725", "from_round2": true, "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/15041725", "ch_note": null }, "place": { "text": "Bath", "postcode": "N1 8QN", "lat": 51.538364, "lng": -0.098222, "region": "England: South West", "admin_district": "Islington", "geocoded": "postcodes.io" }, "people": [ { "name": "Georgina Robinson", "role": "Co-founder and CEO", "from": "2023", "source": "https://www.uktech.news/medtech/gladys-1-5m-ai-home-care-20251013" }, { "name": "Alex Sorisi", "role": "Co-founder", "from": "2023", "source": null } ], "money": [ { "kind": "funding_round", "amount": 1500000, "currency": "GBP", "date": "2025-10-13", "detail": "seed led by Cornerstone VC", "raw": "funding_round: 1500000 GBP 2025-10-13 — seed led by Cornerstone VC", "amount_gbp": 1500000, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£1.5m", "gbp_txt": "" } ], "site": null, "product": null, "dsit_domains": [ "AI implementation" ], "sectors": [ "home care", "social care" ], "confidence": "verified", "checked": "2026-10-29", "as_of": "2026-10-29", "applied": [ { "from": "Companies House check, 29 Oct 2026", "field": "company.ch_number", "text": "company.ch_number → 15041725 (founders named in the record are directors: \"ROBINSON, Georgina Clare\" and \"SORISI, Alexandro William\", both from 1 August 2023)" } ], "held": [], "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "Bath company whose AI platform matches people who need home care with local carers and helpers.", "affiliation": "Start-ups", "sources": [ "https://www.uktech.news/medtech/gladys-1-5m-ai-home-care-20251013", "https://find-and-update.company-information.service.gov.uk/search?q=gladys+ai", "https://find-and-update.company-information.service.gov.uk/company/15041725/officers", "https://find-and-update.company-information.service.gov.uk/company/15041725" ], "source_quotes": [ { "url": "https://www.uktech.news/medtech/gladys-1-5m-ai-home-care-20251013", "quotes": [ "The Bath-based tech firm\" \"an AI-powered tech platform built to support the home care sector\" \"a seed funding round worth £1.5m\" \"Georgina Robinson, co-founder and chief executive of Gladys" ], "accessed": "2026-10-29", "trade": true, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/search?q=gladys+ai", "quotes": [ "GLADYS LTD", "15041725", "Incorporated on 1 August 2023", "4 Elder Walk, London, England, N1 8QN" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/15041725/officers", "quotes": [ "ROBINSON, Georgina Clare", "Director", "1 August 2023", "SORISI, Alexandro William" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/15041725", "quotes": [ "GLADYS LTD | Company number 15041725 | Active" ], "accessed": "2026-10-31", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [ "AI implementation" ], "one_source": false, "confidence_raw": "verified", "depts": [ { "dept": "home care", "div": "health" } ], "div_label": "Health", "location": "Bath", "status_group": "active", "ext_links": [], "label_links": [ { "kind": "funded_by", "name": "Cornerstone VC" }, { "kind": "funded_by", "name": "Ufi Ventures" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-018", "name": "Flexzo AI", "bucket": "co", "status": "active", "status_date": "2026-03-20", "status_detail": "Completed a US$12m (£8.9m) Series A led by Octopus Ventures, with Fuel Ventures, reported 20 March 2026.", "one_line": "Makes AI agent software that helps hospitals find temporary and permanent staff and manage rotas and staff banks.", "description": "Flexzo AI was founded in 2023 by Jack Henderson. It describes its product as an agentic workforce system for healthcare providers: it helps hospitals source temporary and permanent staff and handles rostering and staff bank and float pool management. In March 2026 it completed a US$12m Series A led by Octopus Ventures. Its city and Companies House number were not confirmed.", "uk_status": "uk", "company": { "ch_number": null, "registered_office": null, "incorporated": null, "legal_form": null, "owner_or_acquirer": null, "headcount": null, "ch_number_clean": null, "companies_house_url": null, "ch_note": null }, "place": { "text": null, "postcode": null, "lat": null, "lng": null, "region": null }, "people": [ { "name": "Jack Henderson", "role": "Founder", "from": "2023", "source": "https://www.uktech.news/ai/agentic-healthcare-platform-flexzo-ai-raises-9m-20260320" } ], "money": [ { "kind": "funding_round", "amount": 12000000, "currency": "USD", "date": "2026-03-20", "detail": "Series A led by Octopus Ventures, with Fuel Ventures", "raw": "funding_round: 12000000 USD 2026-03-20 — Series A led by Octopus Ventures, with Fuel Ventures", "amount_gbp": 9021200, "fx_rate": 1.3302, "fx_source": "Bank of England daily spot rate (series XUDLUSS, XUDLERS), US$1.3302 per £ on 2026-03-20", "fx_date": "2026-03-20", "fx_note": "", "txt": "US$12m", "gbp_txt": "£9m" } ], "site": null, "product": null, "dsit_domains": [ "Autonomous and agent systems" ], "sectors": [ "health workforce", "health administration" ], "confidence": "single_source", "checked": "2026-10-29", "as_of": "2026-10-29", "applied": null, "held": [], "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "Makes AI agent software that helps hospitals find temporary and permanent staff and manage rotas and staff banks.", "affiliation": "Start-ups", "sources": [ "https://www.uktech.news/ai/agentic-healthcare-platform-flexzo-ai-raises-9m-20260320" ], "source_quotes": [ { "url": "https://www.uktech.news/ai/agentic-healthcare-platform-flexzo-ai-raises-9m-20260320", "quotes": [ "an agentic workforce system for healthcare providers\" \"completed a $12m (£8.9m) Series A funding round\" \"led by Octopus Ventures" ], "accessed": "2026-10-29", "trade": true, "amendment": false } ], "website": [], "colleges": [], "topics": [ "Autonomous and agent systems" ], "one_source": true, "confidence_raw": "single_source", "depts": [ { "dept": "health workforce", "div": "health" } ], "div_label": "Health", "location": null, "status_group": "active", "ext_links": [ { "kind": "funded_by", "id": "BIZ-INV-201", "name": "Octopus Ventures", "page": "investors", "href": "../../investors/#org=BIZ-INV-201", "page_label": "Investors" } ], "label_links": [ { "kind": "funded_by", "name": "Fuel Ventures" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-019", "name": "Klaris", "bucket": "co", "status": "active", "status_date": "2026-10-31", "status_detail": "Raised a US$1m (£730,000) pre-seed round led by Meridian Health Ventures, reported 17 February 2026. Companies House shows KLARIS AI LTD as Active (checked 31 Oct 2026).", "one_line": "London start-up whose AI writes the technical paperwork medical device makers need for regulatory approval.", "description": "Klaris is a London start-up founded to tackle the difficulty of getting regulatory approval for new medical devices. Its AI platform automates the development of technical documentation. In February 2026 it raised a US$1m pre-seed round led by Meridian Health Ventures, with Antler, Vento Ventures, Alecla7 and angel investors. Francesco Corazza is co-founder and chief executive.", "uk_status": "uk", "company": { "ch_number": "16105493", "registered_office": null, "incorporated": null, "legal_form": null, "owner_or_acquirer": null, "headcount": null, "ch_number_clean": "16105493", "from_round2": true, "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/16105493", "ch_note": null }, "place": { "text": "London", "postcode": "E1 6HU", "lat": 51.524402, "lng": -0.077526, "region": "England: London", "admin_district": "Hackney", "geocoded": "postcodes.io" }, "people": [ { "name": "Francesco Corazza", "role": "Co-founder and CEO", "from": null, "source": "https://www.uktech.news/medtech/klaris-medical-device-pre-seed-20260217" } ], "money": [ { "kind": "funding_round", "amount": 1000000, "currency": "USD", "date": "2026-02-17", "detail": "pre-seed led by Meridian Health Ventures", "raw": "funding_round: 1000000 USD 2026-02-17 — pre-seed led by Meridian Health Ventures", "amount_gbp": 740576, "fx_rate": 1.3503, "fx_source": "Bank of England daily spot rate (series XUDLUSS, XUDLERS), US$1.3503 per £ on 2026-02-17", "fx_date": "2026-02-17", "fx_note": "", "txt": "US$1m", "gbp_txt": "£740,576" } ], "site": null, "product": null, "dsit_domains": [ "Natural language applications", "AI security and assurance" ], "sectors": [ "medical device regulation", "compliance" ], "confidence": "verified", "checked": "2026-10-29", "as_of": "2026-10-29", "applied": null, "held": [], "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "London start-up whose AI writes the technical paperwork medical device makers need for regulatory approval.", "affiliation": "Start-ups", "sources": [ "https://www.uktech.news/medtech/klaris-medical-device-pre-seed-20260217", "https://find-and-update.company-information.service.gov.uk/company/16105493", "https://find-and-update.company-information.service.gov.uk/company/16105493/officers" ], "source_quotes": [ { "url": "https://www.uktech.news/medtech/klaris-medical-device-pre-seed-20260217", "quotes": [ "The London-based startup was founded to address the challenges of securing regulatory approval for new medical devices.\" \"Klaris aims to address this by automating the development of technical documentation\" \"The pre-seed funding round was led by Meridian Health Ventures." ], "accessed": "2026-10-29", "trade": true, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/16105493", "quotes": [ "KLARIS AI LTD\" \"186 Shoreditch High Street, C/O Fora, London, England, E1 6HU\" \"Active\" \"27 November 2024" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/16105493/officers", "quotes": [ "CORAZZA, Francesco\" Director (Active) \"27 November 2024" ], "accessed": "2026-10-29", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [ "Natural language applications", "AI security and assurance" ], "one_source": false, "confidence_raw": "verified", "depts": [ { "dept": "medical device regulation", "div": "health" } ], "div_label": "Health", "location": "London", "status_group": "active", "ext_links": [ { "kind": "funded_by", "id": "BIZ-TAL-193", "name": "Antler UK", "page": "talent", "href": "../../talent/#org=BIZ-TAL-193", "page_label": "Talent" }, { "kind": "linked from: portfolio_of", "id": "BIZ-INV-2176", "name": "Meridian Health Ventures", "page": "investors", "href": "../../investors/#org=BIZ-INV-2176", "page_label": "Investors" }, { "kind": "funded_by", "id": "BIZ-INV-2176", "name": "Meridian Health Ventures", "page": "investors", "href": "../../investors/#org=BIZ-INV-2176", "page_label": "Investors" } ], "label_links": [ { "kind": "funded_by", "name": "Meridian Health Ventures" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-020", "name": "Magnitude Biosciences", "bucket": "co", "status": "active", "status_date": "2026-09-15", "status_detail": "Raised £1.3m led by Northstar Ventures, with Maven-managed regional funds and angel investors, reported 15 September 2026.", "one_line": "Durham University spin-out that tests drug candidates on tiny worms, using imaging, machine learning and robotics to read the results.", "description": "Magnitude Biosciences is a contract research organisation spun out of Durham University. Its VivoScan platform screens potential drugs in C. elegans nematode worms as whole organisms, combining the worms with imaging, machine learning, AI, automation and robotics. In September 2026 it raised £1.3m led by Northstar Ventures. Fozia Saleem is chief executive. The company is registered at NETPark, Sedgefield, County Durham. AI is one named part of a wider laboratory service (diversified).", "uk_status": "uk", "company": { "ch_number": "11579884", "registered_office": "Netpark Plexus, Thomas Wright Way, Sedgefield, England, TS21 3FD", "incorporated": "2018-09-20", "legal_form": "ltd", "owner_or_acquirer": null, "headcount": null, "ch_number_clean": "11579884", "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/11579884", "ch_note": null }, "place": { "text": "NETPark, Sedgefield (TS21 3FD)", "postcode": "TS21 3FD", "lat": 54.67032, "lng": -1.451383, "region": "England: North East", "admin_district": "County Durham", "geocoded": "postcodes.io" }, "people": [ { "name": "Fozia Saleem", "role": "CEO", "from": null, "source": "https://www.uktech.news/funding/magnitude-biosciences-raises-1-3m-to-scale-drug-discovery-platform-20260915" } ], "money": [ { "kind": "funding_round", "amount": 1300000, "currency": "GBP", "date": "2026-09-15", "detail": "led by Northstar Ventures", "raw": "funding_round: 1300000 GBP 2026-09-15 — led by Northstar Ventures", "amount_gbp": 1300000, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£1.3m", "gbp_txt": "" } ], "site": null, "product": null, "dsit_domains": [ "Knowledge generation", "Perceptual systems" ], "sectors": [ "drug discovery", "contract research" ], "confidence": "verified", "checked": "2026-10-29", "as_of": "2026-10-29", "applied": null, "held": [], "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "Durham University spin-out that tests drug candidates on tiny worms, using imaging, machine learning and robotics to read the results.", "affiliation": "Start-ups", "sources": [ "https://www.uktech.news/funding/magnitude-biosciences-raises-1-3m-to-scale-drug-discovery-platform-20260915", "https://find-and-update.company-information.service.gov.uk/search/companies?q=magnitude+biosciences", "https://find-and-update.company-information.service.gov.uk/company/11579884" ], "source_quotes": [ { "url": "https://www.uktech.news/funding/magnitude-biosciences-raises-1-3m-to-scale-drug-discovery-platform-20260915", "quotes": [ "Magnitude combines the worms with imaging, machine learning, AI, automation and robotics.\" \"Northstar Ventures led the £1.3m funding round,\" \"Magnitude Biosciences was spun out of Durham University." ], "accessed": "2026-10-29", "trade": true, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/search/companies?q=magnitude+biosciences", "quotes": [ "MAGNITUDE BIOSCIENCES LIMITED\" \"11579884\" \"20 September 2018\" \"Netpark Plexus, Thomas Wright Way, Sedgefield, England, TS21 3FD" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/11579884", "quotes": [ "MAGNITUDE BIOSCIENCES LIMITED", "Netpark Plexus, Thomas Wright Way, Sedgefield, England, TS21 3FD", "Active", "20 September 2018", "72110 - Research and experimental development on biotechnology" ], "accessed": "2026-10-29", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [ "Knowledge generation", "Perceptual systems" ], "one_source": false, "confidence_raw": "verified", "depts": [ { "dept": "drug discovery", "div": "health" } ], "div_label": "Health", "location": "NETPark, Sedgefield (TS21 3FD)", "status_group": "active", "ext_links": [], "label_links": [ { "kind": "spun_out_of", "name": "Durham University" }, { "kind": "funded_by", "name": "Northstar Ventures" }, { "kind": "funded_by", "name": "Maven Capital Partners" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-021", "name": "Ignota Labs", "bucket": "co", "status": "active", "status_date": "2026-10-31", "status_detail": "Business Weekly reported on 8 July 2025 that its chief scientific officer had been made an Industry and Enterprise Fellow of Clare Hall, after a £5.5m seed raise earlier in 2025 and a collaboration with Sanofi. Companies House shows IGNOTA LABS LIMITED as Active (checked 31 Oct 2026).", "one_line": "Cambridge company that uses AI to work out why promising drugs failed on safety grounds, and then tries to rescue them.", "description": "Ignota Labs takes on drug projects that were abandoned and tries to bring them back. Its AI platform, SAFEPATH, uses deep learning to study why drugs are toxic. Business Weekly reported a £5.5m seed raise in 2025 and a collaboration with Sanofi that includes €120,000 of funding, and said its 12 staff are all in Cambridge. Jordan Lane is chief scientific officer. The company was incorporated in October 2021 and is registered at St John's Innovation Centre, Cambridge.", "uk_status": "uk", "company": { "ch_number": "13678972", "registered_office": "St Johns Innovation Centre, Cowley Road, Cambridge, England, CB4 0WS", "incorporated": "2021-10-14", "legal_form": "ltd", "owner_or_acquirer": null, "headcount": "12, 2025-07-08, Business Weekly", "ch_number_clean": "13678972", "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/13678972", "ch_note": null }, "place": { "text": "Cambridge (CB4 0WS)", "postcode": "CB4 0WS", "lat": 52.234909, "lng": 0.153433, "region": "England: East of England", "admin_district": "Cambridge", "geocoded": "postcodes.io" }, "people": [ { "name": "Jordan Lane", "role": "Chief Scientific Officer", "from": null, "source": "https://www.businessweekly.co.uk/posts/honour-for-cso-maintains-upward-trajectory-for-ignota-labs" } ], "money": [ { "kind": "funding_round", "amount": 5500000, "currency": "GBP", "date": "2025", "detail": "seed (year only, as reported)", "raw": "funding_round: 5500000 GBP 2025 — seed (year only, as reported)", "amount_gbp": 5500000, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£5.5m", "gbp_txt": "" }, { "kind": "contract", "amount": 120000, "currency": "EUR", "date": "2025", "detail": "Sanofi collaboration funding (as reported)", "raw": "contract: 120000 EUR 2025 — Sanofi collaboration funding (as reported)", "amount_gbp": 99182, "fx_rate": 1.2099, "fx_source": "Bank of England daily spot rate (series XUDLUSS, XUDLERS), €1.2099 per £ on 2024-12-31", "fx_date": "2024-12-31", "fx_note": "year only given: rate for 1 January", "txt": "€120,000", "gbp_txt": "£99,182" } ], "site": null, "product": null, "dsit_domains": [ "Knowledge generation" ], "sectors": [ "drug discovery", "drug safety" ], "confidence": "verified", "checked": "2026-10-29", "as_of": "2026-10-29", "applied": null, "held": [], "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "Cambridge company that uses AI to work out why promising drugs failed on safety grounds, and then tries to rescue them.", "affiliation": "Start-ups", "sources": [ "https://www.businessweekly.co.uk/posts/honour-for-cso-maintains-upward-trajectory-for-ignota-labs", "https://find-and-update.company-information.service.gov.uk/search/companies?q=ignota+labs", "https://find-and-update.company-information.service.gov.uk/company/13678972" ], "source_quotes": [ { "url": "https://www.businessweekly.co.uk/posts/honour-for-cso-maintains-upward-trajectory-for-ignota-labs", "quotes": [ "Ignota Labs rescues promising but failing drugs, bringing new life to abandoned projects and new hope to patients.\" \"Its proprietary AI platform, SAFEPATH, uses cutting-edge deep learning\" \"a seed raise of £5.5 million earlier this year\" (dated 8 July 2025)" ], "accessed": "2026-10-29", "trade": true, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/search/companies?q=ignota+labs", "quotes": [ "IGNOTA LABS LIMITED\" \"13678972\" \"14 October 2021\" \"St Johns Innovation Centre, Cowley Road, Cambridge, England, CB4 0WS" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/13678972", "quotes": [ "IGNOTA LABS LIMITED", "Active", "14 October 2021", "ABSOLUTEAI LTD\" \"14 Oct 2021 - 11 Apr 2024" ], "accessed": "2026-10-29", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [ "Knowledge generation" ], "one_source": false, "confidence_raw": "verified", "depts": [ { "dept": "drug discovery", "div": "health" } ], "div_label": "Health", "location": "Cambridge (CB4 0WS)", "status_group": "active", "ext_links": [], "label_links": [ { "kind": "partner_of", "name": "Sanofi" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-022", "name": "Kiin Bio", "bucket": "co", "status": "active", "status_date": "2025-06-05", "status_detail": "Secured a £1.6m pre-seed investment led by b2venture, with Heartfelt, rule30 and angel investors, reported 5 June 2025.", "one_line": "London start-up building a generative-AI 'virtual scientist' to speed up drug discovery.", "description": "Kiin Bio is a London-based firm developing a \"virtual scientist\" drug discovery platform that uses generative AI to speed up the development of new treatments. In June 2025 it raised £1.6m in pre-seed funding led by b2venture to launch the platform. Filippo Abbondanza is chief executive and co-founder. Its Companies House record was not found in this session.", "uk_status": "uk", "company": { "ch_number": "15829728", "registered_office": null, "incorporated": null, "legal_form": null, "owner_or_acquirer": null, "headcount": null, "ch_number_clean": "15829728", "from_round2": true, "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/15829728", "ch_note": null }, "place": { "text": "London", "postcode": "EC2A 1NT", "lat": 51.520378, "lng": -0.087685, "region": "England: London", "admin_district": "Islington", "geocoded": "postcodes.io" }, "people": [ { "name": "Filippo Abbondanza", "role": "Co-founder and CEO", "from": null, "source": "https://www.uktech.news/medtech/ai-drug-discovery-startup-kiin-bio-secures-pre-seed-funding-20250605" } ], "money": [ { "kind": "funding_round", "amount": 1600000, "currency": "GBP", "date": "2025-06-05", "detail": "pre-seed led by b2venture", "raw": "funding_round: 1600000 GBP 2025-06-05 — pre-seed led by b2venture", "amount_gbp": 1600000, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£1.6m", "gbp_txt": "" } ], "site": null, "product": null, "dsit_domains": [ "Autonomous and agent systems", "Knowledge generation" ], "sectors": [ "drug discovery" ], "confidence": "verified", "checked": "2026-10-29", "as_of": "2026-10-29", "applied": null, "held": [], "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "London start-up building a generative-AI 'virtual scientist' to speed up drug discovery.", "affiliation": "Start-ups", "sources": [ "https://www.uktech.news/medtech/ai-drug-discovery-startup-kiin-bio-secures-pre-seed-funding-20250605", "https://find-and-update.company-information.service.gov.uk/company/15829728", "https://find-and-update.company-information.service.gov.uk/company/15829728/officers" ], "source_quotes": [ { "url": "https://www.uktech.news/medtech/ai-drug-discovery-startup-kiin-bio-secures-pre-seed-funding-20250605", "quotes": [ "developing a “virtual scientist” drug discovery platform,\" \"has secured a pre-seed investment of £1.6m.\" \"The funding round was led by b2venture\" \"Filippo Abbondanza, chief executive and co-founder of Kiin Bio." ], "accessed": "2026-10-29", "trade": true, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/15829728", "quotes": [ "KIIN AI LTD\" \"131 Finsbury Pavement, London, United Kingdom, EC2A 1NT\" \"Active\" \"10 July 2024" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/15829728/officers", "quotes": [ "ABBONDANZA, Filippo, Dr\" Director \"10 July 2024\" (Active)" ], "accessed": "2026-10-29", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [ "Autonomous and agent systems", "Knowledge generation" ], "one_source": false, "confidence_raw": "verified", "depts": [ { "dept": "drug discovery", "div": "health" } ], "div_label": "Health", "location": "London", "status_group": "active", "ext_links": [], "label_links": [ { "kind": "funded_by", "name": "b2venture" }, { "kind": "funded_by", "name": "rule30" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-023", "name": "OutSee", "bucket": "co", "status": "active", "status_date": "2026-10-31", "status_detail": "Raised £1.8m in seed funding led by Ahren Innovation Capital, reported 24 June 2025. Companies House shows OUTSEE LIMITED as Active (checked 31 Oct 2026).", "one_line": "University of Cambridge spin-out that uses AI to predict disease from a single genome to find new drug targets.", "description": "OutSee is a University of Cambridge spin-out that describes itself as a drug discovery company using an AI-based predictive genomics approach to find drug targets. Its Nomaly technology predicts disease and traits directly from a single genome. In June 2025 it raised £1.8m in seed funding led by Ahren Innovation Capital, with Kadmos Capital, Empirical Ventures and Panacea Ventures. Julian Gough is founder and chief executive.", "uk_status": "uk", "company": { "ch_number": "14388773", "registered_office": null, "incorporated": null, "legal_form": null, "owner_or_acquirer": null, "headcount": null, "ch_number_clean": "14388773", "from_round2": true, "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/14388773", "ch_note": null }, "place": { "text": "Cambridge", "postcode": "CB1 2JH", "lat": 52.194361, "lng": 0.135318, "region": "England: East of England", "admin_district": "Cambridge", "geocoded": "postcodes.io" }, "people": [ { "name": "Julian Gough", "role": "Founder and CEO", "from": null, "source": "https://www.uktech.news/medtech/outsee-raises-1-8m-seed-funding-20250624" } ], "money": [ { "kind": "funding_round", "amount": 1800000, "currency": "GBP", "date": "2025-06-24", "detail": "seed led by Ahren Innovation Capital", "raw": "funding_round: 1800000 GBP 2025-06-24 — seed led by Ahren Innovation Capital", "amount_gbp": 1800000, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£1.8m", "gbp_txt": "" } ], "site": null, "product": null, "dsit_domains": [ "Knowledge generation" ], "sectors": [ "drug discovery", "genomics" ], "confidence": "verified", "checked": "2026-10-29", "as_of": "2026-10-29", "applied": null, "held": [], "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "University of Cambridge spin-out that uses AI to predict disease from a single genome to find new drug targets.", "affiliation": "Start-ups", "sources": [ "https://www.uktech.news/medtech/outsee-raises-1-8m-seed-funding-20250624", "https://find-and-update.company-information.service.gov.uk/search?q=outsee", "https://www.uktech.news/medtech/outsee-raises-1-8m-seed-funding-20250624", "https://find-and-update.company-information.service.gov.uk/company/14388773" ], "source_quotes": [ { "url": "https://www.uktech.news/medtech/outsee-raises-1-8m-seed-funding-20250624", "quotes": [ "University of Cambridge spinout OutSee\" \"a drug discovery company pioneering an AI-based predictive genomics approach to target discovery." ], "accessed": "2026-10-29", "trade": true, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/search?q=outsee", "quotes": [ "OUTSEE LIMITED", "14388773", "Incorporated on 30 September 2022", "C/O Wework, 50-60 Station Road, Cambridge, England, CB1 2JH" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://www.uktech.news/medtech/outsee-raises-1-8m-seed-funding-20250624", "quotes": [ "University of Cambridge spinout OutSee\" (24 Jun 2025)" ], "accessed": "2026-10-29", "trade": true, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/14388773", "quotes": [ "OUTSEE LIMITED | Company number 14388773 | Active" ], "accessed": "2026-10-31", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [ "Knowledge generation" ], "one_source": false, "confidence_raw": "verified", "depts": [ { "dept": "drug discovery", "div": "health" } ], "div_label": "Health", "location": "Cambridge", "status_group": "active", "ext_links": [ { "kind": "spun_out_of", "id": "UNI:cambridge", "name": "Universities: cambridge", "page": "universities", "href": "https://hazy-wreath-hez6.here.now/cambridge/", "page_label": "UK Universities AI Universe (new tab)" } ], "label_links": [ { "kind": "spun_out_of", "name": "University of Cambridge" }, { "kind": "funded_by", "name": "Ahren Innovation Capital" }, { "kind": "funded_by", "name": "Kadmos Capital" }, { "kind": "funded_by", "name": "Empirical Ventures" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-024", "name": "Scalpel AI", "bucket": "co", "status": "active", "status_date": "2026-10-31", "status_detail": "Closed a £3.8m round led by Mercia Ventures with Tensor Ventures, reported 31 October 2024; no later page opened. Companies House shows SCALPEL LIMITED as Active (checked 31 Oct 2026).", "one_line": "Essex company whose AI identifies and tracks surgical instruments to prevent errors in operating theatres.", "description": "Scalpel AI was founded in 2017 by two doctors who had seen critical errors caused by mismanaged surgical tools. The Essex-based company has built technology to identify and track the performance of surgical instruments. In October 2024 it closed a £3.8m round led by Mercia Ventures with Tensor Ventures. Yeshwanth Pulijala is co-founder and chief executive; Shahnawaz Ahmed is co-founder and chief technology officer. A company named Scalpel Limited, incorporated in November 2017 with an Ingatestone, Essex address, appears on Companies House; the match is likely but not confirmed.", "uk_status": "uk", "company": { "ch_number": "11077030", "registered_office": "46-54 High Street, Ingatestone, Essex, United Kingdom, CM4 9DW", "incorporated": "2017-11-22", "legal_form": "ltd", "owner_or_acquirer": null, "headcount": null, "ch_number_clean": "11077030", "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/11077030", "ch_note": null }, "place": { "text": "Essex", "postcode": "CM4 9DW", "lat": 51.671339, "lng": 0.385829, "region": "England: East of England", "admin_district": "Brentwood", "geocoded": "postcodes.io" }, "people": [ { "name": "Yeshwanth Pulijala", "role": "Co-founder and CEO", "from": "2017", "source": "https://www.uktech.news/medtech/ai-surgery-startup-scalpel-raises-3-8m-20241031" }, { "name": "Shahnawaz Ahmed", "role": "Co-founder and CTO", "from": "2017", "source": null } ], "money": [ { "kind": "funding_round", "amount": 3800000, "currency": "GBP", "date": "2024-10-31", "detail": "led by Mercia Ventures, with Tensor Ventures", "raw": "funding_round: 3800000 GBP 2024-10-31 — led by Mercia Ventures, with Tensor Ventures", "amount_gbp": 3800000, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£3.8m", "gbp_txt": "" } ], "site": null, "product": null, "dsit_domains": [ "Perceptual systems", "AI implementation" ], "sectors": [ "surgery", "hospital operations" ], "confidence": "verified", "checked": "2026-10-29", "as_of": "2026-10-29", "applied": [ { "from": "Companies House check, 29 Oct 2026", "field": "company.ch_number", "text": "company.ch_number → 11077030 (match confirmed: Yeshwanth Pulijala, director from 22 June 2018, and Shahnawaz Ahmed, director from 15 May 2019, are the co-founders named in the record; remove \"likely match, unconfirmed\")" } ], "held": [], "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "Essex company whose AI identifies and tracks surgical instruments to prevent errors in operating theatres.", "affiliation": "Start-ups", "sources": [ "https://www.uktech.news/medtech/ai-surgery-startup-scalpel-raises-3-8m-20241031", "https://find-and-update.company-information.service.gov.uk/search/companies?q=scalpel+ai", "https://find-and-update.company-information.service.gov.uk/company/11077030", "https://find-and-update.company-information.service.gov.uk/company/11077030/officers" ], "source_quotes": [ { "url": "https://www.uktech.news/medtech/ai-surgery-startup-scalpel-raises-3-8m-20241031", "quotes": [ "The Essex-based company has developed technology to identify and track the performance of surgical instruments.\" \"The funding round was led by Mercia Ventures and included participation from Tensor Ventures.\" \"Scalpel AI was founded in 2017 by two doctors" ], "accessed": "2026-10-29", "trade": true, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/search/companies?q=scalpel+ai", "quotes": [ "SCALPEL LIMITED\" \"11077030\" \"22 November 2017\" \"46-54 High Street, Ingatestone, Essex" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/11077030", "quotes": [ "SCALPEL LIMITED", "46-54 High Street, Ingatestone, Essex, United Kingdom, CM4 9DW", "Active", "22 November 2017" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/11077030/officers", "quotes": [ "PULIJALA, Yeshwanth: Director, appointed 22 June 2018", "AHMED, Shahnawaz: Director, appointed 15 May 2019", "MERICA FUND MANAGEMENT (NOMINEES) LIMITED: Director, appointed 17 September 2025\" (as returned by the fetch tool; the name is probably \"MERCIA\")" ], "accessed": "2026-10-29", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [ "Perceptual systems", "AI implementation" ], "one_source": false, "confidence_raw": "verified", "depts": [ { "dept": "surgery", "div": "health" } ], "div_label": "Health", "location": "Essex", "status_group": "active", "ext_links": [ { "kind": "linked from: funds", "id": "BIZ-INV-205", "name": "Mercia (Mercia Ventures, Mercia Asset Management PLC)", "page": "investors", "href": "../../investors/#org=BIZ-INV-205", "page_label": "Investors" } ], "label_links": [ { "kind": "funded_by", "name": "Mercia Ventures" }, { "kind": "funded_by", "name": "Tensor Ventures" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-025", "name": "Shift Bioscience", "bucket": "co", "status": "active", "status_date": "2026-10-31", "status_detail": "Closed a US$16m (£12.2m) seed round led by BGF, with F-Prime Capital, Kindred Capital and Jonathan Milner, reported 15 October 2024; no later page opened. Companies House shows SHIFT BIOSCIENCE LIMITED as Active (checked 31 Oct 2026).", "one_line": "Cambridge company using generative AI to find genes that could make ageing cells young again, as a route to treating age-related disease.", "description": "Shift Bioscience was founded in 2017 by Daniel Ives, its chief executive, who previously worked at the Francis Crick Institute. It uses generative AI models to understand how activating certain genes could rejuvenate cells and address age-related illness. In October 2024 it closed a US$16m seed round led by the Business Growth Fund (BGF). Its Companies House record could not be opened in this session. [Labs Round 7, 30 Oct 2026] key_facts: Chief executive Daniel Ives; seed led by BGF with F-Prime Capital, Kindred Capital and Abcam founder Jonathan Milner (who joined the board) [Labs Round 7, 30 Oct 2026] Listed on Labs (Biology): Cambridge company (founded 2017) whose generative AI cell-simulation platform predicts which gene sets can safely rejuvenate cells; $16m seed 2024-10-15 already on site (DEAL-SU-HLT-034) [Labs Round 8, 31 Oct 2026] research_focus: AI virtual cells that predict cells' gene-activity response to switching genes on or off; first screens in fibrosis [Labs Round 8, 31 Oct 2026] research_leads: Brendan Swain — CSO and founder [Labs Round 8, 31 Oct 2026] chief_executive: Daniel Ives — CEO (as of 2024-10-15) [Labs Round 8, 31 Oct 2026] founded: 2017; Cambridge, UK (founding year stated in article body) [Labs Round 8, 31 Oct 2026] news: 2025-11-11 — earlier press release on a metric calibration framework for genetic perturbation modelling (cited in the 2026-10-05 release)", "uk_status": "uk", "company": { "ch_number": "10793871", "registered_office": null, "incorporated": null, "legal_form": null, "owner_or_acquirer": null, "headcount": null, "ch_number_clean": "10793871", "from_round2": true, "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/10793871", "ch_note": null }, "place": { "text": "Cambridge", "postcode": "CB1 2LA", "lat": 52.194995, "lng": 0.134061, "region": "England: East of England", "admin_district": "Cambridge", "geocoded": "postcodes.io" }, "people": [ { "name": "Daniel Ives", "role": "Founder and CEO", "from": "2017", "source": "https://www.uktech.news/ai/shift-bioscience-gen-ai-reverse-ageing-20241015" }, { "name": "Daniel Ives", "role": "chief executive", "from": null, "source": "https://www.uktech.news/ai/shift-bioscience-gen-ai-reverse-ageing-20241015", "round4": true }, { "name": "Brendan Swain", "role": "CSO and founder", "from": null, "source": "https://www.scientistlive.com/new-research-from-shift-bioscience-increases-confidence-in-ai-virtual-cells-for-novel-target-discovery/", "round4": true }, { "name": "Daniel Ives", "role": "CEO", "from": "as of 2024-10-15", "source": "https://www.uktech.news/ai/shift-bioscience-gen-ai-reverse-ageing-20241015", "round4": true }, { "name": "Laurence Reid", "role": "non-executive director", "from": "2025-03-11", "source": "https://www.businesswire.com/news/home/20250311855995/en/Shift-Bioscience-Announces-Key-Appointments-to-Advance-Rejuvenation-Therapeutics-Pipeline", "round4": true }, { "name": "Jill Reckless", "role": "Translation Advisor", "from": "2025-03-11", "source": "https://www.businesswire.com/news/home/20250311855995/en/Shift-Bioscience-Announces-Key-Appointments-to-Advance-Rejuvenation-Therapeutics-Pipeline", "round4": true } ], "money": [ { "kind": "funding_round", "amount": 16000000, "currency": "USD", "date": "2024-10-15", "detail": "seed led by BGF, with F-Prime Capital, Kindred Capital and Jonathan Milner", "raw": "funding_round: 16000000 USD 2024-10-15 — seed led by BGF, with F-Prime Capital, Kindred Capital and Jonathan Milner", "amount_gbp": 12219337, "fx_rate": 1.3094, "fx_source": "Bank of England daily spot rate (series XUDLUSS, XUDLERS), US$1.3094 per £ on 2024-10-15", "fx_date": "2024-10-15", "fx_note": "", "txt": "US$16m", "gbp_txt": "£12.2m" } ], "site": null, "product": null, "dsit_domains": [ "Knowledge generation", "AI development and training" ], "sectors": [ "drug discovery", "ageing biology" ], "confidence": "verified", "checked": "2026-10-29", "as_of": "2026-10-29", "applied": null, "held": [], "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "Cambridge company using generative AI to find genes that could make ageing cells young again, as a route to treating age-related disease.", "affiliation": "Start-ups", "sources": [ "https://www.uktech.news/ai/shift-bioscience-gen-ai-reverse-ageing-20241015", "https://find-and-update.company-information.service.gov.uk/company/10793871", "https://find-and-update.company-information.service.gov.uk/company/10793871/officers", "https://www.financialcontent.com/article/bizwire-2026-10-5-shift-bioscience-publication-increases-confidence-in-ai-virtual-cells-for-novel-target-discovery", "https://tech.eu/2024/10/15/shift-bioscience-raises-ps125m-to-advance-ai-driven-ageing-research/", "https://www.shiftbioscience.com/news/shift-bioscience-identifies-novel-single-gene-target", "https://www.businesswire.com/news/home/20250311855995/en/Shift-Bioscience-Announces-Key-Appointments-to-Advance-Rejuvenation-Therapeutics-Pipeline", "https://shiftbioscience.com/news/" ], "source_quotes": [ { "url": "https://www.uktech.news/ai/shift-bioscience-gen-ai-reverse-ageing-20241015", "quotes": [ "a Cambridge-based health tech startup\" \"closed a $16m (£12.2m) seed funding round\" \"The BGF-led round included participation from F-Prime Capital, Kindred Capital and Abcam founder Jonathan Milner." ], "accessed": "2026-10-29", "trade": true, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/10793871", "quotes": [ "SHIFT BIOSCIENCE LIMITED\" \"Salisbury House, Station Road, Cambridge, United Kingdom, CB1 2LA\" \"Active\" \"30 May 2017\" \"NEXTNEURAL LIMITED (30 May 2017 - 04 Oct 2017)" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/10793871/officers", "quotes": [ "IVES, Daniel Jeremy, Dr\" Director \"30 May 2017", "MILNER, Jonathan Simon, Dr\" Director \"11 June 2024" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://www.financialcontent.com/article/bizwire-2026-10-5-shift-bioscience-publication-increases-confidence-in-ai-virtual-cells-for-novel-target-discovery", "quotes": [ "are designed to predict how cells respond at a transcriptomic level to genetic interventions" ], "accessed": "2026-10-30", "trade": false, "amendment": false }, { "url": "https://tech.eu/2024/10/15/shift-bioscience-raises-ps125m-to-advance-ai-driven-ageing-research/", "quotes": [ "(trade) — \"Our technology is addressing the current limitations of cellular reprogramming for treatment of age-related illnesses," ], "accessed": "2026-10-30", "trade": false, "amendment": false }, { "url": "https://www.shiftbioscience.com/news/shift-bioscience-identifies-novel-single-gene-target", "quotes": [ "SB000 is well positioned as a target for safer, next-generation cell rejuvenation therapeutics" ], "accessed": "2026-10-30", "trade": false, "amendment": false }, { "url": "https://www.businesswire.com/news/home/20250311855995/en/Shift-Bioscience-Announces-Key-Appointments-to-Advance-Rejuvenation-Therapeutics-Pipeline", "quotes": [ "Shift's technology has clear potential to address this crucial gap" ], "accessed": "2026-10-30", "trade": false, "amendment": false }, { "url": "https://shiftbioscience.com/news/", "quotes": [ "timeline entries \"May 2017\" (founding by Dr Daniel Ives) and \"July 2017\" (initial seed); no verbatim sentence captured" ], "accessed": "2026-10-30", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [ "Knowledge generation", "AI development and training" ], "one_source": false, "confidence_raw": "verified", "depts": [ { "dept": "drug discovery", "div": "health" } ], "div_label": "Health", "location": "Cambridge", "status_group": "active", "ext_links": [ { "kind": "funded_by", "id": "BIZ-INV-026", "name": "Kindred Capital", "page": "investors", "href": "../../investors/#org=BIZ-INV-026", "page_label": "Investors" }, { "kind": "linked from: made_by", "id": "BIZ-LAB-14089", "name": "Shift Bioscience virtual cell and cell-ageing clock platform (SB000 discovery)", "page": "labs", "href": "../../labs/#org=BIZ-LAB-14089", "page_label": "Labs" } ], "label_links": [ { "kind": "funded_by", "name": "BGF" }, { "kind": "funded_by", "name": "F-Prime Capital" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-026", "name": "Presymptom Health", "bucket": "co", "status": "wound_down", "status_date": "2026-05-18", "status_detail": "Raised £1.5m in equity and grant funding from UKI2S, Ploughshare and MedTechToMarket plus Innovate UK, reported 21 March 2024; no later page opened.", "one_line": "Uses machine learning on biobank samples to detect infections and sepsis earlier.", "description": "Presymptom Health was founded in 2019 and uses AI for the early detection of infections and sepsis, applying machine learning to samples from a large biobank. In March 2024 it raised £1.5m in a mix of equity and grant funding from UKI2S, Ploughshare and MedTechToMarket, with Innovate UK grant support. Iain Miller is chief executive. Head office and Companies House record not confirmed in this session.", "uk_status": "uk", "company": { "ch_number": "11834573", "registered_office": null, "incorporated": null, "legal_form": null, "owner_or_acquirer": null, "headcount": null, "ch_number_clean": "11834573", "from_round2": true, "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/11834573", "ch_note": null }, "place": { "text": null, "postcode": null, "lat": null, "lng": null, "region": null }, "people": [ { "name": "Iain Miller", "role": "CEO", "from": null, "source": "https://www.uktech.news/medtech/presymptom-health-ai-sepsis-20240321" } ], "money": [ { "kind": "funding_round", "amount": 1500000, "currency": "GBP", "date": "2024-03-21", "detail": "equity and grant; UKI2S, Ploughshare, MedTechToMarket, Innovate UK", "raw": "funding_round: 1500000 GBP 2024-03-21 — equity and grant; UKI2S, Ploughshare, MedTechToMarket, Innovate UK", "amount_gbp": 1500000, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£1.5m", "gbp_txt": "" } ], "site": null, "product": null, "dsit_domains": [ "Knowledge generation", "AI implementation" ], "sectors": [ "diagnostics", "sepsis" ], "confidence": "verified", "checked": "2026-10-29", "as_of": "2026-10-29", "applied": [ { "from": "Companies House check, 29 Oct 2026", "field": "status", "text": "status → wound_down (members' voluntary liquidation, a solvent winding-up), status_date → 2026-05-18; status_detail → \"Declaration of solvency sworn on 14 May 2026; members' voluntary liquidation began on 18 May 2026, with Andrew James Pear and Mark Delaney appointed liquidators.\" (record says active, 2024-03-21)" } ], "held": [], "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "Uses machine learning on biobank samples to detect infections and sepsis earlier.", "affiliation": "Start-ups", "sources": [ "https://www.uktech.news/medtech/presymptom-health-ai-sepsis-20240321", "https://find-and-update.company-information.service.gov.uk/search?q=presymptom+health", "https://find-and-update.company-information.service.gov.uk/company/11834573/insolvency" ], "source_quotes": [ { "url": "https://www.uktech.news/medtech/presymptom-health-ai-sepsis-20240321", "quotes": [ "a startup using AI for the early detection of infections and sepsis.\" \"Presymptom Health was founded in 2019.\" \"Dr Iain Miller, CEO of Presymptom Health" ], "accessed": "2026-10-29", "trade": true, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/search?q=presymptom+health", "quotes": [ "PRESYMPTOM HEALTH LIMITED", "11834573", "Incorporated on 19 February 2019 - Liquidation", "C/O Moorfields, 1 St Peter's Square, Manchester, M2 3DE" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/11834573/insolvency", "quotes": [ "Members voluntary liquidation", "Commencement of winding up\" \"18 May 2026", "Declaration of solvency sworn on\" \"14 May 2026" ], "accessed": "2026-10-29", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [ "Knowledge generation", "AI implementation" ], "one_source": false, "confidence_raw": "verified", "depts": [ { "dept": "diagnostics", "div": "health" } ], "div_label": "Health", "location": null, "status_group": "wound_down", "ext_links": [], "label_links": [ { "kind": "funded_by", "name": "UK Innovation and Science Seed Fund" }, { "kind": "funded_by", "name": "Ploughshare" }, { "kind": "funded_by", "name": "Innovate UK" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-027", "name": "CHARM Therapeutics", "bucket": "co", "status": "active", "status_date": "2026-10-31", "status_detail": "Named by Business Weekly on 16 October 2025 as raising US$80m in the third quarter of 2025, the largest Cambridge life-sciences raise in its Q3 round-up. Companies House shows CHARM THERAPEUTICS LIMITED as Active (checked 31 Oct 2026).", "one_line": "Structure-led drug discovery company using AI to find cancer medicines.", "description": "Business Weekly describes CHARM Therapeutics as a structure-led drug discovery company using AI to target oncology, and lists a US$80m raise in its round-up of Cambridge life-sciences fundraisings for the third quarter of 2025. Its UK company was incorporated in September 2021 and is registered at the Stanley Building, Pancras Square, London. Lead investors, the date of the round and its leadership were not confirmed on an opened page.", "uk_status": "uk", "company": { "ch_number": "13641471", "registered_office": "The Stanley Building, 7 Pancras Square, London, United Kingdom, N1C 4AG", "incorporated": "2021-09-24", "legal_form": "ltd", "owner_or_acquirer": null, "headcount": null, "ch_number_clean": "13641471", "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/13641471", "ch_note": null }, "place": { "text": "London (N1C 4AG)", "postcode": "N1C 4AG", "lat": 51.533481, "lng": -0.125043, "region": "England: London", "admin_district": "Camden", "geocoded": "postcodes.io" }, "people": [], "money": [ { "kind": "funding_round", "amount": 80000000, "currency": "USD", "date": "2025", "detail": "reported in Q3 2025 round-up; investors not stated", "raw": "funding_round: 80000000 USD 2025 — reported in Q3 2025 round-up; investors not stated", "amount_gbp": 63851864, "fx_rate": 1.2529, "fx_source": "Bank of England daily spot rate (series XUDLUSS, XUDLERS), US$1.2529 per £ on 2024-12-31", "fx_date": "2024-12-31", "fx_note": "year only given: rate for 1 January", "txt": "US$80m", "gbp_txt": "£63.9m" } ], "site": null, "product": null, "dsit_domains": [ "Knowledge generation" ], "sectors": [ "drug discovery", "oncology" ], "confidence": "verified", "checked": "2026-10-29", "as_of": "2026-10-29", "applied": null, "held": [], "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "Structure-led drug discovery company using AI to find cancer medicines.", "affiliation": "Start-ups", "sources": [ "https://www.businessweekly.co.uk/posts/cambridge-life-sciences-fundraisings-pass-700m-as-q3-maintains-strong-momentum", "https://find-and-update.company-information.service.gov.uk/search/companies?q=charm+therapeutics", "https://find-and-update.company-information.service.gov.uk/company/13641471" ], "source_quotes": [ { "url": "https://www.businessweekly.co.uk/posts/cambridge-life-sciences-fundraisings-pass-700m-as-q3-maintains-strong-momentum", "quotes": [ "a structure-led drug discovery company using AI to target oncology.\" ($80.0 million; dated 16 October 2025)" ], "accessed": "2026-10-29", "trade": true, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/search/companies?q=charm+therapeutics", "quotes": [ "CHARM THERAPEUTICS LIMITED\" \"13641471\" \"24 September 2021\" \"The Stanley Building, 7 Pancras Square, London" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/13641471", "quotes": [ "CHARM THERAPEUTICS LIMITED", "Active", "24 September 2021", "72110 - Research and experimental development on biotechnology" ], "accessed": "2026-10-29", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [ "Knowledge generation" ], "one_source": false, "confidence_raw": "verified", "depts": [ { "dept": "drug discovery", "div": "health" } ], "div_label": "Health", "location": "London (N1C 4AG)", "status_group": "active", "ext_links": [], "label_links": [], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-028", "name": "Lenus Health", "bucket": "co", "status": "dissolved", "status_date": "2026-02-28", "status_detail": "Entered administration on 9 January 2025 (FRP Advisory, Edinburgh), moved from administration to dissolution on 28 November 2025 and was dissolved on 28 February 2026.", "one_line": "Edinburgh company that made Lenus Stratify, AI software predicting risk for people with COPD; went into administration in January 2025 and was dissolved in 2026.", "description": "Lenus Health developed Lenus Stratify, a medical device that uses AI to analyse health data and predict risk in patients with chronic obstructive pulmonary disease. It was chosen for the MHRA's AI Airlock pilot announced on 4 December 2024 but later withdrew. Companies House shows an administrator was appointed on 9 January 2025, the registered office moved to FRP Advisory in Edinburgh, and the company was dissolved on 28 February 2026. A separate company once named Lenus Healthcare Limited (now Solersha Ltd, SC828358, incorporated November 2024) exists at the old Leith address; any link is not confirmed. [Round 4, 30 Oct 2026] status (one source, shown as a note; status unchanged): Withdrew from MHRA AI Airlock pilot", "uk_status": "uk", "company": { "ch_number": "SC652563", "registered_office": "C/O Frp Advisory Trading Limited, Apex 3, 95 Haymarket Terrace, Edinburgh, EH12 5HD", "incorporated": "2020-01-24", "legal_form": "ltd", "owner_or_acquirer": null, "headcount": null, "ch_number_clean": "SC652563", "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/SC652563", "ch_note": null }, "place": { "text": "Leith Assembly Rooms, 43 Constitution Street, Edinburgh (former office)", "postcode": null, "lat": null, "lng": null, "region": "Scotland" }, "people": [], "money": [], "site": null, "product": null, "dsit_domains": [ "Knowledge generation", "AI implementation" ], "sectors": [ "respiratory care", "clinical decision support" ], "confidence": "verified", "checked": "2026-10-29", "as_of": "2026-10-29", "applied": null, "held": [], "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "Edinburgh company that made Lenus Stratify, AI software predicting risk for people with COPD; went into administration in January 2025 and was dissolved in 2026.", "affiliation": "Start-ups", "sources": [ "https://find-and-update.company-information.service.gov.uk/company/SC652563", "https://find-and-update.company-information.service.gov.uk/company/SC652563/filing-history", "https://www.gov.uk/government/news/mhra-trials-five-innovative-ai-technologies-as-part-of-pilot-scheme-to-change-regulatory-approach", "https://www.gov.uk/government/publications/ai-airlock-pilot-cohort/ai-airlock-pilot-cohort" ], "source_quotes": [ { "url": "https://find-and-update.company-information.service.gov.uk/company/SC652563", "quotes": [ "LENUS HEALTH LTD\" \"Dissolved\" \"28 February 2026\" \"24 January 2020" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/SC652563/filing-history", "quotes": [ "Final Gazette dissolved following liquidation\" (28 Feb 2026)", "Move from Administration to Dissolution\" (28 Nov 2025)", "Appointment of an administrator\" (09 Jan 2025)" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://www.gov.uk/government/news/mhra-trials-five-innovative-ai-technologies-as-part-of-pilot-scheme-to-change-regulatory-approach", "quotes": [ "Lenus Stratify® is a medical device, developed by Lenus Health, that uses AI to analyse health data\" (4 December 2024)" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://www.gov.uk/government/publications/ai-airlock-pilot-cohort/ai-airlock-pilot-cohort", "quotes": [ "Unfortunately, Lenus Health have withdrawn from the AI Airlock pilot programme." ], "accessed": "2026-10-29", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [ "Knowledge generation", "AI implementation" ], "one_source": false, "confidence_raw": "verified", "depts": [ { "dept": "respiratory care", "div": "health" } ], "div_label": "Health", "location": "Leith Assembly Rooms, 43 Constitution Street, Edinburgh (former office)", "status_group": "dissolved", "ext_links": [ { "kind": "supplies_government", "id": null, "name": "Health And Social Care (Government page)", "page": "government", "href": "../../../government/health/", "page_label": "UK Government AI Universe" } ], "label_links": [ { "kind": "part_of", "name": "MHRA AI Airlock pilot" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-029", "name": "Newton's Tree", "bucket": "co", "status": "active", "status_date": "2025-06-23", "status_detail": "Took part in the MHRA AI Airlock pilot cohort, testing its Federated AI Monitoring Service (FAMOS); MHRA reported the pilot results on 23 June 2025.", "one_line": "Runs a platform that lets hospitals deploy AI tools and watches them for drift and risk once in use.", "description": "Newton's Tree (Newtons Tree Ltd) runs an AI deployment platform for healthcare organisations. Its Federated AI Monitoring Service (FAMOS) runs locally at hospitals and watches for changes in data, in how staff use AI and in the results AI gives. It was one of the companies in the MHRA's AI Airlock pilot, announced in December 2024, and MHRA's June 2025 release described its work to identify and mitigate AI risks in clinical settings. Head office and Companies House record not confirmed. [Round 4, 30 Oct 2026] programme: FAMOS AI monitoring service in MHRA AI Airlock pilot cohort (Newtons Tree Ltd)", "uk_status": "uk", "company": { "ch_number": null, "registered_office": null, "incorporated": null, "legal_form": "ltd", "owner_or_acquirer": null, "headcount": null, "ch_number_clean": null, "companies_house_url": null, "ch_note": null }, "place": { "text": null, "postcode": null, "lat": null, "lng": null, "region": null }, "people": [], "money": [], "site": null, "product": null, "dsit_domains": [ "AI security and assurance", "AI implementation" ], "sectors": [ "AI deployment and monitoring in hospitals" ], "confidence": "verified", "checked": "2026-10-29", "as_of": "2026-10-29", "applied": null, "held": [], "same_as": "BIZ-SAFE-016", "package1_id": null, "type": "Companies", "category": "health", "function": "Runs a platform that lets hospitals deploy AI tools and watches them for drift and risk once in use.", "affiliation": "Start-ups", "sources": [ "https://www.gov.uk/government/publications/ai-airlock-pilot-cohort/ai-airlock-pilot-cohort", "https://www.gov.uk/government/news/ai-breakthroughs-drive-expansion-of-airlock-testing-programme-to-support-ai-powered-healthcare-innovation" ], "source_quotes": [ { "url": "https://www.gov.uk/government/publications/ai-airlock-pilot-cohort/ai-airlock-pilot-cohort", "quotes": [ "Newtons Tree Ltd", "watches for changes in the data, how people use AI, and the results AI gives." ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://www.gov.uk/government/news/ai-breakthroughs-drive-expansion-of-airlock-testing-programme-to-support-ai-powered-healthcare-innovation", "quotes": [ "testing its Federated AI Monitoring Service (FAMOS) to identify and mitigate AI risks in clinical settings\" (23 June 2025)" ], "accessed": "2026-10-29", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [ "AI security and assurance", "AI implementation" ], "one_source": false, "confidence_raw": "verified", "depts": [ { "dept": "AI deployment and monitoring in hospitals", "div": "health" } ], "div_label": "Health", "location": null, "status_group": "active", "ext_links": [ { "kind": "same_as", "id": "BIZ-SAFE-016", "name": "Newton's Tree", "page": "assurance", "href": "../../assurance/#org=BIZ-SAFE-016", "page_label": "Assurance" } ], "label_links": [ { "kind": "part_of", "name": "MHRA AI Airlock pilot" }, { "kind": "partner_of", "name": "MHRA (regulatory sandbox)" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-030", "name": "Automedica", "bucket": "co", "status": "active", "status_date": "2026-10-31", "status_detail": "Took part in the MHRA AI Airlock pilot with SmartGuideline, an AI agent over NICE guidance; MHRA reported the pilot results on 23 June 2025. Companies House shows AUTOMEDICA LTD as Active (checked 31 Oct 2026).", "one_line": "Makes SmartGuideline, an AI agent that answers clinicians' questions from NICE guidance using a checked knowledge base.", "description": "Automedica Ltd makes SmartGuideline, an AI agent that uses curated knowledge graphs and retrieval-augmented generation over NICE resources. It was in the MHRA AI Airlock pilot cohort, where it tested whether combining retrieval with verified knowledge bases and large language models could offer regulatory advantages. Companies House lists Automedica Ltd, incorporated in October 2023, with a High Wycombe address. [Round 4, 30 Oct 2026] programme: SmartGuideline in MHRA AI Airlock pilot cohort", "uk_status": "uk", "company": { "ch_number": "15202457", "registered_office": "Pound Scots Chinnor Road, Bledlow Ridge, High Wycombe, England, HP14 4AJ", "incorporated": "2023-10-10", "legal_form": "ltd", "owner_or_acquirer": null, "headcount": null, "ch_number_clean": "15202457", "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/15202457", "ch_note": null }, "place": { "text": "High Wycombe (HP14 4AJ)", "postcode": "HP14 4AJ", "lat": 51.671796, "lng": -0.848214, "region": "England: South East", "admin_district": "Buckinghamshire", "geocoded": "postcodes.io" }, "people": [], "money": [], "site": null, "product": { "maker": "Automedica Ltd", "launched": null, "what_it_does": "SmartGuideline, an AI agent using knowledge graphs and retrieval over NICE guidance" }, "dsit_domains": [ "Natural language applications", "Autonomous and agent systems" ], "sectors": [ "clinical decision support" ], "confidence": "verified", "checked": "2026-10-29", "as_of": "2026-10-29", "applied": null, "held": [], "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "Makes SmartGuideline, an AI agent that answers clinicians' questions from NICE guidance using a checked knowledge base.", "affiliation": "Start-ups", "sources": [ "https://www.gov.uk/government/publications/ai-airlock-pilot-cohort/ai-airlock-pilot-cohort", "https://find-and-update.company-information.service.gov.uk/search/companies?q=automedica", "https://find-and-update.company-information.service.gov.uk/company/15202457" ], "source_quotes": [ { "url": "https://www.gov.uk/government/publications/ai-airlock-pilot-cohort/ai-airlock-pilot-cohort", "quotes": [ "SmartGuideline is an AI agent that uses curated knowledge graphs with RAG." ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/search/companies?q=automedica", "quotes": [ "AUTOMEDICA LTD\" \"15202457\" \"10 October 2023\" \"Bledlow Ridge, High Wycombe" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/15202457", "quotes": [ "AUTOMEDICA LTD | Company number 15202457 | Active" ], "accessed": "2026-10-31", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [ "Natural language applications", "Autonomous and agent systems" ], "one_source": false, "confidence_raw": "verified", "depts": [ { "dept": "clinical decision support", "div": "health" } ], "div_label": "Health", "location": "High Wycombe (HP14 4AJ)", "status_group": "active", "ext_links": [ { "kind": "supplies_government", "id": null, "name": "Health And Social Care (Government page)", "page": "government", "href": "../../../government/health/", "page_label": "UK Government AI Universe" } ], "label_links": [ { "kind": "part_of", "name": "MHRA AI Airlock pilot" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-031", "name": "Eye2Gene", "bucket": "co", "status": "active", "status_date": "2026-10-31", "status_detail": "Selected on 16 October 2025 for Phase 2 of the MHRA AI Airlock, with Hardian Health, for its Eye2Gene software. Companies House shows EYE2GENE LIMITED as Active (checked 31 Oct 2026).", "one_line": "Makes AI software that suggests which gene is behind an inherited eye disease from a patient's retinal scan.", "description": "Eye2Gene Ltd's software informs the diagnosis of genetic eye disease from a patient's retinal scan. It was selected, with Hardian Health, for the simulation strand of Phase 2 of the MHRA's AI Airlock regulatory sandbox, published on 16 October 2025. Companies House lists Eye2Gene Limited, incorporated in August 2018, with a Paddington, London address. [Round 4, 30 Oct 2026] programme: In MHRA AI Airlock phase 2 cohort (with Hardian Health), published 16 Oct 2025", "uk_status": "uk", "company": { "ch_number": "11534583", "registered_office": "2 Eastbourne Terrace, London, England, W2 6LG", "incorporated": "2018-08-23", "legal_form": "ltd", "owner_or_acquirer": null, "headcount": null, "ch_number_clean": "11534583", "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/11534583", "ch_note": null }, "place": { "text": "London (W2 6LG)", "postcode": "W2 6LG", "lat": 51.516785, "lng": -0.178352, "region": "England: London", "admin_district": "Westminster", "geocoded": "postcodes.io" }, "people": [], "money": [], "site": null, "product": null, "dsit_domains": [ "Perceptual systems", "AI implementation" ], "sectors": [ "ophthalmology", "genetic diagnosis" ], "confidence": "verified", "checked": "2026-10-29", "as_of": "2026-10-29", "applied": null, "held": [], "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "Makes AI software that suggests which gene is behind an inherited eye disease from a patient's retinal scan.", "affiliation": "Start-ups", "sources": [ "https://www.gov.uk/government/publications/ai-airlock-phase-2-cohort", "https://find-and-update.company-information.service.gov.uk/search/companies?q=eye2gene", "https://find-and-update.company-information.service.gov.uk/company/11534583" ], "source_quotes": [ { "url": "https://www.gov.uk/government/publications/ai-airlock-phase-2-cohort", "quotes": [ "informs the diagnosis of genetic eye disease from a patient's retinal scan\" (Eye2Gene Ltd; published 16 October 2025)" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/search/companies?q=eye2gene", "quotes": [ "EYE2GENE LIMITED\" \"11534583\" \"23 August 2018\" \"2 Eastbourne Terrace, London, England, W2 6LG" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/11534583", "quotes": [ "EYE2GENE LIMITED | Company number 11534583 | Active" ], "accessed": "2026-10-31", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [ "Perceptual systems", "AI implementation" ], "one_source": false, "confidence_raw": "verified", "depts": [ { "dept": "ophthalmology", "div": "health" } ], "div_label": "Health", "location": "London (W2 6LG)", "status_group": "active", "ext_links": [ { "kind": "supplies_government", "id": null, "name": "Health And Social Care (Government page)", "page": "government", "href": "../../../government/health/", "page_label": "UK Government AI Universe" } ], "label_links": [ { "kind": "part_of", "name": "MHRA AI Airlock Phase 2" }, { "kind": "partner_of", "name": "Hardian Health" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-032", "name": "DeepX Health", "bucket": "co", "status": "active", "status_date": "2026-10-31", "status_detail": "Selected on 16 October 2025 for Phase 2 of the MHRA AI Airlock for DeepX AI, which analyses images of skin lesions. Companies House shows DEEPX HEALTH LIMITED as Active (checked 31 Oct 2026).", "one_line": "Makes AI software that analyses close-up images of skin lesions to identify the type of lesion.", "description": "The MHRA lists DeepX Health UK Ltd as developer of DeepXAI, which analyses dermoscopic images of skin lesions to identify lesion types; it was selected for the simulation strand of AI Airlock Phase 2 in October 2025. Companies House lists DeepX Health Limited (incorporated November 2019, registered at Discovery Park, Sandwich, Kent); whether this is the same company is not confirmed, as the names differ. [Round 4, 30 Oct 2026] programme: DeepXAI skin lesion tool in MHRA AI Airlock phase 2 cohort (DeepX Health UK Ltd)", "uk_status": "uk", "company": { "ch_number": "12327990", "registered_office": "Innovation House C/O Kreston Reeves Llp, Discovery Park, Sandwich, Kent, United Kingdom, CT13 9FF", "incorporated": "2019-11-22", "legal_form": "ltd", "owner_or_acquirer": null, "headcount": null, "ch_number_clean": "12327990", "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/12327990", "ch_note": null }, "place": { "text": null, "postcode": null, "lat": null, "lng": null, "region": null }, "people": [], "money": [], "site": null, "product": null, "dsit_domains": [ "Perceptual systems" ], "sectors": [ "dermatology", "skin cancer" ], "confidence": "single_source", "checked": "2026-10-29", "as_of": "2026-10-29", "applied": null, "held": [], "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "Makes AI software that analyses close-up images of skin lesions to identify the type of lesion.", "affiliation": "Start-ups", "sources": [ "https://www.gov.uk/government/publications/ai-airlock-phase-2-cohort", "https://find-and-update.company-information.service.gov.uk/search/companies?q=deepx+health+uk", "https://find-and-update.company-information.service.gov.uk/company/12327990/officers", "https://find-and-update.company-information.service.gov.uk/company/12327990" ], "source_quotes": [ { "url": "https://www.gov.uk/government/publications/ai-airlock-phase-2-cohort", "quotes": [ "analyses dermoscopic images of skin lesions to identify lesion types\" (DeepX Health UK Ltd; 16 October 2025)" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/search/companies?q=deepx+health+uk", "quotes": [ "DEEPX HEALTH LIMITED\" \"12327990\" \"22 November 2019\" \"Discovery Park, Sandwich, Kent" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/12327990/officers", "quotes": [ "AYERST, Kurt Frederick\" Director \"1 December 2020\"; \"HORN, Christian\" and \"VALEUR, Mette\" Directors \"1 June 2020" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/12327990", "quotes": [ "DEEPX HEALTH LIMITED | Company number 12327990 | Active" ], "accessed": "2026-10-31", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [ "Perceptual systems" ], "one_source": true, "confidence_raw": "single_source", "depts": [ { "dept": "dermatology", "div": "health" } ], "div_label": "Health", "location": null, "status_group": "active", "ext_links": [ { "kind": "supplies_government", "id": null, "name": "Health And Social Care (Government page)", "page": "government", "href": "../../../government/health/", "page_label": "UK Government AI Universe" } ], "label_links": [ { "kind": "part_of", "name": "MHRA AI Airlock Phase 2" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-033", "name": "Panakeia Technologies", "bucket": "co", "status": "active", "status_date": "2025-10-16", "status_detail": "Selected on 16 October 2025 for the multi-environment strand of MHRA AI Airlock Phase 2 with PANProfiler Colorectal (MSI/MMR).", "one_line": "Makes AI that reads standard pathology slides to detect cancer biomarkers, so patients need fewer laboratory tests.", "description": "Panakeia's PANProfiler Colorectal uses artificial intelligence to analyse the same tissue slides pathologists use for diagnosis, to detect the MSI/MMR biomarkers in bowel cancer. MHRA selected it for Phase 2 of the AI Airlock (multi-environment strand) in October 2025; MHRA said tools in that cohort could cut bowel cancer test times from weeks to minutes. Pahini Pandya was recorded as founder and chief executive in an earlier pass, but that page was not reopened. Companies House record could not be opened in this session. [Round 4, 30 Oct 2026] programme: PANProfiler Colorectal in MHRA AI Airlock phase 2 cohort", "uk_status": "uk", "company": { "ch_number": null, "registered_office": null, "incorporated": null, "legal_form": "ltd", "owner_or_acquirer": null, "headcount": null, "ch_number_clean": null, "companies_house_url": null, "ch_note": null }, "place": { "text": null, "postcode": null, "lat": null, "lng": null, "region": null }, "people": [], "money": [], "site": null, "product": { "maker": "Panakeia Technologies", "launched": null, "what_it_does": "PANProfiler Colorectal, AI that reads pathology slides for MSI/MMR status" }, "dsit_domains": [ "Perceptual systems", "AI implementation" ], "sectors": [ "digital pathology", "cancer" ], "confidence": "verified", "checked": "2026-10-29", "as_of": "2026-10-29", "applied": null, "held": [], "same_as": null, "package1_id": "biz-panakeia", "type": "Companies", "category": "health", "function": "Makes AI that reads standard pathology slides to detect cancer biomarkers, so patients need fewer laboratory tests.", "affiliation": "Start-ups", "sources": [ "https://www.gov.uk/government/publications/ai-airlock-phase-2-cohort", "https://www.gov.uk/government/news/ai-tools-that-could-detect-diseases-earlier-selected-for-next-phase-of-mhras-ai-airlock-programme" ], "source_quotes": [ { "url": "https://www.gov.uk/government/publications/ai-airlock-phase-2-cohort", "quotes": [ "uses artificial intelligence to analyse the same tissue slides pathologists use for diagnosis\" (PANProfiler Colorectal (MSI/MMR), Panakeia Technologies; 16 October 2025)" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://www.gov.uk/government/news/ai-tools-that-could-detect-diseases-earlier-selected-for-next-phase-of-mhras-ai-airlock-programme", "quotes": [ "bowel cancer test times from weeks to minutes\" (16 October 2025)" ], "accessed": "2026-10-29", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [ "Perceptual systems", "AI implementation" ], "one_source": false, "confidence_raw": "verified", "depts": [ { "dept": "digital pathology", "div": "health" } ], "div_label": "Health", "location": null, "status_group": "active", "ext_links": [ { "kind": "supplies_government", "id": null, "name": "Health And Social Care (Government page)", "page": "government", "href": "../../../government/health/", "page_label": "UK Government AI Universe" } ], "label_links": [ { "kind": "part_of", "name": "MHRA AI Airlock Phase 2" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-034", "name": "TORTUS", "bucket": "co", "status": "active", "status_date": "2026-10-31", "status_detail": "Selected on 16 October 2025 for the multi-environment strand of MHRA AI Airlock Phase 2 as a clinical AI assistant. Companies House shows TORTUS AI LTD as Active (checked 31 Oct 2026).", "one_line": "Makes an AI assistant that listens to consultations and drafts clinical notes for doctors to check.", "description": "MHRA describes TORTUS as an evolving clinical AI assistant designed to support healthcare professionals, and selected it for Phase 2 of the AI Airlock in October 2025, in the strand on AI-powered clinical note-taking. TORTUS was founded in 2022 by a cardiologist and a machine learning engineer; Dom Pimenta is a co-founder. Its OSLER platform records clinician–patient conversations and drafts documents for clinicians to sign off. In February 2024 the London start-up raised US$4.2m (£3.3m) led by Khosla Ventures. Companies House lists TORTUS AI Ltd, incorporated in November 2022 and registered in east London. An earlier pass recorded a nine-site London evaluation led by Great Ormond Street Hospital (September 2025); that page could not be reopened in this session. [Round 4, 30 Oct 2026] programme: In MHRA AI Airlock phase 2 cohort [Round 4, 30 Oct 2026] programme: DigitalHealth.London Accelerator cohort (cohort filter 422) [Round 4, 30 Oct 2026] regulatory: Deployed as a self-certified Class I medical device under the UK Medical Device Regulations 2002 (MHRA AI Airlock phase 2 case study)", "uk_status": "uk", "company": { "ch_number": "14487060", "registered_office": "5 Brayford Square, London, England, E1 0SG", "incorporated": "2022-11-15", "legal_form": "ltd", "owner_or_acquirer": null, "headcount": null, "ch_number_clean": "14487060", "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/14487060", "ch_note": null }, "place": { "text": "London (E1 0SG)", "postcode": "E1 0SG", "lat": 51.514214, "lng": -0.050341, "region": "England: London", "admin_district": "Tower Hamlets", "geocoded": "postcodes.io" }, "people": [ { "name": "Dom Pimenta", "role": "Co-founder", "from": "2022", "source": "https://www.uktech.news/ai/tortus-ai-assistant-funding-20240213" } ], "money": [ { "kind": "funding_round", "amount": 4200000, "currency": "USD", "date": "2024-02-13", "detail": "led by Khosla Ventures", "raw": "funding_round: 4200000 USD 2024-02-13 — led by Khosla Ventures", "amount_gbp": 3333069, "fx_rate": 1.2601, "fx_source": "Bank of England daily spot rate (series XUDLUSS, XUDLERS), US$1.2601 per £ on 2024-02-13", "fx_date": "2024-02-13", "fx_note": "", "txt": "US$4.2m", "gbp_txt": "£3.3m" } ], "site": null, "product": null, "dsit_domains": [ "Natural language applications", "AI implementation" ], "sectors": [ "ambient voice", "clinical documentation" ], "confidence": "verified", "checked": "2026-10-29", "as_of": "2026-10-29", "applied": null, "held": [], "same_as": null, "package1_id": "biz-tortus", "type": "Companies", "category": "health", "function": "Makes an AI assistant that listens to consultations and drafts clinical notes for doctors to check.", "affiliation": "Start-ups", "sources": [ "https://www.gov.uk/government/publications/ai-airlock-phase-2-cohort", "https://find-and-update.company-information.service.gov.uk/search/companies?q=tortus+ai", "https://www.uktech.news/ai/tortus-ai-assistant-funding-20240213", "https://digitalhealth.london/innovation-directory?areainnovation=§or=&technology=&cohort=422", "https://assets.publishing.service.gov.uk/media/6a59e205908b618a53702f8b/Phase_2-_Candidate_Case_Studies_for_publication.pdf", "https://find-and-update.company-information.service.gov.uk/company/14487060" ], "source_quotes": [ { "url": "https://www.gov.uk/government/publications/ai-airlock-phase-2-cohort", "quotes": [ "TORTUS is an evolving clinical AI assistant designed to support healthcare professionals\" (16 October 2025)" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/search/companies?q=tortus+ai", "quotes": [ "TORTUS AI LTD\" \"14487060\" \"15 November 2022\" \"5 Brayford Square, London, England, E1 0SG" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://www.uktech.news/ai/tortus-ai-assistant-funding-20240213", "quotes": [ "London-based startup\" \"time-consuming admin tasks\" \"The funding round was led by Khosla Ventures.\" \"Founded in 2022 by a cardiologist and a machine learning engineer." ], "accessed": "2026-10-29", "trade": true, "amendment": false }, { "url": "https://digitalhealth.london/innovation-directory?areainnovation=§or=&technology=&cohort=422", "quotes": [ "an AI-powered assistant that integrates with healthcare systems to streamline documentation" ], "accessed": "2026-10-30", "trade": false, "amendment": false }, { "url": "https://assets.publishing.service.gov.uk/media/6a59e205908b618a53702f8b/Phase_2-_Candidate_Case_Studies_for_publication.pdf", "quotes": [ "TORTUS is currently deployed as a self-certified Class I medical device under the UK Medical Device Regulations 2002." ], "accessed": "2026-10-30", "trade": false, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/14487060", "quotes": [ "TORTUS AI LTD | Company number 14487060 | Active" ], "accessed": "2026-10-31", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [ "Natural language applications", "AI implementation" ], "one_source": false, "confidence_raw": "verified", "depts": [ { "dept": "ambient voice", "div": "health" } ], "div_label": "Health", "location": "London (E1 0SG)", "status_group": "active", "ext_links": [ { "kind": "linked from: funds", "id": "BIZ-INV-030", "name": "Khosla Ventures", "page": "investors", "href": "../../investors/#org=BIZ-INV-030", "page_label": "Investors" }, { "kind": "funded_by", "id": "BIZ-INV-030", "name": "Khosla Ventures", "page": "investors", "href": "../../investors/#org=BIZ-INV-030", "page_label": "Investors" }, { "kind": "linked from: works_at", "id": "BIZ-TAL-173", "name": "Dom Pimenta", "page": "talent", "href": "../../talent/#org=BIZ-TAL-173", "page_label": "Talent" }, { "kind": "linked from: founder_of", "id": "BIZ-TAL-173", "name": "Dom Pimenta", "page": "talent", "href": "../../talent/#org=BIZ-TAL-173", "page_label": "Talent" }, { "kind": "supplies_government", "id": null, "name": "Health And Social Care (Government page)", "page": "government", "href": "../../../government/health/", "page_label": "UK Government AI Universe" } ], "label_links": [ { "kind": "part_of", "name": "MHRA AI Airlock Phase 2" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-035", "name": "Cascader", "bucket": "co", "status": "active", "status_date": "2026-09-23", "status_detail": "Completed a seed funding round (amount and investors not disclosed), reported 23 September 2026.", "one_line": "Moorfields Eye Hospital spin-out that applies AI to detect and manage eye disease, in a field called oculomics.", "description": "Cascader is an AI spin-out from Moorfields Eye Hospital NHS Foundation Trust that applies AI in the field of oculomics and in detecting and managing eye disease. HTN describes it as a partnership between Moorfields, Topcon Healthcare and UCL Ventures. It completed a seed round in September 2026; the amount was not disclosed. Pete Thomas is chief executive and Pearse Keane, a consultant ophthalmologist at Moorfields, is a co-founder. Companies House lists Cascader Ltd, incorporated April 2025, with a Paul Street, London address.", "uk_status": "uk", "company": { "ch_number": "16399605", "registered_office": "3rd Floor 86-90 Paul Street, London, England, EC2A 4NE", "incorporated": "2025-04-22", "legal_form": "ltd", "owner_or_acquirer": null, "headcount": null, "ch_number_clean": "16399605", "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/16399605", "ch_note": null }, "place": { "text": "London (EC2A 4NE)", "postcode": "EC2A 4NE", "lat": 51.525617, "lng": -0.083602, "region": "England: London", "admin_district": "Hackney", "geocoded": "postcodes.io" }, "people": [ { "name": "Pete Thomas", "role": "CEO", "from": null, "source": "https://htn.co.uk/2026/09/23/moorfields-ai-spinout-cascader-completes-seed-funding-round/" }, { "name": "Pearse Keane", "role": "Co-founder", "from": null, "source": null } ], "money": [ { "kind": "note", "amount": null, "currency": null, "date": null, "detail": null, "raw": "null (seed round, amount undisclosed)", "kind_as_written": null, "amount_gbp": null, "fx_rate": null, "fx_source": null, "fx_note": "no amount published", "txt": "", "gbp_txt": "" } ], "site": null, "product": null, "dsit_domains": [ "Perceptual systems" ], "sectors": [ "ophthalmology", "oculomics" ], "confidence": "verified", "checked": "2026-10-29", "as_of": "2026-10-29", "applied": null, "held": [], "same_as": null, "package1_id": "biz-cascader", "type": "Companies", "category": "health", "function": "Moorfields Eye Hospital spin-out that applies AI to detect and manage eye disease, in a field called oculomics.", "affiliation": "Start-ups", "sources": [ "https://htn.co.uk/2026/09/23/moorfields-ai-spinout-cascader-completes-seed-funding-round/", "https://find-and-update.company-information.service.gov.uk/search/companies?q=cascader", "https://find-and-update.company-information.service.gov.uk/company/16399605" ], "source_quotes": [ { "url": "https://htn.co.uk/2026/09/23/moorfields-ai-spinout-cascader-completes-seed-funding-round/", "quotes": [ "An AI spinout from Moorfields Eye Hospital NHS Foundation Trust\" \"a medical technology company applying AI in the field of oculomics, and in the detection and management of eye disease\" (dated 23 September 2026)" ], "accessed": "2026-10-29", "trade": true, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/search/companies?q=cascader", "quotes": [ "CASCADER LTD\" \"16399605\" \"22 April 2025\" \"86-90 Paul Street, London" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/16399605", "quotes": [ "CASCADER LTD", "Active", "22 April 2025", "86900 - Other human health activities" ], "accessed": "2026-10-29", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [ "Perceptual systems" ], "one_source": false, "confidence_raw": "verified", "depts": [ { "dept": "ophthalmology", "div": "health" } ], "div_label": "Health", "location": "London (EC2A 4NE)", "status_group": "active", "ext_links": [ { "kind": "linked from: works_at", "id": "BIZ-TAL-171", "name": "Pete Thomas", "page": "talent", "href": "../../talent/#org=BIZ-TAL-171", "page_label": "Talent" }, { "kind": "linked from: works_at", "id": "BIZ-TAL-172", "name": "Pearse Keane", "page": "talent", "href": "../../talent/#org=BIZ-TAL-172", "page_label": "Talent" }, { "kind": "linked from: founder_of", "id": "BIZ-TAL-172", "name": "Pearse Keane", "page": "talent", "href": "../../talent/#org=BIZ-TAL-172", "page_label": "Talent" } ], "label_links": [ { "kind": "spun_out_of", "name": "Moorfields Eye Hospital NHS Foundation Trust" }, { "kind": "partner_of", "name": "Topcon Healthcare" }, { "kind": "partner_of", "name": "UCL Ventures" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-036", "name": "Dexter AI", "bucket": "co", "status": "active", "status_date": "2026-09-04", "status_detail": "Launched as a University of Birmingham spin-out, reported 4 September 2026.", "one_line": "University of Birmingham spin-out whose software speeds up pulling research data out of electronic health records.", "description": "Dexter AI is an AI spin-out from the University of Birmingham that aims to speed up extracting data from electronic health records for medical researchers. The software was developed by Krishnarajah Nirantharakumar, Krishna Gokhale and Joht Singh Chandan in the university's Department of Applied Health Sciences. Christian Billinghurst is chief executive. Location and Companies House record not confirmed.", "uk_status": "uk", "company": { "ch_number": null, "registered_office": null, "incorporated": null, "legal_form": null, "owner_or_acquirer": null, "headcount": null, "ch_number_clean": null, "companies_house_url": null, "ch_note": null }, "place": { "text": "Birmingham (university origin; office not stated)", "postcode": null, "lat": null, "lng": null, "region": "England: West Midlands" }, "people": [ { "name": "Christian Billinghurst", "role": "CEO", "from": "2026", "source": "https://htn.co.uk/2026/09/04/university-of-birmingham-ai-spin-out-launches-to-facilitate-data-extraction-from-ehrs/" }, { "name": "Krishnarajah Nirantharakumar", "role": "academic developer (University of Birmingham)", "from": null, "source": null } ], "money": [], "site": null, "product": null, "dsit_domains": [ "Natural language applications", "Knowledge generation" ], "sectors": [ "health data", "research" ], "confidence": "single_source", "checked": "2026-10-29", "as_of": "2026-10-29", "applied": null, "held": [], "same_as": null, "package1_id": "biz-dexter-ai", "type": "Companies", "category": "health", "function": "University of Birmingham spin-out whose software speeds up pulling research data out of electronic health records.", "affiliation": "Start-ups", "sources": [ "https://htn.co.uk/2026/09/04/university-of-birmingham-ai-spin-out-launches-to-facilitate-data-extraction-from-ehrs/" ], "source_quotes": [ { "url": "https://htn.co.uk/2026/09/04/university-of-birmingham-ai-spin-out-launches-to-facilitate-data-extraction-from-ehrs/", "quotes": [ "An AI spin-out from the University of Birmingham has launched\" \"speed up the process of extracting data from EHRs to support medical researchers\" \"CEO Christian Billinghurst\" (dated 4 September 2026)" ], "accessed": "2026-10-29", "trade": true, "amendment": false } ], "website": [], "colleges": [], "topics": [ "Natural language applications", "Knowledge generation" ], "one_source": true, "confidence_raw": "single_source", "depts": [ { "dept": "health data", "div": "health" } ], "div_label": "Health", "location": "Birmingham (university origin; office not stated)", "status_group": "active", "ext_links": [], "label_links": [ { "kind": "spun_out_of", "name": "University of Birmingham" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-037", "name": "Healx", "bucket": "co", "status": "active", "status_date": "2026-10-31", "status_detail": "Raised a US$47m (£37m) Series C led by R42 Group and Atomico, reported 2 August 2024, to take HLX-1502 into a phase 2 trial; no later page opened. Companies House shows HEALX LIMITED as Active (checked 31 Oct 2026).", "one_line": "Cambridge company that uses AI to find treatments for rare diseases and runs its own clinical trials.", "description": "Healx was founded in 2014 and is based in Cambridge. It uses AI to search for treatments for rare diseases, letting machine learning choose both drugs and targets. In August 2024 it announced a US$47m Series C led by R42 Group and Atomico, to take its HLX-1502 programme into a phase 2 trial, which had US FDA approval. Tim Guilliams is co-founder and chief executive. Its company is registered on Hills Road, Cambridge. [Labs Round 8, 31 Oct 2026] what_it_does: Describes itself as an AI-native rare-disease drug company, from discovery to clinic [Labs Round 8, 31 Oct 2026] status_now: Lead candidate HLX-1502 (neurofibromatosis); FDA approved the trial and a Phase 2 start was planned by December 2024 (as of 2024-08-02) [Labs Round 8, 31 Oct 2026] Listed on Labs (Drug discovery): builds its own generative AI drug-discovery engine for rare diseases", "uk_status": "uk", "company": { "ch_number": "09018507", "registered_office": "3rd Floor Charter House, 66-68 Hills Road, Cambridge, England, CB2 1LA", "incorporated": "2014-04-30", "legal_form": "ltd", "owner_or_acquirer": null, "headcount": null, "ch_number_clean": "09018507", "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/09018507", "ch_note": null }, "place": { "text": "Cambridge (CB2 1LA)", "postcode": "CB2 1LA", "lat": 52.196862, "lng": 0.129263, "region": "England: East of England", "admin_district": "Cambridge", "geocoded": "postcodes.io" }, "people": [ { "name": "Tim Guilliams", "role": "Co-founder and CEO", "from": "2014", "source": "https://www.uktech.news/medtech/healx-series-c-round-20240802" }, { "name": "Tim Guilliams", "role": "Co-founder and CEO", "from": "as of 2024-08-02", "source": "https://www.uktech.news/medtech/healx-series-c-round-20240802", "round4": true } ], "money": [ { "kind": "funding_round", "amount": 47000000, "currency": "USD", "date": "2024-08-02", "detail": "Series C led by R42 Group and Atomico", "raw": "funding_round: 47000000 USD 2024-08-02 — Series C led by R42 Group and Atomico", "amount_gbp": 36698680, "fx_rate": 1.2807, "fx_source": "Bank of England daily spot rate (series XUDLUSS, XUDLERS), US$1.2807 per £ on 2024-08-02", "fx_date": "2024-08-02", "fx_note": "", "txt": "US$47m", "gbp_txt": "£36.7m" } ], "site": null, "product": null, "dsit_domains": [ "Knowledge generation" ], "sectors": [ "drug discovery", "rare diseases" ], "confidence": "verified", "checked": "2026-10-29", "as_of": "2026-10-29", "applied": null, "held": [], "same_as": null, "package1_id": "biz-healx", "type": "Companies", "category": "health", "function": "Cambridge company that uses AI to find treatments for rare diseases and runs its own clinical trials.", "affiliation": "Start-ups", "sources": [ "https://www.uktech.news/medtech/healx-series-c-round-20240802", "https://find-and-update.company-information.service.gov.uk/search/companies?q=healx", "https://sifted.eu/articles/ai-drug-discovery-startups", "https://find-and-update.company-information.service.gov.uk/company/09018507", "https://healx.ai/" ], "source_quotes": [ { "url": "https://www.uktech.news/medtech/healx-series-c-round-20240802", "quotes": [ "Cambridge-based drug discovery startup Healx\" \"$47m (£37m) Series C funding round\" \"led by R42 Group and Atomico\" \"Founded in 2014" ], "accessed": "2026-10-29", "trade": true, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/search/companies?q=healx", "quotes": [ "HEALX LIMITED (previously HEALX3 LIMITED)\" \"09018507\" \"30 April 2014" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://sifted.eu/articles/ai-drug-discovery-startups", "quotes": [ "Healx aims to remove this bias by entrusting the selection of both drugs and their targets to machine learning algorithms." ], "accessed": "2026-10-29", "trade": true, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/09018507", "quotes": [ "HEALX LIMITED\" \"3rd Floor Charter House, 66-68 Hills Road, Cambridge, England, CB2 1LA\" \"Active\" \"30 April 2014\" \"HEALX3 LIMITED" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://healx.ai/", "quotes": [ "Building the world's first AI-native rare disease pharma." ], "accessed": "2026-10-30", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [ "Knowledge generation" ], "one_source": false, "confidence_raw": "verified", "depts": [ { "dept": "drug discovery", "div": "health" } ], "div_label": "Health", "location": "Cambridge (CB2 1LA)", "status_group": "active", "ext_links": [ { "kind": "linked from: funds", "id": "BIZ-INV-010", "name": "Balderton Capital", "page": "investors", "href": "../../investors/#org=BIZ-INV-010", "page_label": "Investors" }, { "kind": "funded_by", "id": "BIZ-INV-011", "name": "Atomico", "page": "investors", "href": "../../investors/#org=BIZ-INV-011", "page_label": "Investors" } ], "label_links": [ { "kind": "funded_by", "name": "R42 Group" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-038", "name": "LabGenius", "bucket": "co", "status": "active", "status_date": "2026-10-31", "status_detail": "Raised a £35m Series B led by M Ventures, reported 21 May 2024, taking total funding to £58m; no later page opened. Companies House shows LABGENIUS LIMITED as Active (checked 31 Oct 2026).", "one_line": "London company that uses machine learning and robotic experiments to design antibody drugs.", "description": "LabGenius was founded in 2012 and is based in London. Its EVA platform uses machine learning to design, run and learn from experiments to find high-performing antibodies. In May 2024 it raised a £35m Series B led by M Ventures, with Octopus Ventures, LG Corp and existing investors Atomico, Kindred Capital, Lux Capital and Obvious Ventures, bringing total funding to £58m. James Field is chief executive. Companies House could not be opened in this session. [Round 4, 30 Oct 2026] LABS: Uses machine learning and its EVA robotic platform, running closed-loop experiments, to discover therapeutic antibodies. [Labs Round 7, 30 Oct 2026] rounds: £35m Series B (2024-05-21) led by M Ventures with Octopus Ventures, LG Corp, Atomico, Kindred Capital, Lux Capital, Obvious Ventures; £58m raised in total incl. $10m Series A (2019) [Labs Round 7, 30 Oct 2026] models_released: EVA machine-learning antibody discovery platform; programmes against solid tumours [Labs Round 7, 30 Oct 2026] chief_executive: James Field — chief executive [Labs Round 8, 31 Oct 2026] founded: 2012; London [Labs Round 8, 31 Oct 2026] funding_total_as_published: £58m (2024-05-21) [Labs Round 8, 31 Oct 2026] chief_executive: James Field — CEO (2024-05-21)", "uk_status": "uk", "company": { "ch_number": "08183505", "registered_office": null, "incorporated": null, "legal_form": null, "owner_or_acquirer": null, "headcount": null, "ch_number_clean": "08183505", "from_round2": true, "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/08183505", "ch_note": null }, "place": { "text": "London", "postcode": "SE16 4DG", "lat": 51.493965, "lng": -0.061909, "region": "England: London", "admin_district": "Southwark", "geocoded": "postcodes.io" }, "people": [ { "name": "James Field", "role": "CEO", "from": null, "source": "https://www.uktech.news/medtech/labgenius-drug-discovery-series-b-20240521" }, { "name": "James Field", "role": "CEO", "from": null, "source": "https://tech.eu/2024/05/22/labgenius-secures-ps35m-series-b-funding-for-therapeutic-antibody-discovery/", "round4": true }, { "name": "James Field", "role": "CEO", "from": "as of 2024-05-21", "source": "https://www.uktech.news/medtech/labgenius-drug-discovery-series-b-20240521", "round4": true } ], "money": [ { "kind": "funding_round", "amount": 35000000, "currency": "GBP", "date": "2024-05-21", "detail": "Series B led by M Ventures; total funding £58m", "raw": "funding_round: 35000000 GBP 2024-05-21 — Series B led by M Ventures; total funding £58m", "amount_gbp": 35000000, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£35m", "gbp_txt": "" } ], "site": null, "product": null, "dsit_domains": [ "Knowledge generation", "AI development and training" ], "sectors": [ "drug discovery", "antibodies" ], "confidence": "verified", "checked": "2026-10-29", "as_of": "2026-10-29", "applied": null, "held": [], "same_as": null, "package1_id": "biz-labgenius", "type": "Companies", "category": "health", "function": "London company that uses machine learning and robotic experiments to design antibody drugs.", "affiliation": "Start-ups", "sources": [ "https://www.uktech.news/medtech/labgenius-drug-discovery-series-b-20240521", "https://find-and-update.company-information.service.gov.uk/search/companies?q=labgenius+ltd", "https://tech.eu/2024/05/22/labgenius-secures-ps35m-series-b-funding-for-therapeutic-antibody-discovery/", "https://tech.eu/2020/10/29/labgenius-series-a/", "https://tech.eu/2017/11/24/labgenius-funding/", "https://find-and-update.company-information.service.gov.uk/company/08183505" ], "source_quotes": [ { "url": "https://www.uktech.news/medtech/labgenius-drug-discovery-series-b-20240521", "quotes": [ "London-based life science firm LabGenius\" \"The funding round was led by M Ventures.\" \"brings LabGenius' total funding to £58m.\" \"Founded in 2012" ], "accessed": "2026-10-29", "trade": true, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/search/companies?q=labgenius+ltd", "quotes": [ "LABGENIUS LIMITED", "08183505", "Incorporated on 17 August 2012", "G04 Cocoa Studios The Biscuit Factory, 100 Drummond Road, London, United Kingdom, SE16 4DG" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://tech.eu/2024/05/22/labgenius-secures-ps35m-series-b-funding-for-therapeutic-antibody-discovery/", "quotes": [ "a drug discovery company pioneering the use of machine learning for the discovery of novel therapeutic antibodies" ], "accessed": "2026-10-30", "trade": true, "amendment": false }, { "url": "https://tech.eu/2020/10/29/labgenius-series-a/", "quotes": [ "(trade) — headline \"LabGenius closes $15 million Series A extension led by Atomico, brings round to $25 million" ], "accessed": "2026-10-30", "trade": false, "amendment": false }, { "url": "https://tech.eu/2017/11/24/labgenius-funding/", "quotes": [ "(trade) — \"EVA is a Silicon Scientist hooked up to a bank of liquid handling robots." ], "accessed": "2026-10-30", "trade": false, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/08183505", "quotes": [ "LABGENIUS LIMITED | Company number 08183505 | Active" ], "accessed": "2026-10-31", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [ "Knowledge generation", "AI development and training" ], "one_source": false, "confidence_raw": "verified", "depts": [ { "dept": "drug discovery", "div": "health" } ], "div_label": "Health", "location": "London", "status_group": "active", "ext_links": [ { "kind": "funded_by", "id": "BIZ-INV-201", "name": "Octopus Ventures", "page": "investors", "href": "../../investors/#org=BIZ-INV-201", "page_label": "Investors" }, { "kind": "funded_by", "id": "BIZ-INV-011", "name": "Atomico", "page": "investors", "href": "../../investors/#org=BIZ-INV-011", "page_label": "Investors" }, { "kind": "funded_by", "id": "BIZ-INV-026", "name": "Kindred Capital", "page": "investors", "href": "../../investors/#org=BIZ-INV-026", "page_label": "Investors" }, { "kind": "linked from: works_at", "id": "BIZ-TAL-177", "name": "James Field", "page": "talent", "href": "../../talent/#org=BIZ-TAL-177", "page_label": "Talent" }, { "kind": "funded_by", "id": "BIZ-INV-201", "name": "Octopus Ventures", "page": "investors", "href": "../../investors/#org=BIZ-INV-201", "page_label": "Investors" }, { "kind": "linked from: made_by", "id": "BIZ-LAB-12027", "name": "EVA drug discovery platform (LabGenius)", "page": "labs", "href": "../../labs/#org=BIZ-LAB-12027", "page_label": "Labs" } ], "label_links": [ { "kind": "funded_by", "name": "M Ventures" }, { "kind": "funded_by", "name": "LG Corp" }, { "kind": "funded_by", "name": "M Ventures" }, { "kind": "funded_by", "name": "LG Corp" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-039", "name": "ieso", "bucket": "co", "status": "active", "status_date": "2021-11-23", "status_detail": "Raised a US$53m Series B led by Morningside, reported 23 November 2021; current status not confirmed on a 2025 or 2026 page.", "one_line": "Cambridge digital mental health company offering typed online therapy to NHS patients and building AI therapy tools from that data.", "description": "ieso is a Cambridge-based digital mental healthcare company. In November 2021 it raised a US$53m Series B led by Morningside, with Sony Innovation Fund and existing shareholders IP Group, Molten Ventures and Ananda Impact Ventures, taking total funding to US$77.9m, to develop autonomous therapy systems. Nigel Pitchford was chief executive at that date. No later page was opened, so its position on 29 October 2026 is not confirmed.", "uk_status": "uk", "company": { "ch_number": "04063351", "registered_office": null, "incorporated": null, "legal_form": null, "owner_or_acquirer": null, "headcount": null, "ch_number_clean": "04063351", "from_round2": true, "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/04063351", "ch_note": null }, "place": { "text": "Cambridge", "postcode": "CB4 0DS", "lat": 52.234255, "lng": 0.151849, "region": "England: East of England", "admin_district": "South Cambridgeshire", "geocoded": "postcodes.io" }, "people": [ { "name": "Nigel Pitchford", "role": "CEO (as of November 2021)", "from": null, "source": "https://tech.eu/2021/11/23/addressing-mental-health-with-digital-therapeutics-ieso-raises-53-million/" } ], "money": [ { "kind": "funding_round", "amount": 53000000, "currency": "USD", "date": "2021-11-23", "detail": "Series B led by Morningside; total raised US$77.9m", "raw": "funding_round: 53000000 USD 2021-11-23 — Series B led by Morningside; total raised US$77.9m", "amount_gbp": 39640987, "fx_rate": 1.337, "fx_source": "Bank of England daily spot rate (series XUDLUSS, XUDLERS), US$1.337 per £ on 2021-11-23", "fx_date": "2021-11-23", "fx_note": "", "txt": "US$53m", "gbp_txt": "£39.6m" } ], "site": null, "product": null, "dsit_domains": [ "Natural language applications", "AI implementation" ], "sectors": [ "mental health" ], "confidence": "verified", "checked": "2026-10-29", "as_of": "2026-10-29", "applied": null, "held": [], "same_as": null, "package1_id": "biz-ieso", "type": "Companies", "category": "health", "function": "Cambridge digital mental health company offering typed online therapy to NHS patients and building AI therapy tools from that data.", "affiliation": "Start-ups", "sources": [ "https://tech.eu/2021/11/23/addressing-mental-health-with-digital-therapeutics-ieso-raises-53-million/", "https://find-and-update.company-information.service.gov.uk/company/04063351" ], "source_quotes": [ { "url": "https://tech.eu/2021/11/23/addressing-mental-health-with-digital-therapeutics-ieso-raises-53-million/", "quotes": [ "Cambridge-based digital mental healthcare ieso has raised $53 million in a Series B funding round.\" \"The funding will be used to develop autonomous therapy systems.\" \"In total, the startup has raised $77.9 million." ], "accessed": "2026-10-29", "trade": true, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/04063351", "quotes": [ "IESO DIGITAL HEALTH LIMITED", "Active", "1 September 2000", "PSYCHOLOGYONLINE.CO.UK LIMITED" ], "accessed": "2026-10-29", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [ "Natural language applications", "AI implementation" ], "one_source": false, "confidence_raw": "verified", "depts": [ { "dept": "mental health", "div": "health" } ], "div_label": "Health", "location": "Cambridge", "status_group": "active", "ext_links": [ { "kind": "funded_by", "id": "BIZ-INV-008", "name": "IP Group", "page": "investors", "href": "../../investors/#org=BIZ-INV-008", "page_label": "Investors" } ], "label_links": [ { "kind": "funded_by", "name": "Morningside" }, { "kind": "funded_by", "name": "Sony Innovation Fund" }, { "kind": "funded_by", "name": "Molten Ventures" }, { "kind": "supplies", "name": "NHS" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-040", "name": "Optellum", "bucket": "co", "status": "active", "status_date": "2026-10-31", "status_detail": "Raised a US$14m Series A led by Mercia, reported 27 September 2022; no later page opened. Companies House shows OPTELLUM LTD as Active (checked 31 Oct 2026).", "one_line": "Oxford company whose software helps doctors judge whether lung nodules on CT scans are cancer.", "description": "Optellum is an Oxford medtech company whose Virtual Nodule Clinic platform helps physicians identify and track patients at risk of early-stage lung cancer. In September 2022 it raised a US$14m Series A led by Mercia, with Intuitive Ventures and Black Opal Ventures and existing investors St John's College Oxford, IQ Capital and the Wood family office. Jason Pesterfield was chief executive. The company was incorporated in October 2015 and is registered at Osney Mead, Oxford.", "uk_status": "uk", "company": { "ch_number": "09846477", "registered_office": "5 Kings Meadow, Osney Mead, Ferry Hinksey Road, Oxford, Oxfordshire, England, OX2 0DP", "incorporated": "2015-10-28", "legal_form": "ltd", "owner_or_acquirer": null, "headcount": null, "ch_number_clean": "09846477", "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/09846477", "ch_note": null }, "place": { "text": "Oxford (OX2 0DP)", "postcode": "OX2 0DP", "lat": 51.748456, "lng": -1.277503, "region": "England: South East", "admin_district": "Oxford", "geocoded": "postcodes.io" }, "people": [ { "name": "Jason Pesterfield", "role": "CEO (as of September 2022)", "from": null, "source": "https://tech.eu/2022/09/27/oxford-based-medtech-optellum-gets-14-million-shot-to-accelerate-early-detection-of-lung-cancer/" } ], "money": [ { "kind": "funding_round", "amount": 14000000, "currency": "USD", "date": "2022-09-27", "detail": "Series A led by Mercia", "raw": "funding_round: 14000000 USD 2022-09-27 — Series A led by Mercia", "amount_gbp": 12994245, "fx_rate": 1.0774, "fx_source": "Bank of England daily spot rate (series XUDLUSS, XUDLERS), US$1.0774 per £ on 2022-09-27", "fx_date": "2022-09-27", "fx_note": "", "txt": "US$14m", "gbp_txt": "£13m" } ], "site": null, "product": null, "dsit_domains": [ "Perceptual systems", "AI implementation" ], "sectors": [ "medical imaging", "lung cancer" ], "confidence": "verified", "checked": "2026-10-29", "as_of": "2026-10-29", "applied": [ { "from": "Part 2.4", "field": "links (add)", "text": "supplies_government → GOV:NHS AI in Health and Care Award (round 2, Phase 3, 2021, DOLCE)" } ], "held": [], "same_as": null, "package1_id": "biz-optellum", "type": "Companies", "category": "health", "function": "Oxford company whose software helps doctors judge whether lung nodules on CT scans are cancer.", "affiliation": "Start-ups", "sources": [ "https://tech.eu/2022/09/27/oxford-based-medtech-optellum-gets-14-million-shot-to-accelerate-early-detection-of-lung-cancer/", "https://find-and-update.company-information.service.gov.uk/search/companies?q=optellum", "https://find-and-update.company-information.service.gov.uk/company/09846477", "https://www.gov.uk/government/news/36-million-boost-for-ai-technologies-to-revolutionise-nhs-care" ], "source_quotes": [ { "url": "https://tech.eu/2022/09/27/oxford-based-medtech-optellum-gets-14-million-shot-to-accelerate-early-detection-of-lung-cancer/", "quotes": [ "Virtual Nodule Clinic is a platform that helps physicians identify and track at-risk patients\" \"The Series A round was led by Mercia." ], "accessed": "2026-10-29", "trade": true, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/search/companies?q=optellum", "quotes": [ "OPTELLUM LTD\" \"09846477\" \"28 October 2015\" \"Osney Mead, Ferry Hinksey Road, Oxford" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/09846477", "quotes": [ "OPTELLUM LTD\" \"5 Kings Meadow, Osney Mead, Ferry Hinksey Road, Oxford", "OX2 0DP\" \"Active\" \"28 October 2015\" \"Confirmation statement overdue" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://www.gov.uk/government/news/36-million-boost-for-ai-technologies-to-revolutionise-nhs-care", "quotes": [ "examines lung nodules to determine which are precancerous" ], "accessed": "2026-10-29", "trade": false, "amendment": true } ], "website": [], "colleges": [], "topics": [ "Perceptual systems", "AI implementation" ], "one_source": false, "confidence_raw": "verified", "depts": [ { "dept": "medical imaging", "div": "health" } ], "div_label": "Health", "location": "Oxford (OX2 0DP)", "status_group": "active", "ext_links": [ { "kind": "funded_by", "id": "BIZ-INV-205", "name": "Mercia (Mercia Ventures, Mercia Asset Management PLC)", "page": "investors", "href": "../../investors/#org=BIZ-INV-205", "page_label": "Investors" }, { "kind": "linked from: funds", "id": "BIZ-INV-205", "name": "Mercia (Mercia Ventures, Mercia Asset Management PLC)", "page": "investors", "href": "../../investors/#org=BIZ-INV-205", "page_label": "Investors" } ], "label_links": [ { "kind": "funded_by", "name": "IQ Capital" }, { "kind": "funded_by", "name": "Intuitive Ventures" }, { "kind": "supplies_government", "name": "Government: NHS AI in Health and Care Award" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-041", "name": "Navenio", "bucket": "co", "status": "active", "status_date": "2026-10-31", "status_detail": "Oxford Science Enterprises led a £5m investment, reported 20 September 2023, to take the company into the US; no later page opened. Companies House shows NAVENIO LIMITED as Active (checked 31 Oct 2026).", "one_line": "University of Oxford spin-out whose indoor-location software tracks hospital staff and assigns tasks such as portering.", "description": "Navenio is an Oxford-based spin-out of Oxford University that provides indoor location technology needing no added infrastructure. Hospitals use it to manage staff movement: it crowdsources sensor data from staff smartphones and uses AI to allocate jobs based on where staff and equipment are. In May 2020 it announced a £9m Series A led by QBN Capital (Tim Weil was chief executive then). In September 2023 Oxford Science Enterprises led a £5m round, with G.K. Goh Ventures, Big Pi Ventures, George Robinson and the University of Oxford, to expand into the US; Connie Moser was chief executive. No page from 2025 or 2026 was opened.", "uk_status": "uk", "company": { "ch_number": "09845565", "registered_office": null, "incorporated": null, "legal_form": null, "owner_or_acquirer": null, "headcount": null, "ch_number_clean": "09845565", "from_round2": true, "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/09845565", "ch_note": null }, "place": { "text": "Oxford", "postcode": "W1W 5PF", "lat": 51.521673, "lng": -0.143705, "region": "England: South East", "admin_district": "Westminster", "geocoded": "postcodes.io" }, "people": [ { "name": "Connie Moser", "role": "CEO (as of September 2023)", "from": null, "source": "https://www.uktech.news/ai/indoor-mapping-navenio-5m-20230920" }, { "name": "Tim Weil", "role": "CEO (as of May 2020)", "from": null, "source": "https://www.uktech.news/news/navenio-raises-9m-for-hospital-workforce-ai-platform-wednesday-20200518" } ], "money": [ { "kind": "funding_round", "amount": 5000000, "currency": "GBP", "date": "2023-09-20", "detail": "led by Oxford Science Enterprises", "raw": "funding_round: 5000000 GBP 2023-09-20 — led by Oxford Science Enterprises", "amount_gbp": 5000000, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£5m", "gbp_txt": "" }, { "kind": "funding_round", "amount": 9000000, "currency": "GBP", "date": "2020-05-21", "detail": "Series A led by QBN Capital", "raw": "funding_round: 9000000 GBP 2020-05-21 — Series A led by QBN Capital", "amount_gbp": 9000000, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£9m", "gbp_txt": "" } ], "site": null, "product": null, "dsit_domains": [ "AI implementation", "Perceptual systems" ], "sectors": [ "hospital operations", "workforce" ], "confidence": "verified", "checked": "2026-10-29", "as_of": "2026-10-29", "applied": [ { "from": "Part 2.4", "field": "links (add)", "text": "supplies_government → GOV:NHS AI in Health and Care Award (round 2, Phase 3, 2021, workforce deployment)" } ], "held": [], "same_as": null, "package1_id": "biz-navenio", "type": "Companies", "category": "health", "function": "University of Oxford spin-out whose indoor-location software tracks hospital staff and assigns tasks such as portering.", "affiliation": "Start-ups", "sources": [ "https://www.uktech.news/news/navenio-raises-9m-for-hospital-workforce-ai-platform-wednesday-20200518", "https://www.uktech.news/ai/indoor-mapping-navenio-5m-20230920", "https://find-and-update.company-information.service.gov.uk/search?q=navenio", "https://www.uktech.news/news/navenio-raises-9m-for-hospital-workforce-ai-platform-wednesday-20200518", "https://www.gov.uk/government/news/36-million-boost-for-ai-technologies-to-revolutionise-nhs-care", "https://find-and-update.company-information.service.gov.uk/company/09845565" ], "source_quotes": [ { "url": "https://www.uktech.news/news/navenio-raises-9m-for-hospital-workforce-ai-platform-wednesday-20200518", "quotes": [ "Navenio, a spin-out of Oxford University, provides infrastructure-free indoor location solutions\" \"today announced £9m in series A funding\" \"The series A funding round was led by QBN Capital" ], "accessed": "2026-10-29", "trade": true, "amendment": false }, { "url": "https://www.uktech.news/ai/indoor-mapping-navenio-5m-20230920", "quotes": [ "Oxford Science Enterprises is leading a £5m investment into Navenio\" \"uses AI to allocate jobs, based on the physical location of staff and assets.\" \"Connie Moser, CEO of Navenio" ], "accessed": "2026-10-29", "trade": true, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/search?q=navenio", "quotes": [ "NAVENIO LIMITED", "09845565", "Incorporated on 28 October 2015", "167-169 Great Portland Street, London, England, W1W 5PF" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://www.uktech.news/news/navenio-raises-9m-for-hospital-workforce-ai-platform-wednesday-20200518", "quotes": [ "Navenio, a spin-out of Oxford University, provides infrastructure-free indoor location solutions.\" (May 2020)" ], "accessed": "2026-10-29", "trade": true, "amendment": false }, { "url": "https://www.gov.uk/government/news/36-million-boost-for-ai-technologies-to-revolutionise-nhs-care", "quotes": [ "ensuring that both clinical and support staff are in the right place" ], "accessed": "2026-10-29", "trade": false, "amendment": true }, { "url": "https://find-and-update.company-information.service.gov.uk/company/09845565", "quotes": [ "NAVENIO LIMITED | Company number 09845565 | Active" ], "accessed": "2026-10-31", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [ "AI implementation", "Perceptual systems" ], "one_source": false, "confidence_raw": "verified", "depts": [ { "dept": "hospital operations", "div": "health" } ], "div_label": "Health", "location": "Oxford", "status_group": "active", "ext_links": [ { "kind": "funded_by", "id": "BIZ-INV-007", "name": "Oxford Science Enterprises", "page": "investors", "href": "../../investors/#org=BIZ-INV-007", "page_label": "Investors" }, { "kind": "spun_out_of", "id": "UNI:oxford", "name": "Universities: oxford", "page": "universities", "href": "https://hazy-wreath-hez6.here.now/oxford/", "page_label": "UK Universities AI Universe (new tab)" } ], "label_links": [ { "kind": "spun_out_of", "name": "University of Oxford" }, { "kind": "funded_by", "name": "QBN Capital" }, { "kind": "supplies_government", "name": "Government: NHS AI in Health and Care Award" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-042", "name": "Proximie", "bucket": "co", "status": "active", "status_date": "2026-10-07", "status_detail": "Won Innovation of the year at the HTN Health Tech Awards 2026 (announced 7 October 2026) for \"The Intelligence Suite\".", "one_line": "Runs a platform that connects operating theatres so surgeons can join operations remotely, and records and analyses the footage.", "description": "Proximie runs a digital operating-room platform. Its product \"The Intelligence Suite\" won Innovation of the year at the HTN Health Tech Awards 2026, announced on 7 October 2026. An earlier pass recorded US$80m Series C (2022) and US$38m Series B (2021) rounds and founder Nadine Hachach-Haram; those sources were not reopened in this session, so they are not entered here.", "uk_status": "uk", "company": { "ch_number": "10509541", "registered_office": null, "incorporated": null, "legal_form": null, "owner_or_acquirer": null, "headcount": null, "ch_number_clean": "10509541", "from_round2": true, "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/10509541", "ch_note": null }, "place": { "text": "London", "postcode": "WA14 2DT", "lat": 53.384157, "lng": -2.35191, "region": "England: London", "admin_district": "Trafford", "geocoded": "postcodes.io" }, "people": [], "money": [], "site": null, "product": null, "dsit_domains": [ "Perceptual systems", "AI implementation" ], "sectors": [ "surgery", "digital operating room" ], "confidence": "verified", "checked": "2026-10-29", "as_of": "2026-10-29", "applied": null, "held": [], "same_as": null, "package1_id": "biz-proximie", "type": "Companies", "category": "health", "function": "Runs a platform that connects operating theatres so surgeons can join operations remotely, and records and analyses the footage.", "affiliation": "Start-ups", "sources": [ "https://htn.co.uk/2026/10/07/health-tech-awards-2026-meet-the-winners/", "https://find-and-update.company-information.service.gov.uk/company/10509541" ], "source_quotes": [ { "url": "https://htn.co.uk/2026/10/07/health-tech-awards-2026-meet-the-winners/", "quotes": [ "Innovation of the year\" \"Proximie: The Intelligence Suite" ], "accessed": "2026-10-29", "trade": true, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/10509541", "quotes": [ "PROXIMIE LIMITED", "Active", "5 December 2016" ], "accessed": "2026-10-29", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [ "Perceptual systems", "AI implementation" ], "one_source": false, "confidence_raw": "verified", "depts": [ { "dept": "surgery", "div": "health" } ], "div_label": "Health", "location": "London", "status_group": "active", "ext_links": [], "label_links": [], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-043", "name": "Health Navigator", "bucket": "co", "status": "active", "status_date": "2026-10-07", "status_detail": "Won Partnership of the year at the HTN Health Tech Awards 2026 (7 October 2026) with NHS North East London ICB and UCLPartners for AI for urgent and emergency care prevention.", "one_line": "Supplies AI that picks out patients most likely to need emergency care so they can be offered support at home.", "description": "Health Navigator works with NHS North East London Integrated Care Board and UCLPartners on an AI programme to prevent urgent and emergency care use. The partnership won Partnership of the year at the HTN Health Tech Awards 2026. Company details (location, ownership, founders) were not on an opened page; Alex may wish to keep this record thin or drop it. [Round 4, 30 Oct 2026] name: Listed on DigitalHealth.London Accelerator page as alumni 2018/19 (spelled \"Heath Navigator\")", "uk_status": "uk", "company": { "ch_number": "09364491", "registered_office": null, "incorporated": null, "legal_form": null, "owner_or_acquirer": null, "headcount": null, "ch_number_clean": "09364491", "from_round2": true, "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/09364491", "ch_note": null }, "place": { "text": null, "postcode": "W1B 1NT", "lat": 51.521688, "lng": -0.145218, "region": null, "admin_district": "Westminster", "geocoded": "postcodes.io" }, "people": [ { "name": "Joachim Werr", "role": "CEO", "from": "2018/19 (DigitalHealth.London Accelerator cohort)", "source": "https://digitalhealth.london/programmes/accelerator", "round4": true } ], "money": [], "site": null, "product": null, "dsit_domains": [ "Knowledge generation", "AI implementation" ], "sectors": [ "population health", "urgent and emergency care" ], "confidence": "verified", "checked": "2026-10-29", "as_of": "2026-10-29", "applied": null, "held": [], "same_as": null, "package1_id": "biz-health-navigator", "type": "Companies", "category": "health", "function": "Supplies AI that picks out patients most likely to need emergency care so they can be offered support at home.", "affiliation": "Start-ups", "sources": [ "https://htn.co.uk/2026/10/07/health-tech-awards-2026-meet-the-winners/", "https://find-and-update.company-information.service.gov.uk/company/09364491", "https://digitalhealth.london/programmes/accelerator" ], "source_quotes": [ { "url": "https://htn.co.uk/2026/10/07/health-tech-awards-2026-meet-the-winners/", "quotes": [ "Partnership of the year\" \"NHS North East London ICB, UCLPartners, and Health Navigator: AI for urgent and emergency care prevention" ], "accessed": "2026-10-29", "trade": true, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/09364491", "quotes": [ "HEALTH NAVIGATOR LIMITED\" \"Hale House, 76 Portland Place, London, England, W1B 1NT\" \"Active\" \"22 December 2014\" \"86900 - Other human health activities" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://digitalhealth.london/programmes/accelerator", "quotes": [ "Heath Navigator" ], "accessed": "2026-10-30", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [ "Knowledge generation", "AI implementation" ], "one_source": false, "confidence_raw": "verified", "depts": [ { "dept": "population health", "div": "health" } ], "div_label": "Health", "location": null, "status_group": "active", "ext_links": [], "label_links": [ { "kind": "supplies", "name": "NHS North East London ICB" }, { "kind": "partner_of", "name": "UCLPartners" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-044", "name": "Simple Life", "bucket": "co", "status": "active", "status_date": "2025-10-03", "status_detail": "Raised £26m co-led by HartBeat Ventures, with Liquidity, reported 3 October 2025.", "one_line": "London health and fitness app whose AI coach, Avo, gives weight-loss support and can scan food and menus.", "description": "Simple Life was founded in 2019 to offer practical weight-loss support and is based in London. Its app relies heavily on AI tools, including an automated health coach called Avo and Avo Vision, which scans food, menus and shopping aisles. In October 2025 it raised £26m co-led by HartBeat Ventures, the venture fund of Kevin Hart, with Liquidity. Leaders and Companies House record were not confirmed. It is a consumer wellness app rather than a clinical product; Alex may prefer to drop it.", "uk_status": "uk", "company": { "ch_number": null, "registered_office": null, "incorporated": null, "legal_form": null, "owner_or_acquirer": null, "headcount": null, "ch_number_clean": null, "companies_house_url": null, "ch_note": null }, "place": { "text": "London", "postcode": null, "lat": null, "lng": null, "region": "England: London" }, "people": [], "money": [ { "kind": "funding_round", "amount": 26000000, "currency": "GBP", "date": "2025-10-03", "detail": "co-led by HartBeat Ventures, with Liquidity", "raw": "funding_round: 26000000 GBP 2025-10-03 — co-led by HartBeat Ventures, with Liquidity", "amount_gbp": 26000000, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£26m", "gbp_txt": "" } ], "site": null, "product": null, "dsit_domains": [ "Natural language applications", "Perceptual systems" ], "sectors": [ "consumer health", "weight loss" ], "confidence": "single_source", "checked": "2026-10-29", "as_of": "2026-10-29", "applied": null, "held": [], "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "London health and fitness app whose AI coach, Avo, gives weight-loss support and can scan food and menus.", "affiliation": "Start-ups", "sources": [ "https://www.uktech.news/medtech/kevin-harts-vc-fund-leads-26m-round-for-ai-health-app-20251003", "https://find-and-update.company-information.service.gov.uk/search?q=simple+life+app" ], "source_quotes": [ { "url": "https://www.uktech.news/medtech/kevin-harts-vc-fund-leads-26m-round-for-ai-health-app-20251003", "quotes": [ "has co-led a £26m investment in London-based health and fitness app Simple Life.\" \"leans heavily on AI tools, including an automated health coach, called Avo.\" \"Founded in 2019" ], "accessed": "2026-10-29", "trade": true, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/search?q=simple+life+app", "quotes": [ "SIMPLE.LIFE APPS UK LTD", "13409801", "Incorporated on 20 May 2021" ], "accessed": "2026-10-29", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [ "Natural language applications", "Perceptual systems" ], "one_source": true, "confidence_raw": "single_source", "depts": [ { "dept": "consumer health", "div": "health" } ], "div_label": "Health", "location": "London", "status_group": "active", "ext_links": [ { "kind": "linked from: portfolio_of", "id": "BIZ-INV-2122", "name": "HartBeat Ventures", "page": "investors", "href": "../../investors/#org=BIZ-INV-2122", "page_label": "Investors" }, { "kind": "funded_by", "id": "BIZ-INV-2122", "name": "HartBeat Ventures", "page": "investors", "href": "../../investors/#org=BIZ-INV-2122", "page_label": "Investors" }, { "kind": "linked from: portfolio_of", "id": "BIZ-BIG-2028", "name": "Liquidity (UK)", "page": "big-tech", "href": "../../big-tech/#org=BIZ-BIG-2028", "page_label": "Big tech in the UK" }, { "kind": "funded_by", "id": "BIZ-BIG-2028", "name": "Liquidity (UK)", "page": "big-tech", "href": "../../big-tech/#org=BIZ-BIG-2028", "page_label": "Big tech in the UK" } ], "label_links": [ { "kind": "funded_by", "name": "HartBeat Ventures" }, { "kind": "funded_by", "name": "Liquidity" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-045", "name": "Concinnity Genetics", "bucket": "co", "status": "active", "status_date": "2026-10-31", "status_detail": "Raised £3m in a round led by Eos Advisory, with Scottish Enterprise, Old College Capital and Maven Capital Partners, reported 16 December 2024. Companies House shows CONCINNITY GENETICS LTD as Active (checked 31 Oct 2026).", "one_line": "Edinburgh spin-out designing gene therapies with built-in controls, using synthetic biology and machine learning.", "description": "Concinnity Genetics was founded in 2023 as an Edinburgh spin-out developing gene therapies with control mechanisms. Its lead investor described the approach as combining synthetic biology and AI-machine learning. In December 2024 it raised £3m led by Eos Advisory, with Scottish Enterprise, Old College Capital (the University of Edinburgh's venture fund) and Maven Capital Partners. Jessica Birt is co-founder and chief executive. AI is part of the method rather than the product (diversified).", "uk_status": "uk", "company": { "ch_number": "SC786187", "registered_office": null, "incorporated": null, "legal_form": null, "owner_or_acquirer": null, "headcount": null, "ch_number_clean": "SC786187", "from_round2": true, "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/SC786187", "ch_note": null }, "place": { "text": "Edinburgh", "postcode": "EH1 2EN", "lat": 55.947551, "lng": -3.204174, "region": "Scotland", "admin_district": "City of Edinburgh", "geocoded": "postcodes.io" }, "people": [ { "name": "Jessica Birt", "role": "Co-founder and CEO", "from": "2023", "source": "https://www.uktech.news/medtech/edinburgh-health-tech-spinout-concinnity-genetics-raises-3m-20241216" } ], "money": [ { "kind": "funding_round", "amount": 3000000, "currency": "GBP", "date": "2024-12-16", "detail": "led by Eos Advisory", "raw": "funding_round: 3000000 GBP 2024-12-16 — led by Eos Advisory", "amount_gbp": 3000000, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£3m", "gbp_txt": "" } ], "site": null, "product": null, "dsit_domains": [ "Knowledge generation" ], "sectors": [ "gene therapy", "synthetic biology" ], "confidence": "verified", "checked": "2026-10-29", "as_of": "2026-10-29", "applied": null, "held": [], "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "Edinburgh spin-out designing gene therapies with built-in controls, using synthetic biology and machine learning.", "affiliation": "Start-ups", "sources": [ "https://www.uktech.news/medtech/edinburgh-health-tech-spinout-concinnity-genetics-raises-3m-20241216", "https://find-and-update.company-information.service.gov.uk/company/SC786187" ], "source_quotes": [ { "url": "https://www.uktech.news/medtech/edinburgh-health-tech-spinout-concinnity-genetics-raises-3m-20241216", "quotes": [ "Founded in 2023, Concinnity Genetics is a spinout developing novel gene therapies with control mechanisms.\" \"By combining synthetic biology and AI-machine learning," ], "accessed": "2026-10-29", "trade": true, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/SC786187", "quotes": [ "CONCINNITY GENETICS LTD", "Active", "17 October 2023", "72110 - Research and experimental development on biotechnology" ], "accessed": "2026-10-29", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [ "Knowledge generation" ], "one_source": false, "confidence_raw": "verified", "depts": [ { "dept": "gene therapy", "div": "health" } ], "div_label": "Health", "location": "Edinburgh", "status_group": "active", "ext_links": [], "label_links": [ { "kind": "spun_out_of", "name": "University of Edinburgh (current academic post)" }, { "kind": "funded_by", "name": "Eos Advisory" }, { "kind": "funded_by", "name": "Scottish Enterprise" }, { "kind": "funded_by", "name": "Old College Capital" }, { "kind": "funded_by", "name": "Maven Capital Partners" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-046", "name": "Elyndra", "bucket": "co", "status": "active", "status_date": "2025-06-27", "status_detail": "Secured a £1.1m investment led by Outward VC, reported 27 June 2025.", "one_line": "Gives social care managers and frontline carers AI tools to improve the quality and efficiency of care.", "description": "Elyndra calls itself an \"operating system for social care\". It supplies care managers and frontline staff with AI tools to improve the quality and efficiency of care. In June 2025 it raised £1.1m led by Outward VC. Marcus Williamson is the founder. Head office and Companies House record not confirmed.", "uk_status": "uk", "company": { "ch_number": null, "registered_office": null, "incorporated": null, "legal_form": null, "owner_or_acquirer": null, "headcount": null, "ch_number_clean": null, "companies_house_url": null, "ch_note": null }, "place": { "text": null, "postcode": null, "lat": null, "lng": null, "region": null }, "people": [ { "name": "Marcus Williamson", "role": "Founder", "from": null, "source": "https://www.uktech.news/medtech/social-care-platform-elyndra-scores-1-1m-20250627" } ], "money": [ { "kind": "funding_round", "amount": 1100000, "currency": "GBP", "date": "2025-06-27", "detail": "led by Outward VC", "raw": "funding_round: 1100000 GBP 2025-06-27 — led by Outward VC", "amount_gbp": 1100000, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£1.1m", "gbp_txt": "" } ], "site": null, "product": null, "dsit_domains": [ "AI implementation", "Natural language applications" ], "sectors": [ "social care" ], "confidence": "single_source", "checked": "2026-10-29", "as_of": "2026-10-29", "applied": null, "held": [], "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "Gives social care managers and frontline carers AI tools to improve the quality and efficiency of care.", "affiliation": "Start-ups", "sources": [ "https://www.uktech.news/medtech/social-care-platform-elyndra-scores-1-1m-20250627" ], "source_quotes": [ { "url": "https://www.uktech.news/medtech/social-care-platform-elyndra-scores-1-1m-20250627", "quotes": [ "The company supplies care managers and frontline staff with AI tools to improve the quality and efficiency of care.\" \"Elyndra, the self-described 'operating system for social care' has secured a £1.1m investment led by Outward VC." ], "accessed": "2026-10-29", "trade": true, "amendment": false } ], "website": [], "colleges": [], "topics": [ "AI implementation", "Natural language applications" ], "one_source": true, "confidence_raw": "single_source", "depts": [ { "dept": "social care", "div": "health" } ], "div_label": "Health", "location": null, "status_group": "active", "ext_links": [], "label_links": [ { "kind": "funded_by", "name": "Outward VC" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-047", "name": "ThinkSono", "bucket": "co", "status": "active", "status_date": "2026-10-31", "status_detail": "Raised £2.1m led by Id4 Ventures, taking total funding to £5m, reported 15 March 2024; no later page opened. Companies House shows THINKSONO LTD as Active (checked 31 Oct 2026).", "one_line": "Makes AI software that guides staff without ultrasound training to check for deep vein thrombosis blood clots.", "description": "ThinkSono was founded in 2016 and uses AI to make ultrasound procedures more efficient; its software helps staff who are not trained in ultrasound look for deep vein thrombosis. In March 2024 it raised £2.1m led by Id4 Ventures, bringing total funding to £5m. Fouad Al Noor is chief executive. Companies House lists ThinkSono Ltd, incorporated November 2016, with a Ruislip address.", "uk_status": "uk", "company": { "ch_number": "10470929", "registered_office": "33 Flowers Avenue, Ruislip, England, HA4 8GA", "incorporated": "2016-11-09", "legal_form": "ltd", "owner_or_acquirer": null, "headcount": null, "ch_number_clean": "10470929", "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/10470929", "ch_note": null }, "place": { "text": null, "postcode": "HA4 8GA", "lat": 51.582887, "lng": -0.406957, "region": null, "admin_district": "Hillingdon", "geocoded": "postcodes.io" }, "people": [ { "name": "Fouad Al Noor", "role": "CEO", "from": null, "source": "https://www.uktech.news/medtech/thinksono-ai-ultrasound-20240315" } ], "money": [ { "kind": "funding_round", "amount": 2100000, "currency": "GBP", "date": "2024-03-15", "detail": "led by Id4 Ventures; total raised £5m", "raw": "funding_round: 2100000 GBP 2024-03-15 — led by Id4 Ventures; total raised £5m", "amount_gbp": 2100000, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£2.1m", "gbp_txt": "" } ], "site": null, "product": null, "dsit_domains": [ "Perceptual systems", "AI implementation" ], "sectors": [ "ultrasound", "vascular" ], "confidence": "verified", "checked": "2026-10-29", "as_of": "2026-10-29", "applied": null, "held": [], "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "Makes AI software that guides staff without ultrasound training to check for deep vein thrombosis blood clots.", "affiliation": "Start-ups", "sources": [ "https://www.uktech.news/medtech/thinksono-ai-ultrasound-20240315", "https://find-and-update.company-information.service.gov.uk/search/companies?q=thinksono", "https://find-and-update.company-information.service.gov.uk/company/10470929" ], "source_quotes": [ { "url": "https://www.uktech.news/medtech/thinksono-ai-ultrasound-20240315", "quotes": [ "a health tech startup looking to use AI to improve the efficiency of ultrasound procedures." ], "accessed": "2026-10-29", "trade": true, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/search/companies?q=thinksono", "quotes": [ "THINKSONO LTD\" \"10470929\" \"9 November 2016\" \"33 Flowers Avenue, Ruislip" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/10470929", "quotes": [ "THINKSONO LTD", "Active", "9 November 2016", "KHIROP DIAGNOSTICS LTD", "MEDTECH DIAGNOSTICS LIMITED" ], "accessed": "2026-10-29", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [ "Perceptual systems", "AI implementation" ], "one_source": false, "confidence_raw": "verified", "depts": [ { "dept": "ultrasound", "div": "health" } ], "div_label": "Health", "location": null, "status_group": "active", "ext_links": [], "label_links": [ { "kind": "funded_by", "name": "Id4 Ventures" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-048", "name": "AMPLY Discovery", "bucket": "co", "status": "active", "status_date": "2026-10-31", "status_detail": "Raised £1.4m in Innovate UK grant funding across two projects (one also supported by Innosuisse), reported 12 February 2024; no later page opened. Companies House shows AMPLY DISCOVERY LIMITED as Active (checked 31 Oct 2026).", "one_line": "Queen's University Belfast spin-out that uses its own AI model to cut the cost of discovering new drugs.", "description": "AMPLY is a Belfast AI drug discovery start-up spun out of Queen's University Belfast. It uses a proprietary AI model that it says reduces the cost of discovering new drugs; UKTN's headline called it a \"ChatGPT for molecule discovery\". In February 2024 it won £1.4m of Innovate UK grant funding. Ben Thomas is co-founder and chief executive and Dermot Tierney is co-founder and chief operating officer. Companies House lists Amply Discovery Limited (NI676691), incorporated February 2021, care of Qubis Ltd at University Road, Belfast. [Round 4, 30 Oct 2026] LABS: Queen's University Belfast spin-out combining AI, sequencing and synthetic biology to find treatments for genetically linked diseases. [Labs Round 7, 30 Oct 2026] founders: Ben Thomas — chief executive and chief architect; Dermot Tierney and Chris Creevey also named as founders; spun out of Queen's University Belfast (Creevey Lab, over 10 years of research) [Labs Round 7, 30 Oct 2026] models_released: AMPLYfolioAI platform: AI, next-generation sequencing and synthetic biology to design biologic drugs [Labs Round 7, 30 Oct 2026] rounds: $1.75m seed (2025-05-01) led by Twin Path Ventures with Venture Science, Co-fund NI, British Business Bank, QUBIS (already on site as DEAL-LAB-2013; investors added here) [Labs Round 8, 31 Oct 2026] founders: Ben Thomas — co-founder and CEO; Dermot Tierney — co-founder and COO; Queen's University Belfast spin-out, 2021 [Labs Round 8, 31 Oct 2026] what_it_does: Proprietary AI model for drug discovery against antibiotic-resistant infections; calls itself \"ChatGPT for molecule discovery\" [Labs Round 8, 31 Oct 2026] uk_government_links: Innovate UK grants: £835,000 (RNAi cancer therapies, with Innosuisse) and £602,000 (inhaled antimicrobials) (2024-02-12)", "uk_status": "uk", "company": { "ch_number": "NI676691", "registered_office": "C/O Qubis Ltd, 63 University Road, Belfast, Northern Ireland, BT7 1NF", "incorporated": "2021-02-19", "legal_form": "ltd", "owner_or_acquirer": null, "headcount": null, "ch_number_clean": "NI676691", "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/NI676691", "ch_note": null }, "place": { "text": "Belfast (BT7 1NF)", "postcode": "BT7 1NF", "lat": 54.585528, "lng": -5.93641, "region": "Northern Ireland", "admin_district": "Belfast", "geocoded": "postcodes.io" }, "people": [ { "name": "Ben Thomas", "role": "Co-founder and CEO", "from": null, "source": "https://www.uktech.news/medtech/amply-ai-drug-grant-20240212" }, { "name": "Dermot Tierney", "role": "Co-founder and COO", "from": null, "source": null }, { "name": "Ben Thomas", "role": "CEO and chief architect", "from": null, "source": "https://tech.eu/2025/05/01/queens-university-spin-off-amply-secures-175m-for-ai-drug-discovery/", "round4": true }, { "name": "Chris Creevey", "role": "co-founder", "from": null, "source": "https://tech.eu/2025/05/01/queens-university-spin-off-amply-secures-175m-for-ai-drug-discovery/", "round4": true }, { "name": "Ben Thomas", "role": "chief executive and chief architect", "from": null, "source": "https://tech.eu/2025/05/01/queens-university-spin-off-amply-secures-175m-for-ai-drug-discovery/", "round4": true }, { "name": "Ben Thomas", "role": "Co-founder and CEO", "from": "2021", "source": "https://www.uktech.news/medtech/amply-ai-drug-grant-20240212", "round4": true }, { "name": "Dermot Tierney", "role": "Co-founder and COO", "from": "2021", "source": "https://www.uktech.news/medtech/amply-ai-drug-grant-20240212", "round4": true }, { "name": "Chris Creevey", "role": "co-founder", "from": null, "source": "https://tech.eu/2025/05/01/queens-university-spin-off-amply-secures-175m-for-ai-drug-discovery/", "round4": true } ], "money": [ { "kind": "grant", "amount": 1400000, "currency": "GBP", "date": "2024-02-12", "detail": "Innovate UK (two projects)", "raw": "grant: 1400000 GBP 2024-02-12 — Innovate UK (two projects)", "amount_gbp": 1400000, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£1.4m", "gbp_txt": "" } ], "site": null, "product": null, "dsit_domains": [ "Knowledge generation", "AI development and training" ], "sectors": [ "drug discovery" ], "confidence": "verified", "checked": "2026-10-29", "as_of": "2026-10-29", "applied": null, "held": [], "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "Queen's University Belfast spin-out that uses its own AI model to cut the cost of discovering new drugs.", "affiliation": "Start-ups", "sources": [ "https://www.uktech.news/medtech/amply-ai-drug-grant-20240212", "https://find-and-update.company-information.service.gov.uk/search/companies?q=amply+discovery", "https://find-and-update.company-information.service.gov.uk/company/NI676691", "https://tech.eu/2025/05/01/queens-university-spin-off-amply-secures-175m-for-ai-drug-discovery/" ], "source_quotes": [ { "url": "https://www.uktech.news/medtech/amply-ai-drug-grant-20240212", "quotes": [ "Belfast-based AI drug discovery startup AMPLY\" \"The company uses a proprietary AI model that it says reduces the cost of discovering new drugs.\" \"AMPLY is a spinout from Queen's University Belfast." ], "accessed": "2026-10-29", "trade": true, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/search/companies?q=amply+discovery", "quotes": [ "AMPLY DISCOVERY LIMITED\" \"NI676691\" \"19 February 2021\" \"C/O Qubis Ltd, 63 University Road, Belfast" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/NI676691", "quotes": [ "AMPLY DISCOVERY LIMITED", "C/O Qubis Ltd, 63 University Road, Belfast, Northern Ireland, BT7 1NF", "Active", "19 February 2021" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://tech.eu/2025/05/01/queens-university-spin-off-amply-secures-175m-for-ai-drug-discovery/", "quotes": [ "now we're using AI to unlock this wisdom" ], "accessed": "2026-10-30", "trade": true, "amendment": false } ], "website": [], "colleges": [], "topics": [ "Knowledge generation", "AI development and training" ], "one_source": false, "confidence_raw": "verified", "depts": [ { "dept": "drug discovery", "div": "health" } ], "div_label": "Health", "location": "Belfast (BT7 1NF)", "status_group": "active", "ext_links": [ { "kind": "funded_by", "id": "BIZ-INV-2253", "name": "Twin Path Ventures", "page": "investors", "href": "../../investors/#org=BIZ-INV-2253", "page_label": "Investors" }, { "kind": "funded_by", "id": "BIZ-INV-002", "name": "British Business Bank", "page": "investors", "href": "../../investors/#org=BIZ-INV-002", "page_label": "Investors" } ], "label_links": [ { "kind": "spun_out_of", "name": "Queen's University Belfast" }, { "kind": "funded_by", "name": "Innovate UK" }, { "kind": "spun_out_of", "name": "Queen's University Belfast" }, { "kind": "funded_by", "name": "Co-fund NI" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-049", "name": "Sable Bio", "bucket": "co", "status": "active", "status_date": "2026-10-31", "status_detail": "Raised £1.5m pre-seed led by Episode 1 Ventures with Seedcamp, reported 6 February 2024; no later page opened. Companies House shows SABLEBIO LIMITED as Active (checked 31 Oct 2026).", "one_line": "London start-up that uses AI on biomedical data to test whether candidate medicines will be toxic.", "description": "Sable Bio is a London-based business-to-business biotech founded in 2023. It uses AI to analyse broad sets of biomedical data to test potential medicines for toxicity. In February 2024 it raised £1.5m in a pre-seed round led by Episode 1 Ventures, with Seedcamp. Josh Almond-Thynne is a co-founder. Companies House record could not be opened in this session.", "uk_status": "uk", "company": { "ch_number": "15084894", "registered_office": null, "incorporated": null, "legal_form": null, "owner_or_acquirer": null, "headcount": null, "ch_number_clean": "15084894", "from_round2": true, "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/15084894", "ch_note": null }, "place": { "text": "London", "postcode": "E1 1EW", "lat": 51.516758, "lng": -0.067672, "region": "England: London", "admin_district": "Tower Hamlets", "geocoded": "postcodes.io" }, "people": [ { "name": "Josh Almond-Thynne", "role": "Co-founder", "from": "2023", "source": "https://www.uktech.news/medtech/ai-drug-testing-startup-sable-bio-20240206" } ], "money": [ { "kind": "funding_round", "amount": 1500000, "currency": "GBP", "date": "2024-02-06", "detail": "pre-seed led by Episode 1 Ventures, with Seedcamp", "raw": "funding_round: 1500000 GBP 2024-02-06 — pre-seed led by Episode 1 Ventures, with Seedcamp", "amount_gbp": 1500000, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£1.5m", "gbp_txt": "" } ], "site": null, "product": null, "dsit_domains": [ "Knowledge generation" ], "sectors": [ "drug safety" ], "confidence": "verified", "checked": "2026-10-29", "as_of": "2026-10-29", "applied": null, "held": [], "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "London start-up that uses AI on biomedical data to test whether candidate medicines will be toxic.", "affiliation": "Start-ups", "sources": [ "https://www.uktech.news/medtech/ai-drug-testing-startup-sable-bio-20240206", "https://find-and-update.company-information.service.gov.uk/company/15084894", "https://find-and-update.company-information.service.gov.uk/company/15084894/officers" ], "source_quotes": [ { "url": "https://www.uktech.news/medtech/ai-drug-testing-startup-sable-bio-20240206", "quotes": [ "a London-based B2B biotech startup\" \"uses AI to analyse broad sets of biomedical data to test potential medicines for toxicity.\" \"The investment round was led by Episode 1 Ventures," ], "accessed": "2026-10-29", "trade": true, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/15084894", "quotes": [ "SABLEBIO LIMITED\" \"2 Whitechapel Road, London, England, E1 1EW\" \"Active\" \"21 August 2023" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/15084894/officers", "quotes": [ "ALMOND-THYNNE, Joshua\" Director (Active) \"21 August 2023" ], "accessed": "2026-10-29", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [ "Knowledge generation" ], "one_source": false, "confidence_raw": "verified", "depts": [ { "dept": "drug safety", "div": "health" } ], "div_label": "Health", "location": "London", "status_group": "active", "ext_links": [ { "kind": "funded_by", "id": "BIZ-INV-012", "name": "Episode 1 Ventures", "page": "investors", "href": "../../investors/#org=BIZ-INV-012", "page_label": "Investors" }, { "kind": "funded_by", "id": "BIZ-INV-202", "name": "Seedcamp", "page": "investors", "href": "../../investors/#org=BIZ-INV-202", "page_label": "Investors" } ], "label_links": [], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-050", "name": "Vitrue Health", "bucket": "co", "status": "active", "status_date": "2026-10-31", "status_detail": "Raised £3.2m led by MMC Ventures and Hambro Perks, reported 1 March 2024; no later page opened. Companies House shows VITRUE LTD as Active (checked 31 Oct 2026).", "one_line": "Uses computer vision and AI to assess office workers at risk of back and joint problems and help prevent them.", "description": "Vitrue Health launched in 2018. It runs a digital platform for workplaces that uses computer vision and AI to give preventive care to workers at risk of musculoskeletal conditions. In March 2024 it raised £3.2m led by MMC Ventures and Hambro Perks. Shane Lowe is co-founder and chief executive; Alex Haslehurst is named as a founder. Head office and Companies House record not confirmed.", "uk_status": "uk", "company": { "ch_number": "10775942", "registered_office": null, "incorporated": null, "legal_form": null, "owner_or_acquirer": null, "headcount": null, "ch_number_clean": "10775942", "from_round2": true, "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/10775942", "ch_note": null }, "place": { "text": "London (EC1V 8BU)", "postcode": "EC1V 8BU", "lat": 51.526914, "lng": -0.09697, "region": "England: London", "admin_district": "Islington", "geocoded": "postcodes.io" }, "people": [ { "name": "Shane Lowe", "role": "Co-founder and CEO", "from": "2018", "source": "https://www.uktech.news/medtech/vitrue-health-funding-back-pain-20240301" } ], "money": [ { "kind": "funding_round", "amount": 3200000, "currency": "GBP", "date": "2024-03-01", "detail": "led by MMC Ventures and Hambro Perks", "raw": "funding_round: 3200000 GBP 2024-03-01 — led by MMC Ventures and Hambro Perks", "amount_gbp": 3200000, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£3.2m", "gbp_txt": "" } ], "site": null, "product": null, "dsit_domains": [ "Perceptual systems" ], "sectors": [ "musculoskeletal health", "workplace health" ], "confidence": "verified", "checked": "2026-10-29", "as_of": "2026-10-29", "applied": [ { "from": "Companies House check, 29 Oct 2026", "field": "place", "text": "place → London (EC1V 8BU) — region: England: London (was null); company.ch_number → 10775942 (CEO Shane Lowe a director since 17 May 2017)" } ], "held": [], "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "Uses computer vision and AI to assess office workers at risk of back and joint problems and help prevent them.", "affiliation": "Start-ups", "sources": [ "https://www.uktech.news/medtech/vitrue-health-funding-back-pain-20240301", "https://find-and-update.company-information.service.gov.uk/search?q=vitrue+health", "https://find-and-update.company-information.service.gov.uk/company/10775942/officers", "https://find-and-update.company-information.service.gov.uk/company/10775942" ], "source_quotes": [ { "url": "https://www.uktech.news/medtech/vitrue-health-funding-back-pain-20240301", "quotes": [ "a digital platform for workplaces that uses computer vision and AI\" \"has raised £3.2m\" \"The funding round was led by MMC Ventures and Hambro Perks" ], "accessed": "2026-10-29", "trade": true, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/search?q=vitrue+health", "quotes": [ "VITRUE LTD", "10775942", "Incorporated on 17 May 2017", "71 Central Street, London, England, EC1V 8BU" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/10775942/officers", "quotes": [ "LOWE, Shane, Dr.", "Director", "17 May 2017" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/10775942", "quotes": [ "VITRUE LTD | Company number 10775942 | Active" ], "accessed": "2026-10-31", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [ "Perceptual systems" ], "one_source": false, "confidence_raw": "verified", "depts": [ { "dept": "musculoskeletal health", "div": "health" } ], "div_label": "Health", "location": "London (EC1V 8BU)", "status_group": "active", "ext_links": [ { "kind": "linked from: funds", "id": "BIZ-INV-032", "name": "MMC Ventures", "page": "investors", "href": "../../investors/#org=BIZ-INV-032", "page_label": "Investors" }, { "kind": "funded_by", "id": "BIZ-INV-032", "name": "MMC Ventures", "page": "investors", "href": "../../investors/#org=BIZ-INV-032", "page_label": "Investors" } ], "label_links": [ { "kind": "funded_by", "name": "Hambro Perks" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-051", "name": "Adsilico", "bucket": "co", "status": "active", "status_date": "2026-10-31", "status_detail": "Raised £3.5m from Northern Gritstone and Parkwalk Advisors, reported 26 February 2024; no later page opened. Companies House shows ADSILICO LIMITED as Active (checked 31 Oct 2026).", "one_line": "University of Leeds spin-out that uses AI to test new medical devices on computer models before human trials.", "description": "Adsilico was founded in 2022 on research from the University of Leeds by Alejandro Frangi. It has developed a method for trialling new medical devices before they enter human clinical tests (UKTN's headline calls it an \"AI medical testing spinout\"). In February 2024 it raised £3.5m from Northern Gritstone and Parkwalk Advisors. Head office and Companies House record not confirmed.", "uk_status": "uk", "company": { "ch_number": "14263453", "registered_office": null, "incorporated": null, "legal_form": null, "owner_or_acquirer": null, "headcount": null, "ch_number_clean": "14263453", "from_round2": true, "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/14263453", "ch_note": null }, "place": { "text": "Leeds (LS2 3AA)", "postcode": "LS2 3AA", "lat": 53.805411, "lng": -1.550355, "region": "England: Yorkshire and the Humber", "admin_district": "Leeds", "geocoded": "postcodes.io" }, "people": [ { "name": "Alejandro Frangi", "role": "Founder", "from": "2022", "source": "https://www.uktech.news/medtech/ai-medical-testing-spinout-adsilico-20240226" } ], "money": [ { "kind": "funding_round", "amount": 3500000, "currency": "GBP", "date": "2024-02-26", "detail": "Northern Gritstone and Parkwalk Advisors", "raw": "funding_round: 3500000 GBP 2024-02-26 — Northern Gritstone and Parkwalk Advisors", "amount_gbp": 3500000, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£3.5m", "gbp_txt": "" } ], "site": null, "product": null, "dsit_domains": [ "Knowledge generation", "AI security and assurance" ], "sectors": [ "medical devices", "in-silico trials" ], "confidence": "verified", "checked": "2026-10-29", "as_of": "2026-10-29", "applied": [ { "from": "Companies House check, 29 Oct 2026", "field": "place", "text": "place → Leeds (LS2 3AA) — region: England: Yorkshire and the Humber (registered office confirmed; was \"university origin\")" } ], "held": [], "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "University of Leeds spin-out that uses AI to test new medical devices on computer models before human trials.", "affiliation": "Start-ups", "sources": [ "https://www.uktech.news/medtech/ai-medical-testing-spinout-adsilico-20240226", "https://find-and-update.company-information.service.gov.uk/company/14263453", "https://www.uktech.news/medtech/ai-medical-testing-spinout-adsilico-20240226" ], "source_quotes": [ { "url": "https://www.uktech.news/medtech/ai-medical-testing-spinout-adsilico-20240226", "quotes": [ "AI medical testing spinout Adsilico raises £3.5m\" \"Adsilico has developed a method for trialling new devices before entering human clinical tests\" \"Prof Alejandro Frangi, founder of Adsilico." ], "accessed": "2026-10-29", "trade": true, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/14263453", "quotes": [ "ADSILICO LIMITED", "Nexus, Discovery Way, Leeds, West Yorkshire, United Kingdom, LS2 3AA", "Active", "29 July 2022" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://www.uktech.news/medtech/ai-medical-testing-spinout-adsilico-20240226", "quotes": [ "University of Leeds spinout Adsilico has secured a £3.5m investment for its AI-powered medical device testing system." ], "accessed": "2026-10-29", "trade": true, "amendment": false } ], "website": [], "colleges": [], "topics": [ "Knowledge generation", "AI security and assurance" ], "one_source": false, "confidence_raw": "verified", "depts": [ { "dept": "medical devices", "div": "health" } ], "div_label": "Health", "location": "Leeds (LS2 3AA)", "status_group": "active", "ext_links": [ { "kind": "linked from: funds", "id": "BIZ-INV-051", "name": "Northern Gritstone", "page": "investors", "href": "../../investors/#org=BIZ-INV-051", "page_label": "Investors" }, { "kind": "funded_by", "id": "BIZ-INV-051", "name": "Northern Gritstone", "page": "investors", "href": "../../investors/#org=BIZ-INV-051", "page_label": "Investors" }, { "kind": "spun_out_of", "id": "UNI:leeds/LEEAI-008", "name": "Universities: leeds/LEEAI-008", "page": "universities", "href": "https://hazy-wreath-hez6.here.now/leeds/", "page_label": "UK Universities AI Universe (new tab)" } ], "label_links": [ { "kind": "spun_out_of", "name": "University of Leeds" }, { "kind": "funded_by", "name": "Parkwalk Advisors" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-052", "name": "Lilli", "bucket": "co", "status": "active", "status_date": "2024-02-09", "status_detail": "Raised £8.2m led by previous investor West Hill Capital, reported 9 February 2024; no later page opened.", "one_line": "Woking company whose AI monitoring software helps care providers look after people living in care.", "description": "Lilli is a Woking-based software-as-a-service company providing management tools for those living in care; UKTN describes it as an AI-powered patient monitoring app. In February 2024 it raised £8.2m led by previous investor West Hill Capital. Gren Paull is chief executive. Companies House record not confirmed.", "uk_status": "uk", "company": { "ch_number": null, "registered_office": null, "incorporated": null, "legal_form": null, "owner_or_acquirer": null, "headcount": null, "ch_number_clean": null, "companies_house_url": null, "ch_note": null }, "place": { "text": "Woking", "postcode": null, "lat": null, "lng": null, "region": "England: South East" }, "people": [ { "name": "Gren Paull", "role": "CEO", "from": null, "source": "https://www.uktech.news/medtech/lilli-raises-8-2m-20240209" } ], "money": [ { "kind": "funding_round", "amount": 8200000, "currency": "GBP", "date": "2024-02-09", "detail": "led by West Hill Capital", "raw": "funding_round: 8200000 GBP 2024-02-09 — led by West Hill Capital", "amount_gbp": 8200000, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£8.2m", "gbp_txt": "" } ], "site": null, "product": null, "dsit_domains": [ "AI implementation", "Perceptual systems" ], "sectors": [ "social care", "remote monitoring" ], "confidence": "single_source", "checked": "2026-10-29", "as_of": "2026-10-29", "applied": null, "held": [], "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "Woking company whose AI monitoring software helps care providers look after people living in care.", "affiliation": "Start-ups", "sources": [ "https://www.uktech.news/medtech/lilli-raises-8-2m-20240209" ], "source_quotes": [ { "url": "https://www.uktech.news/medtech/lilli-raises-8-2m-20240209", "quotes": [ "AI-powered patient monitoring app Lilli raises £8.2m\" \"a software-as-a-service company providing management tools for those living in care\" \"led by previous investor West Hill Capital\" \"CEO Gren Paull" ], "accessed": "2026-10-29", "trade": true, "amendment": false } ], "website": [], "colleges": [], "topics": [ "AI implementation", "Perceptual systems" ], "one_source": true, "confidence_raw": "single_source", "depts": [ { "dept": "social care", "div": "health" } ], "div_label": "Health", "location": "Woking", "status_group": "active", "ext_links": [], "label_links": [ { "kind": "funded_by", "name": "West Hill Capital" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-053", "name": "Phare Health", "bucket": "co", "status": "active", "status_date": "2026-10-31", "status_detail": "Raised £2.5m led by General Catalyst, with KHP Ventures and Bertelsmann Investments, reported 22 November 2023; no later page opened. Companies House shows PHARE HEALTH LTD as Active (checked 31 Oct 2026).", "one_line": "London start-up founded by DeepMind and Google Health alumni that uses a large language model to turn clinical notes into data for hospital back offices.", "description": "Phare Health is a London start-up founded by DeepMind and Google Health alumni. It develops AI tools to support the administrative work of healthcare professionals; its first product uses a large language model to review clinicians' notes and turn them into data for administrative, operational and finance teams. In November 2023 it raised £2.5m led by General Catalyst, with KHP Ventures and Bertelsmann Investments. Martin Seneviratne is co-founder and co-chief executive.", "uk_status": "uk", "company": { "ch_number": "15084747", "registered_office": null, "incorporated": null, "legal_form": null, "owner_or_acquirer": null, "headcount": null, "ch_number_clean": "15084747", "from_round2": true, "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/15084747", "ch_note": null }, "place": { "text": "London", "postcode": "EC2N 4BQ", "lat": 51.514149, "lng": -0.083493, "region": "England: London", "admin_district": "City of London", "geocoded": "postcodes.io" }, "people": [ { "name": "Martin Seneviratne", "role": "Co-founder and co-CEO", "from": null, "source": "https://www.uktech.news/medtech/phare-health-funding-ai-20231122" } ], "money": [ { "kind": "funding_round", "amount": 2500000, "currency": "GBP", "date": "2023-11-22", "detail": "led by General Catalyst, with KHP Ventures and Bertelsmann Investments", "raw": "funding_round: 2500000 GBP 2023-11-22 — led by General Catalyst, with KHP Ventures and Bertelsmann Investments", "amount_gbp": 2500000, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£2.5m", "gbp_txt": "" } ], "site": null, "product": null, "dsit_domains": [ "Natural language applications" ], "sectors": [ "health administration", "clinical coding" ], "confidence": "verified", "checked": "2026-10-29", "as_of": "2026-10-29", "applied": null, "held": [], "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "London start-up founded by DeepMind and Google Health alumni that uses a large language model to turn clinical notes into data for hospital back offices.", "affiliation": "Start-ups", "sources": [ "https://www.uktech.news/medtech/phare-health-funding-ai-20231122", "https://find-and-update.company-information.service.gov.uk/search?q=phare+health", "https://find-and-update.company-information.service.gov.uk/company/15084747" ], "source_quotes": [ { "url": "https://www.uktech.news/medtech/phare-health-funding-ai-20231122", "quotes": [ "London-based startup\" \"founded by DeepMind and Google Health alumni.\" \"developing AI tools to support the administrative efforts of healthcare professionals\" \"The funding round was led by General Catalyst" ], "accessed": "2026-10-29", "trade": true, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/search?q=phare+health", "quotes": [ "PHARE HEALTH LTD", "15084747", "Incorporated on 21 August 2023", "22 Bishopsgate, 50th Floor, London, United Kingdom, EC2N 4BQ" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/15084747", "quotes": [ "PHARE HEALTH LTD | Company number 15084747 | Active" ], "accessed": "2026-10-31", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [ "Natural language applications" ], "one_source": false, "confidence_raw": "verified", "depts": [ { "dept": "health administration", "div": "health" } ], "div_label": "Health", "location": "London", "status_group": "active", "ext_links": [ { "kind": "linked from: funds", "id": "BIZ-INV-038", "name": "General Catalyst", "page": "investors", "href": "../../investors/#org=BIZ-INV-038", "page_label": "Investors" }, { "kind": "funded_by", "id": "BIZ-INV-038", "name": "General Catalyst", "page": "investors", "href": "../../investors/#org=BIZ-INV-038", "page_label": "Investors" }, { "kind": "alumni_of", "id": "BIZ-LAB-001", "name": "Google DeepMind", "page": "labs", "href": "../../labs/#org=BIZ-LAB-001", "page_label": "Labs" }, { "kind": "linked from: works_at", "id": "BIZ-TAL-170", "name": "Martin Seneviratne", "page": "talent", "href": "../../talent/#org=BIZ-TAL-170", "page_label": "Talent" }, { "kind": "linked from: founder_of", "id": "BIZ-TAL-170", "name": "Martin Seneviratne", "page": "talent", "href": "../../talent/#org=BIZ-TAL-170", "page_label": "Talent" } ], "label_links": [ { "kind": "funded_by", "name": "KHP Ventures" }, { "kind": "funded_by", "name": "Bertelsmann Investments" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-054", "name": "Holly Health", "bucket": "co", "status": "active", "status_date": "2026-10-31", "status_detail": "Secured £650,000 in equity and Innovate UK grant funding, with Plug and Play Ventures and Modality Partnership, reported 8 December 2023; no later page opened. Companies House shows HOLLY HEALTH LTD as Active (checked 31 Oct 2026).", "one_line": "London app whose AI chatbot coaches people with several long-term conditions on daily habits; partnered with over 150 GPs.", "description": "Holly Health is a London-based personalised digital coaching app for people with multiple chronic conditions. Its proprietary AI chatbot coaches users on lifestyle behaviours. It had partnered with over 150 GPs by December 2023, when it secured £650,000 in joint equity and grant funding from Innovate UK, the Innovation SuperNetwork, Plug and Play Ventures and the GP network Modality Partnership. Grace Gimson is co-founder and chief executive.", "uk_status": "uk", "company": { "ch_number": "12551800", "registered_office": null, "incorporated": null, "legal_form": null, "owner_or_acquirer": null, "headcount": null, "ch_number_clean": "12551800", "from_round2": true, "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/12551800", "ch_note": null }, "place": { "text": "London", "postcode": null, "lat": null, "lng": null, "region": "England: London" }, "people": [ { "name": "Grace Gimson", "role": "Co-founder and CEO", "from": null, "source": "https://www.uktech.news/medtech/holly-health-app-650k-20231208" } ], "money": [ { "kind": "funding_round", "amount": 650000, "currency": "GBP", "date": "2023-12-08", "detail": "equity and grant (Innovate UK, Plug and Play Ventures, Modality Partnership)", "raw": "funding_round: 650000 GBP 2023-12-08 — equity and grant (Innovate UK, Plug and Play Ventures, Modality Partnership)", "amount_gbp": 650000, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£650,000", "gbp_txt": "" } ], "site": null, "product": null, "dsit_domains": [ "Natural language applications" ], "sectors": [ "long-term conditions", "primary care" ], "confidence": "verified", "checked": "2026-10-29", "as_of": "2026-10-29", "applied": null, "held": [], "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "London app whose AI chatbot coaches people with several long-term conditions on daily habits; partnered with over 150 GPs.", "affiliation": "Start-ups", "sources": [ "https://www.uktech.news/medtech/holly-health-app-650k-20231208", "https://find-and-update.company-information.service.gov.uk/company/12551800", "https://find-and-update.company-information.service.gov.uk/company/12551800/officers" ], "source_quotes": [ { "url": "https://www.uktech.news/medtech/holly-health-app-650k-20231208", "quotes": [ "The app uses a proprietary AI chatbot to coach users on lifestyle behaviours to ease the harm caused by their conditions.\" \"which has partnered with over 150 GPs" ], "accessed": "2026-10-29", "trade": true, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/12551800", "quotes": [ "HOLLY HEALTH LTD", "Active", "8 April 2020", "HOLISTIC TECHNOLOGY LTD" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/12551800/officers", "quotes": [ "GIMSON, Grace Elizabeth: Director, appointed 8 April 2020" ], "accessed": "2026-10-29", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [ "Natural language applications" ], "one_source": false, "confidence_raw": "verified", "depts": [ { "dept": "long-term conditions", "div": "health" } ], "div_label": "Health", "location": "London", "status_group": "active", "ext_links": [], "label_links": [ { "kind": "funded_by", "name": "Innovate UK" }, { "kind": "funded_by", "name": "Plug and Play Ventures" }, { "kind": "partner_of", "name": "Modality Partnership" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-055", "name": "Kuano", "bucket": "co", "status": "active", "status_date": "2026-10-31", "status_detail": "Mercia Ventures led a £1.8m seed round, reported 13 September 2023; no later page opened. Companies House shows KUANO LTD as Active (checked 31 Oct 2026).", "one_line": "Cambridge start-up combining AI and quantum simulation of enzymes to design drugs.", "description": "Kuano was co-founded in 2020 by Jarryl D'Oyley, Parminder Ruprah, David Wright and Vid Stojevic, who is chief executive. Its quantum simulation platform lets scientists view enzymes in their dynamic state, and it uses AI to estimate the ideal form of a drug. In September 2023 Mercia Ventures led a £1.8m seed round. Companies House record not confirmed. [Round 4, 30 Oct 2026] LABS: Combines quantum simulation of enzymes with AI tools to design drugs that target specific enzymes. [Labs Round 7, 30 Oct 2026] founders: Vid Stojevic — co-founder and chief executive; co-founders Jarryl D'Oyley, Parminder Ruprah, David Wright; founded 2020 (UKTN 2021: March 2020) [Labs Round 7, 30 Oct 2026] rounds: £1m seed (2021-07-08) from ACF Investors, o2h Ventures and Cambridge angels; £1.8m seed (2023-09-13) led by Mercia Ventures with ACF Investors, Ascension Ventures, o2h Ventures, Meltwind Advisory [Labs Round 7, 30 Oct 2026] partners: Alzheimer's Research UK UCL Drug Discovery Institute research collaboration (2021) [Labs Round 8, 31 Oct 2026] news: 2026-09-01 — \"Kuano demonstrates its agent-supported platform in Singapore\" [Labs Round 8, 31 Oct 2026] news: 2026-05-15 — \"From discussion to demonstration: agentic AI in drug discovery\" (Kuano-hosted event) [Labs Round 8, 31 Oct 2026] news: 2024-08-30 — \"Kuano makes significant strides towards novel bowel cancer therapy\" [Labs Round 8, 31 Oct 2026] uk_government_links: Innovate UK grants: 2020-06-25 and 2023-01-09 (\"design a new generation of cancer drugs\") [Labs Round 8, 31 Oct 2026] chief_executive: Vid Stojevic — CEO (as of 2023-12-15)", "uk_status": "uk", "company": { "ch_number": "12466186", "registered_office": null, "incorporated": null, "legal_form": null, "owner_or_acquirer": null, "headcount": null, "ch_number_clean": "12466186", "from_round2": true, "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/12466186", "ch_note": null }, "place": { "text": "Cambridge", "postcode": "CB22 5HX", "lat": 52.153615, "lng": 0.091763, "region": "England: East of England", "admin_district": "South Cambridgeshire", "geocoded": "postcodes.io" }, "people": [ { "name": "Vid Stojevic", "role": "Co-founder and CEO", "from": "2020", "source": "https://www.uktech.news/medtech/kuano-seed-20230913" }, { "name": "Vid Stojevic", "role": "co-founder and CEO", "from": null, "source": "https://tech.eu/2023/09/12/kuano-raises1-8m-for-drug-discovery/", "round4": true }, { "name": "Vid Stojevic", "role": "co-founder and chief executive", "from": null, "source": "https://www.uktech.news/medtech/kuano-seed-20230913", "round4": true }, { "name": "Vid Stojevic", "role": "CEO", "from": "as of 2023-12-15", "source": "https://www.kuano.ai/news/older/", "round4": true }, { "name": "Ted Witek", "role": "Board director", "from": "2024-02-20", "source": "https://www.kuano.ai/news/older/", "round4": true }, { "name": "Cat Stace", "role": "EVP Business Development", "from": "2024-02-29", "source": "https://www.kuano.ai/news/older/", "round4": true }, { "name": "David Barrett", "role": "Scientific Advisory Board member", "from": "2024-05-10", "source": "https://www.kuano.ai/news/older/", "round4": true }, { "name": "David Wright", "role": "CTO and co-founder", "from": null, "source": "https://www.kuano.ai/people", "round4": true }, { "name": "Antonio Benedetti", "role": "Executive Chairman", "from": "2022-07-13", "source": "https://www.kuano.ai/news/older/", "round4": true } ], "money": [ { "kind": "funding_round", "amount": 1800000, "currency": "GBP", "date": "2023-09-13", "detail": "seed led by Mercia Ventures", "raw": "funding_round: 1800000 GBP 2023-09-13 — seed led by Mercia Ventures", "amount_gbp": 1800000, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£1.8m", "gbp_txt": "" } ], "site": null, "product": null, "dsit_domains": [ "Knowledge generation" ], "sectors": [ "drug discovery", "quantum simulation" ], "confidence": "verified", "checked": "2026-10-29", "as_of": "2026-10-29", "applied": null, "held": [], "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "Cambridge start-up combining AI and quantum simulation of enzymes to design drugs.", "affiliation": "Start-ups", "sources": [ "https://www.uktech.news/medtech/kuano-seed-20230913", "https://find-and-update.company-information.service.gov.uk/company/12466186", "https://find-and-update.company-information.service.gov.uk/company/12466186/officers", "https://tech.eu/2023/09/12/kuano-raises1-8m-for-drug-discovery/", "https://www.uktech.news/ai/uk-biotech-startup-kuano-lands-1m-for-ai-driven-drug-discovery-20210707", "https://www.kuano.ai/news/", "https://www.kuano.ai/news/older/", "https://www.kuano.ai/news/we-are-delighted-to-announce-the-close-of-our-18m-seed-funding-round-to-accelerate-our-quantum-based-drug-discovery", "https://www.kuano.ai/about/" ], "source_quotes": [ { "url": "https://www.uktech.news/medtech/kuano-seed-20230913", "quotes": [ "Cambridge-based AI drug-finding startup Kuano.\" \"Mercia Ventures has led a £1.8m seed financing round." ], "accessed": "2026-10-29", "trade": true, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/12466186", "quotes": [ "KUANO LTD\" \"Hauxton House, Mill Scitech Park, Mill Lane, Cambridge, England, CB22 5HX\" \"Active\" \"17 February 2020" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/12466186/officers", "quotes": [ "STOJEVIC, Vid\" Director appointed \"17 February 2020\" (active)" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://tech.eu/2023/09/12/kuano-raises1-8m-for-drug-discovery/", "quotes": [ "Our platform creates a 'quantum lens' that reveals the difference between enzymes" ], "accessed": "2026-10-30", "trade": true, "amendment": false }, { "url": "https://www.uktech.news/ai/uk-biotech-startup-kuano-lands-1m-for-ai-driven-drug-discovery-20210707", "quotes": [ "quantum physics, artificial intelligence (AI) and medicinal chemistry" ], "accessed": "2026-10-30", "trade": true, "amendment": false }, { "url": "https://www.kuano.ai/news/", "quotes": [ "Kuano demonstrates its agent-supported platform in Singapore" ], "accessed": "2026-10-30", "trade": false, "amendment": false }, { "url": "https://www.kuano.ai/news/older/", "quotes": [ "Kuano makes significant strides towards novel bowel cancer therapy" ], "accessed": "2026-10-30", "trade": false, "amendment": false }, { "url": "https://www.kuano.ai/news/we-are-delighted-to-announce-the-close-of-our-18m-seed-funding-round-to-accelerate-our-quantum-based-drug-discovery", "quotes": [ "further validation of Kuano's quantum simulation platform" ], "accessed": "2026-10-30", "trade": false, "amendment": false }, { "url": "https://www.kuano.ai/about/", "quotes": [ "connects quantum chemistry, molecular simulation and molecular design" ], "accessed": "2026-10-30", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [ "Knowledge generation" ], "one_source": false, "confidence_raw": "verified", "depts": [ { "dept": "drug discovery", "div": "health" } ], "div_label": "Health", "location": "Cambridge", "status_group": "active", "ext_links": [ { "kind": "linked from: funds", "id": "BIZ-INV-205", "name": "Mercia (Mercia Ventures, Mercia Asset Management PLC)", "page": "investors", "href": "../../investors/#org=BIZ-INV-205", "page_label": "Investors" }, { "kind": "funded_by", "id": "BIZ-INV-205", "name": "Mercia (Mercia Ventures, Mercia Asset Management PLC)", "page": "investors", "href": "../../investors/#org=BIZ-INV-205", "page_label": "Investors" } ], "label_links": [ { "kind": "funded_by", "name": "Mercia Ventures" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-056", "name": "Decently", "bucket": "co", "status": "active", "status_date": "2026-10-31", "status_detail": "Secured £500,000 led by Praetura Ventures' GMC Life Sciences Fund with SFC Capital, reported 21 September 2023; no later page opened. Companies House shows DECENTLY LIMITED as Active (checked 31 Oct 2026).", "one_line": "Manchester start-up whose AI tool, Melo, helps clinicians collect and record information on patients with brain injuries.", "description": "Decently was launched in 2021 by James Burch and James Chapman and is based in Manchester. Its Melo tool uses AI to support healthcare professionals in collecting and recording patient information for people with brain injuries. In September 2023 it secured £500,000 led by Praetura Ventures through its GMC Life Sciences Fund, with SFC Capital. Companies House record not confirmed.", "uk_status": "uk", "company": { "ch_number": "13604268", "registered_office": null, "incorporated": null, "legal_form": null, "owner_or_acquirer": null, "headcount": null, "ch_number_clean": "13604268", "from_round2": true, "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/13604268", "ch_note": null }, "place": { "text": "Manchester", "postcode": "M3 4FP", "lat": 53.476744, "lng": -2.254741, "region": "England: North West", "admin_district": "Manchester", "geocoded": "postcodes.io" }, "people": [ { "name": "James Burch", "role": "Co-founder", "from": "2021", "source": "https://www.uktech.news/medtech/brain-injury-ai-startup-20230921" }, { "name": "James Chapman", "role": "Co-founder", "from": "2021", "source": null } ], "money": [ { "kind": "funding_round", "amount": 500000, "currency": "GBP", "date": "2023-09-21", "detail": "led by Praetura Ventures (GMC Life Sciences Fund), with SFC Capital", "raw": "funding_round: 500000 GBP 2023-09-21 — led by Praetura Ventures (GMC Life Sciences Fund), with SFC Capital", "amount_gbp": 500000, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£500,000", "gbp_txt": "" } ], "site": null, "product": null, "dsit_domains": [ "Natural language applications", "AI implementation" ], "sectors": [ "brain injury", "clinical decision support" ], "confidence": "verified", "checked": "2026-10-29", "as_of": "2026-10-29", "applied": null, "held": [], "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "Manchester start-up whose AI tool, Melo, helps clinicians collect and record information on patients with brain injuries.", "affiliation": "Start-ups", "sources": [ "https://www.uktech.news/medtech/brain-injury-ai-startup-20230921", "https://find-and-update.company-information.service.gov.uk/search?q=decently", "https://find-and-update.company-information.service.gov.uk/company/13604268" ], "source_quotes": [ { "url": "https://www.uktech.news/medtech/brain-injury-ai-startup-20230921", "quotes": [ "Manchester-based\" \"uses AI to support healthcare professionals\" \"Launched in 2021 by James Burch and James Chapman." ], "accessed": "2026-10-29", "trade": true, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/search?q=decently", "quotes": [ "DECENTLY LIMITED", "13604268", "Incorporated on 6 September 2021", "Department Campfield, Lower Byrom Street, Manchester, England, M3 4FP" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/13604268", "quotes": [ "DECENTLY LIMITED | Company number 13604268 | Active" ], "accessed": "2026-10-31", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [ "Natural language applications", "AI implementation" ], "one_source": false, "confidence_raw": "verified", "depts": [ { "dept": "brain injury", "div": "health" } ], "div_label": "Health", "location": "Manchester", "status_group": "active", "ext_links": [], "label_links": [ { "kind": "funded_by", "name": "Praetura Ventures" }, { "kind": "funded_by", "name": "SFC Capital" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-057", "name": "Myma Medical", "bucket": "co", "status": "active", "status_date": "2026-10-31", "status_detail": "Received £145,000 from LYVA Labs, reported 13 September 2023; no later page opened. Companies House shows MYMA MEDICAL LIMITED as Active (checked 31 Oct 2026).", "one_line": "University of Birmingham spin-out building an automated IVF system that uses AI cameras to assess eggs and sperm.", "description": "Myma Medical was formed in 2020 as a spin-out from the University of Birmingham. It is developing an automated fertility treatment: its AutoICSI system uses AI-powered cameras to assess eggs and sperm before injection, to raise IVF success rates. In September 2023 it received £145,000 from Liverpool-based LYVA Labs. Yash Khandhia is chief executive. Head office and Companies House record not confirmed.", "uk_status": "uk", "company": { "ch_number": "12983130", "registered_office": null, "incorporated": null, "legal_form": null, "owner_or_acquirer": null, "headcount": null, "ch_number_clean": "12983130", "from_round2": true, "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/12983130", "ch_note": null }, "place": { "text": "Liverpool", "postcode": "L3 4BJ", "lat": 53.384908, "lng": -2.979558, "region": "England: North West", "admin_district": "Liverpool", "geocoded": "postcodes.io" }, "people": [ { "name": "Yash Khandhia", "role": "CEO", "from": null, "source": "https://www.uktech.news/medtech/myma-medical-lyva-labs-funding-20230913" } ], "money": [ { "kind": "funding_round", "amount": 145000, "currency": "GBP", "date": "2023-09-13", "detail": "LYVA Labs", "raw": "funding_round: 145000 GBP 2023-09-13 — LYVA Labs", "amount_gbp": 145000, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£145,000", "gbp_txt": "" } ], "site": null, "product": null, "dsit_domains": [ "Perceptual systems", "Autonomous and agent systems" ], "sectors": [ "fertility", "IVF" ], "confidence": "verified", "checked": "2026-10-29", "as_of": "2026-10-29", "applied": [ { "from": "Companies House check, 29 Oct 2026", "field": "place", "text": "place → Liverpool (registered office) — region: England: North West (was null), operating base not confirmed" } ], "held": [], "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "University of Birmingham spin-out building an automated IVF system that uses AI cameras to assess eggs and sperm.", "affiliation": "Start-ups", "sources": [ "https://www.uktech.news/medtech/myma-medical-lyva-labs-funding-20230913", "https://find-and-update.company-information.service.gov.uk/company/12983130" ], "source_quotes": [ { "url": "https://www.uktech.news/medtech/myma-medical-lyva-labs-funding-20230913", "quotes": [ "AI fertility treatment startup Myma Medical secures £145k\" \"an automated fertility treatment" ], "accessed": "2026-10-29", "trade": true, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/12983130", "quotes": [ "MYMA MEDICAL LIMITED", "Active", "29 October 2020", "accounts due \"by 31 December 2024", "confirmation statement due \"by 7 December 2024" ], "accessed": "2026-10-29", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [ "Perceptual systems", "Autonomous and agent systems" ], "one_source": false, "confidence_raw": "verified", "depts": [ { "dept": "fertility", "div": "health" } ], "div_label": "Health", "location": "Liverpool", "status_group": "active", "ext_links": [], "label_links": [ { "kind": "spun_out_of", "name": "University of Birmingham" }, { "kind": "funded_by", "name": "LYVA Labs" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-058", "name": "Mimetrik", "bucket": "co", "status": "active", "status_date": "2023-08-31", "status_detail": "Raised £2m led by Northern Gritstone, reported 31 August 2023; no later page opened.", "one_line": "University of Leeds spin-out using machine learning to produce 3D scans of patients' mouths for dentists.", "description": "Mimetrik is a digital dentistry start-up, founded as a spin-out from the University of Leeds, that uses machine learning to generate 3D scans of patients' mouths. In August 2023 it raised £2m led by Northern Gritstone. Alyn Morgan is co-founder and chief executive. Head office and Companies House record not confirmed.", "uk_status": "uk", "company": { "ch_number": null, "registered_office": null, "incorporated": null, "legal_form": null, "owner_or_acquirer": null, "headcount": null, "ch_number_clean": null, "companies_house_url": null, "ch_note": null }, "place": { "text": "Leeds (university origin)", "postcode": null, "lat": null, "lng": null, "region": "England: Yorkshire and the Humber" }, "people": [ { "name": "Alyn Morgan", "role": "Co-founder and CEO", "from": null, "source": "https://www.uktech.news/medtech/mimetrik-raises-2m-20230831" } ], "money": [ { "kind": "funding_round", "amount": 2000000, "currency": "GBP", "date": "2023-08-31", "detail": "led by Northern Gritstone", "raw": "funding_round: 2000000 GBP 2023-08-31 — led by Northern Gritstone", "amount_gbp": 2000000, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£2m", "gbp_txt": "" } ], "site": null, "product": null, "dsit_domains": [ "Perceptual systems" ], "sectors": [ "dentistry" ], "confidence": "single_source", "checked": "2026-10-29", "as_of": "2026-10-29", "applied": null, "held": [], "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "University of Leeds spin-out using machine learning to produce 3D scans of patients' mouths for dentists.", "affiliation": "Start-ups", "sources": [ "https://www.uktech.news/medtech/mimetrik-raises-2m-20230831" ], "source_quotes": [ { "url": "https://www.uktech.news/medtech/mimetrik-raises-2m-20230831", "quotes": [ "Mimetrik, a digital dentistry startup using machine learning to generate 3D scans of patient mouths, has raised £2m.\" \"The investment was led by UK regional investor Northern Gritstone, which specialises in spinouts." ], "accessed": "2026-10-29", "trade": true, "amendment": false } ], "website": [], "colleges": [], "topics": [ "Perceptual systems" ], "one_source": true, "confidence_raw": "single_source", "depts": [ { "dept": "dentistry", "div": "health" } ], "div_label": "Health", "location": "Leeds (university origin)", "status_group": "active", "ext_links": [ { "kind": "linked from: funds", "id": "BIZ-INV-051", "name": "Northern Gritstone", "page": "investors", "href": "../../investors/#org=BIZ-INV-051", "page_label": "Investors" }, { "kind": "funded_by", "id": "BIZ-INV-051", "name": "Northern Gritstone", "page": "investors", "href": "../../investors/#org=BIZ-INV-051", "page_label": "Investors" } ], "label_links": [ { "kind": "spun_out_of", "name": "University of Leeds" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-059", "name": "GeneralPractice.AI", "bucket": "co", "status": "active", "status_date": null, "status_detail": "Secured £250,000 in a round led by Deepbridge Capital (date not given on the page) and was seeking new markets.", "one_line": "Glasgow firm founded by a Highland GP that makes an AI assistant, care-planning tool and consultation scribe for GPs and patients.", "description": "GeneralPractice.AI is a Glasgow tech firm that has built an AI assistant for patients and clinicians, including a lifestyle app (My Lifestyle Hub), an AI-powered GP Management Plan and a Post-Consultation Scribe for note-taking. Its founder, Angus Perry, is a practising GP in Alness and Invergordon; the company launched in 2023, the year he joined the Scottish cohort of the NHS Clinical Entrepreneur Programme. It secured £250,000 in a round led by Deepbridge Capital; FutureScot's page gives no date.", "uk_status": "uk", "company": { "ch_number": null, "registered_office": null, "incorporated": null, "legal_form": null, "owner_or_acquirer": null, "headcount": null, "ch_number_clean": null, "companies_house_url": null, "ch_note": null }, "place": { "text": "Glasgow", "postcode": null, "lat": null, "lng": null, "region": "Scotland" }, "people": [ { "name": "Angus Perry", "role": "Founder", "from": "2023", "source": "https://futurescot.com/glasgow-ai-assistant-for-gps-eyes-new-markets-after-securing-250000-investment/" } ], "money": [ { "kind": "funding_round", "amount": 250000, "currency": "GBP", "date": null, "detail": "led by Deepbridge Capital (date not stated)", "raw": "funding_round: 250000 GBP null — led by Deepbridge Capital (date not stated)", "amount_gbp": 250000, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£250,000", "gbp_txt": "" } ], "site": null, "product": null, "dsit_domains": [ "Natural language applications" ], "sectors": [ "primary care", "clinical documentation" ], "confidence": "single_source", "checked": "2026-10-29", "as_of": "2026-10-29", "applied": null, "held": [], "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "Glasgow firm founded by a Highland GP that makes an AI assistant, care-planning tool and consultation scribe for GPs and patients.", "affiliation": "Start-ups", "sources": [ "https://futurescot.com/glasgow-ai-assistant-for-gps-eyes-new-markets-after-securing-250000-investment/" ], "source_quotes": [ { "url": "https://futurescot.com/glasgow-ai-assistant-for-gps-eyes-new-markets-after-securing-250000-investment/", "quotes": [ "A Glasgow tech firm that has developed an AI assistant for patients and clinicians.\" \"securing £250,000 investment" ], "accessed": "2026-10-29", "trade": true, "amendment": false } ], "website": [], "colleges": [], "topics": [ "Natural language applications" ], "one_source": true, "confidence_raw": "single_source", "depts": [ { "dept": "primary care", "div": "health" } ], "div_label": "Health", "location": "Glasgow", "status_group": "active", "ext_links": [], "label_links": [ { "kind": "funded_by", "name": "Deepbridge Capital" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-060", "name": "Lindus Health", "bucket": "co", "status": "active", "status_date": "2026-10-31", "status_detail": "Raised about US$18m (£14.1m) in a Series A led by Creandum, reported 16 August 2023; an earlier pass recorded a US$55m Series B led by Balderton Capital in January 2025 and a possible move of headquarters to the US, which could not be reopened here. Companies House shows LINDUS HEALTH LIMITED as Active (checked 31 Oct 2026).", "one_line": "London company that runs clinical trials for drug and device makers on its own software, which an investor describes as AI-powered.", "description": "Lindus Health was established in 2021 and is headquartered in London. It sells clinical trial services built on its own software; its lead Series A investor described it as a tech-first, AI-powered, end-to-end offering. In August 2023 it raised about US$18m in a Series A led by Creandum, with Peter Thiel, firstminute, Seedcamp, Hambro Perks and Amino Collective. Michael Young and Meri Beckwith are co-founders. Its January 2025 Series B and any change of head office (see status_detail) were not confirmed in this session.", "uk_status": "uk", "company": { "ch_number": "13298185", "registered_office": null, "incorporated": null, "legal_form": null, "owner_or_acquirer": null, "headcount": null, "ch_number_clean": "13298185", "from_round2": true, "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/13298185", "ch_note": null }, "place": { "text": "London", "postcode": "SE1 0HR", "lat": 51.505027, "lng": -0.097608, "region": "England: London", "admin_district": "Southwark", "geocoded": "postcodes.io" }, "people": [ { "name": "Michael Young", "role": "Co-founder", "from": "2021", "source": "https://www.uktech.news/medtech/lindus-health-series-a-20230816" }, { "name": "Meri Beckwith", "role": "Co-founder", "from": "2021", "source": null } ], "money": [ { "kind": "funding_round", "amount": 18000000, "currency": "USD", "date": "2023-08-16", "detail": "Series A led by Creandum", "raw": "funding_round: 18000000 USD 2023-08-16 — Series A led by Creandum", "amount_gbp": 14114326, "fx_rate": 1.2753, "fx_source": "Bank of England daily spot rate (series XUDLUSS, XUDLERS), US$1.2753 per £ on 2023-08-16", "fx_date": "2023-08-16", "fx_note": "", "txt": "US$18m", "gbp_txt": "£14.1m" } ], "site": null, "product": null, "dsit_domains": [ "AI implementation" ], "sectors": [ "clinical trials" ], "confidence": "verified", "checked": "2026-10-29", "as_of": "2026-10-29", "applied": null, "held": [], "same_as": null, "package1_id": "biz-lindus-health", "type": "Companies", "category": "health", "function": "London company that runs clinical trials for drug and device makers on its own software, which an investor describes as AI-powered.", "affiliation": "Start-ups", "sources": [ "https://www.uktech.news/medtech/lindus-health-series-a-20230816", "https://find-and-update.company-information.service.gov.uk/search/companies?q=Lindus+Health", "https://find-and-update.company-information.service.gov.uk/company/13298185/persons-with-significant-control", "https://find-and-update.company-information.service.gov.uk/company/13298185" ], "source_quotes": [ { "url": "https://www.uktech.news/medtech/lindus-health-series-a-20230816", "quotes": [ "Headquartered in London\" \"tech-first, AI-powered, end-to-end offering.\" \"led by venture capital firm Creandum.\" \"Established in 2021" ], "accessed": "2026-10-29", "trade": true, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/search/companies?q=Lindus+Health", "quotes": [ "LINDUS HEALTH LIMITED\" \"13298185\" \"Incorporated on 29 March 2021\" \"65 Southwark Street, London, United Kingdom, SE1 0HR" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/13298185/persons-with-significant-control", "quotes": [ "Mr Michael John Richard Young", "ceased \"11 August 2023", "Meriwether Beckwith", "ceased \"11 August 2023" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/13298185", "quotes": [ "LINDUS HEALTH LIMITED | Company number 13298185 | Active" ], "accessed": "2026-10-31", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [ "AI implementation" ], "one_source": false, "confidence_raw": "verified", "depts": [ { "dept": "clinical trials", "div": "health" } ], "div_label": "Health", "location": "London", "status_group": "active", "ext_links": [ { "kind": "funded_by", "id": "BIZ-INV-202", "name": "Seedcamp", "page": "investors", "href": "../../investors/#org=BIZ-INV-202", "page_label": "Investors" }, { "kind": "funded_by", "id": "BIZ-INV-206", "name": "firstminute capital", "page": "investors", "href": "../../investors/#org=BIZ-INV-206", "page_label": "Investors" }, { "kind": "linked from: funds", "id": "BIZ-INV-202", "name": "Seedcamp", "page": "investors", "href": "../../investors/#org=BIZ-INV-202", "page_label": "Investors" }, { "kind": "linked from: funds", "id": "BIZ-INV-206", "name": "firstminute capital", "page": "investors", "href": "../../investors/#org=BIZ-INV-206", "page_label": "Investors" } ], "label_links": [ { "kind": "funded_by", "name": "Creandum" }, { "kind": "funded_by", "name": "Hambro Perks" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-061", "name": "Thymia", "bucket": "co", "status": "active", "status_date": "2026-10-31", "status_detail": "Closed a US$2.7m (£2m) seed round led by Kodori Ventures, reported 27 July 2023; no later page opened. Companies House shows THYMIA LIMITED as Active (checked 31 Oct 2026).", "one_line": "Makes video games that track users' mental health by analysing speech, facial expressions and behaviour with AI.", "description": "Thymia was founded in 2020 and develops video games designed to track users' mental health; the games analyse speech, facial expressions and behaviour, and its chief executive describes its technology as ethical, explainable AI. In July 2023 it closed a US$2.7m seed round led by Kodori Ventures. Its co-founders are Emilia Molimpakis (chief executive), Gabrielle Powell and Stefano Goria. Head office and Companies House record not confirmed.", "uk_status": "uk", "company": { "ch_number": "12609104", "registered_office": null, "incorporated": null, "legal_form": null, "owner_or_acquirer": null, "headcount": null, "ch_number_clean": "12609104", "from_round2": true, "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/12609104", "ch_note": null }, "place": { "text": "London (EC2V 6DN)", "postcode": "EC2V 6DN", "lat": 51.514178, "lng": -0.093552, "region": "England: London", "admin_district": "City of London", "geocoded": "postcodes.io" }, "people": [ { "name": "Emilia Molimpakis", "role": "Co-founder and CEO", "from": "2020", "source": "https://www.uktech.news/medtech/thymia-seed-round-20230727" }, { "name": "Gabrielle Powell", "role": "Co-founder", "from": "2020", "source": null }, { "name": "Stefano Goria", "role": "Co-founder", "from": "2020", "source": null } ], "money": [ { "kind": "funding_round", "amount": 2700000, "currency": "USD", "date": "2023-07-27", "detail": "seed led by Kodori Ventures", "raw": "funding_round: 2700000 USD 2023-07-27 — seed led by Kodori Ventures", "amount_gbp": 2101331, "fx_rate": 1.2849, "fx_source": "Bank of England daily spot rate (series XUDLUSS, XUDLERS), US$1.2849 per £ on 2023-07-27", "fx_date": "2023-07-27", "fx_note": "", "txt": "US$2.7m", "gbp_txt": "£2.1m" } ], "site": null, "product": null, "dsit_domains": [ "Perceptual systems", "Natural language applications" ], "sectors": [ "mental health" ], "confidence": "verified", "checked": "2026-10-29", "as_of": "2026-10-29", "applied": [ { "from": "Companies House check, 29 Oct 2026", "field": "place", "text": "place → London (registered office, EC2V 6DN) — region: England: London (record had null)" } ], "held": [], "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "Makes video games that track users' mental health by analysing speech, facial expressions and behaviour with AI.", "affiliation": "Start-ups", "sources": [ "https://www.uktech.news/medtech/thymia-seed-round-20230727", "https://find-and-update.company-information.service.gov.uk/company/12609104", "https://find-and-update.company-information.service.gov.uk/company/12609104/officers" ], "source_quotes": [ { "url": "https://www.uktech.news/medtech/thymia-seed-round-20230727", "quotes": [ "Founded in 2020, Thymia develops video games that are designed to track users’ mental health.\" \"has closed a $2.7m (£2m) seed round.\" \"The investment round was led by Kodori Ventures." ], "accessed": "2026-10-29", "trade": true, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/12609104", "quotes": [ "THYMIA LIMITED\" \"9th Floor 107 Cheapside, London, United Kingdom, EC2V 6DN\" \"Active\" \"18 May 2020" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/12609104/officers", "quotes": [ "MOLIMPAKIS, Emilia, Dr\" and \"GORIA, Stefano, Dr\" Directors appointed \"18 May 2020" ], "accessed": "2026-10-29", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [ "Perceptual systems", "Natural language applications" ], "one_source": false, "confidence_raw": "verified", "depts": [ { "dept": "mental health", "div": "health" } ], "div_label": "Health", "location": "London (EC2V 6DN)", "status_group": "active", "ext_links": [], "label_links": [ { "kind": "funded_by", "name": "Kodori Ventures" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-062", "name": "Causaly", "bucket": "co", "status": "active", "status_date": "2026-10-31", "status_detail": "Secured US$60m (£45.8m) in a Series B led by ICONIQ Growth, reported 14 July 2023; no later page opened. Companies House shows CAUSALY LTD as Active (checked 31 Oct 2026).", "one_line": "London company whose AI platform reads biomedical research to help drug companies speed up drug discovery.", "description": "Causaly was founded in 2018 and is headquartered in London. It has built a drug discovery platform that uses AI to speed up pharmaceutical research. In July 2023 it secured US$60m in a Series B led by ICONIQ Growth. Yiannis Kiachopoulos is co-founder and chief executive. Companies House record not confirmed.", "uk_status": "uk", "company": { "ch_number": "11368328", "registered_office": null, "incorporated": null, "legal_form": null, "owner_or_acquirer": null, "headcount": null, "ch_number_clean": "11368328", "from_round2": true, "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/11368328", "ch_note": null }, "place": { "text": "London", "postcode": "WC1X 0BJ", "lat": 51.52301, "lng": -0.113595, "region": "England: London", "admin_district": "Camden", "geocoded": "postcodes.io" }, "people": [ { "name": "Yiannis Kiachopoulos", "role": "Co-founder and CEO", "from": "2018", "source": "https://www.uktech.news/medtech/ai-biotech-research-platform-causaly-secures-45-8m-20230714" } ], "money": [ { "kind": "funding_round", "amount": 60000000, "currency": "USD", "date": "2023-07-14", "detail": "Series B led by ICONIQ Growth", "raw": "funding_round: 60000000 USD 2023-07-14 — Series B led by ICONIQ Growth", "amount_gbp": 45745654, "fx_rate": 1.3116, "fx_source": "Bank of England daily spot rate (series XUDLUSS, XUDLERS), US$1.3116 per £ on 2023-07-14", "fx_date": "2023-07-14", "fx_note": "", "txt": "US$60m", "gbp_txt": "£45.7m" } ], "site": null, "product": null, "dsit_domains": [ "Natural language applications", "Knowledge generation" ], "sectors": [ "drug discovery", "biomedical research" ], "confidence": "verified", "checked": "2026-10-29", "as_of": "2026-10-29", "applied": null, "held": [], "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "London company whose AI platform reads biomedical research to help drug companies speed up drug discovery.", "affiliation": "Start-ups", "sources": [ "https://www.uktech.news/medtech/ai-biotech-research-platform-causaly-secures-45-8m-20230714", "https://find-and-update.company-information.service.gov.uk/company/11368328" ], "source_quotes": [ { "url": "https://www.uktech.news/medtech/ai-biotech-research-platform-causaly-secures-45-8m-20230714", "quotes": [ "London-headquartered AI biotech research platform Causaly has secured $60m (£45.8m) in a Series B funding round.\" \"led by ICONIQ Growth.\" \"Founded in 2018." ], "accessed": "2026-10-29", "trade": true, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/11368328", "quotes": [ "CAUSALY LTD", "10-16 Elm Street, London, England, WC1X 0BJ", "Active", "17 May 2018", "62090 - Other information technology service activities" ], "accessed": "2026-10-29", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [ "Natural language applications", "Knowledge generation" ], "one_source": false, "confidence_raw": "verified", "depts": [ { "dept": "drug discovery", "div": "health" } ], "div_label": "Health", "location": "London", "status_group": "active", "ext_links": [ { "kind": "linked from: same_as", "id": "BIZ-SW-027", "name": "Causaly", "page": "software", "href": "../../software/#org=BIZ-SW-027", "page_label": "Software and tools" } ], "label_links": [ { "kind": "funded_by", "name": "ICONIQ Growth" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-401", "name": "TileBio", "bucket": "co", "status": "active", "status_date": "2026-10-31", "status_detail": "University of Glasgow spin-out incorporated on 6 August 2025; DIGIT reported a £1.6m seed round in March 2026. Companies House shows TILEBIO LTD as Active (checked 31 Oct 2026).", "one_line": "Builds AI that learns from unlabelled pathology images to help diagnose cancer.", "description": "TileBio is a University of Glasgow spin-out that builds AI which learns from unlabelled medical pathology images, with the aim of faster cancer diagnosis. DIGIT's March 2026 deal roundup reported a £1.6m seed round led by Twin Path Ventures, with Scottish Enterprise and GU Holdings, the university's investment arm. Its registered office is at the University of Glasgow.", "uk_status": "uk", "company": { "ch_number": "SC858142", "registered_office": "11 The Square University Of Glasgow, University Avenue, Glasgow, United Kingdom, G12 8QQ", "incorporated": "2025-08-06", "legal_form": "ltd", "owner_or_acquirer": null, "headcount": null, "ch_number_clean": "SC858142", "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/SC858142", "ch_note": null }, "place": { "text": "Glasgow (G12 8QQ)", "postcode": "G12 8QQ", "lat": 55.871746, "lng": -4.288345, "region": "Scotland", "admin_district": "Glasgow City", "geocoded": "postcodes.io" }, "people": [], "money": [ { "kind": "funding_round", "amount": 1600000, "currency": "GBP", "date": "2026-03", "detail": "seed round led by Twin Path Ventures, with Scottish Enterprise and GU Holdings", "raw": "funding_round: 1600000 GBP 2026-03 — seed round led by Twin Path Ventures, with Scottish Enterprise and GU Holdings", "amount_gbp": 1600000, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£1.6m", "gbp_txt": "" } ], "site": null, "product": null, "dsit_domains": [ "Perceptual systems", "Knowledge generation" ], "sectors": [ "health", "pathology", "cancer diagnosis" ], "confidence": "verified", "checked": "2026-10-29", "as_of": "2026-10-29", "applied": null, "held": [], "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "Builds AI that learns from unlabelled pathology images to help diagnose cancer.", "affiliation": "Start-ups", "sources": [ "https://www.digit.fyi/digit-deal-roundup-march-2026/", "https://find-and-update.company-information.service.gov.uk/company/SC858142" ], "source_quotes": [ { "url": "https://www.digit.fyi/digit-deal-roundup-march-2026/", "quotes": [ "AI technology that learns ‘the language of cancer’\" (accessed 2026-10-29) (trade)" ], "accessed": null, "trade": false, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/SC858142", "quotes": [ "11 The Square University Of Glasgow, University Avenue, Glasgow", "Active", "6 August 2025" ], "accessed": "2026-10-29", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [ "Perceptual systems", "Knowledge generation" ], "one_source": false, "confidence_raw": "verified", "depts": [ { "dept": "health", "div": "health" } ], "div_label": "Health", "location": "Glasgow (G12 8QQ)", "status_group": "active", "ext_links": [], "label_links": [ { "kind": "spun_out_of", "name": "University of Glasgow" }, { "kind": "funded_by", "name": "Twin Path Ventures" }, { "kind": "funded_by", "name": "Scottish Enterprise" } ], "degree": 1, "related_ids": [ "BIZ-SU-HLT-508" ] }, { "id": "BIZ-SU-HLT-402", "name": "Entourage AI", "bucket": "co", "status": "active", "status_date": "2026-03", "status_detail": "DIGIT reported a $5m pre-seed round in March 2026; Companies House entry not yet found.", "one_line": "Analyses blood proteins to map organ health and estimate how fast a person's body is ageing.", "description": "Entourage AI, based in Glasgow, uses its own platform to analyse thousands of human proteins and produce organ wellness maps and an estimate of biological ageing. DIGIT's March 2026 deal roundup reported a $5m (£3.75m) pre-seed round led by Provision, with GU Holdings (University of Glasgow) and angel investors. The roundup does not state the AI method directly.", "uk_status": "uk", "company": { "ch_number": null, "registered_office": null, "incorporated": null, "legal_form": null, "owner_or_acquirer": null, "headcount": null, "ch_number_clean": null, "companies_house_url": null, "ch_note": null }, "place": { "text": "Glasgow (null)", "postcode": null, "lat": null, "lng": null, "region": "Scotland" }, "people": [], "money": [ { "kind": "funding_round", "amount": 5000000, "currency": "USD", "date": "2026-03", "detail": "pre-seed round led by Provision, with GU Holdings and angels", "raw": "funding_round: 5000000 USD 2026-03 — pre-seed round led by Provision, with GU Holdings and angels", "amount_gbp": 3719408, "fx_rate": 1.3443, "fx_source": "Bank of England daily spot rate (series XUDLUSS, XUDLERS), US$1.3443 per £ on 2026-02-27", "fx_date": "2026-02-27", "fx_note": "month only given: rate for the 1st", "txt": "US$5m", "gbp_txt": "£3.7m" } ], "site": null, "product": null, "dsit_domains": [ "Knowledge generation" ], "sectors": [ "health", "ageing", "proteomics" ], "confidence": "single_source", "checked": "2026-10-29", "as_of": "2026-10-29", "applied": null, "held": [], "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "Analyses blood proteins to map organ health and estimate how fast a person's body is ageing.", "affiliation": "Start-ups", "sources": [ "https://www.digit.fyi/digit-deal-roundup-march-2026/" ], "source_quotes": [ { "url": "https://www.digit.fyi/digit-deal-roundup-march-2026/", "quotes": [ "Using its proprietary platform to analyse thousands of human proteins\" (accessed 2026-10-29) (trade)" ], "accessed": null, "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [ "Knowledge generation" ], "one_source": true, "confidence_raw": "single_source", "depts": [ { "dept": "health", "div": "health" } ], "div_label": "Health", "location": "Glasgow (null)", "status_group": "active", "ext_links": [], "label_links": [ { "kind": "funded_by", "name": "Provision" }, { "kind": "funded_by", "name": "GU Holdings" } ], "degree": 1, "related_ids": [ "BIZ-SU-HLT-509" ] }, { "id": "BIZ-SU-HLT-403", "name": "Eyoto", "bucket": "co", "status": "active", "status_date": null, "status_detail": "Listed in UKTN's AI in the West Midlands report (undated page) with £2.5m raised; current status not checked.", "one_line": "Birmingham company using AI and machine learning in eye-health products.", "description": "Eyoto, in Birmingham, uses AI and machine learning to develop optical health products. UKTN's AI in the West Midlands report lists it with £2.5m raised. The page carries no date and no later source was opened.", "uk_status": "uk", "company": { "ch_number": null, "registered_office": null, "incorporated": null, "legal_form": null, "owner_or_acquirer": null, "headcount": null, "ch_number_clean": null, "companies_house_url": null, "ch_note": null }, "place": { "text": "Birmingham (null)", "postcode": null, "lat": null, "lng": null, "region": "England: West Midlands" }, "people": [], "money": [ { "kind": "note", "amount": null, "currency": null, "date": null, "detail": null, "raw": "null (total of £2.5m raised listed without a date)", "kind_as_written": null, "amount_gbp": null, "fx_rate": null, "fx_source": null, "fx_note": "no amount published", "txt": "", "gbp_txt": "" } ], "site": null, "product": null, "dsit_domains": [ "Perceptual systems" ], "sectors": [ "eye health", "optometry" ], "confidence": "single_source", "checked": "2026-10-29", "as_of": "2026-10-29", "applied": null, "held": [], "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "Birmingham company using AI and machine learning in eye-health products.", "affiliation": "Start-ups", "sources": [ "https://www.uktech.news/tech-report-ai-in-the-west-midlands-3" ], "source_quotes": [ { "url": "https://www.uktech.news/tech-report-ai-in-the-west-midlands-3", "quotes": [ "Eyoto uses AI and machine learning to develop optical health solutions.\" (accessed 2026-10-29) (trade)" ], "accessed": null, "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [ "Perceptual systems" ], "one_source": true, "confidence_raw": "single_source", "depts": [ { "dept": "eye health", "div": "health" } ], "div_label": "Health", "location": "Birmingham (null)", "status_group": "active", "ext_links": [], "label_links": [], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-501", "name": "Fraiya", "bucket": "co", "status": "active", "status_date": "2026-10-31", "status_detail": "Companies House lists the company as active; on 27 May 2026 King's College London reported it had launched an NIHR-funded trial of its scan tools. Companies House shows FRAIYA LTD as Active (checked 31 Oct 2026).", "one_line": "Software that helps sonographers capture and review the 20-week pregnancy ultrasound scan using AI.", "description": "Fraiya is a King's College London spin-out from the School of Biomedical Engineering & Imaging Sciences. Its tools, FraiyaScan and FraiyaDetect, support routine fetal anomaly screening at about 20 weeks: they help sonographers take images and measurements and let specialists review scans afterwards. In May 2026 King's reported the start of The FRAIYA Study, a randomised controlled trial funded by the National Institute for Health and Care Research. King's says the company is based at the London Institute for Healthcare Engineering.", "uk_status": "uk", "company": { "ch_number": "15278125", "registered_office": "61 Bridge Street, Kington, England, HR5 3DJ", "incorporated": "2023-11-13", "legal_form": "ltd", "owner_or_acquirer": null, "headcount": null, "ch_number_clean": "15278125", "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/15278125", "ch_note": null }, "place": { "text": "London Institute for Healthcare Engineering, London (postcode not published on the page opened; null; null)", "postcode": null, "lat": null, "lng": null, "region": "England: London" }, "people": [ { "name": "Reza Razavi", "role": "co-founder and chief executive", "from": null, "source": "https://www.kcl.ac.uk/news/kings-spinout-launches-study-into-ai-assisted-ultrasound-scans" }, { "name": "Jackie Matthew", "role": "co-founder and chief medical officer", "from": null, "source": "https://www.kcl.ac.uk/news/kings-spinout-launches-study-into-ai-assisted-ultrasound-scans" } ], "money": [], "site": null, "product": null, "dsit_domains": [ "Perceptual systems", "AI implementation" ], "sectors": [ "health", "maternity care", "medical imaging" ], "confidence": "verified", "checked": "2026-10-29", "as_of": "2026-10-29", "applied": null, "held": [], "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "Software that helps sonographers capture and review the 20-week pregnancy ultrasound scan using AI.", "affiliation": "Start-ups", "sources": [ "https://www.kcl.ac.uk/news/kings-spinout-launches-study-into-ai-assisted-ultrasound-scans", "https://www.kcl.ac.uk/news/ukri-leader-meets-kings-academics-and-entrepreneurs", "https://find-and-update.company-information.service.gov.uk/company/15278125" ], "source_quotes": [ { "url": "https://www.kcl.ac.uk/news/kings-spinout-launches-study-into-ai-assisted-ultrasound-scans", "quotes": [ "King's spinout Fraiya", "Funded by the National Institute for Health and Care Research" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://www.kcl.ac.uk/news/ukri-leader-meets-kings-academics-and-entrepreneurs", "quotes": [ "One spinout based at the LIHE is Fraiya AI, which is already having an impact on maternal care." ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/15278125", "quotes": [ "FRAIYA LTD", "Active", "13 November 2023", "86900 - Other human health activities" ], "accessed": "2026-10-29", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [ "Perceptual systems", "AI implementation" ], "one_source": false, "confidence_raw": "verified", "depts": [ { "dept": "health", "div": "health" } ], "div_label": "Health", "location": "London Institute for Healthcare Engineering, London (postcode not published on the page opened; null; null)", "status_group": "active", "ext_links": [ { "kind": "spun_out_of", "id": "UNI:kings/KCLAI-047", "name": "Universities: kings/KCLAI-047", "page": "universities", "href": "https://hazy-wreath-hez6.here.now/kings/", "page_label": "UK Universities AI Universe (new tab)" } ], "label_links": [], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-502", "name": "BeCertain", "bucket": "co", "status": "active", "status_date": "2026-07-16", "status_detail": "On 16 July 2026 King's College London announced a £1.7 million pre-seed round led by Sure Valley Ventures (SVV); Companies House lists the company as active.", "one_line": "AI software that helps dentists read intraoral X-rays and shows how confident each reading is.", "description": "BeCertain is a spin-out from King's College London and the University of Surrey, built on research led by Dr Yunpeng Li and Professor Owen Addison. Its first product reads 2D intraoral X-rays and gives a calibrated confidence level for each assessment. The initial project was funded by a £1.75 million NIHR i4i Product Development Award. In July 2026 it raised £1.7 million in a pre-seed round led by SVV, supported by Innovate UK's Investor Partnership Growth Catalyst programme. The company was incorporated as Nimbus Health Ltd in July 2024 and renamed in September 2024.", "uk_status": "uk", "company": { "ch_number": "15853880", "registered_office": "14 Culworth House West Road, Guildford, England, GU1 2AS", "incorporated": "2024-07-23", "legal_form": "ltd", "owner_or_acquirer": null, "headcount": null, "ch_number_clean": "15853880", "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/15853880", "ch_note": null }, "place": { "text": "Guildford (registered office) (GU1 2AS; null; null)", "postcode": "GU1 2AS", "lat": 51.238269, "lng": -0.563446, "region": "England: South East", "admin_district": "Guildford", "geocoded": "postcodes.io" }, "people": [ { "name": "Yunpeng Li", "role": "co-founder and chief executive", "from": null, "source": "https://www.kcl.ac.uk/news/university-spin-out-becertain-raises-1.7-million-to-bring-clinical-grade-ai-to-dental-diagnostics" }, { "name": "Owen Addison", "role": "co-founder and chief medical officer", "from": null, "source": "https://www.kcl.ac.uk/news/university-spin-out-becertain-raises-1.7-million-to-bring-clinical-grade-ai-to-dental-diagnostics" } ], "money": [ { "kind": "funding_round", "amount": 1700000, "currency": "GBP", "date": "2026-07-16", "detail": "pre-seed led by SVV", "raw": "funding_round: 1700000 GBP 2026-07-16 — pre-seed led by SVV", "amount_gbp": 1700000, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£1.7m", "gbp_txt": "" }, { "kind": "grant", "amount": 1750000, "currency": "GBP", "date": null, "detail": "NIHR i4i Product Development Award for the initial project", "raw": "grant: 1750000 GBP null — NIHR i4i Product Development Award for the initial project", "amount_gbp": 1750000, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£1.8m", "gbp_txt": "" } ], "site": null, "product": null, "dsit_domains": [ "Perceptual systems", "AI implementation" ], "sectors": [ "health", "dentistry", "medical imaging" ], "confidence": "single_source", "checked": "2026-10-29", "as_of": "2026-10-29", "applied": null, "held": [], "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "AI software that helps dentists read intraoral X-rays and shows how confident each reading is.", "affiliation": "Start-ups", "sources": [ "https://www.kcl.ac.uk/news/university-spin-out-becertain-raises-1.7-million-to-bring-clinical-grade-ai-to-dental-diagnostics", "https://find-and-update.company-information.service.gov.uk/company/15853880" ], "source_quotes": [ { "url": "https://www.kcl.ac.uk/news/university-spin-out-becertain-raises-1.7-million-to-bring-clinical-grade-ai-to-dental-diagnostics", "quotes": [ "AI software assistant designed to support clinicians in their workflow", "pre-seed investment round" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/15853880", "quotes": [ "BECERTAIN LTD", "Active", "23 July 2024", "NIMBUS HEALTH LTD (23 Jul 2024 - 30 Sep 2024)" ], "accessed": "2026-10-29", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [ "Perceptual systems", "AI implementation" ], "one_source": true, "confidence_raw": "single_source", "depts": [ { "dept": "health", "div": "health" } ], "div_label": "Health", "location": "Guildford (registered office) (GU1 2AS; null; null)", "status_group": "active", "ext_links": [ { "kind": "spun_out_of", "id": "UNI:kings/KCLAI-044", "name": "Universities: kings/KCLAI-044", "page": "universities", "href": "https://hazy-wreath-hez6.here.now/kings/", "page_label": "UK Universities AI Universe (new tab)" } ], "label_links": [ { "kind": "funded_by", "name": "Sure Valley Ventures" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-503", "name": "Hypervision Surgical", "bucket": "co", "status": "active", "status_date": "2026-09-25", "status_detail": "On 25 September 2026 King's College London reported that the company, based at the London Institute for Healthcare Engineering, had recently raised £17 million; Companies House lists it as active.", "one_line": "Builds an AI-assisted hyperspectral camera system that shows surgeons tissue detail the eye cannot see.", "description": "Hypervision Surgical is a spin-out from the School of Biomedical Engineering & Imaging Sciences at King's College London. It is turning an imaging system first developed there into a medical device for surgery, combining interventional imaging, AI and medical-device work. It went through the Creative Destruction Lab's 2021–22 Health stream. King's reported in September 2026 that it had recently raised £17 million.", "uk_status": "uk", "company": { "ch_number": "12614766", "registered_office": "London Institute For Healthcare Engineering, 100 Lambeth Palace Road, London, United Kingdom, SE1 7AR", "incorporated": "2020-05-20", "legal_form": "ltd", "owner_or_acquirer": null, "headcount": null, "ch_number_clean": "12614766", "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/12614766", "ch_note": null }, "place": { "text": "London Institute for Healthcare Engineering, 100 Lambeth Palace Road, London (SE1 7AR; null; null)", "postcode": "SE1 7AR", "lat": 51.497494, "lng": -0.120095, "region": "England: London", "admin_district": "Lambeth", "geocoded": "postcodes.io" }, "people": [ { "name": "Michael Ebner", "role": "co-founder and chief executive", "from": null, "source": "https://www.kcl.ac.uk/news/biomedical-engineering-spinout-hypervision-surgical-graduates-from-prestigious-programme" }, { "name": "Tom Vercauteren", "role": "co-founder and chief scientific officer", "from": null, "source": "https://www.kcl.ac.uk/news/biomedical-engineering-spinout-hypervision-surgical-graduates-from-prestigious-programme" } ], "money": [ { "kind": "funding_round", "amount": null, "currency": null, "date": null, "detail": null, "raw": "funding_round: 17000000 GBP 2026 (date not stated) — reported by King's as \"recently raised\"; round name and lead investor not read on an opened page", "amount_gbp": null, "fx_rate": null, "fx_source": null, "fx_note": "no amount published", "txt": "", "gbp_txt": "" } ], "site": null, "product": null, "dsit_domains": [ "Perceptual systems" ], "sectors": [ "health", "surgery", "medical imaging" ], "confidence": "single_source", "checked": "2026-10-29", "as_of": "2026-10-29", "applied": null, "held": [], "same_as": "BIZ-SU-HLT-804", "package1_id": null, "type": "Companies", "category": "health", "function": "Builds an AI-assisted hyperspectral camera system that shows surgeons tissue detail the eye cannot see.", "affiliation": "Start-ups", "sources": [ "https://www.kcl.ac.uk/research/kings-innovation-catalyst/investors/discover-our-spinouts", "https://www.kcl.ac.uk/news/biomedical-engineering-spinout-hypervision-surgical-graduates-from-prestigious-programme", "https://www.kcl.ac.uk/news/ukri-leader-meets-kings-academics-and-entrepreneurs", "https://find-and-update.company-information.service.gov.uk/company/12614766" ], "source_quotes": [ { "url": "https://www.kcl.ac.uk/research/kings-innovation-catalyst/investors/discover-our-spinouts", "quotes": [ "With expertise in interventional imaging, AI and medical devices" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://www.kcl.ac.uk/news/biomedical-engineering-spinout-hypervision-surgical-graduates-from-prestigious-programme", "quotes": [ "Spinout from King’s School of Biomedical Engineering & Imaging Sciences" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://www.kcl.ac.uk/news/ukri-leader-meets-kings-academics-and-entrepreneurs", "quotes": [ "Another King’s spinout, Hypervision surgical, also based at the LIHE, aims to break down visual limitations for surgeons." ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/12614766", "quotes": [ "HYPERVISION SURGICAL LTD", "Active", "20 May 2020" ], "accessed": "2026-10-29", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [ "Perceptual systems" ], "one_source": true, "confidence_raw": "single_source", "depts": [ { "dept": "health", "div": "health" } ], "div_label": "Health", "location": "London Institute for Healthcare Engineering, 100 Lambeth Palace Road, London (SE1 7AR; null; null)", "status_group": "active", "ext_links": [ { "kind": "spun_out_of", "id": "UNI:kings/KCLAI-048", "name": "Universities: kings/KCLAI-048", "page": "universities", "href": "https://hazy-wreath-hez6.here.now/kings/", "page_label": "UK Universities AI Universe (new tab)" } ], "label_links": [], "degree": 1, "related_ids": [ "BIZ-SU-HLT-804" ] }, { "id": "BIZ-SU-HLT-504", "name": "Cydar Medical", "bucket": "co", "status": "active", "status_date": null, "status_detail": "Listed by King's College London among its spin-outs; Companies House lists Cydar Limited as active (match by name, see Gaps).", "one_line": "Cloud-based AI software for surgeons and imaging teams working on vascular procedures.", "description": "King's College London lists Cydar Medical among its medical-imaging spin-outs and says it \"provides regulated cloud-based AI clinical applications within an enterprise data architecture\". The Companies House entry matched by name is Cydar Limited, incorporated in March 2012 with a registered office in Cambridge.", "uk_status": "uk", "company": { "ch_number": "07986624", "registered_office": "20 Station Road, Cambridge, England, CB1 2JD", "incorporated": "2012-03-12", "legal_form": "ltd", "owner_or_acquirer": null, "headcount": null, "ch_number_clean": "07986624", "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/07986624", "ch_note": null }, "place": { "text": "Cambridge (registered office) (CB1 2JD; null; null)", "postcode": "CB1 2JD", "lat": 52.194439, "lng": 0.133975, "region": "England: East of England", "admin_district": "Cambridge", "geocoded": "postcodes.io" }, "people": [], "money": [], "site": null, "product": null, "dsit_domains": [ "Perceptual systems", "AI implementation" ], "sectors": [ "health", "surgery", "medical imaging" ], "confidence": "single_source", "checked": "2026-10-29", "as_of": "2026-10-29", "applied": null, "held": [], "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "Cloud-based AI software for surgeons and imaging teams working on vascular procedures.", "affiliation": "Start-ups", "sources": [ "https://www.kcl.ac.uk/research/kings-innovation-catalyst/investors/discover-our-spinouts", "https://find-and-update.company-information.service.gov.uk/company/07986624" ], "source_quotes": [ { "url": "https://www.kcl.ac.uk/research/kings-innovation-catalyst/investors/discover-our-spinouts", "quotes": [ "provides regulated cloud-based AI clinical applications within an enterprise data architecture" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/07986624", "quotes": [ "CYDAR LIMITED", "Active", "12 March 2012" ], "accessed": "2026-10-29", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [ "Perceptual systems", "AI implementation" ], "one_source": true, "confidence_raw": "single_source", "depts": [ { "dept": "health", "div": "health" } ], "div_label": "Health", "location": "Cambridge (registered office) (CB1 2JD; null; null)", "status_group": "active", "ext_links": [ { "kind": "spun_out_of", "id": "UNI:kings/KCLAI-046", "name": "Universities: kings/KCLAI-046", "page": "universities", "href": "https://hazy-wreath-hez6.here.now/kings/", "page_label": "UK Universities AI Universe (new tab)" } ], "label_links": [], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-505", "name": "CogStack", "bucket": "co", "status": "active", "status_date": "2026-10-31", "status_detail": "King's College London announced CogStack as a new spin-out company on 3 December 2025; Companies House lists CogStack Limited as active. Companies House shows COGSTACK LIMITED as Active (checked 31 Oct 2026).", "one_line": "Software that reads the free text in NHS patient records so clinicians and researchers can search and use it.", "description": "CogStack began as a set of tools at King's College London for collating, transforming and understanding the text in health-care records. It is deployed across NHS trusts and abroad. Its Foresight model uses large language model methods to learn from patient records and predict future medical events. Professor Richard Dobson co-founded the platform; Dr Tom Searle led an NHS AI Lab-funded programme to deploy it. King's announced a spin-out company in December 2025 to help health-care providers modernise their digital operations.", "uk_status": "uk", "company": { "ch_number": "14463252", "registered_office": "Unit 9 The Stables Goblands Farm Business Centre, Cemetery Lane, Hadlow, England, TN11 0LT", "incorporated": "2022-11-04", "legal_form": "ltd", "owner_or_acquirer": null, "headcount": null, "ch_number_clean": "14463252", "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/14463252", "ch_note": null }, "place": { "text": "Hadlow, Kent (registered office) (TN11 0LT; null; null)", "postcode": "TN11 0LT", "lat": 51.225292, "lng": 0.350384, "region": "England: South East", "admin_district": "Tonbridge and Malling", "geocoded": "postcodes.io" }, "people": [ { "name": "Richard Dobson", "role": "co-founder of the CogStack platform (King's academic)", "from": null, "source": "https://www.kcl.ac.uk/people/richard-dobson" } ], "money": [], "site": null, "product": null, "dsit_domains": [ "Natural language applications", "AI implementation" ], "sectors": [ "health", "clinical records", "NHS" ], "confidence": "verified", "checked": "2026-10-29", "as_of": "2026-10-29", "applied": null, "held": [], "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "Software that reads the free text in NHS patient records so clinicians and researchers can search and use it.", "affiliation": "Start-ups", "sources": [ "https://www.kcl.ac.uk/people/richard-dobson", "https://www.kcl.ac.uk/people/tom-searle", "https://find-and-update.company-information.service.gov.uk/company/14463252" ], "source_quotes": [ { "url": "https://www.kcl.ac.uk/people/richard-dobson", "quotes": [ "co-founding the CogStack platform", "Foresight is a recent development of the CogStack family, using large language modelling technologies" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://www.kcl.ac.uk/people/tom-searle", "quotes": [ "CogStack is an information retrieval and extraction platform.", "New spinout CogStack is unlocking the power of healthcare data through AI to transform clinical care" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/14463252", "quotes": [ "COGSTACK LIMITED", "Active", "4 November 2022", "62012 - Business and domestic software development" ], "accessed": "2026-10-29", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [ "Natural language applications", "AI implementation" ], "one_source": false, "confidence_raw": "verified", "depts": [ { "dept": "health", "div": "health" } ], "div_label": "Health", "location": "Hadlow, Kent (registered office) (TN11 0LT; null; null)", "status_group": "active", "ext_links": [ { "kind": "spun_out_of", "id": "UNI:kings/KCLAI-045", "name": "Universities: kings/KCLAI-045", "page": "universities", "href": "https://hazy-wreath-hez6.here.now/kings/", "page_label": "UK Universities AI Universe (new tab)" } ], "label_links": [], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-506", "name": "BlueSkeye AI", "bucket": "co", "status": "active", "status_date": null, "status_detail": "Companies House lists BlueSkeye AI Ltd as active; the University of Nottingham listed it in its spin-out portfolio in March 2022.", "one_line": "Software that reads facial expressions and behaviour to help detect and track mental-health conditions.", "description": "BlueSkeye AI was founded by Dr Michel Valstar, Dr Anthony Brown and Dr Timur Almaev from the University of Nottingham's School of Computer Science. It turns their research on detecting changes in facial expression linked to mental-health conditions into a business, with support from Nottingham Technology Ventures, which manages the university's spin-outs. The company's registered office is in the university's Sir Colin Campbell Building.", "uk_status": "uk", "company": { "ch_number": "11953581", "registered_office": "The Sir Colin Campbell Building, Triumph Road, Nottingham, England, NG7 2TU", "incorporated": "2019-04-18", "legal_form": "ltd", "owner_or_acquirer": null, "headcount": null, "ch_number_clean": "11953581", "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/11953581", "ch_note": null }, "place": { "text": "The Sir Colin Campbell Building, Triumph Road, Nottingham (NG7 2TU; null; null)", "postcode": "NG7 2TU", "lat": 52.951156, "lng": -1.183344, "region": "England: East Midlands", "admin_district": "Nottingham", "geocoded": "postcodes.io" }, "people": [ { "name": "Michel Valstar", "role": "co-founder", "from": null, "source": "https://www.nottingham.ac.uk/computerscience/news/nottingham-tech-ventures.aspx" }, { "name": "Anthony Brown", "role": "co-founder", "from": null, "source": "https://www.nottingham.ac.uk/computerscience/news/nottingham-tech-ventures.aspx" }, { "name": "Timur Almaev", "role": "co-founder", "from": null, "source": "https://www.nottingham.ac.uk/computerscience/news/nottingham-tech-ventures.aspx" } ], "money": [], "site": null, "product": null, "dsit_domains": [ "Perceptual systems" ], "sectors": [ "health", "mental health" ], "confidence": "verified", "checked": "2026-10-29", "as_of": "2026-10-29", "applied": null, "held": [], "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "Software that reads facial expressions and behaviour to help detect and track mental-health conditions.", "affiliation": "Start-ups", "sources": [ "https://www.nottingham.ac.uk/computerscience/news/nottingham-tech-ventures.aspx", "https://www.nottingham.ac.uk/fabs/documents/nottingham-technology-ventures-annual-report-2022.pdf", "https://find-and-update.company-information.service.gov.uk/company/11953581" ], "source_quotes": [ { "url": "https://www.nottingham.ac.uk/computerscience/news/nottingham-tech-ventures.aspx", "quotes": [ "They have now turned that technology into a business, BlueSkeye AI", "which manages the University’s portfolio of spin-out businesses" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://www.nottingham.ac.uk/fabs/documents/nottingham-technology-ventures-annual-report-2022.pdf", "quotes": [ "BlueSkeye AI Ltd\" (spin-out portfolio list, March 2022)" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/11953581", "quotes": [ "BLUESKEYE AI LTD", "Active", "18 April 2019", "63110 - Data processing, hosting and related activities" ], "accessed": "2026-10-29", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [ "Perceptual systems" ], "one_source": false, "confidence_raw": "verified", "depts": [ { "dept": "health", "div": "health" } ], "div_label": "Health", "location": "The Sir Colin Campbell Building, Triumph Road, Nottingham (NG7 2TU; null; null)", "status_group": "active", "ext_links": [ { "kind": "spun_out_of", "id": "UNI:nottingham/NOTAI-002", "name": "Universities: nottingham/NOTAI-002", "page": "universities", "href": "https://hazy-wreath-hez6.here.now/nottingham/", "page_label": "UK Universities AI Universe (new tab)" } ], "label_links": [], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-507", "name": "AI Sight", "bucket": "co", "status": "active", "status_date": null, "status_detail": "Spun out of the University of Liverpool in 2022; Companies House search lists AI Sight Limited, incorporated 22 September 2022, with no dissolution shown (company page would not open).", "one_line": "An AI system for diabetic eye screening, developed from University of Liverpool eye research.", "description": "AI Sight was set up to commercialise an AI system for diabetic eye screening conceived by academics in the University of Liverpool's Department of Eye and Vision Science. The university says it spun out in 2022. Its published leadership includes Dr Steven Powell (chief executive), Professor Simon Harding (chief medical officer) and Professor David Wong (chief scientific officer). Companies House gives a registered office at the Innovation Centre, Sci-Tech Daresbury.", "uk_status": "uk", "company": { "ch_number": "14370887", "registered_office": "The Innovation Centre Sci-Tech Daresbury, Keckwick Lane, Daresbury, Cheshire, England, WA4 4FS", "incorporated": "2022-09-22", "legal_form": "ltd", "owner_or_acquirer": null, "headcount": null, "ch_number_clean": "14370887", "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/14370887", "ch_note": null }, "place": { "text": "Sci-Tech Daresbury, Cheshire (WA4 4FS; null; null)", "postcode": "WA4 4FS", "lat": 53.345237, "lng": -2.639191, "region": "England: North West", "admin_district": "Halton", "geocoded": "postcodes.io" }, "people": [ { "name": "Steven Powell", "role": "chief executive", "from": null, "source": "https://www.liverpool.ac.uk/collaborate/enterprise/spin-out-companies/ai-sight/" }, { "name": "Simon Harding", "role": "chief medical officer", "from": null, "source": null }, { "name": "David Wong", "role": "chief scientific officer", "from": null, "source": null } ], "money": [], "site": null, "product": null, "dsit_domains": [ "Perceptual systems" ], "sectors": [ "health", "ophthalmology", "screening" ], "confidence": "single_source", "checked": "2026-10-29", "as_of": "2026-10-29", "applied": null, "held": [], "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "An AI system for diabetic eye screening, developed from University of Liverpool eye research.", "affiliation": "Start-ups", "sources": [ "https://www.liverpool.ac.uk/collaborate/enterprise/spin-out-companies/ai-sight/", "https://find-and-update.company-information.service.gov.uk/search/companies?q=AI-Sight" ], "source_quotes": [ { "url": "https://www.liverpool.ac.uk/collaborate/enterprise/spin-out-companies/ai-sight/", "quotes": [ "commercialise a next generation artificial intelligence (AI) system that will revolutionise diabetic eye screening.", "spun out from the University in 2022." ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/search/companies?q=AI-Sight", "quotes": [ "AI SIGHT LIMITED", "14370887", "22 September 2022" ], "accessed": "2026-10-29", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [ "Perceptual systems" ], "one_source": true, "confidence_raw": "single_source", "depts": [ { "dept": "health", "div": "health" } ], "div_label": "Health", "location": "Sci-Tech Daresbury, Cheshire (WA4 4FS; null; null)", "status_group": "active", "ext_links": [ { "kind": "spun_out_of", "id": "UNI:liverpool/LIVAI-020", "name": "Universities: liverpool/LIVAI-020", "page": "universities", "href": "https://hazy-wreath-hez6.here.now/liverpool/", "page_label": "UK Universities AI Universe (new tab)" } ], "label_links": [], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-508", "name": "TileBio", "bucket": "co", "status": "active", "status_date": "2026-10-31", "status_detail": "Launched on 2 March 2026 as a University of Glasgow spin-out with £1.6 million seed funding led by Twin Path Ventures; Companies House lists it as active. Companies House shows TILEBIO LTD as Active (checked 31 Oct 2026).", "one_line": "AI that learns from millions of unlabelled pathology slide images to help diagnose cancer.", "description": "TileBio is a University of Glasgow spin-out from research in computational pathology led by Dr Ke Yuan, Dr Adalberto Claudio Quiros, Professor John Le Quesne, Professor David Chang and Dr Christopher Walsh, who is chief executive. Its AI learns patterns of diseased tissue from large sets of unlabelled pathology images, with the aim of faster and more accurate cancer diagnosis. It launched in March 2026 with a £1.6 million seed round led by Twin Path Ventures, with Scottish Enterprise and GU Holdings Ltd, the university's investment company.", "uk_status": "uk", "company": { "ch_number": "SC858142", "registered_office": "11 The Square University Of Glasgow, University Avenue, Glasgow, United Kingdom, G12 8QQ", "incorporated": "2025-08-06", "legal_form": "ltd", "owner_or_acquirer": null, "headcount": null, "ch_number_clean": "SC858142", "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/SC858142", "ch_note": null }, "place": { "text": "University of Glasgow, Glasgow (G12 8QQ; null; null)", "postcode": "G12 8QQ", "lat": 55.871746, "lng": -4.288345, "region": "Scotland", "admin_district": "Glasgow City", "geocoded": "postcodes.io" }, "people": [ { "name": "Christopher Walsh", "role": "chief executive", "from": null, "source": "https://www.gla.ac.uk/news/headline_1249369_en.html" } ], "money": [ { "kind": "funding_round", "amount": 1600000, "currency": "GBP", "date": "2026-03-02", "detail": "seed led by Twin Path Ventures, with Scottish Enterprise and GU Holdings", "raw": "funding_round: 1600000 GBP 2026-03-02 — seed led by Twin Path Ventures, with Scottish Enterprise and GU Holdings", "amount_gbp": 1600000, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£1.6m", "gbp_txt": "" } ], "site": null, "product": null, "dsit_domains": [ "Perceptual systems", "Knowledge generation" ], "sectors": [ "health", "pathology", "cancer diagnosis" ], "confidence": "single_source", "checked": "2026-10-29", "as_of": "2026-10-29", "applied": null, "held": [], "same_as": "BIZ-SU-HLT-401", "package1_id": null, "type": "Companies", "category": "health", "function": "AI that learns from millions of unlabelled pathology slide images to help diagnose cancer.", "affiliation": "Start-ups", "sources": [ "https://www.gla.ac.uk/news/headline_1249369_en.html", "https://find-and-update.company-information.service.gov.uk/company/SC858142" ], "source_quotes": [ { "url": "https://www.gla.ac.uk/news/headline_1249369_en.html", "quotes": [ "A spin-out company from the University of Glasgow", "learn the language of diseased tissues directly from millions of unlabelled medical pathology images", "led by Twin Path Ventures with participation from Scottish Enterprise" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/SC858142", "quotes": [ "TILEBIO LTD", "Active", "6 August 2025" ], "accessed": "2026-10-29", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [ "Perceptual systems", "Knowledge generation" ], "one_source": true, "confidence_raw": "single_source", "depts": [ { "dept": "health", "div": "health" } ], "div_label": "Health", "location": "University of Glasgow, Glasgow (G12 8QQ; null; null)", "status_group": "active", "ext_links": [ { "kind": "spun_out_of", "id": "UNI:glasgow/GLAAI-036", "name": "Universities: glasgow/GLAAI-036", "page": "universities", "href": "https://hazy-wreath-hez6.here.now/glasgow/", "page_label": "UK Universities AI Universe (new tab)" } ], "label_links": [ { "kind": "funded_by", "name": "Twin Path Ventures" }, { "kind": "funded_by", "name": "Scottish Enterprise" } ], "degree": 1, "related_ids": [ "BIZ-SU-HLT-401" ] }, { "id": "BIZ-SU-HLT-509", "name": "Entourage AI", "bucket": "co", "status": "active", "status_date": "2026-03-18", "status_detail": "Launched on 18 March 2026 as a University of Glasgow spin-out with a $5 million pre-seed round led by Provision.", "one_line": "Protein tests and an AI coach that estimate biological age and the health of individual organs.", "description": "Entourage AI is a University of Glasgow spin-out described by the university as a longevity and healthspan data company. It analyses proteins to estimate biological age and give organ-specific health insights, sold as an Aging Clock, Organ Health analysis and an AI Coach to consumers in the UK and US and to research partners. It was founded by Professor Patrick T. Gunning, who is chief executive; Gerard Cunningham is executive chair. It has a Research and Operations Centre at the West of Scotland Science Park, Glasgow. The Companies House entity was not identified (see Gaps).", "uk_status": "uk", "company": { "ch_number": null, "registered_office": null, "incorporated": null, "legal_form": null, "owner_or_acquirer": null, "headcount": null, "ch_number_clean": null, "companies_house_url": null, "ch_note": null }, "place": { "text": "West of Scotland Science Park, Glasgow", "postcode": null, "lat": null, "lng": null, "region": "Scotland" }, "people": [ { "name": "Patrick T. Gunning", "role": "founder and chief executive", "from": null, "source": "https://www.gla.ac.uk/news/archiveofnews/2026/march/headline_1254829_en.html" }, { "name": "Gerard Cunningham", "role": "executive chair", "from": null, "source": null } ], "money": [ { "kind": "funding_round", "amount": 5000000, "currency": "USD", "date": "2026-03-18", "detail": "pre-seed led by Provision, with GU Holdings", "raw": "funding_round: 5000000 USD 2026-03-18 — pre-seed led by Provision, with GU Holdings", "amount_gbp": 3752909, "fx_rate": 1.3323, "fx_source": "Bank of England daily spot rate (series XUDLUSS, XUDLERS), US$1.3323 per £ on 2026-03-18", "fx_date": "2026-03-18", "fx_note": "", "txt": "US$5m", "gbp_txt": "£3.8m" } ], "site": null, "product": null, "dsit_domains": [ "Knowledge generation", "AI implementation" ], "sectors": [ "health", "longevity", "diagnostics" ], "confidence": "single_source", "checked": "2026-10-29", "as_of": "2026-10-29", "applied": null, "held": [], "same_as": "BIZ-SU-HLT-402", "package1_id": null, "type": "Companies", "category": "health", "function": "Protein tests and an AI coach that estimate biological age and the health of individual organs.", "affiliation": "Start-ups", "sources": [ "https://www.gla.ac.uk/news/archiveofnews/2026/march/headline_1254829_en.html" ], "source_quotes": [ { "url": "https://www.gla.ac.uk/news/archiveofnews/2026/march/headline_1254829_en.html", "quotes": [ "a longevity and healthspan focused data company", "Published: 18 March 2026" ], "accessed": "2026-10-29", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [ "Knowledge generation", "AI implementation" ], "one_source": true, "confidence_raw": "single_source", "depts": [ { "dept": "health", "div": "health" } ], "div_label": "Health", "location": "West of Scotland Science Park, Glasgow", "status_group": "active", "ext_links": [ { "kind": "spun_out_of", "id": "UNI:glasgow/GLAAI-030", "name": "Universities: glasgow/GLAAI-030", "page": "universities", "href": "https://hazy-wreath-hez6.here.now/glasgow/", "page_label": "UK Universities AI Universe (new tab)" } ], "label_links": [ { "kind": "funded_by", "name": "Provision" } ], "degree": 1, "related_ids": [ "BIZ-SU-HLT-402" ] }, { "id": "BIZ-SU-HLT-601", "name": "BioBeats", "bucket": "co", "status": "dissolved", "status_date": "2024-08-27", "status_detail": "Bought by Huma (formerly Medopad), announced 15 April 2020; Huma Therapeutics Limited became its controlling shareholder from 9 April 2020; the company was dissolved on 27 August 2024.", "one_line": "Mental-health AI start-up, bought by the London digital-health firm Huma in 2020 and later dissolved.", "description": "BioBeats was a mental-health AI start-up. TechCrunch reported on 15 April 2020 that Medopad was rebranding as Huma and acquiring BioBeats, one of two AI start-ups bought to extend its biomarker platform; terms were not disclosed. Companies House shows BioBeats Group Ltd (formerly Mindful Sound Ltd), incorporated on 3 August 2011, with Huma Therapeutics Limited as person with significant control from 9 April 2020, and dissolved on 27 August 2024.", "uk_status": "uk", "company": { "ch_number": "07727135", "registered_office": "13th Floor Millbank Tower, 21-24 Millbank, London, England, SW1P 4QP", "incorporated": "2011-08-03", "legal_form": "ltd", "owner_or_acquirer": "Huma Therapeutics Limited (from 2020-04-09)", "headcount": null, "ch_number_clean": "07727135", "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/07727135", "ch_note": null }, "place": { "text": "London (registered office) (SW1P 4QP)", "postcode": "SW1P 4QP", "lat": 51.491984, "lng": -0.125882, "region": "England: London", "admin_district": "Westminster", "geocoded": "postcodes.io" }, "people": [], "money": [], "site": null, "product": null, "dsit_domains": [ "AI implementation" ], "sectors": [ "mental health", "digital health" ], "confidence": "verified", "checked": "2026-10-29", "as_of": "2026-10-29", "applied": null, "held": [], "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "Mental-health AI start-up, bought by the London digital-health firm Huma in 2020 and later dissolved.", "affiliation": "Start-ups", "sources": [ "https://techcrunch.com/2020/04/15/medopad-rebrands-as-huma-acquires-biobeats-and-tlt-to-expand-its-biomarker-platform/", "https://find-and-update.company-information.service.gov.uk/company/07727135", "https://find-and-update.company-information.service.gov.uk/company/07727135/persons-with-significant-control" ], "source_quotes": [ { "url": "https://techcrunch.com/2020/04/15/medopad-rebrands-as-huma-acquires-biobeats-and-tlt-to-expand-its-biomarker-platform/", "quotes": [ "the mental health-focused BioBeats", "AI startups" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/07727135", "quotes": [ "BIOBEATS GROUP LTD\" \"Dissolved\" \"27 August 2024\" \"3 August 2011\" \"MINDFUL SOUND LTD (03 Aug 2011 - 25 Feb 2016)" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/07727135/persons-with-significant-control", "quotes": [ "Huma Therapeutics Limited\" \"Notified on\" \"9 April 2020" ], "accessed": "2026-10-29", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [ "AI implementation" ], "one_source": false, "confidence_raw": "verified", "depts": [ { "dept": "mental health", "div": "health" } ], "div_label": "Health", "location": "London (registered office) (SW1P 4QP)", "status_group": "dissolved", "ext_links": [], "label_links": [], "degree": 1, "related_ids": [ "BIZ-SU-HLT-801" ] }, { "id": "BIZ-SU-HLT-602", "name": "iLoF (Intelligent Lab on Fiber)", "bucket": "co", "status": "active", "status_date": null, "status_detail": "Companies House lists iLoF - Intelligent Lab on Fiber Limited as active (checked 29 October 2026).", "one_line": "Oxford and Porto company building an AI library of disease biomarkers to help drug firms pick patients for trials.", "description": "iLoF runs an AI platform for drug discovery and development: a digital library of disease biomarkers and biological profiles that drug companies use to speed up clinical trials. In July 2022 UKTN reported a US$5m round led by Faber, with Microsoft's venture fund (M12) among others, and said the company was based in Oxford and Porto. It named Luis Valente as co-founder and chief executive. Companies House lists iLoF - Intelligent Lab on Fiber Limited, incorporated on 22 May 2020, as active, with Luis Filipe Carvalho Valente a director since incorporation; its registered office is in London.", "uk_status": "uk", "company": { "ch_number": "12619573", "registered_office": "124 City Road City Road, 124, London, England, EC1V 2NX", "incorporated": "2020-05-22", "legal_form": "ltd", "owner_or_acquirer": null, "headcount": null, "ch_number_clean": "12619573", "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/12619573", "ch_note": null }, "place": { "text": "Oxford (null)", "postcode": null, "lat": null, "lng": null, "region": "England: South East" }, "people": [ { "name": "Luis Valente", "role": "co-founder and chief executive; director from 2020-05-22", "from": null, "source": "https://find-and-update.company-information.service.gov.uk/company/12619573/officers" } ], "money": [ { "kind": "funding_round", "amount": 5000000, "currency": "USD", "date": "2022-07-28", "detail": "round led by Faber (single source)", "raw": "funding_round: 5000000 USD 2022-07-28 — round led by Faber (single source)", "amount_gbp": 4127456, "fx_rate": 1.2114, "fx_source": "Bank of England daily spot rate (series XUDLUSS, XUDLERS), US$1.2114 per £ on 2022-07-28", "fx_date": "2022-07-28", "fx_note": "", "txt": "US$5m", "gbp_txt": "£4.1m" } ], "site": null, "product": null, "dsit_domains": [ "Knowledge generation", "Perceptual systems" ], "sectors": [ "drug discovery", "clinical trials" ], "confidence": "verified", "checked": "2026-10-29", "as_of": "2026-10-29", "applied": null, "held": [], "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "Oxford and Porto company building an AI library of disease biomarkers to help drug firms pick patients for trials.", "affiliation": "Start-ups", "sources": [ "https://www.uktech.news/medtech/ilof-funding-20220728", "https://find-and-update.company-information.service.gov.uk/company/12619573", "https://find-and-update.company-information.service.gov.uk/company/12619573/officers" ], "source_quotes": [ { "url": "https://www.uktech.news/medtech/ilof-funding-20220728", "quotes": [ "Based in Oxford, UK, and Porto, Portugal", "digital library of disease biomarkers and biological profiles", "co-founder and CEO Luis Valente" ], "accessed": "2026-10-29", "trade": true, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/12619573", "quotes": [ "ILOF - INTELLIGENT LAB ON FIBER LIMITED\" \"Active\" \"22 May 2020" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/12619573/officers", "quotes": [ "VALENTE, Luis Filipe Carvalho. Role Active. Director. Appointed on 22 May 2020." ], "accessed": "2026-10-29", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [ "Knowledge generation", "Perceptual systems" ], "one_source": false, "confidence_raw": "verified", "depts": [ { "dept": "drug discovery", "div": "health" } ], "div_label": "Health", "location": "Oxford (null)", "status_group": "active", "ext_links": [], "label_links": [ { "kind": "funded_by", "name": "Faber" }, { "kind": "founded_by", "name": "Luis Valente" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-603", "name": "Biorelate", "bucket": "co", "status": "active", "status_date": null, "status_detail": "Companies House lists Biorelate Limited as active, registered at Manchester Science Park (checked 29 October 2026).", "one_line": "Manchester company whose Galactic AI platform reads biomedical literature and data to help drug developers.", "description": "Biorelate's Galactic AI platform uses natural language processing and machine learning to gather billions of biomedical data points for drug developers. In November 2022 UKTN reported a £6.5m Series A from YFM, Maven, Triple Point Ventures, the Northern Powerhouse Investment Fund and Manchester Tech Trust angels, and named Dan Jamieson as founder and chief executive. Companies House lists Biorelate Limited, incorporated on 16 June 2014, as active, with Daniel Jamieson a director since incorporation.", "uk_status": "uk", "company": { "ch_number": "09087514", "registered_office": "Unit 9 Williams House Lloyd Street North, Manchester Science Park, Manchester, England, M15 6SE", "incorporated": "2014-06-16", "legal_form": "ltd", "owner_or_acquirer": null, "headcount": null, "ch_number_clean": "09087514", "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/09087514", "ch_note": null }, "place": { "text": "Manchester (M15 6SE)", "postcode": "M15 6SE", "lat": 53.46303, "lng": -2.236012, "region": "England: North West", "admin_district": "Manchester", "geocoded": "postcodes.io" }, "people": [ { "name": "Daniel Jamieson", "role": "founder and chief executive; director from 2014-06-16", "from": null, "source": "https://find-and-update.company-information.service.gov.uk/company/09087514/officers" } ], "money": [ { "kind": "funding_round", "amount": 6500000, "currency": "GBP", "date": "2022-11-29", "detail": "Series A from YFM, Maven, Triple Point, Northern Powerhouse Investment Fund (single source)", "raw": "funding_round: 6500000 GBP 2022-11-29 — Series A from YFM, Maven, Triple Point, Northern Powerhouse Investment Fund (single source)", "amount_gbp": 6500000, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£6.5m", "gbp_txt": "" } ], "site": null, "product": null, "dsit_domains": [ "Natural language applications", "Knowledge generation" ], "sectors": [ "drug discovery", "biomedical data" ], "confidence": "verified", "checked": "2026-10-29", "as_of": "2026-10-29", "applied": null, "held": [], "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "Manchester company whose Galactic AI platform reads biomedical literature and data to help drug developers.", "affiliation": "Start-ups", "sources": [ "https://www.uktech.news/medtech/biorelate-series-a-20221129", "https://find-and-update.company-information.service.gov.uk/company/09087514", "https://find-and-update.company-information.service.gov.uk/company/09087514/officers" ], "source_quotes": [ { "url": "https://www.uktech.news/medtech/biorelate-series-a-20221129", "quotes": [ "Manchester-based Biorelate has bagged £6.5m in Series A investment for its AI drug discovery platform" ], "accessed": "2026-10-29", "trade": true, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/09087514", "quotes": [ "BIORELATE LIMITED\" \"Unit 9 Williams House Lloyd Street North, Manchester Science Park, Manchester, England, M15 6SE\" \"Active\" \"16 June 2014" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/09087514/officers", "quotes": [ "JAMIESON, Daniel\" \"Director\" \"16 June 2014" ], "accessed": "2026-10-29", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [ "Natural language applications", "Knowledge generation" ], "one_source": false, "confidence_raw": "verified", "depts": [ { "dept": "drug discovery", "div": "health" } ], "div_label": "Health", "location": "Manchester (M15 6SE)", "status_group": "active", "ext_links": [], "label_links": [ { "kind": "funded_by", "name": "YFM" }, { "kind": "funded_by", "name": "Maven" }, { "kind": "funded_by", "name": "Northern Powerhouse Investment Fund" }, { "kind": "founded_by", "name": "Daniel Jamieson" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-604", "name": "Waire Health", "bucket": "co", "status": "dissolved", "status_date": "2025-10-22", "status_detail": "Entered creditors' voluntary liquidation on 15 February 2024 and was dissolved on 22 October 2025 (Companies House).", "one_line": "Edinburgh company that made C-Detect, a wearable device using AI to monitor patients in hospital and at home; now dissolved.", "description": "Waire Health developed remote ward monitoring equipment; its C-Detect device used AI to track patients in hospital and at home. In January 2023 UKTN reported a £2m round led by Eos Advisory with Scottish Enterprise and said the company was headquartered in Edinburgh. Companies House shows Waire Health Ltd (formerly Sentinel Biosensor Ltd and Awair Health Ltd), incorporated on 23 April 2018, entered creditors' voluntary liquidation on 15 February 2024 and was dissolved on 22 October 2025.", "uk_status": "uk", "company": { "ch_number": "11323471", "registered_office": "C/O Grant Thornton Uk Advisory & Tax Llp 11th Floor Landmark St Peter's Square, 1 Oxford St, Manchester, M1 4PB", "incorporated": "2018-04-23", "legal_form": "ltd", "owner_or_acquirer": null, "headcount": null, "ch_number_clean": "11323471", "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/11323471", "ch_note": null }, "place": { "text": "Edinburgh (null)", "postcode": null, "lat": null, "lng": null, "region": "Scotland" }, "people": [], "money": [ { "kind": "funding_round", "amount": 2000000, "currency": "GBP", "date": "2023-01-24", "detail": "led by Eos Advisory with Scottish Enterprise (single source)", "raw": "funding_round: 2000000 GBP 2023-01-24 — led by Eos Advisory with Scottish Enterprise (single source)", "amount_gbp": 2000000, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£2m", "gbp_txt": "" } ], "site": null, "product": null, "dsit_domains": [ "Perceptual systems", "AI implementation" ], "sectors": [ "remote patient monitoring", "medical devices" ], "confidence": "verified", "checked": "2026-10-29", "as_of": "2026-10-29", "applied": null, "held": [], "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "Edinburgh company that made C-Detect, a wearable device using AI to monitor patients in hospital and at home; now dissolved.", "affiliation": "Start-ups", "sources": [ "https://www.uktech.news/medtech/waire-health-funding-20230124", "https://find-and-update.company-information.service.gov.uk/company/11323471", "https://find-and-update.company-information.service.gov.uk/company/11323471/insolvency" ], "source_quotes": [ { "url": "https://www.uktech.news/medtech/waire-health-funding-20230124", "quotes": [ "Waire has developed the C-Detect device, which uses AI to keep track of patients both in the hospital and at home." ], "accessed": "2026-10-29", "trade": true, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/11323471", "quotes": [ "WAIRE HEALTH LTD\" \"Dissolved\" \"22 October 2025\" \"23 April 2018\" \"SENTINEL BIOSENSOR LTD (23 Apr 2018 - 30 Jul 2020)" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/11323471/insolvency", "quotes": [ "Creditors voluntary liquidation\" \"Commencement of winding up\" \"15 February 2024\" \"Dissolved on\" \"22 October 2025" ], "accessed": "2026-10-29", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [ "Perceptual systems", "AI implementation" ], "one_source": false, "confidence_raw": "verified", "depts": [ { "dept": "remote patient monitoring", "div": "health" } ], "div_label": "Health", "location": "Edinburgh (null)", "status_group": "dissolved", "ext_links": [], "label_links": [ { "kind": "funded_by", "name": "Eos Advisory" }, { "kind": "funded_by", "name": "Scottish Enterprise" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-605", "name": "Syndi Health", "bucket": "co", "status": "dissolved", "status_date": "2026-04-07", "status_detail": "Companies House shows Syndi Ltd dissolved on 7 April 2026; co-founders Jorge Alexander and Benjamin Lakey resigned as directors in June 2024 and May 2025.", "one_line": "London start-up whose app used AI to suggest mental-health and wellbeing support to employees; its company is now dissolved.", "description": "Syndi Health ran a digital mental health platform for employees that used AI to recommend wellbeing support. In February 2023 UKTN reported a US$2m pre-seed round from Founders Factory, Plug and Play and others, and named Ben Lakey as co-founder and chief executive, with co-founder Jorge Alexander. Companies House shows Syndi Ltd, incorporated on 2 November 2020, with both men as directors from that date; Jorge Alexander resigned on 24 June 2024 and Benjamin Lakey on 1 May 2025. The company was dissolved on 7 April 2026.", "uk_status": "uk", "company": { "ch_number": "12988822", "registered_office": "Tamar House 19 Kennington Lane, London, England, SE11 4XA", "incorporated": "2020-11-02", "legal_form": "ltd", "owner_or_acquirer": null, "headcount": null, "ch_number_clean": "12988822", "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/12988822", "ch_note": null }, "place": { "text": "London (null)", "postcode": null, "lat": null, "lng": null, "region": "England: London" }, "people": [ { "name": "Ben Lakey", "role": "co-founder and chief executive (2023 source); director 2020-11-02 to 2025-05-01", "from": null, "source": "https://find-and-update.company-information.service.gov.uk/company/12988822/officers" } ], "money": [ { "kind": "funding_round", "amount": 2000000, "currency": "USD", "date": "2023-02-07", "detail": "pre-seed from Founders Factory, Plug and Play and others (single source)", "raw": "funding_round: 2000000 USD 2023-02-07 — pre-seed from Founders Factory, Plug and Play and others (single source)", "amount_gbp": 1664586, "fx_rate": 1.2015, "fx_source": "Bank of England daily spot rate (series XUDLUSS, XUDLERS), US$1.2015 per £ on 2023-02-07", "fx_date": "2023-02-07", "fx_note": "", "txt": "US$2m", "gbp_txt": "£1.7m" } ], "site": null, "product": null, "dsit_domains": [ "AI implementation" ], "sectors": [ "workplace wellbeing", "mental health" ], "confidence": "verified", "checked": "2026-10-29", "as_of": "2026-10-29", "applied": null, "held": [], "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "London start-up whose app used AI to suggest mental-health and wellbeing support to employees; its company is now dissolved.", "affiliation": "Start-ups", "sources": [ "https://www.uktech.news/medtech/syndi-health-pre-seed-20230207", "https://find-and-update.company-information.service.gov.uk/company/12988822", "https://find-and-update.company-information.service.gov.uk/company/12988822/officers" ], "source_quotes": [ { "url": "https://www.uktech.news/medtech/syndi-health-pre-seed-20230207", "quotes": [ "Syndi Health's platform uses artificial intelligence to recommend well-being support to employees.", "co-founder and CEO" ], "accessed": "2026-10-29", "trade": true, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/12988822", "quotes": [ "SYNDI LTD\" \"Dissolved\" \"7 April 2026\" \"2 November 2020" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/12988822/officers", "quotes": [ "LAKEY, Benjamin Karl\" Director resigned 1 May 2025; \"ALEXANDER, Jorge Nicolas\" Director resigned 24 June 2024" ], "accessed": "2026-10-29", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [ "AI implementation" ], "one_source": false, "confidence_raw": "verified", "depts": [ { "dept": "workplace wellbeing", "div": "health" } ], "div_label": "Health", "location": "London (null)", "status_group": "dissolved", "ext_links": [ { "kind": "funded_by", "id": "BIZ-TAL-190", "name": "Founders Factory", "page": "talent", "href": "../../talent/#org=BIZ-TAL-190", "page_label": "Talent" } ], "label_links": [ { "kind": "funded_by", "name": "Plug and Play" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-701", "name": "CardiaTec", "bucket": "co", "status": "active", "status_date": null, "status_detail": "Companies House shows CardiaTec Biosciences Ltd active on 29 October 2026.", "one_line": "Uses AI on large heart-disease datasets to find new targets for drugs.", "description": "Cambridge company founded at the University of Cambridge that is building a target discovery platform using AI to analyse large-scale cardiovascular data. UKTN reported a £1.4 million pre-seed round in July 2022 led by Laidlaw Scholars Ventures and APEX Ventures, with Cambridge Enterprise taking part. Raphael Peralta was named as chief executive and is a director at Companies House. The registered office is in Oakham, Rutland.", "uk_status": "uk", "company": { "ch_number": "13634184", "registered_office": "Ketton Suite The King Centre, Main Road, Barleythorpe, Oakham, Rutland, England, LE15 7WD", "incorporated": "2021-09-21", "legal_form": "ltd", "owner_or_acquirer": null, "headcount": null, "ch_number_clean": "13634184", "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/13634184", "ch_note": null }, "place": { "text": "Cambridge (as published; lat/lng null)", "postcode": null, "lat": null, "lng": null, "region": "England: East of England" }, "people": [ { "name": "Raphael Peralta", "role": "chief executive (2022); director since 2021-09-21", "from": null, "source": "https://find-and-update.company-information.service.gov.uk/company/13634184/officers" } ], "money": [ { "kind": "funding_round", "amount": 1400000, "currency": "GBP", "date": "2022-07-06", "detail": "pre-seed led by Laidlaw Scholars Ventures and APEX Ventures (single source)", "raw": "funding_round: 1400000 GBP 2022-07-06 — pre-seed led by Laidlaw Scholars Ventures and APEX Ventures (single source)", "amount_gbp": 1400000, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£1.4m", "gbp_txt": "" } ], "site": null, "product": null, "dsit_domains": [ "Knowledge generation" ], "sectors": [ "health", "drug discovery", "cardiovascular" ], "confidence": "verified", "checked": "2026-10-29", "as_of": "2026-10-29", "applied": null, "held": [], "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "Uses AI on large heart-disease datasets to find new targets for drugs.", "affiliation": "Start-ups", "sources": [ "https://www.uktech.news/medtech/cardiatec-raises-1-4m-20220706", "https://find-and-update.company-information.service.gov.uk/company/13634184", "https://find-and-update.company-information.service.gov.uk/company/13634184/officers" ], "source_quotes": [ { "url": "https://www.uktech.news/medtech/cardiatec-raises-1-4m-20220706", "quotes": [ "CardiaTec is developing a target discovery platform that uses AI to analyse large-scale cardiovascular data" ], "accessed": "2026-10-29", "trade": true, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/13634184", "quotes": [ "CARDIATEC BIOSCIENCES LTD", "Active", "Incorporated on 21 September 2021", "72110" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/13634184/officers", "quotes": [ "PERALTA, Raphael", "Director", "21 September 2021" ], "accessed": "2026-10-29", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [ "Knowledge generation" ], "one_source": false, "confidence_raw": "verified", "depts": [ { "dept": "health", "div": "health" } ], "div_label": "Health", "location": "Cambridge (as published; lat/lng null)", "status_group": "active", "ext_links": [], "label_links": [ { "kind": "spun_out_of", "name": "University of Cambridge" }, { "kind": "funded_by", "name": "Laidlaw Scholars Ventures" }, { "kind": "funded_by", "name": "APEX Ventures" }, { "kind": "funded_by", "name": "Cambridge Enterprise" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-702", "name": "Nucleome Therapeutics", "bucket": "co", "status": "active", "status_date": null, "status_detail": "Companies House shows Nucleome Therapeutics Limited active on 29 October 2026; co-founder Danuta Jeziorska resigned as a director on 19 April 2024.", "one_line": "Oxford biotech using machine learning on the non-coding genome to find new medicines.", "description": "University of Oxford spin-out that uses machine learning to predict disease-linked genetic variants in the non-coding \"dark genome\" and turn them into drug targets. UKTN reported a £37.5 million Series A in October 2022 led by M Ventures, with Johnson & Johnson, Pfizer Ventures, British Patient Capital and Oxford Science Enterprises. Dr Danuta Jeziorska was then chief executive and co-founder; Companies House shows she resigned as a director on 19 April 2024. The company is active with its registered office on Botley Road, Oxford. [Labs Round 8, 31 Oct 2026] Listed on Labs (Biology): Oxford spin-out using machine learning to find disease-linked variants in the non-coding (\"dark\") genome", "uk_status": "uk", "company": { "ch_number": "12109297", "registered_office": "Nucleome Therapeutics Limited, Inventa, Botley Road, Oxford, United Kingdom, OX2 0HA", "incorporated": "2019-07-17", "legal_form": "ltd", "owner_or_acquirer": null, "headcount": null, "ch_number_clean": "12109297", "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/12109297", "ch_note": null }, "place": { "text": "Oxford (OX2 0HA; lat/lng null)", "postcode": "OX2 0HA", "lat": 51.751766, "lng": -1.286562, "region": "England: South East", "admin_district": "Oxford", "geocoded": "postcodes.io" }, "people": [ { "name": "Danuta Jeziorska", "role": "co-founder and chief executive (2022); director 2019-08-02 to 2024-04-19", "from": null, "source": "https://find-and-update.company-information.service.gov.uk/company/12109297/officers" }, { "name": "Danuta Jeziorska", "role": "CEO and co-founder", "from": "as of 2022-10-20", "source": "https://www.uktech.news/ai/nucleome-therapeutics-series-a-20221020", "round4": true } ], "money": [ { "kind": "funding_round", "amount": 37500000, "currency": "GBP", "date": "2022-10-20", "detail": "Series A led by M Ventures (single source)", "raw": "funding_round: 37500000 GBP 2022-10-20 — Series A led by M Ventures (single source)", "amount_gbp": 37500000, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£37.5m", "gbp_txt": "" } ], "site": null, "product": null, "dsit_domains": [ "Knowledge generation" ], "sectors": [ "health", "drug discovery", "genomics" ], "confidence": "verified", "checked": "2026-10-29", "as_of": "2026-10-29", "applied": null, "held": [], "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "Oxford biotech using machine learning on the non-coding genome to find new medicines.", "affiliation": "Start-ups", "sources": [ "https://www.uktech.news/ai/nucleome-therapeutics-series-a-20221020", "https://find-and-update.company-information.service.gov.uk/company/12109297", "https://find-and-update.company-information.service.gov.uk/company/12109297/officers" ], "source_quotes": [ { "url": "https://www.uktech.news/ai/nucleome-therapeutics-series-a-20221020", "quotes": [ "machine learning to predict disease-linked genetic variants", "has raised £37.5m in an oversubscribed Series A round" ], "accessed": "2026-10-29", "trade": true, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/12109297", "quotes": [ "NUCLEOME THERAPEUTICS LIMITED", "Active", "Incorporated on 17 July 2019" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/12109297/officers", "quotes": [ "DANUTA MARIOLA JEZIORSKA, Dr", "Resigned on 19 April 2024" ], "accessed": "2026-10-29", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [ "Knowledge generation" ], "one_source": false, "confidence_raw": "verified", "depts": [ { "dept": "health", "div": "health" } ], "div_label": "Health", "location": "Oxford (OX2 0HA; lat/lng null)", "status_group": "active", "ext_links": [ { "kind": "funded_by", "id": "BIZ-INV-003", "name": "British Patient Capital", "page": "investors", "href": "../../investors/#org=BIZ-INV-003", "page_label": "Investors" }, { "kind": "funded_by", "id": "BIZ-INV-007", "name": "Oxford Science Enterprises", "page": "investors", "href": "../../investors/#org=BIZ-INV-007", "page_label": "Investors" } ], "label_links": [ { "kind": "spun_out_of", "name": "University of Oxford" }, { "kind": "funded_by", "name": "M Ventures" }, { "kind": "funded_by", "name": "Pfizer Ventures" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-703", "name": "Blackford Analysis", "bucket": "co", "status": "acquired", "status_date": "2023-02-09", "status_detail": "Bayer acquired the company (announced January 2023); Companies House shows Bayer Plc as controlling owner from 9 February 2023 until 1 October 2026, when Blackford Analysis Holdings, Inc. became the person with significant control.", "one_line": "Edinburgh software that lets hospitals run many medical-imaging AI applications through one platform.", "description": "Edinburgh company, founded in 2010, that provides tools for healthcare staff to use medical imaging AI applications. UKTN reported in January 2023 that Bayer had acquired it for an undisclosed sum, with Ben Panter as founder and chief executive. Companies House records Bayer Plc as owning 75% or more from 9 February 2023. On 1 October 2026 Bayer Plc ceased to be the person with significant control and Blackford Analysis Holdings, Inc. was notified as the new controlling owner; what this transaction was (for example a sale by Bayer) was not found on a page opened in this pass.", "uk_status": "uk", "company": { "ch_number": "SC380297", "registered_office": "160 Causewayside, Edinburgh, Scotland, EH9 1PR", "incorporated": "2010-06-14", "legal_form": "ltd", "owner_or_acquirer": "Blackford Analysis Holdings, Inc. (from 2026-10-01; Bayer Plc 2023-02-09 to 2026-10-01)", "headcount": null, "ch_number_clean": "SC380297", "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/SC380297", "ch_note": null }, "place": { "text": "Edinburgh (EH9 1PR; lat/lng null)", "postcode": "EH9 1PR", "lat": 55.936446, "lng": -3.180825, "region": "Scotland", "admin_district": "City of Edinburgh", "geocoded": "postcodes.io" }, "people": [ { "name": "Ben Panter", "role": "founder and chief executive (2023)", "from": null, "source": "https://www.uktech.news/growth-strategy/exit-strategy/bayer-buys-blackford-analysis-20230119" } ], "money": [ { "kind": "note", "amount": null, "currency": null, "date": null, "detail": null, "raw": "null (acquisition price undisclosed)", "kind_as_written": null, "amount_gbp": null, "fx_rate": null, "fx_source": null, "fx_note": "no amount published", "txt": "", "gbp_txt": "" } ], "site": null, "product": null, "dsit_domains": [ "Perceptual systems", "AI implementation" ], "sectors": [ "health", "medical imaging" ], "confidence": "verified", "checked": "2026-10-29", "as_of": "2026-10-29", "applied": null, "held": [], "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "Edinburgh software that lets hospitals run many medical-imaging AI applications through one platform.", "affiliation": "Start-ups", "sources": [ "https://www.uktech.news/growth-strategy/exit-strategy/bayer-buys-blackford-analysis-20230119", "https://find-and-update.company-information.service.gov.uk/company/SC380297", "https://find-and-update.company-information.service.gov.uk/company/SC380297/persons-with-significant-control" ], "source_quotes": [ { "url": "https://www.uktech.news/growth-strategy/exit-strategy/bayer-buys-blackford-analysis-20230119", "quotes": [ "Blackford Analysis provides tools for those working in healthcare to use medical imaging AI applications.", "has acquired artificial intelligence company Blackford Analysis for an unspecified sum" ], "accessed": "2026-10-29", "trade": true, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/SC380297", "quotes": [ "BLACKFORD ANALYSIS LIMITED", "Active", "Incorporated on 14 June 2010" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/SC380297/persons-with-significant-control", "quotes": [ "Blackford Analysis Holdings, Inc.", "Notified on 1 October 2026", "Bayer Plc", "Notified on 9 February 2023", "Ceased on 1 October 2026" ], "accessed": "2026-10-29", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [ "Perceptual systems", "AI implementation" ], "one_source": false, "confidence_raw": "verified", "depts": [ { "dept": "health", "div": "health" } ], "div_label": "Health", "location": "Edinburgh (EH9 1PR; lat/lng null)", "status_group": "acquired", "ext_links": [], "label_links": [ { "kind": "acquired_by", "name": "Bayer" }, { "kind": "part_of", "name": "Blackford Analysis Holdings, Inc." } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-704", "name": "CellVoyant", "bucket": "co", "status": "active", "status_date": null, "status_detail": "Companies House shows CellVoyant Technologies Limited active on 29 October 2026.", "one_line": "Imaging and AI that predict how living stem cells will behave, to help make cell therapies.", "description": "University of Bristol spin-out, founded in 2021, whose imaging technology uses AI to predict the behaviour of live stem cells and how mixed cell populations will evolve. UKTN reported £7.6 million of seed funding in January 2024 led by Octopus Ventures, with Horizons Ventures, Verve Ventures and Air Street Capital. Dr Rafael Carazo Salas is founder and chief executive, and a director since August 2021. [Labs Round 8, 31 Oct 2026] Listed on Labs (Biology): Bristol spin-out (2021) whose AI predicts the behaviour of live stem cells from imaging", "uk_status": "uk", "company": { "ch_number": "13594965", "registered_office": "C/O Origin Workspace, 40 Berkeley Square, Bristol, United Kingdom, BS8 1HP", "incorporated": "2021-08-31", "legal_form": "ltd", "owner_or_acquirer": null, "headcount": null, "ch_number_clean": "13594965", "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/13594965", "ch_note": null }, "place": { "text": "Bristol (BS8 1HP; lat/lng null)", "postcode": "BS8 1HP", "lat": 51.455528, "lng": -2.605448, "region": "England: South West", "admin_district": "Bristol, City of", "geocoded": "postcodes.io" }, "people": [ { "name": "Rafael Carazo Salas", "role": "founder and chief executive (2024); director since 2021-08-31", "from": null, "source": "https://find-and-update.company-information.service.gov.uk/company/13594965/officers" }, { "name": "Rafael Carazo Salas", "role": "CEO and founder", "from": "2021", "source": "https://www.uktech.news/tech-hubs/south-west/bristol/bristol-biotech-cellvoyant-funding-20240116", "round4": true } ], "money": [ { "kind": "funding_round", "amount": 7600000, "currency": "GBP", "date": "2024-01-16", "detail": "seed led by Octopus Ventures (single source)", "raw": "funding_round: 7600000 GBP 2024-01-16 — seed led by Octopus Ventures (single source)", "amount_gbp": 7600000, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£7.6m", "gbp_txt": "" } ], "site": null, "product": null, "dsit_domains": [ "Perceptual systems", "Knowledge generation" ], "sectors": [ "health", "cell therapy", "biotechnology" ], "confidence": "verified", "checked": "2026-10-29", "as_of": "2026-10-29", "applied": null, "held": [], "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "Imaging and AI that predict how living stem cells will behave, to help make cell therapies.", "affiliation": "Start-ups", "sources": [ "https://www.uktech.news/tech-hubs/south-west/bristol/bristol-biotech-cellvoyant-funding-20240116", "https://find-and-update.company-information.service.gov.uk/company/13594965", "https://find-and-update.company-information.service.gov.uk/company/13594965/officers" ], "source_quotes": [ { "url": "https://www.uktech.news/tech-hubs/south-west/bristol/bristol-biotech-cellvoyant-funding-20240116", "quotes": [ "imaging technology that uses AI to predict the behaviour of live stem cells" ], "accessed": "2026-10-29", "trade": true, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/13594965", "quotes": [ "CELLVOYANT TECHNOLOGIES LIMITED", "Active", "Incorporated on 31 August 2021" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/13594965/officers", "quotes": [ "CARAZO SALAS, Rafael Edgardo, Dr", "Director", "31 August 2021" ], "accessed": "2026-10-29", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [ "Perceptual systems", "Knowledge generation" ], "one_source": false, "confidence_raw": "verified", "depts": [ { "dept": "health", "div": "health" } ], "div_label": "Health", "location": "Bristol (BS8 1HP; lat/lng null)", "status_group": "active", "ext_links": [ { "kind": "funded_by", "id": "BIZ-INV-201", "name": "Octopus Ventures", "page": "investors", "href": "../../investors/#org=BIZ-INV-201", "page_label": "Investors" }, { "kind": "funded_by", "id": "BIZ-INV-009", "name": "Air Street Capital", "page": "investors", "href": "../../investors/#org=BIZ-INV-009", "page_label": "Investors" } ], "label_links": [ { "kind": "spun_out_of", "name": "University of Bristol" }, { "kind": "funded_by", "name": "Horizons Ventures" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-705", "name": "Ogma", "bucket": "co", "status": "acquired", "status_date": "2026-07", "status_detail": "tech.eu's recap of 6 July 2026 reported that Saltroad acquired the AI platform Ogma; no Companies House company for Ogma was identified.", "one_line": "AI platform for speech therapy for children, now owned by Saltroad.", "description": "UK AI platform for children's speech therapy. tech.eu's weekly recap of 6 July 2026 listed, under the UK, \"Saltroad raises £1.5M and acquires AI platform Ogma to scale speech therapy for children\"; the £1.5 million is Saltroad's raise, not a price for Ogma. No other details were given. Companies House searches found no Ogma company that could be linked to it; a Saltroad Ltd (NI709928, Lisburn, Northern Ireland, incorporated February 2024) exists, but the page opened does not confirm it is the buyer.", "uk_status": "uk", "company": { "ch_number": null, "registered_office": null, "incorporated": null, "legal_form": null, "owner_or_acquirer": "Saltroad (2026, per tech.eu)", "headcount": null, "ch_number_clean": null, "companies_house_url": null, "ch_note": null }, "place": { "text": null, "postcode": null, "lat": null, "lng": null, "region": null }, "people": [], "money": [], "site": null, "product": null, "dsit_domains": [ "Natural language applications" ], "sectors": [ "health", "speech therapy", "children" ], "confidence": "single_source", "checked": "2026-10-29", "as_of": "2026-10-29", "applied": null, "held": [], "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "AI platform for speech therapy for children, now owned by Saltroad.", "affiliation": "Start-ups", "sources": [ "https://tech.eu/2026/07/06/european-tech-weekly-recap-more-than-55-tech-funding-deals-worth-over-eur16b/" ], "source_quotes": [ { "url": "https://tech.eu/2026/07/06/european-tech-weekly-recap-more-than-55-tech-funding-deals-worth-over-eur16b/", "quotes": [ "Saltroad raises £1.5M and acquires AI platform Ogma to scale speech therapy for children" ], "accessed": "2026-10-29", "trade": true, "amendment": false } ], "website": [], "colleges": [], "topics": [ "Natural language applications" ], "one_source": true, "confidence_raw": "single_source", "depts": [ { "dept": "health", "div": "health" } ], "div_label": "Health", "location": null, "status_group": "acquired", "ext_links": [], "label_links": [ { "kind": "acquired_by", "name": "Saltroad" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-706", "name": "Revela (formerly Spotlight Health)", "bucket": "co", "status": "renamed", "status_date": "2025-10-07", "status_detail": "Companies House shows Spotlight Health Limited renamed Revela Health Limited on 7 October 2025; active on 29 October 2026.", "one_line": "AI analysis of ultrasound scans to speed up diagnosis of endometriosis.", "description": "Newcastle medical-technology company developing technology to shorten the time it takes to diagnose endometriosis, by performing AI analysis on ultrasound scans. BusinessCloud reported in December 2025 that it was among eight businesses each receiving £200,000 from PXN's PraeSeed programme. Companies House shows Revela Health Limited, incorporated September 2023 as Spotlight Health Limited and renamed on 7 October 2025, active, with a Newcastle registered office.", "uk_status": "uk", "company": { "ch_number": "15171762", "registered_office": "13 Towers Avenue, Newcastle Upon Tyne, United Kingdom, NE2 3QE", "incorporated": "2023-09-28", "legal_form": "ltd", "owner_or_acquirer": null, "headcount": null, "ch_number_clean": "15171762", "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/15171762", "ch_note": null }, "place": { "text": "Newcastle upon Tyne (NE2 3QE; lat/lng null)", "postcode": "NE2 3QE", "lat": 54.997846, "lng": -1.608918, "region": "England: North East", "admin_district": "Newcastle upon Tyne", "geocoded": "postcodes.io" }, "people": [], "money": [ { "kind": "funding_round", "amount": 200000, "currency": "GBP", "date": "2025-12-03", "detail": "PXN PraeSeed programme award, inferred from the article's statement that eight of 12 businesses each won £200,000 (single source)", "raw": "funding_round: 200000 GBP 2025-12-03 — PXN PraeSeed programme award, inferred from the article's statement that eight of 12 businesses each won £200,000 (single source)", "amount_gbp": 200000, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£200,000", "gbp_txt": "" } ], "site": null, "product": null, "dsit_domains": [ "Perceptual systems" ], "sectors": [ "health", "women's health", "medical imaging" ], "confidence": "verified", "checked": "2026-10-29", "as_of": "2026-10-29", "applied": null, "held": [], "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "AI analysis of ultrasound scans to speed up diagnosis of endometriosis.", "affiliation": "Start-ups", "sources": [ "https://businesscloud.co.uk/news/8-startups-funded-by-pxns-praeseed-programme/", "https://find-and-update.company-information.service.gov.uk/company/15171762" ], "source_quotes": [ { "url": "https://businesscloud.co.uk/news/8-startups-funded-by-pxns-praeseed-programme/", "quotes": [ "performing AI analysis on ultrasound scans to spot the subtle signs of a condition", "Now eight of the 12 businesses have each won £200,000 funding" ], "accessed": "2026-10-29", "trade": true, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/15171762", "quotes": [ "REVELA HEALTH LIMITED", "Active", "SPOTLIGHT HEALTH LIMITED 28 Sep 2023 - 07 Oct 2025" ], "accessed": "2026-10-29", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [ "Perceptual systems" ], "one_source": false, "confidence_raw": "verified", "depts": [ { "dept": "health", "div": "health" } ], "div_label": "Health", "location": "Newcastle upon Tyne (NE2 3QE; lat/lng null)", "status_group": "renamed", "ext_links": [], "label_links": [ { "kind": "funded_by", "name": "PXN Group" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-707", "name": "VitVio", "bucket": "co", "status": "active", "status_date": null, "status_detail": "Companies House shows VitVio Ltd active on 29 October 2026.", "one_line": "Computer vision that tracks how surgical and other medical procedures are performed.", "description": "London company founded in 2023 that develops computer vision technology to track the performance of medical procedures. UKTN's round-up of 10 January 2025 listed a £1.5 million pre-seed round from LDV Capital, Bek Ventures, Tiny Supercomputer Investment Company and angels. Companies House shows VitVio Ltd, incorporated November 2023, active, with a London registered office.", "uk_status": "uk", "company": { "ch_number": "15305830", "registered_office": "167-169 Great Portland Street 5th Floor, London, United Kingdom, W1W 5PF", "incorporated": "2023-11-23", "legal_form": "ltd", "owner_or_acquirer": null, "headcount": null, "ch_number_clean": "15305830", "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/15305830", "ch_note": null }, "place": { "text": "London (registered office; lat/lng null)", "postcode": null, "lat": null, "lng": null, "region": "England: London" }, "people": [], "money": [ { "kind": "funding_round", "amount": 1500000, "currency": "GBP", "date": "2025-01-10", "detail": "pre-seed with LDV Capital and Bek Ventures (single source)", "raw": "funding_round: 1500000 GBP 2025-01-10 — pre-seed with LDV Capital and Bek Ventures (single source)", "amount_gbp": 1500000, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£1.5m", "gbp_txt": "" } ], "site": null, "product": null, "dsit_domains": [ "Perceptual systems" ], "sectors": [ "health", "surgery" ], "confidence": "verified", "checked": "2026-10-29", "as_of": "2026-10-29", "applied": null, "held": [], "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "Computer vision that tracks how surgical and other medical procedures are performed.", "affiliation": "Start-ups", "sources": [ "https://www.uktech.news/funding/uk-tech-funding-roundup-this-weeks-deals-from-verdiva-to-robok-20250110", "https://find-and-update.company-information.service.gov.uk/company/15305830" ], "source_quotes": [ { "url": "https://www.uktech.news/funding/uk-tech-funding-roundup-this-weeks-deals-from-verdiva-to-robok-20250110", "quotes": [ "Founded in 2023, VitVio develops computer vision technology to track the performance of medical procedures." ], "accessed": "2026-10-29", "trade": true, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/15305830", "quotes": [ "VITVIO LTD", "Active", "Incorporated on 23 November 2023" ], "accessed": "2026-10-29", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [ "Perceptual systems" ], "one_source": false, "confidence_raw": "verified", "depts": [ { "dept": "health", "div": "health" } ], "div_label": "Health", "location": "London (registered office; lat/lng null)", "status_group": "active", "ext_links": [], "label_links": [ { "kind": "funded_by", "name": "LDV Capital" }, { "kind": "funded_by", "name": "Bek Ventures" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-801", "name": "Huma (formerly Medopad)", "bucket": "co", "status": "renamed", "status_date": "2020-04-17", "status_detail": "Medopad Ltd was renamed (briefly Humaforhealth Limited, then Huma Therapeutics Limited) in April 2020; Companies House shows it active on 29 October 2026.", "one_line": "Software that monitors patients remotely and supports medical research, using AI and biomarkers.", "description": "Huma monitors patients at home and supports medical research using AI and biomarkers. TechCrunch reported in April 2020 that Medopad rebranded as Huma and bought BioBeats and TLT, and in May 2021 that Huma raised $130m. The registered company, Huma Therapeutics Limited, was incorporated as Medopad Ltd in 2011 and is active. Its last filed accounts run to 31 December 2024 and the next were due by 29 September 2026.", "uk_status": "uk", "company": { "ch_number": "07725451", "registered_office": "13th Floor Millbank Tower, 21-24 Millbank, London, England, SW1P 4QP", "incorporated": "2011-08-02", "legal_form": "ltd", "owner_or_acquirer": null, "headcount": null, "ch_number_clean": "07725451", "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/07725451", "ch_note": null }, "place": { "text": "London (SW1P 4QP; null; null)", "postcode": "SW1P 4QP", "lat": 51.491984, "lng": -0.125882, "region": "England: London", "admin_district": "Westminster", "geocoded": "postcodes.io" }, "people": [], "money": [ { "kind": "funding_round", "amount": 130000000, "currency": "USD", "date": "2021-05", "detail": "round reported by TechCrunch (investors not read)", "raw": "funding_round: 130000000 USD 2021-05 — round reported by TechCrunch (investors not read)", "amount_gbp": 93896714, "fx_rate": 1.3845, "fx_source": "Bank of England daily spot rate (series XUDLUSS, XUDLERS), US$1.3845 per £ on 2021-04-30", "fx_date": "2021-04-30", "fx_note": "month only given: rate for the 1st", "txt": "US$130m", "gbp_txt": "£93.9m" } ], "site": null, "product": null, "dsit_domains": [ "Knowledge generation", "AI implementation" ], "sectors": [ "digital health", "remote patient monitoring", "clinical research" ], "confidence": "verified", "checked": "2026-10-29", "as_of": "2026-10-29", "applied": null, "held": [], "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "Software that monitors patients remotely and supports medical research, using AI and biomarkers.", "affiliation": "Start-ups", "sources": [ "https://techcrunch.com/tag/huma/", "https://find-and-update.company-information.service.gov.uk/company/07725451" ], "source_quotes": [ { "url": "https://techcrunch.com/tag/huma/", "quotes": [ "Huma, which uses AI and biomarkers to monitor patients and for medical research, raises $130M", "Medopad rebrands as Huma, acquires BioBeats and TLT to expand its biomarker platform" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/07725451", "quotes": [ "HUMA THERAPEUTICS LIMITED", "Active", "Incorporated on 2 August 2011", "MEDOPAD LTD 02 Aug 2011 - 16 Apr 2020" ], "accessed": "2026-10-29", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [ "Knowledge generation", "AI implementation" ], "one_source": false, "confidence_raw": "verified", "depts": [ { "dept": "digital health", "div": "health" } ], "div_label": "Health", "location": "London (SW1P 4QP; null; null)", "status_group": "renamed", "ext_links": [], "label_links": [], "degree": 1, "related_ids": [ "BIZ-SU-HLT-601" ] }, { "id": "BIZ-SU-HLT-802", "name": "Re:course AI", "bucket": "co", "status": "active", "status_date": null, "status_detail": "Companies House shows Recourse AI Ltd. active, with a confirmation statement dated 21 March 2026.", "one_line": "Training software in which AI avatars play patients, so healthcare staff can practise conversations and get feedback.", "description": "Re:course AI is a Manchester company founded by Dr Scott Martin (chief executive) and Dr Maksim Belousov (chief technology officer). Its virtual training platform uses AI-driven digital avatars to simulate healthcare training tasks. UKTN reported a $4.3m (£3.5m) seed round led by Par Equity in February 2023, with Northern Gritstone and Praetura's GMC Life Sciences Fund. The company was called AIPatient Ltd. until January 2021.", "uk_status": "uk", "company": { "ch_number": "11269312", "registered_office": "8 Hewitt Street, Manchester, England, M15 4GB", "incorporated": "2018-03-22", "legal_form": "ltd", "owner_or_acquirer": null, "headcount": null, "ch_number_clean": "11269312", "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/11269312", "ch_note": null }, "place": { "text": "Manchester (M15 4GB; null; null)", "postcode": "M15 4GB", "lat": 53.473768, "lng": -2.250625, "region": "England: North West", "admin_district": "Manchester", "geocoded": "postcodes.io" }, "people": [ { "name": "Dr Scott Martin", "role": "co-founder and chief executive; director since 2018-03-22", "from": null, "source": "https://www.uktech.news/medtech/recourse-ai-seed-20230202" }, { "name": "Dr Maksim Belousov", "role": "co-founder and chief technology officer; director since 2020-01-09", "from": null, "source": "https://www.uktech.news/medtech/recourse-ai-seed-20230202" } ], "money": [ { "kind": "funding_round", "amount": 4300000, "currency": "USD", "date": "2023-02", "detail": "seed led by Par Equity (reported as £3.5m)", "raw": "funding_round: 4300000 USD 2023-02 — seed led by Par Equity (reported as £3.5m)", "amount_gbp": 3488561, "fx_rate": 1.2326, "fx_source": "Bank of England daily spot rate (series XUDLUSS, XUDLERS), US$1.2326 per £ on 2023-02-01", "fx_date": "2023-02-01", "fx_note": "month only given: rate for the 1st", "txt": "US$4.3m", "gbp_txt": "£3.5m" } ], "site": null, "product": null, "dsit_domains": [ "Natural language applications" ], "sectors": [ "healthcare training" ], "confidence": "verified", "checked": "2026-10-29", "as_of": "2026-10-29", "applied": null, "held": [], "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "Training software in which AI avatars play patients, so healthcare staff can practise conversations and get feedback.", "affiliation": "Start-ups", "sources": [ "https://www.uktech.news/medtech/recourse-ai-seed-20230202", "https://find-and-update.company-information.service.gov.uk/company/11269312", "https://find-and-update.company-information.service.gov.uk/company/11269312/officers" ], "source_quotes": [ { "url": "https://www.uktech.news/medtech/recourse-ai-seed-20230202", "quotes": [ "Manchester-based Re:course AI", "Founded by Dr Scott Martin, CEO, and Dr Maksim Belousov, CTO." ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/11269312", "quotes": [ "RECOURSE AI LTD.", "Active", "Incorporated on 22 March 2018", "AIPATIENT LTD." ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/11269312/officers", "quotes": [ "MARTIN, Scott", "Director", "22 March 2018", "BELOUSOV, Maksim", "9 January 2020" ], "accessed": "2026-10-29", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [ "Natural language applications" ], "one_source": false, "confidence_raw": "verified", "depts": [ { "dept": "healthcare training", "div": "health" } ], "div_label": "Health", "location": "Manchester (M15 4GB; null; null)", "status_group": "active", "ext_links": [ { "kind": "funded_by", "id": "BIZ-INV-051", "name": "Northern Gritstone", "page": "investors", "href": "../../investors/#org=BIZ-INV-051", "page_label": "Investors" } ], "label_links": [ { "kind": "funded_by", "name": "Par Equity" }, { "kind": "funded_by", "name": "Praetura Ventures" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-803", "name": "CanSense", "bucket": "co", "status": "active", "status_date": null, "status_detail": "Companies House shows CanSense Ltd active, with a confirmation statement dated 16 May 2026.", "one_line": "Blood test for bowel cancer that reads samples with laser light and artificial intelligence.", "description": "CanSense is a Swansea University spinout commercialising research by Professor Peter Dunstan, Professor Dean Harris and Dr Cerys Jenkins. It has developed a bowel-cancer blood test that uses laser light and AI, as an alternative to colonoscopy and faecal tests. UKTN reported £1.5m in March 2023 from Mercia, the Development Bank of Wales and Nonacus, with Dr Adam Bryant as chief executive. CanSense Ltd is registered at Swansea University and active.", "uk_status": "uk", "company": { "ch_number": "11367637", "registered_office": "Institute Of Life Science 2, Swansea University, Singleton Park, Swansea, Wales, SA2 8PP", "incorporated": "2018-05-17", "legal_form": "ltd", "owner_or_acquirer": null, "headcount": null, "ch_number_clean": "11367637", "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/11367637", "ch_note": null }, "place": { "text": "Swansea (SA2 8PP; null; null)", "postcode": "SA2 8PP", "lat": 51.609631, "lng": -3.980635, "region": "Wales", "admin_district": "Swansea", "geocoded": "postcodes.io" }, "people": [ { "name": "Dr Adam Bryant", "role": "chief executive; director since 2018-05-17", "from": null, "source": "https://www.uktech.news/medtech/cansense-funding-20230309" } ], "money": [ { "kind": "funding_round", "amount": 1500000, "currency": "GBP", "date": "2023-03", "detail": "Mercia, Development Bank of Wales, Nonacus", "raw": "funding_round: 1500000 GBP 2023-03 — Mercia, Development Bank of Wales, Nonacus", "amount_gbp": 1500000, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£1.5m", "gbp_txt": "" } ], "site": null, "product": null, "dsit_domains": [ "Perceptual systems", "Knowledge generation" ], "sectors": [ "diagnostics", "cancer" ], "confidence": "verified", "checked": "2026-10-29", "as_of": "2026-10-29", "applied": null, "held": [], "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "Blood test for bowel cancer that reads samples with laser light and artificial intelligence.", "affiliation": "Start-ups", "sources": [ "https://www.uktech.news/medtech/cansense-funding-20230309", "https://find-and-update.company-information.service.gov.uk/company/11367637", "https://find-and-update.company-information.service.gov.uk/company/11367637/officers" ], "source_quotes": [ { "url": "https://www.uktech.news/medtech/cansense-funding-20230309", "quotes": [ "a blood test to detect bowel cancer that uses laser light and artificial intelligence (AI)", "Dr Adam Bryant, now CEO and director of CanSense," ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/11367637", "quotes": [ "CANSENSE LTD", "Active", "Incorporated on 17 May 2018", "86220 - Specialists medical practice activities" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/11367637/officers", "quotes": [ "Adam Lee Bryant", "Director", "17 May 2018" ], "accessed": "2026-10-29", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [ "Perceptual systems", "Knowledge generation" ], "one_source": false, "confidence_raw": "verified", "depts": [ { "dept": "diagnostics", "div": "health" } ], "div_label": "Health", "location": "Swansea (SA2 8PP; null; null)", "status_group": "active", "ext_links": [ { "kind": "funded_by", "id": "BIZ-INV-205", "name": "Mercia (Mercia Ventures, Mercia Asset Management PLC)", "page": "investors", "href": "../../investors/#org=BIZ-INV-205", "page_label": "Investors" }, { "kind": "funded_by", "id": "BIZ-INV-052", "name": "Development Bank of Wales", "page": "investors", "href": "../../investors/#org=BIZ-INV-052", "page_label": "Investors" } ], "label_links": [ { "kind": "spun_out_of", "name": "Swansea University" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-804", "name": "Hypervision Surgical", "bucket": "co", "status": "active", "status_date": null, "status_detail": "Companies House shows Hypervision Surgical Ltd active; a director was appointed on 23 September 2026.", "one_line": "Surgical imaging that combines hyperspectral cameras, AI and edge computing to help surgeons see tissue during operations.", "description": "Hypervision Surgical is a King's College London spinout led by co-founder and chief executive Dr Michael Ebner. It develops medical imaging for surgery by combining AI hyperspectral imaging and edge computing. UKTN reported a £6.5m seed round in June 2023 backed by HERAN Partners, Redalpine, LifeX Ventures and ZEISS Ventures. Its registered office is at the London Institute for Healthcare Engineering.", "uk_status": "uk", "company": { "ch_number": "12614766", "registered_office": "London Institute For Healthcare Engineering, 100 Lambeth Palace Road, London, United Kingdom, SE1 7AR", "incorporated": "2020-05-20", "legal_form": "ltd", "owner_or_acquirer": null, "headcount": null, "ch_number_clean": "12614766", "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/12614766", "ch_note": null }, "place": { "text": "London (SE1 7AR; null; null)", "postcode": "SE1 7AR", "lat": 51.497494, "lng": -0.120095, "region": "England: London", "admin_district": "Lambeth", "geocoded": "postcodes.io" }, "people": [ { "name": "Dr Michael Ebner", "role": "co-founder and chief executive; director since 2020-05-20", "from": null, "source": "https://www.uktech.news/medtech/hypervision-surgical-seed-20230601" } ], "money": [ { "kind": "funding_round", "amount": 6500000, "currency": "GBP", "date": "2023-06", "detail": "seed; HERAN Partners, Redalpine, LifeX Ventures, ZEISS Ventures", "raw": "funding_round: 6500000 GBP 2023-06 — seed; HERAN Partners, Redalpine, LifeX Ventures, ZEISS Ventures", "amount_gbp": 6500000, "fx_rate": 1.0, "fx_source": "as published (GBP)", "fx_note": "", "txt": "£6.5m", "gbp_txt": "" } ], "site": null, "product": null, "dsit_domains": [ "Perceptual systems" ], "sectors": [ "surgery", "medical imaging" ], "confidence": "verified", "checked": "2026-10-29", "as_of": "2026-10-29", "applied": null, "held": [], "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "Surgical imaging that combines hyperspectral cameras, AI and edge computing to help surgeons see tissue during operations.", "affiliation": "Start-ups", "sources": [ "https://www.uktech.news/medtech/hypervision-surgical-seed-20230601", "https://find-and-update.company-information.service.gov.uk/company/12614766", "https://find-and-update.company-information.service.gov.uk/company/12614766/officers" ], "source_quotes": [ { "url": "https://www.uktech.news/medtech/hypervision-surgical-seed-20230601", "quotes": [ "developing medical imaging for surgery by combining AI hyperspectral imaging and edge computing", "The King's College London spinout" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/12614766", "quotes": [ "HYPERVISION SURGICAL LTD", "Active", "Incorporated on 20 May 2020" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/12614766/officers", "quotes": [ "EBNER, Michael, Dr", "Director", "20 May 2020" ], "accessed": "2026-10-29", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [ "Perceptual systems" ], "one_source": false, "confidence_raw": "verified", "depts": [ { "dept": "surgery", "div": "health" } ], "div_label": "Health", "location": "London (SE1 7AR; null; null)", "status_group": "active", "ext_links": [], "label_links": [ { "kind": "spun_out_of", "name": "King's College London" }, { "kind": "funded_by", "name": "HERAN Partners" }, { "kind": "funded_by", "name": "ZEISS Ventures" } ], "degree": 1, "related_ids": [ "BIZ-SU-HLT-503" ] }, { "id": "BIZ-SU-HLT-805", "name": "Big Picture Bio", "bucket": "co", "status": "active", "status_date": "2026-09", "status_detail": "tech.eu reported in September 2026 that Big Picture Bio emerged from stealth with €2.55m; Companies House shows the company active, incorporated 26 January 2026.", "one_line": "Biotech start-up using AI to design combinations of cancer drugs.", "description": "Big Picture Bio is a UK biotech start-up that develops AI-designed cancer drug combinations. tech.eu reported in September 2026 that it emerged from stealth with €2.55m; investors were not named. Companies House shows Big Picture Bio Limited, registered care of Deep Science Ventures and called Masar Bio Limited until 12 February 2026. Founders were not named in the source read.", "uk_status": "uk", "company": { "ch_number": "16987710", "registered_office": "C/O Deep Science Ventures, 46-54 High Street, Ingatestone, Essex, United Kingdom, CM4 9DW", "incorporated": "2026-01-26", "legal_form": "ltd", "owner_or_acquirer": null, "headcount": null, "ch_number_clean": "16987710", "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/16987710", "ch_note": null }, "place": { "text": "Ingatestone (registered office, CM4 9DW; null; null)", "postcode": "CM4 9DW", "lat": 51.671339, "lng": 0.385829, "region": "England: East of England", "admin_district": "Brentwood", "geocoded": "postcodes.io" }, "people": [], "money": [ { "kind": "funding_round", "amount": 2550000, "currency": "EUR", "date": "2026-09", "detail": "investors not named", "raw": "funding_round: 2550000 EUR 2026-09 — investors not named", "amount_gbp": 2184154, "fx_rate": 1.1675, "fx_source": "Bank of England daily spot rate (series XUDLUSS, XUDLERS), €1.1675 per £ on 2026-09-01", "fx_date": "2026-09-01", "fx_note": "month only given: rate for the 1st", "txt": "€2.5m", "gbp_txt": "£2.2m" } ], "site": null, "product": null, "dsit_domains": [ "Knowledge generation" ], "sectors": [ "drug discovery", "oncology" ], "confidence": "verified", "checked": "2026-10-29", "as_of": "2026-10-29", "applied": null, "held": [], "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "Biotech start-up using AI to design combinations of cancer drugs.", "affiliation": "Start-ups", "sources": [ "https://tech.eu/2026/09/21/european-tech-weekly-recap-over-eur17b-invested-across-70-deals", "https://find-and-update.company-information.service.gov.uk/company/16987710" ], "source_quotes": [ { "url": "https://tech.eu/2026/09/21/european-tech-weekly-recap-over-eur17b-invested-across-70-deals", "quotes": [ "UK: Big Picture Bio emerges from stealth with €2.55M to develop AI-designed cancer drug combinations" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/16987710", "quotes": [ "BIG PICTURE BIO LIMITED", "Active", "Incorporated on 26 January 2026", "MASAR BIO LIMITED" ], "accessed": "2026-10-29", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [ "Knowledge generation" ], "one_source": false, "confidence_raw": "verified", "depts": [ { "dept": "drug discovery", "div": "health" } ], "div_label": "Health", "location": "Ingatestone (registered office, CM4 9DW; null; null)", "status_group": "active", "ext_links": [], "label_links": [ { "kind": "partner_of", "name": "Deep Science Ventures (registered care of)" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-806", "name": "Perceptic", "bucket": "co", "status": "active", "status_date": "2026-10-31", "status_detail": "UKTN reported a $12m seed round in May 2026; Companies House shows Perceptic Technologies Limited active. Companies House shows PERCEPTIC TECHNOLOGIES LIMITED as Active (checked 31 Oct 2026).", "one_line": "Single AI system that joins up asset scouting, scientific evaluation and clinical data for drug discovery and development decisions.", "description": "Perceptic was founded by Tilman Flock (chief executive), Martin Copes and Zaki Trache. It is building a single AI system that brings research, development and clinical decision-making onto a shared intelligence layer. UKTN reported a $12m (£9m) seed round in May 2026 led by Accel, Air Street Capital and Elder Gull. The registered company is Perceptic Technologies Limited, London.", "uk_status": "uk", "company": { "ch_number": "16054598", "registered_office": "35 Ballards Lane, London, United Kingdom, N3 1XW", "incorporated": "2024-11-01", "legal_form": "ltd", "owner_or_acquirer": null, "headcount": null, "ch_number_clean": "16054598", "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/16054598", "ch_note": null }, "place": { "text": "London (N3 1XW; null; null)", "postcode": "N3 1XW", "lat": 51.6032, "lng": -0.192079, "region": "England: London", "admin_district": "Barnet", "geocoded": "postcodes.io" }, "people": [ { "name": "Tilman Flock", "role": "co-founder and chief executive; director since 2024-11-01", "from": null, "source": "https://www.uktech.news/ai/perceptic-raises-9m-to-boost-ai-system-for-drug-discovery-and-development-20260528" }, { "name": "Martin Copes", "role": "co-founder; director (Martin Copes Sabaj) since 2024-11-01", "from": "same source", "source": null }, { "name": "Zaki Trache", "role": "co-founder; director (Mohamed Zaki Yassine Trache) since 2024-11-01", "from": "same source", "source": null } ], "money": [ { "kind": "funding_round", "amount": 12000000, "currency": "USD", "date": "2026-05", "detail": "seed led by Accel, Air Street Capital and Elder Gull (reported as £9m)", "raw": "funding_round: 12000000 USD 2026-05 — seed led by Accel, Air Street Capital and Elder Gull (reported as £9m)", "amount_gbp": 8807986, "fx_rate": 1.3624, "fx_source": "Bank of England daily spot rate (series XUDLUSS, XUDLERS), US$1.3624 per £ on 2026-05-01", "fx_date": "2026-05-01", "fx_note": "month only given: rate for the 1st", "txt": "US$12m", "gbp_txt": "£8.8m" } ], "site": null, "product": null, "dsit_domains": [ "Knowledge generation" ], "sectors": [ "drug discovery", "pharmaceutical development" ], "confidence": "verified", "checked": "2026-10-29", "as_of": "2026-10-29", "applied": null, "held": [], "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "Single AI system that joins up asset scouting, scientific evaluation and clinical data for drug discovery and development decisions.", "affiliation": "Start-ups", "sources": [ "https://www.uktech.news/ai/perceptic-raises-9m-to-boost-ai-system-for-drug-discovery-and-development-20260528", "https://find-and-update.company-information.service.gov.uk/company/16054598", "https://find-and-update.company-information.service.gov.uk/company/16054598/officers" ], "source_quotes": [ { "url": "https://www.uktech.news/ai/perceptic-raises-9m-to-boost-ai-system-for-drug-discovery-and-development-20260528", "quotes": [ "Perceptic has raised a $12m (£9m) seed round led by Accel, Air Street Capital and Elder Gull" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/16054598", "quotes": [ "PERCEPTIC TECHNOLOGIES LIMITED", "Active", "Incorporated on 1 November 2024" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/16054598/officers", "quotes": [ "Tilman Flock", "COPES SABAJ, Martin", "TRACHE, Mohamed Zaki Yassine", "1 November 2024" ], "accessed": "2026-10-29", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [ "Knowledge generation" ], "one_source": false, "confidence_raw": "verified", "depts": [ { "dept": "drug discovery", "div": "health" } ], "div_label": "Health", "location": "London (N3 1XW; null; null)", "status_group": "active", "ext_links": [ { "kind": "funded_by", "id": "BIZ-INV-033", "name": "Accel", "page": "investors", "href": "../../investors/#org=BIZ-INV-033", "page_label": "Investors" }, { "kind": "funded_by", "id": "BIZ-INV-009", "name": "Air Street Capital", "page": "investors", "href": "../../investors/#org=BIZ-INV-009", "page_label": "Investors" }, { "kind": "linked from: portfolio_of", "id": "BIZ-INV-2086", "name": "Elder Gull", "page": "investors", "href": "../../investors/#org=BIZ-INV-2086", "page_label": "Investors" }, { "kind": "funded_by", "id": "BIZ-INV-2086", "name": "Elder Gull", "page": "investors", "href": "../../investors/#org=BIZ-INV-2086", "page_label": "Investors" }, { "kind": "linked from: portfolio_of", "id": "BIZ-INV-033", "name": "Accel", "page": "investors", "href": "../../investors/#org=BIZ-INV-033", "page_label": "Investors" }, { "kind": "funded_by", "id": "BIZ-INV-033", "name": "Accel", "page": "investors", "href": "../../investors/#org=BIZ-INV-033", "page_label": "Investors" }, { "kind": "linked from: portfolio_of", "id": "BIZ-INV-009", "name": "Air Street Capital", "page": "investors", "href": "../../investors/#org=BIZ-INV-009", "page_label": "Investors" }, { "kind": "funded_by", "id": "BIZ-INV-009", "name": "Air Street Capital", "page": "investors", "href": "../../investors/#org=BIZ-INV-009", "page_label": "Investors" } ], "label_links": [ { "kind": "funded_by", "name": "Elder Gull" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-807", "name": "ScienceMachine", "bucket": "co", "status": "active", "status_date": "2026-10-31", "status_detail": "Science Machine Ltd was incorporated on 15 October 2025 with Lorenzo Sani as a director; a Delaware company, Science Machine Inc., has had a London UK establishment since 16 July 2024 (Companies House). Companies House shows SCIENCE MACHINE LTD as Active (checked 31 Oct 2026).", "one_line": "Autonomous AI agent, \"Sam\", that works as a round-the-clock bioinformatician for biotech and pharma companies.", "description": "ScienceMachine is a London AI start-up led by co-founder and chief executive Lorenzo Sani. Its agent, Sam, automates the whole data-analysis pipeline for biotech and pharma companies, acting as a 24/7 AI bioinformatician. tech.eu reported a $3.5m pre-seed round in July 2025 led by Revent and Nucleus Capital. Companies House shows Science Machine Inc. (Delaware) with a London establishment from July 2024 and a UK company, Science Machine Ltd, from October 2025, both at 15 Fitzroy Street. [Labs Round 7, 30 Oct 2026] Listed on Labs (AI for science): London company whose agent \"Sam\" acts as an always-on AI bioinformatician; $3.5m pre-seed 2025-07-09 already on site (DEAL-LC-030); chief executive Lorenzo Sani", "uk_status": "uk", "company": { "ch_number": "16785689", "registered_office": "15 Fitzroy Street, London, England, W1T 4DG", "incorporated": "2025-10-15", "legal_form": "ltd", "owner_or_acquirer": null, "headcount": null, "ch_number_clean": "16785689", "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/16785689", "ch_note": null }, "place": { "text": "London (W1T 4DG; null; null)", "postcode": "W1T 4DG", "lat": 51.521644, "lng": -0.138445, "region": "England: London", "admin_district": "Camden", "geocoded": "postcodes.io" }, "people": [ { "name": "Lorenzo Sani", "role": "co-founder and chief executive; director since 2025-10-15", "from": null, "source": "https://tech.eu/2025/07/09/sciencemachine-raises-35m-for-leading-autonomous-ai-in-biotech-research/" }, { "name": "Lorenzo Sani", "role": "co-founder and chief executive", "from": null, "source": "https://tech.eu/2025/07/09/sciencemachine-raises-35m-for-leading-autonomous-ai-in-biotech-research/", "round4": true }, { "name": "Lorenzo Sani", "role": "CEO and co-founder", "from": null, "source": "https://tech.eu/2025/07/09/sciencemachine-raises-35m-for-leading-autonomous-ai-in-biotech-research/", "round4": true } ], "money": [ { "kind": "funding_round", "amount": 3500000, "currency": "USD", "date": "2025-07", "detail": "pre-seed led by Revent and Nucleus Capital", "raw": "funding_round: 3500000 USD 2025-07 — pre-seed led by Revent and Nucleus Capital", "amount_gbp": 2551392, "fx_rate": 1.3718, "fx_source": "Bank of England daily spot rate (series XUDLUSS, XUDLERS), US$1.3718 per £ on 2025-07-01", "fx_date": "2025-07-01", "fx_note": "month only given: rate for the 1st", "txt": "US$3.5m", "gbp_txt": "£2.6m" } ], "site": null, "product": null, "dsit_domains": [ "Autonomous and agent systems", "Knowledge generation" ], "sectors": [ "bioinformatics", "biotech research" ], "confidence": "verified", "checked": "2026-10-29", "as_of": "2026-10-29", "applied": null, "held": [], "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "Autonomous AI agent, \"Sam\", that works as a round-the-clock bioinformatician for biotech and pharma companies.", "affiliation": "Start-ups", "sources": [ "https://tech.eu/2025/07/09/sciencemachine-raises-35m-for-leading-autonomous-ai-in-biotech-research/", "https://find-and-update.company-information.service.gov.uk/company/16785689", "https://find-and-update.company-information.service.gov.uk/company/16785689/officers", "https://www.sciencemachine.ai/", "https://www.sciencemachine.ai/solutions/lc-ms-review" ], "source_quotes": [ { "url": "https://tech.eu/2025/07/09/sciencemachine-raises-35m-for-leading-autonomous-ai-in-biotech-research/", "quotes": [ "has raised a $3.5 million pre-seed funding round.", "London-based AI startup" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/16785689", "quotes": [ "SCIENCE MACHINE LTD", "Active", "Incorporated on 15 October 2025" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://find-and-update.company-information.service.gov.uk/company/16785689/officers", "quotes": [ "Lorenzo Sani", "Director", "15 October 2025" ], "accessed": "2026-10-29", "trade": false, "amendment": false }, { "url": "https://www.sciencemachine.ai/", "quotes": [ "Scientists review exceptions, not every chromatogram." ], "accessed": "2026-10-30", "trade": false, "amendment": false }, { "url": "https://www.sciencemachine.ai/solutions/lc-ms-review", "quotes": [ "They helped us reduce the time we were spending on QC and reporting by 80%" ], "accessed": "2026-10-30", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [ "Autonomous and agent systems", "Knowledge generation" ], "one_source": false, "confidence_raw": "verified", "depts": [ { "dept": "bioinformatics", "div": "health" } ], "div_label": "Health", "location": "London (W1T 4DG; null; null)", "status_group": "active", "ext_links": [ { "kind": "linked from: portfolio_of", "id": "BIZ-INV-2191", "name": "Nucleus Capital", "page": "investors", "href": "../../investors/#org=BIZ-INV-2191", "page_label": "Investors" }, { "kind": "funded_by", "id": "BIZ-INV-2191", "name": "Nucleus Capital", "page": "investors", "href": "../../investors/#org=BIZ-INV-2191", "page_label": "Investors" }, { "kind": "linked from: portfolio_of", "id": "BIZ-INV-2216", "name": "Revent", "page": "investors", "href": "../../investors/#org=BIZ-INV-2216", "page_label": "Investors" }, { "kind": "funded_by", "id": "BIZ-INV-2216", "name": "Revent", "page": "investors", "href": "../../investors/#org=BIZ-INV-2216", "page_label": "Investors" } ], "label_links": [ { "kind": "funded_by", "name": "Revent" }, { "kind": "funded_by", "name": "Nucleus Capital" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-2001", "name": "Novoic", "bucket": "co", "status": "active", "status_date": "2020-09-08", "status_detail": null, "one_line": "Analyses speech and language patterns with AI to detect neurological and psychiatric disease (Project Rhapsody); NHS AI Award phase 1 winner.", "description": null, "uk_status": "uk", "company": null, "place": null, "people": [], "money": [], "site": null, "product": null, "dsit_domains": [], "sectors": [], "confidence": "single_source", "checked": "2026-10-30", "as_of": "2026-10-30", "applied": null, "held": null, "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "Analyses speech and language patterns with AI to detect neurological and psychiatric disease (Project Rhapsody); NHS AI Award phase 1 winner.", "affiliation": "Start-ups", "sources": [ "https://transform.england.nhs.uk/ai-lab/ai-lab-programmes/ai-health-and-care-award/ai-health-and-care-award-winners" ], "source_quotes": [ { "url": "https://transform.england.nhs.uk/ai-lab/ai-lab-programmes/ai-health-and-care-award/ai-health-and-care-award-winners", "quotes": [ "This AI technology offers a novel way to analyse complex speech or language patterns" ], "accessed": "2026-10-30", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [], "one_source": true, "confidence_raw": "single_source", "depts": [ { "dept": "Health", "div": "health" } ], "div_label": "Health", "location": null, "status_group": "active", "ext_links": [], "label_links": [ { "kind": "funded_by", "name": "NHS AI Lab" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-2002", "name": "Mirada Medical", "bucket": "co", "status": "active", "status_date": "2020-09-08", "status_detail": null, "one_line": "Medical software firm; its NHS AI Award phase 1 project uses AI to review radiotherapy treatment plans for cancer patients.", "description": null, "uk_status": "uk", "company": null, "place": null, "people": [], "money": [], "site": null, "product": null, "dsit_domains": [], "sectors": [], "confidence": "single_source", "checked": "2026-10-30", "as_of": "2026-10-30", "applied": null, "held": null, "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "Medical software firm; its NHS AI Award phase 1 project uses AI to review radiotherapy treatment plans for cancer patients.", "affiliation": "Start-ups", "sources": [ "https://transform.england.nhs.uk/ai-lab/ai-lab-programmes/ai-health-and-care-award/ai-health-and-care-award-winners" ], "source_quotes": [ { "url": "https://transform.england.nhs.uk/ai-lab/ai-lab-programmes/ai-health-and-care-award/ai-health-and-care-award-winners", "quotes": [ "using AI for review of RT treatment plans for cancer patients" ], "accessed": "2026-10-30", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [], "one_source": true, "confidence_raw": "single_source", "depts": [ { "dept": "Health", "div": "health" } ], "div_label": "Health", "location": null, "status_group": "active", "ext_links": [], "label_links": [ { "kind": "funded_by", "name": "NHS AI Lab" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-2003", "name": "Neuronostics", "bucket": "co", "status": "active", "status_date": "2020-09-08", "status_detail": null, "one_line": "Builds BioEP, a computer biomarker of epilepsy read from EEG, plus a smartphone EEG app; two NHS AI Award projects.", "description": null, "uk_status": "uk", "company": null, "place": null, "people": [], "money": [], "site": null, "product": null, "dsit_domains": [], "sectors": [], "confidence": "single_source", "checked": "2026-10-30", "as_of": "2026-10-30", "applied": null, "held": null, "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "Builds BioEP, a computer biomarker of epilepsy read from EEG, plus a smartphone EEG app; two NHS AI Award projects.", "affiliation": "Start-ups", "sources": [ "https://transform.england.nhs.uk/ai-lab/ai-lab-programmes/ai-health-and-care-award/ai-health-and-care-award-winners" ], "source_quotes": [ { "url": "https://transform.england.nhs.uk/ai-lab/ai-lab-programmes/ai-health-and-care-award/ai-health-and-care-award-winners", "quotes": [ "BioEP is a computer biomarker of epilepsy" ], "accessed": "2026-10-30", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [], "one_source": true, "confidence_raw": "single_source", "depts": [ { "dept": "Health", "div": "health" } ], "div_label": "Health", "location": null, "status_group": "active", "ext_links": [], "label_links": [ { "kind": "funded_by", "name": "NHS AI Lab" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-2004", "name": "Senti Tech", "bucket": "co", "status": "active", "status_date": "2020-09-08", "status_detail": null, "one_line": "Makes Senti, a device for remote chest examination of respiratory patients; NHS AI Award phase 1 winner.", "description": null, "uk_status": "uk", "company": null, "place": null, "people": [], "money": [], "site": null, "product": null, "dsit_domains": [], "sectors": [], "confidence": "single_source", "checked": "2026-10-30", "as_of": "2026-10-30", "applied": null, "held": null, "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "Makes Senti, a device for remote chest examination of respiratory patients; NHS AI Award phase 1 winner.", "affiliation": "Start-ups", "sources": [ "https://transform.england.nhs.uk/ai-lab/ai-lab-programmes/ai-health-and-care-award/ai-health-and-care-award-winners" ], "source_quotes": [ { "url": "https://transform.england.nhs.uk/ai-lab/ai-lab-programmes/ai-health-and-care-award/ai-health-and-care-award-winners", "quotes": [ "a device which enables remote chest examination for respiratory patients" ], "accessed": "2026-10-30", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [], "one_source": true, "confidence_raw": "single_source", "depts": [ { "dept": "Health", "div": "health" } ], "div_label": "Health", "location": null, "status_group": "active", "ext_links": [], "label_links": [ { "kind": "funded_by", "name": "NHS AI Lab" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-2005", "name": "Nine Health Global", "bucket": "co", "status": "active", "status_date": "2020-09-08", "status_detail": null, "one_line": "Develops Woubot, automated software tools for wound care pathways in community and wound clinics; NHS AI Award phase 1 winner.", "description": null, "uk_status": "uk", "company": null, "place": null, "people": [], "money": [], "site": null, "product": null, "dsit_domains": [], "sectors": [], "confidence": "single_source", "checked": "2026-10-30", "as_of": "2026-10-30", "applied": null, "held": null, "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "Develops Woubot, automated software tools for wound care pathways in community and wound clinics; NHS AI Award phase 1 winner.", "affiliation": "Start-ups", "sources": [ "https://transform.england.nhs.uk/ai-lab/ai-lab-programmes/ai-health-and-care-award/ai-health-and-care-award-winners" ], "source_quotes": [ { "url": "https://transform.england.nhs.uk/ai-lab/ai-lab-programmes/ai-health-and-care-award/ai-health-and-care-award-winners", "quotes": [ "This project will create a suite of automated software tools for community and wound clinics" ], "accessed": "2026-10-30", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [], "one_source": true, "confidence_raw": "single_source", "depts": [ { "dept": "Health", "div": "health" } ], "div_label": "Health", "location": null, "status_group": "active", "ext_links": [], "label_links": [ { "kind": "funded_by", "name": "NHS AI Lab" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-2006", "name": "Advanced Expert Systems", "bucket": "co", "status": "active", "status_date": "2020-09-08", "status_detail": null, "one_line": "Builds a computer model using FIT results to prioritise likely bowel cancer or polyp cases for colonoscopy; NHS AI Award phase 1.", "description": null, "uk_status": "uk", "company": null, "place": null, "people": [], "money": [], "site": null, "product": null, "dsit_domains": [], "sectors": [], "confidence": "single_source", "checked": "2026-10-30", "as_of": "2026-10-30", "applied": null, "held": null, "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "Builds a computer model using FIT results to prioritise likely bowel cancer or polyp cases for colonoscopy; NHS AI Award phase 1.", "affiliation": "Start-ups", "sources": [ "https://transform.england.nhs.uk/ai-lab/ai-lab-programmes/ai-health-and-care-award/ai-health-and-care-award-winners" ], "source_quotes": [ { "url": "https://transform.england.nhs.uk/ai-lab/ai-lab-programmes/ai-health-and-care-award/ai-health-and-care-award-winners", "quotes": [ "This project will develop a computer model to identify potential cases of bowel cancer or polyps" ], "accessed": "2026-10-30", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [], "one_source": true, "confidence_raw": "single_source", "depts": [ { "dept": "Health", "div": "health" } ], "div_label": "Health", "location": null, "status_group": "active", "ext_links": [], "label_links": [ { "kind": "funded_by", "name": "NHS AI Lab" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-2007", "name": "Macusoft", "bucket": "co", "status": "active", "status_date": "2020-09-08", "status_detail": null, "one_line": "Software that judges whether an eye condition is stable, to cut routine eye clinic check-ups; NHS AI Award winner and DigitalHealth.London Accelerator SME.", "description": null, "uk_status": "uk", "company": null, "place": null, "people": [], "money": [], "site": null, "product": null, "dsit_domains": [], "sectors": [], "confidence": "single_source", "checked": "2026-10-30", "as_of": "2026-10-30", "applied": null, "held": null, "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "Software that judges whether an eye condition is stable, to cut routine eye clinic check-ups; NHS AI Award winner and DigitalHealth.London Accelerator SME.", "affiliation": "Start-ups", "sources": [ "https://transform.england.nhs.uk/ai-lab/ai-lab-programmes/ai-health-and-care-award/ai-health-and-care-award-winners", "https://digitalhealth.london/accelerator-smes-among-winners-of-ai-in-health-and-care-award" ], "source_quotes": [ { "url": "https://transform.england.nhs.uk/ai-lab/ai-lab-programmes/ai-health-and-care-award/ai-health-and-care-award-winners", "quotes": [ "This project will complete development of computer software" ], "accessed": "2026-10-30", "trade": false, "amendment": false }, { "url": "https://digitalhealth.london/accelerator-smes-among-winners-of-ai-in-health-and-care-award", "quotes": [ "Among the 42 successful winners were 7 DigitalHealth.London Accelerator SMEs" ], "accessed": "2026-10-30", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [], "one_source": true, "confidence_raw": "single_source", "depts": [ { "dept": "Health", "div": "health" } ], "div_label": "Health", "location": null, "status_group": "active", "ext_links": [], "label_links": [ { "kind": "funded_by", "name": "NHS AI Lab" }, { "kind": "alumni_of", "name": "DigitalHealth.London Accelerator" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-2008", "name": "Odin Vision", "bucket": "co", "status": "active", "status_date": "2020-09-08", "status_detail": null, "one_line": "AI that helps endoscopists detect and characterise polyps during colonoscopy (FORE-AI project); NHS AI Award phase 2 winner.", "description": null, "uk_status": "uk", "company": null, "place": null, "people": [], "money": [], "site": null, "product": null, "dsit_domains": [], "sectors": [], "confidence": "single_source", "checked": "2026-10-30", "as_of": "2026-10-30", "applied": null, "held": null, "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "AI that helps endoscopists detect and characterise polyps during colonoscopy (FORE-AI project); NHS AI Award phase 2 winner.", "affiliation": "Start-ups", "sources": [ "https://transform.england.nhs.uk/ai-lab/ai-lab-programmes/ai-health-and-care-award/ai-health-and-care-award-winners" ], "source_quotes": [ { "url": "https://transform.england.nhs.uk/ai-lab/ai-lab-programmes/ai-health-and-care-award/ai-health-and-care-award-winners", "quotes": [ "award winning AI technology assists doctors to detect and characterise polyps" ], "accessed": "2026-10-30", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [], "one_source": true, "confidence_raw": "single_source", "depts": [ { "dept": "Health", "div": "health" } ], "div_label": "Health", "location": null, "status_group": "active", "ext_links": [], "label_links": [ { "kind": "funded_by", "name": "NHS AI Lab" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-2009", "name": "Xim (Lifelight)", "bucket": "co", "status": "active", "status_date": "2020-09-08", "status_detail": null, "one_line": "Lifelight software measures blood pressure and other vital signs contactlessly through a smartphone camera; NHS AI Award phase 2 winner.", "description": "[Round 4, 30 Oct 2026] note: Also named as \"earmarked for funding\" in an 8 September NHSX AI Award announcement reposted by Kamet Ventures", "uk_status": "uk", "company": null, "place": null, "people": [], "money": [], "site": null, "product": null, "dsit_domains": [], "sectors": [], "confidence": "single_source", "checked": "2026-10-30", "as_of": "2026-10-30", "applied": null, "held": null, "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "Lifelight software measures blood pressure and other vital signs contactlessly through a smartphone camera; NHS AI Award phase 2 winner.", "affiliation": "Start-ups", "sources": [ "https://transform.england.nhs.uk/ai-lab/ai-lab-programmes/ai-health-and-care-award/ai-health-and-care-award-winners", "https://digitalhealth.london/accelerator-smes-among-winners-of-ai-in-health-and-care-award", "https://www.kametventures.com/nhsx-unveils-first-winners-of-50m-ai-in-health-and-care-award/" ], "source_quotes": [ { "url": "https://transform.england.nhs.uk/ai-lab/ai-lab-programmes/ai-health-and-care-award/ai-health-and-care-award-winners", "quotes": [ "Lifelight is software technology that completely contactlessly measures blood pressure" ], "accessed": "2026-10-30", "trade": false, "amendment": false }, { "url": "https://digitalhealth.london/accelerator-smes-among-winners-of-ai-in-health-and-care-award", "quotes": [ "Among the 42 successful winners were 7 DigitalHealth.London Accelerator SMEs" ], "accessed": "2026-10-30", "trade": false, "amendment": false }, { "url": "https://www.kametventures.com/nhsx-unveils-first-winners-of-50m-ai-in-health-and-care-award/", "quotes": [ "earmarked for funding" ], "accessed": "2026-10-30", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [], "one_source": true, "confidence_raw": "single_source", "depts": [ { "dept": "Health", "div": "health" } ], "div_label": "Health", "location": null, "status_group": "active", "ext_links": [], "label_links": [ { "kind": "funded_by", "name": "NHS AI Lab" }, { "kind": "alumni_of", "name": "DigitalHealth.London Accelerator" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-2010", "name": "Dem Dx", "bucket": "co", "status": "active", "status_date": "2020-09-08", "status_detail": null, "one_line": "Triage support platform that processes patient eye symptoms to support ophthalmology referral decisions; NHS AI Award phase 2 winner.", "description": null, "uk_status": "uk", "company": null, "place": null, "people": [], "money": [], "site": null, "product": null, "dsit_domains": [], "sectors": [], "confidence": "single_source", "checked": "2026-10-30", "as_of": "2026-10-30", "applied": null, "held": null, "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "Triage support platform that processes patient eye symptoms to support ophthalmology referral decisions; NHS AI Award phase 2 winner.", "affiliation": "Start-ups", "sources": [ "https://transform.england.nhs.uk/ai-lab/ai-lab-programmes/ai-health-and-care-award/ai-health-and-care-award-winners", "https://digitalhealth.london/accelerator-smes-among-winners-of-ai-in-health-and-care-award" ], "source_quotes": [ { "url": "https://transform.england.nhs.uk/ai-lab/ai-lab-programmes/ai-health-and-care-award/ai-health-and-care-award-winners", "quotes": [ "This project will develop and test a new technology to gather and process information" ], "accessed": "2026-10-30", "trade": false, "amendment": false }, { "url": "https://digitalhealth.london/accelerator-smes-among-winners-of-ai-in-health-and-care-award", "quotes": [ "Among the 42 successful winners were 7 DigitalHealth.London Accelerator SMEs" ], "accessed": "2026-10-30", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [], "one_source": true, "confidence_raw": "single_source", "depts": [ { "dept": "Health", "div": "health" } ], "div_label": "Health", "location": null, "status_group": "active", "ext_links": [], "label_links": [ { "kind": "funded_by", "name": "NHS AI Lab" }, { "kind": "alumni_of", "name": "DigitalHealth.London Accelerator" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-2011", "name": "BreatheOx (Albus Health)", "bucket": "co", "status": "active", "status_date": "2020-09-08", "status_detail": null, "one_line": "Table-top home device from Albus Health that monitors symptoms to predict preventable childhood asthma attacks; NHS AI Award phase 2 winner.", "description": null, "uk_status": "uk", "company": null, "place": null, "people": [], "money": [], "site": null, "product": null, "dsit_domains": [], "sectors": [], "confidence": "single_source", "checked": "2026-10-30", "as_of": "2026-10-30", "applied": null, "held": null, "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "Table-top home device from Albus Health that monitors symptoms to predict preventable childhood asthma attacks; NHS AI Award phase 2 winner.", "affiliation": "Start-ups", "sources": [ "https://transform.england.nhs.uk/ai-lab/ai-lab-programmes/ai-health-and-care-award/ai-health-and-care-award-winners" ], "source_quotes": [ { "url": "https://transform.england.nhs.uk/ai-lab/ai-lab-programmes/ai-health-and-care-award/ai-health-and-care-award-winners", "quotes": [ "a small table-top device that can automatically monitor a range of symptoms and metrics" ], "accessed": "2026-10-30", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [], "one_source": true, "confidence_raw": "single_source", "depts": [ { "dept": "Health", "div": "health" } ], "div_label": "Health", "location": null, "status_group": "active", "ext_links": [], "label_links": [ { "kind": "funded_by", "name": "NHS AI Lab" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-2012", "name": "Ufonia", "bucket": "co", "status": "active", "status_date": "2020-09-08", "status_detail": null, "one_line": "Natural-language AI assistant that calls patients by ordinary telephone for routine follow-up, first used after cataract surgery; NHS AI Award phase 2.", "description": null, "uk_status": "uk", "company": null, "place": null, "people": [], "money": [], "site": null, "product": null, "dsit_domains": [], "sectors": [], "confidence": "single_source", "checked": "2026-10-30", "as_of": "2026-10-30", "applied": null, "held": null, "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "Natural-language AI assistant that calls patients by ordinary telephone for routine follow-up, first used after cataract surgery; NHS AI Award phase 2.", "affiliation": "Start-ups", "sources": [ "https://transform.england.nhs.uk/ai-lab/ai-lab-programmes/ai-health-and-care-award/ai-health-and-care-award-winners" ], "source_quotes": [ { "url": "https://transform.england.nhs.uk/ai-lab/ai-lab-programmes/ai-health-and-care-award/ai-health-and-care-award-winners", "quotes": [ "Ufonia's natural-language AI assistant delivered via a normal telephone call" ], "accessed": "2026-10-30", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [], "one_source": true, "confidence_raw": "single_source", "depts": [ { "dept": "Health", "div": "health" } ], "div_label": "Health", "location": null, "status_group": "active", "ext_links": [], "label_links": [ { "kind": "funded_by", "name": "NHS AI Lab" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-2013", "name": "Oxford Heartbeat", "bucket": "co", "status": "active", "status_date": "2020-09-08", "status_detail": null, "one_line": "PreSize Neurovascular software helps surgeons choose stents when planning high-risk brain surgery; NHS AI Award phase 3 winner.", "description": null, "uk_status": "uk", "company": null, "place": null, "people": [ { "name": "Katerina Spranger", "role": "Founder or CEO (SBRI/NIHR i4i female founders cohort)", "from": "2025-05-21", "source": "https://sbrihealthcare.co.uk/news/first-cohort-of-female-founders-on-sbri-healthcare-and-nihr-invention-for-innovation-i4i-investment-readiness-programme-announce", "round4": true } ], "money": [], "site": null, "product": null, "dsit_domains": [], "sectors": [], "confidence": "single_source", "checked": "2026-10-30", "as_of": "2026-10-30", "applied": null, "held": null, "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "PreSize Neurovascular software helps surgeons choose stents when planning high-risk brain surgery; NHS AI Award phase 3 winner.", "affiliation": "Start-ups", "sources": [ "https://transform.england.nhs.uk/ai-lab/ai-lab-programmes/ai-health-and-care-award/ai-health-and-care-award-winners", "https://digitalhealth.london/accelerator-smes-among-winners-of-ai-in-health-and-care-award" ], "source_quotes": [ { "url": "https://transform.england.nhs.uk/ai-lab/ai-lab-programmes/ai-health-and-care-award/ai-health-and-care-award-winners", "quotes": [ "Testing medical device software that can help doctors plan for high-risk brain surgeries" ], "accessed": "2026-10-30", "trade": false, "amendment": false }, { "url": "https://digitalhealth.london/accelerator-smes-among-winners-of-ai-in-health-and-care-award", "quotes": [ "Among the 42 successful winners were 7 DigitalHealth.London Accelerator SMEs" ], "accessed": "2026-10-30", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [], "one_source": true, "confidence_raw": "single_source", "depts": [ { "dept": "Health", "div": "health" } ], "div_label": "Health", "location": null, "status_group": "active", "ext_links": [], "label_links": [ { "kind": "funded_by", "name": "NHS AI Lab" }, { "kind": "alumni_of", "name": "DigitalHealth.London Accelerator" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-2014", "name": "Vayla Health", "bucket": "co", "status": "active", "status_date": "2026-10-30", "status_detail": null, "one_line": "Voice-AI telephone service that helps NHS teams follow up frail older adults at home.", "description": null, "uk_status": "uk", "company": null, "place": null, "people": [], "money": [], "site": null, "product": null, "dsit_domains": [], "sectors": [], "confidence": "single_source", "checked": "2026-10-30", "as_of": "2026-10-30", "applied": null, "held": null, "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "Voice-AI telephone service that helps NHS teams follow up frail older adults at home.", "affiliation": "Start-ups", "sources": [ "https://digitalhealth.london/innovation-directory/companies" ], "source_quotes": [ { "url": "https://digitalhealth.london/innovation-directory/companies", "quotes": [ "Vayla is a voice-AI telephone service that helps NHS teams follow up frail older adults at home," ], "accessed": "2026-10-30", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [], "one_source": true, "confidence_raw": "single_source", "depts": [ { "dept": "Health", "div": "health" } ], "div_label": "Health", "location": null, "status_group": "active", "ext_links": [], "label_links": [ { "kind": "member_of", "name": "DigitalHealth.London innovation directory" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-2015", "name": "Primary Care Management Solutions (GPChatbot)", "bucket": "co", "status": "active", "status_date": "2026-10-30", "status_detail": null, "one_line": "Makes GPChatbot, an AI web and WhatsApp tool for patients to contact their GP practice.", "description": null, "uk_status": "uk", "company": null, "place": null, "people": [], "money": [], "site": null, "product": null, "dsit_domains": [], "sectors": [], "confidence": "single_source", "checked": "2026-10-30", "as_of": "2026-10-30", "applied": null, "held": null, "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "Makes GPChatbot, an AI web and WhatsApp tool for patients to contact their GP practice.", "affiliation": "Start-ups", "sources": [ "https://digitalhealth.london/innovation-directory/companies" ], "source_quotes": [ { "url": "https://digitalhealth.london/innovation-directory/companies", "quotes": [ "PCMS has developed GPChatbot, an AI-powered web and WhatsApp patient access solution" ], "accessed": "2026-10-30", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [], "one_source": true, "confidence_raw": "single_source", "depts": [ { "dept": "Health", "div": "health" } ], "div_label": "Health", "location": null, "status_group": "active", "ext_links": [], "label_links": [ { "kind": "member_of", "name": "DigitalHealth.London innovation directory" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-2016", "name": "Physmo (LV8 Sport)", "bucket": "co", "status": "active", "status_date": "2026-10-30", "status_detail": null, "one_line": "AI rehabilitation platform that uses a smartphone camera to guide patients through physiotherapy exercises.", "description": null, "uk_status": "uk", "company": null, "place": null, "people": [], "money": [], "site": null, "product": null, "dsit_domains": [], "sectors": [], "confidence": "single_source", "checked": "2026-10-30", "as_of": "2026-10-30", "applied": null, "held": null, "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "AI rehabilitation platform that uses a smartphone camera to guide patients through physiotherapy exercises.", "affiliation": "Start-ups", "sources": [ "https://digitalhealth.london/innovation-directory/companies" ], "source_quotes": [ { "url": "https://digitalhealth.london/innovation-directory/companies", "quotes": [ "Physmo is an AI-powered rehabilitation platform that uses a smartphone camera to guide patients" ], "accessed": "2026-10-30", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [], "one_source": true, "confidence_raw": "single_source", "depts": [ { "dept": "Health", "div": "health" } ], "div_label": "Health", "location": null, "status_group": "active", "ext_links": [], "label_links": [ { "kind": "member_of", "name": "DigitalHealth.London innovation directory" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-2017", "name": "DeepInfinity", "bucket": "co", "status": "active", "status_date": "2026-10-30", "status_detail": null, "one_line": "Suite of clinical AI agents that turn healthcare speech into documentation and other outputs.", "description": null, "uk_status": "uk", "company": null, "place": null, "people": [], "money": [], "site": null, "product": null, "dsit_domains": [], "sectors": [], "confidence": "single_source", "checked": "2026-10-30", "as_of": "2026-10-30", "applied": null, "held": null, "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "Suite of clinical AI agents that turn healthcare speech into documentation and other outputs.", "affiliation": "Start-ups", "sources": [ "https://digitalhealth.london/innovation-directory/companies" ], "source_quotes": [ { "url": "https://digitalhealth.london/innovation-directory/companies", "quotes": [ "DeepInfinity.AI is an integrated suite of clinically informed AI agents that transforms healthcare speech" ], "accessed": "2026-10-30", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [], "one_source": true, "confidence_raw": "single_source", "depts": [ { "dept": "Health", "div": "health" } ], "div_label": "Health", "location": null, "status_group": "active", "ext_links": [], "label_links": [ { "kind": "member_of", "name": "DigitalHealth.London innovation directory" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-2018", "name": "Auxilis AI", "bucket": "co", "status": "active", "status_date": "2026-10-30", "status_detail": null, "one_line": "Builds safety-governed AI workers for frontline healthcare, starting with Jackie, an AI receptionist.", "description": null, "uk_status": "uk", "company": null, "place": null, "people": [], "money": [], "site": null, "product": null, "dsit_domains": [], "sectors": [], "confidence": "single_source", "checked": "2026-10-30", "as_of": "2026-10-30", "applied": null, "held": null, "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "Builds safety-governed AI workers for frontline healthcare, starting with Jackie, an AI receptionist.", "affiliation": "Start-ups", "sources": [ "https://digitalhealth.london/innovation-directory/companies" ], "source_quotes": [ { "url": "https://digitalhealth.london/innovation-directory/companies", "quotes": [ "Auxilis AI builds safety-governed AI workers for frontline healthcare, starting with Jackie, an AI receptionist" ], "accessed": "2026-10-30", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [], "one_source": true, "confidence_raw": "single_source", "depts": [ { "dept": "Health", "div": "health" } ], "div_label": "Health", "location": null, "status_group": "active", "ext_links": [], "label_links": [ { "kind": "member_of", "name": "DigitalHealth.London innovation directory" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-2019", "name": "LeapForward.AI", "bucket": "co", "status": "active", "status_date": "2026-10-30", "status_detail": null, "one_line": "Health technology company using AI to widen access to mental wellbeing support.", "description": null, "uk_status": "uk", "company": null, "place": null, "people": [], "money": [], "site": null, "product": null, "dsit_domains": [], "sectors": [], "confidence": "single_source", "checked": "2026-10-30", "as_of": "2026-10-30", "applied": null, "held": null, "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "Health technology company using AI to widen access to mental wellbeing support.", "affiliation": "Start-ups", "sources": [ "https://digitalhealth.london/innovation-directory/companies/page/2" ], "source_quotes": [ { "url": "https://digitalhealth.london/innovation-directory/companies/page/2", "quotes": [ "LeapForward.AI is a health technology company that expands access to mental wellbeing support" ], "accessed": "2026-10-30", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [], "one_source": true, "confidence_raw": "single_source", "depts": [ { "dept": "Health", "div": "health" } ], "div_label": "Health", "location": null, "status_group": "active", "ext_links": [], "label_links": [ { "kind": "member_of", "name": "DigitalHealth.London innovation directory" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-2020", "name": "The Health and Care Expert", "bucket": "co", "status": "active", "status_date": "2026-10-30", "status_detail": null, "one_line": "AI tool that helps clinicians find local services for their patients.", "description": null, "uk_status": "uk", "company": null, "place": null, "people": [], "money": [], "site": null, "product": null, "dsit_domains": [], "sectors": [], "confidence": "single_source", "checked": "2026-10-30", "as_of": "2026-10-30", "applied": null, "held": null, "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "AI tool that helps clinicians find local services for their patients.", "affiliation": "Start-ups", "sources": [ "https://digitalhealth.london/innovation-directory/companies/page/2" ], "source_quotes": [ { "url": "https://digitalhealth.london/innovation-directory/companies/page/2", "quotes": [ "The Health and Care Expert is an AI driven solution that helps clinicians find services for their patients" ], "accessed": "2026-10-30", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [], "one_source": true, "confidence_raw": "single_source", "depts": [ { "dept": "Health", "div": "health" } ], "div_label": "Health", "location": null, "status_group": "active", "ext_links": [], "label_links": [ { "kind": "member_of", "name": "DigitalHealth.London innovation directory" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-2021", "name": "Nura XR", "bucket": "co", "status": "active", "status_date": "2026-10-30", "status_detail": null, "one_line": "AI virtual reality platform for neurodiversity diagnostic assessments.", "description": null, "uk_status": "uk", "company": null, "place": null, "people": [], "money": [], "site": null, "product": null, "dsit_domains": [], "sectors": [], "confidence": "single_source", "checked": "2026-10-30", "as_of": "2026-10-30", "applied": null, "held": null, "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "AI virtual reality platform for neurodiversity diagnostic assessments.", "affiliation": "Start-ups", "sources": [ "https://digitalhealth.london/innovation-directory/companies/page/2" ], "source_quotes": [ { "url": "https://digitalhealth.london/innovation-directory/companies/page/2", "quotes": [ "Nura XR is an AI-powered virtual reality platform that delivers fast, engaging, and scalable neurodiversity diagnostics" ], "accessed": "2026-10-30", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [], "one_source": true, "confidence_raw": "single_source", "depts": [ { "dept": "Health", "div": "health" } ], "div_label": "Health", "location": null, "status_group": "active", "ext_links": [], "label_links": [ { "kind": "member_of", "name": "DigitalHealth.London innovation directory" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-2022", "name": "Medhaya", "bucket": "co", "status": "active", "status_date": "2026-10-30", "status_detail": null, "one_line": "AI clinical co-pilot that automates clinical documentation and patient interactions.", "description": null, "uk_status": "uk", "company": null, "place": null, "people": [], "money": [], "site": null, "product": null, "dsit_domains": [], "sectors": [], "confidence": "single_source", "checked": "2026-10-30", "as_of": "2026-10-30", "applied": null, "held": null, "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "AI clinical co-pilot that automates clinical documentation and patient interactions.", "affiliation": "Start-ups", "sources": [ "https://digitalhealth.london/innovation-directory/companies/page/2" ], "source_quotes": [ { "url": "https://digitalhealth.london/innovation-directory/companies/page/2", "quotes": [ "Medhaya is an AI-powered clinical co-pilot that automates documentation, streamlines patient interactions" ], "accessed": "2026-10-30", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [], "one_source": true, "confidence_raw": "single_source", "depts": [ { "dept": "Health", "div": "health" } ], "div_label": "Health", "location": null, "status_group": "active", "ext_links": [], "label_links": [ { "kind": "member_of", "name": "DigitalHealth.London innovation directory" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-2023", "name": "Pinpoint Data Science", "bucket": "co", "status": "active", "status_date": "2022-02-06", "status_detail": null, "one_line": "Uses an AI-driven blood test to help prioritise urgent cancer referrals in NHS pathways; SBRI Healthcare cancer award winner.", "description": "[Places Round 1, 31 Oct 2026] Alex's Places file (line 71, tile 08) places this in Leeds; region set to Yorkshire and the Humber. The file gives no source; not re-researched.", "uk_status": "uk", "company": null, "place": { "postcode": null, "lat": null, "lng": null, "region": "England: Yorkshire and the Humber", "text": "Leeds (Alex's Places file; not verified)" }, "people": [], "money": [], "site": null, "product": null, "dsit_domains": [], "sectors": [], "confidence": "single_source", "checked": "2026-10-30", "as_of": "2026-10-30", "applied": null, "held": null, "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "Uses an AI-driven blood test to help prioritise urgent cancer referrals in NHS pathways; SBRI Healthcare cancer award winner.", "affiliation": "Start-ups", "sources": [ "https://sbrihealthcare.co.uk/news/sbri-healthcare-awards-multi-million-pound-funding-for-late-stage-innovation-projects-that-advance-earlier-and-faster-diagnosis" ], "source_quotes": [ { "url": "https://sbrihealthcare.co.uk/news/sbri-healthcare-awards-multi-million-pound-funding-for-late-stage-innovation-projects-that-advance-earlier-and-faster-diagnosis", "quotes": [ "Optimising NHS urgent cancer referral pathways with their AI-driven, affordable blood test" ], "accessed": "2026-10-30", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [], "one_source": true, "confidence_raw": "single_source", "depts": [ { "dept": "Health", "div": "health" } ], "div_label": "Health", "location": "Leeds (Alex's Places file; not verified)", "status_group": "active", "ext_links": [], "label_links": [ { "kind": "funded_by", "name": "SBRI Healthcare" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-2024", "name": "InsideOut 25", "bucket": "co", "status": "active", "status_date": "2025-03-31", "status_detail": null, "one_line": "Uses AI avatars to deliver mental health interventions that help employees stay in work; SBRI Healthcare award winner.", "description": null, "uk_status": "uk", "company": null, "place": null, "people": [], "money": [], "site": null, "product": null, "dsit_domains": [], "sectors": [], "confidence": "single_source", "checked": "2026-10-30", "as_of": "2026-10-30", "applied": null, "held": null, "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "Uses AI avatars to deliver mental health interventions that help employees stay in work; SBRI Healthcare award winner.", "affiliation": "Start-ups", "sources": [ "https://sbrihealthcare.co.uk/news/sbri-healthcare-funding-awarded-to-work-related-digital-innovations-for-individuals-with-poor-mental-health" ], "source_quotes": [ { "url": "https://sbrihealthcare.co.uk/news/sbri-healthcare-funding-awarded-to-work-related-digital-innovations-for-individuals-with-poor-mental-health", "quotes": [ "Using AI Avatar-led Mental Health Interventions for keeping employees in work." ], "accessed": "2026-10-30", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [], "one_source": true, "confidence_raw": "single_source", "depts": [ { "dept": "Health", "div": "health" } ], "div_label": "Health", "location": null, "status_group": "active", "ext_links": [], "label_links": [ { "kind": "funded_by", "name": "SBRI Healthcare" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-2025", "name": "Affiniti AI", "bucket": "co", "status": "active", "status_date": "2025-03-31", "status_detail": null, "one_line": "AI mental health co-therapist that supports patients between therapy sessions; SBRI Healthcare award winner.", "description": null, "uk_status": "uk", "company": null, "place": null, "people": [], "money": [], "site": null, "product": null, "dsit_domains": [], "sectors": [], "confidence": "single_source", "checked": "2026-10-30", "as_of": "2026-10-30", "applied": null, "held": null, "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "AI mental health co-therapist that supports patients between therapy sessions; SBRI Healthcare award winner.", "affiliation": "Start-ups", "sources": [ "https://sbrihealthcare.co.uk/news/sbri-healthcare-funding-awarded-to-work-related-digital-innovations-for-individuals-with-poor-mental-health" ], "source_quotes": [ { "url": "https://sbrihealthcare.co.uk/news/sbri-healthcare-funding-awarded-to-work-related-digital-innovations-for-individuals-with-poor-mental-health", "quotes": [ "a personalised mental health co-therapist that supports patients between therapy sessions." ], "accessed": "2026-10-30", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [], "one_source": true, "confidence_raw": "single_source", "depts": [ { "dept": "Health", "div": "health" } ], "div_label": "Health", "location": null, "status_group": "active", "ext_links": [], "label_links": [ { "kind": "funded_by", "name": "SBRI Healthcare" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-2026", "name": "Nelus AI", "bucket": "co", "status": "active", "status_date": "2020-02-06", "status_detail": null, "one_line": "Links an outreach hearing test with an AI-enabled chatbot; SBRI Healthcare integrated and social care award winner.", "description": null, "uk_status": "uk", "company": null, "place": null, "people": [], "money": [], "site": null, "product": null, "dsit_domains": [], "sectors": [], "confidence": "single_source", "checked": "2026-10-30", "as_of": "2026-10-30", "applied": null, "held": null, "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "Links an outreach hearing test with an AI-enabled chatbot; SBRI Healthcare integrated and social care award winner.", "affiliation": "Start-ups", "sources": [ "https://sbrihealthcare.co.uk/news/sbri-healthcare-awards-1-million-to-pioneering-innovations-in-cardiovascular-disease-and-integrated-care-social-care/" ], "source_quotes": [ { "url": "https://sbrihealthcare.co.uk/news/sbri-healthcare-awards-1-million-to-pioneering-innovations-in-cardiovascular-disease-and-integrated-care-social-care/", "quotes": [ "Integration of an outreach hearing test with an AI-enabled BOT" ], "accessed": "2026-10-30", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [], "one_source": true, "confidence_raw": "single_source", "depts": [ { "dept": "Health", "div": "health" } ], "div_label": "Health", "location": null, "status_group": "active", "ext_links": [], "label_links": [ { "kind": "funded_by", "name": "SBRI Healthcare" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-2027", "name": "Upstream Health (Bridgit)", "bucket": "co", "status": "active", "status_date": "2020-02-06", "status_detail": null, "one_line": "Bridgit support system uses AI, connected devices and two-way messaging to help older people stay well and independent at home.", "description": null, "uk_status": "uk", "company": null, "place": null, "people": [], "money": [], "site": null, "product": null, "dsit_domains": [], "sectors": [], "confidence": "single_source", "checked": "2026-10-30", "as_of": "2026-10-30", "applied": null, "held": null, "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "Bridgit support system uses AI, connected devices and two-way messaging to help older people stay well and independent at home.", "affiliation": "Start-ups", "sources": [ "https://sbrihealthcare.co.uk/news/sbri-healthcare-awards-1-million-to-pioneering-innovations-in-cardiovascular-disease-and-integrated-care-social-care/" ], "source_quotes": [ { "url": "https://sbrihealthcare.co.uk/news/sbri-healthcare-awards-1-million-to-pioneering-innovations-in-cardiovascular-disease-and-integrated-care-social-care/", "quotes": [ "Bridgit™ is a support system helping elderly people keep well and independent", "Using Artificial Intelligence, Internet of Things and 2-way communication" ], "accessed": "2026-10-30", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [], "one_source": true, "confidence_raw": "single_source", "depts": [ { "dept": "Health", "div": "health" } ], "div_label": "Health", "location": null, "status_group": "active", "ext_links": [], "label_links": [ { "kind": "funded_by", "name": "SBRI Healthcare" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-2028", "name": "Lighthearted AI Health", "bucket": "co", "status": "active", "status_date": "2025-02-20", "status_detail": null, "one_line": "LightScope uses laser light to read vital signs and give AI-assisted diagnosis; SBRI Healthcare women's health phase 1 winner.", "description": null, "uk_status": "uk", "company": null, "place": null, "people": [], "money": [], "site": null, "product": null, "dsit_domains": [], "sectors": [], "confidence": "single_source", "checked": "2026-10-30", "as_of": "2026-10-30", "applied": null, "held": null, "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "LightScope uses laser light to read vital signs and give AI-assisted diagnosis; SBRI Healthcare women's health phase 1 winner.", "affiliation": "Start-ups", "sources": [ "https://sbrihealthcare.co.uk/news/sbri-healthcare-funding-awarded-to-innovations-that-improve-women-s-health" ], "source_quotes": [ { "url": "https://sbrihealthcare.co.uk/news/sbri-healthcare-funding-awarded-to-innovations-that-improve-women-s-health", "quotes": [ "LightScope uses laser light to capture high-precision bio-vitals and deliver accurate AI-assisted diagnosis" ], "accessed": "2026-10-30", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [], "one_source": true, "confidence_raw": "single_source", "depts": [ { "dept": "Health", "div": "health" } ], "div_label": "Health", "location": null, "status_group": "active", "ext_links": [], "label_links": [ { "kind": "funded_by", "name": "SBRI Healthcare" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-2029", "name": "Spryt", "bucket": "co", "status": "active", "status_date": "2025-02-20", "status_detail": null, "one_line": "Asa, an AI receptionist that lets patients book, cancel or move medical appointments over WhatsApp; SBRI Healthcare winner.", "description": null, "uk_status": "uk", "company": null, "place": null, "people": [], "money": [], "site": null, "product": null, "dsit_domains": [], "sectors": [], "confidence": "single_source", "checked": "2026-10-30", "as_of": "2026-10-30", "applied": null, "held": null, "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "Asa, an AI receptionist that lets patients book, cancel or move medical appointments over WhatsApp; SBRI Healthcare winner.", "affiliation": "Start-ups", "sources": [ "https://sbrihealthcare.co.uk/news/sbri-healthcare-funding-awarded-to-innovations-that-improve-women-s-health" ], "source_quotes": [ { "url": "https://sbrihealthcare.co.uk/news/sbri-healthcare-funding-awarded-to-innovations-that-improve-women-s-health", "quotes": [ "Asa is an AI receptionist that enables patients to book, cancel or reschedule medical appointments via WhatsApp" ], "accessed": "2026-10-30", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [], "one_source": true, "confidence_raw": "single_source", "depts": [ { "dept": "Health", "div": "health" } ], "div_label": "Health", "location": null, "status_group": "active", "ext_links": [], "label_links": [ { "kind": "funded_by", "name": "SBRI Healthcare" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-2030", "name": "CareLoop Health", "bucket": "co", "status": "active", "status_date": "2025-03-18", "status_detail": null, "one_line": "AI digital therapeutic platform: patients give regular feedback by smartphone and use self-management tools; SBRI Healthcare urgent care phase 3.", "description": null, "uk_status": "uk", "company": null, "place": null, "people": [], "money": [], "site": null, "product": null, "dsit_domains": [], "sectors": [], "confidence": "single_source", "checked": "2026-10-30", "as_of": "2026-10-30", "applied": null, "held": null, "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "AI digital therapeutic platform: patients give regular feedback by smartphone and use self-management tools; SBRI Healthcare urgent care phase 3.", "affiliation": "Start-ups", "sources": [ "https://sbrihealthcare.co.uk/news/funding-awarded-to-innovations-that-support-the-delivery-of-urgent-emergency-care" ], "source_quotes": [ { "url": "https://sbrihealthcare.co.uk/news/funding-awarded-to-innovations-that-support-the-delivery-of-urgent-emergency-care", "quotes": [ "Using a smartphone, patients give regular feedback and access self-management tools." ], "accessed": "2026-10-30", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [], "one_source": true, "confidence_raw": "single_source", "depts": [ { "dept": "Health", "div": "health" } ], "div_label": "Health", "location": null, "status_group": "active", "ext_links": [], "label_links": [ { "kind": "funded_by", "name": "SBRI Healthcare" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-2031", "name": "Bering", "bucket": "co", "status": "active", "status_date": "2025-03-18", "status_detail": null, "one_line": "Machine-learning tool that flags people at risk of unplanned hospital admission; SBRI Healthcare urgent care phase 3 winner.", "description": null, "uk_status": "uk", "company": null, "place": null, "people": [], "money": [], "site": null, "product": null, "dsit_domains": [], "sectors": [], "confidence": "single_source", "checked": "2026-10-30", "as_of": "2026-10-30", "applied": null, "held": null, "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "Machine-learning tool that flags people at risk of unplanned hospital admission; SBRI Healthcare urgent care phase 3 winner.", "affiliation": "Start-ups", "sources": [ "https://sbrihealthcare.co.uk/news/funding-awarded-to-innovations-that-support-the-delivery-of-urgent-emergency-care" ], "source_quotes": [ { "url": "https://sbrihealthcare.co.uk/news/funding-awarded-to-innovations-that-support-the-delivery-of-urgent-emergency-care", "quotes": [ "digital tool for early identification of individuals that may be at risk of unplanned hospital admissions" ], "accessed": "2026-10-30", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [], "one_source": true, "confidence_raw": "single_source", "depts": [ { "dept": "Health", "div": "health" } ], "div_label": "Health", "location": null, "status_group": "active", "ext_links": [], "label_links": [ { "kind": "funded_by", "name": "SBRI Healthcare" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-2032", "name": "Anya", "bucket": "co", "status": "active", "status_date": "2023", "status_detail": null, "one_line": "Parent support app with #AskAnya, an AI virtual supporter giving round-the-clock evidence-based breastfeeding and early-parenthood support; NHS Innovation Accelerator 2023.", "description": null, "uk_status": "uk", "company": null, "place": null, "people": [ { "name": "Chen Mao Davies", "role": "Founder and CEO; NIA Fellow", "from": "2023 (NIA entry year)", "source": "https://nhsaccelerator.com/innovations/anya/", "round4": true } ], "money": [], "site": null, "product": null, "dsit_domains": [], "sectors": [], "confidence": "single_source", "checked": "2026-10-30", "as_of": "2026-10-30", "applied": null, "held": null, "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "Parent support app with #AskAnya, an AI virtual supporter giving round-the-clock evidence-based breastfeeding and early-parenthood support; NHS Innovation Accelerator 2023.", "affiliation": "Start-ups", "sources": [ "https://nhsaccelerator.com/innovations/anya/" ], "source_quotes": [ { "url": "https://nhsaccelerator.com/innovations/anya/", "quotes": [ "Empathic #AskAnya AI powered virtual supporter for personalised evidence-based support and companionship 24/7" ], "accessed": "2026-10-30", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [], "one_source": true, "confidence_raw": "single_source", "depts": [ { "dept": "Health", "div": "health" } ], "div_label": "Health", "location": null, "status_group": "active", "ext_links": [], "label_links": [ { "kind": "alumni_of", "name": "NHS Innovation Accelerator" }, { "kind": "founded_by", "name": "Chen Mao Davies" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-2033", "name": "Ai Dimension (formerly Procomp)", "bucket": "co", "status": "active", "status_date": "2026-10-30", "status_detail": null, "one_line": "Adapts AI-based planning tools for use in healthcare settings; NHS Innovation Accelerator innovation.", "description": null, "uk_status": "uk", "company": null, "place": null, "people": [], "money": [], "site": null, "product": null, "dsit_domains": [], "sectors": [], "confidence": "single_source", "checked": "2026-10-30", "as_of": "2026-10-30", "applied": null, "held": null, "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "Adapts AI-based planning tools for use in healthcare settings; NHS Innovation Accelerator innovation.", "affiliation": "Start-ups", "sources": [ "https://nhsaccelerator.com/innovations/" ], "source_quotes": [ { "url": "https://nhsaccelerator.com/innovations/", "quotes": [ "Ai Dimension (previously Procomp) has adapted its Artificial Intelligence (AI)-based planning tools" ], "accessed": "2026-10-30", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [], "one_source": true, "confidence_raw": "single_source", "depts": [ { "dept": "Health", "div": "health" } ], "div_label": "Health", "location": null, "status_group": "active", "ext_links": [], "label_links": [ { "kind": "alumni_of", "name": "NHS Innovation Accelerator" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-2034", "name": "Ascelus", "bucket": "co", "status": "active", "status_date": "2026-10-30", "status_detail": null, "one_line": "AI digital platform that integrates with hospital IT systems; NHS Innovation Accelerator innovation.", "description": null, "uk_status": "uk", "company": null, "place": null, "people": [], "money": [], "site": null, "product": null, "dsit_domains": [], "sectors": [], "confidence": "single_source", "checked": "2026-10-30", "as_of": "2026-10-30", "applied": null, "held": null, "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "AI digital platform that integrates with hospital IT systems; NHS Innovation Accelerator innovation.", "affiliation": "Start-ups", "sources": [ "https://nhsaccelerator.com/innovations/" ], "source_quotes": [ { "url": "https://nhsaccelerator.com/innovations/", "quotes": [ "Ascelus is an AI (Artificial Intelligence) powered digital platform that integrates with hospital IT systems" ], "accessed": "2026-10-30", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [], "one_source": true, "confidence_raw": "single_source", "depts": [ { "dept": "Health", "div": "health" } ], "div_label": "Health", "location": null, "status_group": "active", "ext_links": [], "label_links": [ { "kind": "alumni_of", "name": "NHS Innovation Accelerator" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-2035", "name": "Allos", "bucket": "co", "status": "active", "status_date": "2026-10-30", "status_detail": null, "one_line": "Causal AI platform used to reformulate existing drugs and plan their lifecycle; Oxford Science Enterprises portfolio company.", "description": null, "uk_status": "uk", "company": null, "place": null, "people": [], "money": [], "site": null, "product": null, "dsit_domains": [], "sectors": [], "confidence": "single_source", "checked": "2026-10-30", "as_of": "2026-10-30", "applied": null, "held": null, "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "Causal AI platform used to reformulate existing drugs and plan their lifecycle; Oxford Science Enterprises portfolio company.", "affiliation": "Start-ups", "sources": [ "https://www.oxfordscienceenterprises.com/portfolio/" ], "source_quotes": [ { "url": "https://www.oxfordscienceenterprises.com/portfolio/", "quotes": [ "Causal AI platform for drug reformulation and lifecycle optimisation" ], "accessed": "2026-10-30", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [], "one_source": true, "confidence_raw": "single_source", "depts": [ { "dept": "Health", "div": "health" } ], "div_label": "Health", "location": null, "status_group": "active", "ext_links": [ { "kind": "portfolio_of", "id": "BIZ-INV-007", "name": "Oxford Science Enterprises", "page": "investors", "href": "../../investors/#org=BIZ-INV-007", "page_label": "Investors" }, { "kind": "linked from: funded_by", "id": "BIZ-INV-007", "name": "Oxford Science Enterprises", "page": "investors", "href": "../../investors/#org=BIZ-INV-007", "page_label": "Investors" } ], "label_links": [], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-2036", "name": "Mirae Health", "bucket": "co", "status": "active", "status_date": "2026-10-30", "status_detail": null, "one_line": "AI continuous-care platform for people with autoimmune disease; Oxford Science Enterprises portfolio company.", "description": null, "uk_status": "uk", "company": null, "place": null, "people": [], "money": [], "site": null, "product": null, "dsit_domains": [], "sectors": [], "confidence": "single_source", "checked": "2026-10-30", "as_of": "2026-10-30", "applied": null, "held": null, "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "AI continuous-care platform for people with autoimmune disease; Oxford Science Enterprises portfolio company.", "affiliation": "Start-ups", "sources": [ "https://www.oxfordscienceenterprises.com/portfolio/" ], "source_quotes": [ { "url": "https://www.oxfordscienceenterprises.com/portfolio/", "quotes": [ "AI-driven continuous care platform for autoimmune disease" ], "accessed": "2026-10-30", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [], "one_source": true, "confidence_raw": "single_source", "depts": [ { "dept": "Health", "div": "health" } ], "div_label": "Health", "location": null, "status_group": "active", "ext_links": [ { "kind": "portfolio_of", "id": "BIZ-INV-007", "name": "Oxford Science Enterprises", "page": "investors", "href": "../../investors/#org=BIZ-INV-007", "page_label": "Investors" }, { "kind": "linked from: funded_by", "id": "BIZ-INV-007", "name": "Oxford Science Enterprises", "page": "investors", "href": "../../investors/#org=BIZ-INV-007", "page_label": "Investors" } ], "label_links": [], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-2037", "name": "Kneu Health", "bucket": "co", "status": "active", "status_date": "2026-10-30", "status_detail": null, "one_line": "Care platform for dementia and Parkinson's using machine learning and AI analytics; OSE portfolio and DigitalHealth.London Accelerator cohort member.", "description": null, "uk_status": "uk", "company": null, "place": null, "people": [], "money": [], "site": null, "product": null, "dsit_domains": [], "sectors": [], "confidence": "single_source", "checked": "2026-10-30", "as_of": "2026-10-30", "applied": null, "held": null, "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "Care platform for dementia and Parkinson's using machine learning and AI analytics; OSE portfolio and DigitalHealth.London Accelerator cohort member.", "affiliation": "Start-ups", "sources": [ "https://digitalhealth.london/innovation-directory?areainnovation=§or=&technology=&cohort=422", "https://www.oxfordscienceenterprises.com/portfolio/" ], "source_quotes": [ { "url": "https://digitalhealth.london/innovation-directory?areainnovation=§or=&technology=&cohort=422", "quotes": [ "advanced machine learning and artificial intelligence analytics to empower patients and optimise clinical services." ], "accessed": "2026-10-30", "trade": false, "amendment": false }, { "url": "https://www.oxfordscienceenterprises.com/portfolio/", "quotes": [ "Reimagining care for dementia and Parkinson’s" ], "accessed": "2026-10-30", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [], "one_source": true, "confidence_raw": "single_source", "depts": [ { "dept": "Health", "div": "health" } ], "div_label": "Health", "location": null, "status_group": "active", "ext_links": [ { "kind": "portfolio_of", "id": "BIZ-INV-007", "name": "Oxford Science Enterprises", "page": "investors", "href": "../../investors/#org=BIZ-INV-007", "page_label": "Investors" }, { "kind": "linked from: funded_by", "id": "BIZ-INV-007", "name": "Oxford Science Enterprises", "page": "investors", "href": "../../investors/#org=BIZ-INV-007", "page_label": "Investors" } ], "label_links": [ { "kind": "member_of", "name": "DigitalHealth.London Accelerator" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-2038", "name": "RAIQC", "bucket": "co", "status": "active", "status_date": "2024-02-06", "status_detail": null, "one_line": "Clinical simulation platform for medical image interpretation; UKRI-funded tools to evaluate and monitor medical imaging AI before and after market.", "description": null, "uk_status": "uk", "company": null, "place": null, "people": [], "money": [], "site": null, "product": null, "dsit_domains": [], "sectors": [], "confidence": "single_source", "checked": "2026-10-30", "as_of": "2026-10-30", "applied": null, "held": null, "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "Clinical simulation platform for medical image interpretation; UKRI-funded tools to evaluate and monitor medical imaging AI before and after market.", "affiliation": "Start-ups", "sources": [ "https://www.ukri.org/news/19-million-to-accelerate-trustworthy-and-responsible-ai/", "https://sbrihealthcare.co.uk/news/sbri-healthcare-awards-over-8-million-to-progress-pioneering-innovations-in-urgent-and-emergency-care-to-the-next-level/" ], "source_quotes": [ { "url": "https://www.ukri.org/news/19-million-to-accelerate-trustworthy-and-responsible-ai/", "quotes": [ "Developing tools for pre-market evaluation and post-market surveillance of medical imaging AI" ], "accessed": "2026-10-30", "trade": false, "amendment": false }, { "url": "https://sbrihealthcare.co.uk/news/sbri-healthcare-awards-over-8-million-to-progress-pioneering-innovations-in-urgent-and-emergency-care-to-the-next-level/", "quotes": [ "RAIQC is a clinical simulation platform for medical image interpretation." ], "accessed": "2026-10-30", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [], "one_source": true, "confidence_raw": "single_source", "depts": [ { "dept": "Health", "div": "health" } ], "div_label": "Health", "location": null, "status_group": "active", "ext_links": [], "label_links": [ { "kind": "funded_by", "name": "UKRI Technology Missions Fund (Accelerating trustworthy AI)" }, { "kind": "funded_by", "name": "SBRI Healthcare" } ], "degree": 0, "related_ids": [] }, { "id": "BIZ-SU-HLT-2040", "name": "Pyrexia", "bucket": "co", "status": "active", "status_date": "2026-10-30", "status_detail": null, "one_line": "Uses AI and machine learning to streamline HR processes for healthcare employers; DigitalHealth.London Accelerator cohort and NHS Innovation Accelerator fellow-led.", "description": null, "uk_status": "uk", "company": null, "place": null, "people": [ { "name": "Ali Jawad", "role": "Co-Founder and Chief Executive Officer; NIA Fellow", "from": null, "source": "https://nhsaccelerator.com/about-the-nia-programme/fellows/", "round4": true } ], "money": [], "site": null, "product": null, "dsit_domains": [], "sectors": [], "confidence": "single_source", "checked": "2026-10-30", "as_of": "2026-10-30", "applied": null, "held": null, "same_as": null, "package1_id": null, "type": "Companies", "category": "health", "function": "Uses AI and machine learning to streamline HR processes for healthcare employers; DigitalHealth.London Accelerator cohort and NHS Innovation Accelerator fellow-led.", "affiliation": "Start-ups", "sources": [ "https://digitalhealth.london/innovation-directory/page/2?cohort=422", "https://nhsaccelerator.com/about-the-nia-programme/fellows/" ], "source_quotes": [ { "url": "https://digitalhealth.london/innovation-directory/page/2?cohort=422", "quotes": [ "utilises AI and machine learning to streamline key HR processes" ], "accessed": "2026-10-30", "trade": false, "amendment": false }, { "url": "https://nhsaccelerator.com/about-the-nia-programme/fellows/", "quotes": [ "Co-Founder & Chief Executive Officer, Pyrexia" ], "accessed": "2026-10-30", "trade": false, "amendment": false } ], "website": [], "colleges": [], "topics": [], "one_source": true, "confidence_raw": "single_source", "depts": [ { "dept": "Health", "div": "health" } ], "div_label": "Health", "location": null, "status_group": "active", "ext_links": [], "label_links": [ { "kind": "member_of", "name": "DigitalHealth.London Accelerator" }, { "kind": "founded_by", "name": "Ali Jawad" } ], "degree": 0, "related_ids": [] } ], "links": [ { "source": "BIZ-SU-HLT-601", "target": "BIZ-SU-HLT-801", "kind": "acquired_by", "evidence": "BIZ-SU-HLT-601 links: acquired_by → Huma (Huma Therapeutics Limited)" }, { "source": "BIZ-SU-HLT-509", "target": "BIZ-SU-HLT-402", "kind": "same_as", "evidence": "BIZ-SU-HLT-509 links: same_as → Entourage AI" }, { "source": "BIZ-SU-HLT-503", "target": "BIZ-SU-HLT-804", "kind": "same_as", "evidence": "BIZ-SU-HLT-503 links: same_as → Hypervision Surgical" }, { "source": "BIZ-SU-HLT-508", "target": "BIZ-SU-HLT-401", "kind": "same_as", "evidence": "BIZ-SU-HLT-508 links: same_as → TileBio" } ], "placement_method": { "by_sub_page_or_type": 146 } }